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Abstract 
 
Nitrogen-containing 1,3-dipoles such as azomethine ylides and zwitterionic 1,3-dipoles were utilised 
in cycloaddition reactions with aromatic dipolarophile partners via inter- and intramolecular modes. In 
addition, the reactivity of the zwitterionic 1,3-dipoles was investigated in a proposed [3 + 3] 
cycloaddition process. Firstly, in Chapter 2, the reaction of in-situ generated azomethine ylides with 
pendent nitro-aromatics was developed for the construction of potentially bioactive fused 
heterocycles. The initial dearomatised cycloadducts rapidly lost nitrous acid with concomitant 
rearomatisation forming tetracyclic isoindoline containing systems. In Chapter 3, a [3 + 2] 
dearomatisation reaction of highly electron-deficient 3-nitroindoles with nitrogen-containing 
zwitterionic 1,3-dipoles was developed. This reaction proceeds via the Pd(0)-catalysed ring-opening 
of a N-tosylvinylaziridine to reveal the corresponding zwitterionic 1,3-dipole, delivering densely 
functionalised pyrroloindolines in a diastereoselective manner. The reactions favoured the trans 
diastereoisomers in most cases, however, if the 4-position of the nitro-indole is occupied, a switch in 
diastereoselectivity towards the cis diastereoisomer is observed. In Chapter 4, efforts in achieving [3 + 
3] cycloaddition between two in-situ generated 1,3-dipoles derived from 3-membered rings are 
detailed. A series of vinyl-substituted cyclopropanes and aziridines were reacted directly with other 
donor-acceptor cyclopropanes and arylaziridines under Pd(0) and Lewis acid catalysed conditions. 
Unexpectedly, a preference in reactivity toward dimerization, lactone formation, and Friedel–Crafts 
substitution with electron-rich aromatic and heteroaromatics was uncovered instead of the proposed 
cycloaddition. 
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Chapter 1: Introduction 
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1.1: General Introduction 
 
One of the most efficient methods in the organic chemist’s toolbox to make cyclic molecules is the 
1,3-dipolar cycloaddition reaction.1 This is a class of highly atom-efficient reactions that combine a 
1,3-dipole and a dipolarophile to afford heterocycles that are ubiquitous in drug molecules. The 
pervasiveness of heterocycles in bioactive molecules is due to their intrinsic ability to effectively 
interact with enzymes and target molecules while also demonstrating enhanced pharmacokinetic and 
pharmaceutical properties.2 Finding new ways of harnessing 1,3-dipolar cycloaddition reactions 
remains an attractive and exciting area of research for the synthesis of new heterocycles. In particular, 
while there has been intense focus on the cycloaddition of 1,3-dipoles to alkenes as dipolarophiles, the 
use of aromatic dipolarophiles has been barely explored, but would allow access to previously 
inaccessible heterocyclic systems from readily available aromatics. Not surprisingly, the use of these 
less reactive aromatic substrates has only garnered sporadic attention and therefore development of 
such processes will represent a major theme of this thesis. A literature review into the use of nitrogen-
containing 1,3-dipoles such as azomethine ylides and aziridine-derived zwitterionic systems within 
the context of [3 + 2] cycloaddition with aromatic dipolarophiles, and in [3 + 3] cycloadditions, will 
now be discussed below.  
	 9 
1.1.1: 1,3-Dipoles used in 1,3-Dipolar Cycloaddition Reactions 
 
First, it is important to discuss the basic aspects of 1,3-dipolar cycloaddition chemistry. A 1,3-dipole 
is best characterised as a three-atom allyl anion system in which 4-π electrons are delocalised over the 
three atoms with three pz-orbitals arranged in parallel in a bent conformation. The central atom carries 
a positive charge and the negative charge is distributed between the two terminal atoms (Figure 1.1, 
a).3 Resonance structures can be drawn to show the delocalisation of the negative charge onto any 
terminus of the 1,3-dipole. Therefore, the 1,3-dipole can be considered as both nucleophilic and 
electrophilic, leading to a wide variety of reaction pathways. The term ‘zwitterionic 1,3-dipole’ is 
used to define a related system in which a neutral central atom separates the charges on the three-atom 
species (Figure 1.1, c). As a consequence, both 1,3-dipoles and zwitterionic 1,3-dipoles are highly 
reactive and are most commonly generated in-situ. However, some 1,3-dipoles are stable and may be 
isolated, these include nitrones and some specific arrangements of azomethine ylides and azomethine 
imines.4  
 
 
Figure 1.1: Resonance structures of general 1,3-dipoles. 
 
  
a
b c a b c
a: 1,3-dipole 
    allyl type
a b c a b cb: 1,3-dipole      propargyl 
     allenyl type
a b c
c: zwitterionic
    1,3-dipole
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1,3-Dipoles commonly consist of the elements carbon, nitrogen, and oxygen. Due to the 
limited number of combinations of the aforementioned elements, twelve permutations can be obtained 
(Table 1.1). In the context of this thesis, there will be a focus on the nitrogen centered 1,3-dipole; 
azomethine ylides, as well as N-containing zwitterionic dipoles (not shown in Table 1.1 but will be 
discussed in section 1.2). 
 
Table 1.1: Classification of allyl-type 1,3-dipoles. 
Nitrogen Centered Oxygen Centered 
Azomethine Ylide 
 
Carbonyl Ylide 
 
Azomethine Imine 
 
Carbonyl Imine 
 
Nitrone 
 
Carbonyl Oxide 
 
Azimine 
 
Nitrosimine 
 
Azoxy 
 
Nitrosoxides 
 
Nitro 
 
Ozone 
 
 
1,3-Dipoles are most commonly known to partake in cycloaddition reactions with a 2-π 
dipolarophile partner in a [3 + 2] fashion to generate 5-membered cycloadducts.5 They are also less 
known to react with other 3-atom 1,3-dipoles in a [3 + 3] manner to generate 6-membered 
cycloadducts (Scheme 1.1). 
 
 
Scheme 1.1: [3 + 2] or [3 + 3] cycloaddition routes of a 1,3-dipole. 
N
R
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Mechanistically, the 4-π electrons of the dipole’s three pz-orbitals interact with the 2-π 
electrons of the dipolarophile’s two pz-orbitals in a concerted manner. Therefore, the transition state 
of a concerted 1,3-dipolar cycloaddition reaction selectivity is rationalised using frontier molecular 
orbitals (FMO) in which, in azomethine ylides, the electron-rich HOMOdipole interacts with the 
electron-deficient LUMOdipolarophile. Indeed, the introduction of different substitution groups on the 
dipole and/or dipolarophile alter the dominant FMO interaction, such as with electron-withdrawing 
groups or metals. As a consequence, 1,3-dipolar cycloaddition reactions are highly stereoselective 
where the stereochemistry of the dipolarophile is conserved in the cycloadduct due to the concerted 
mechanism of the reaction (Scheme 1.2).6 
 
 
Scheme 1.2: General 1,3-dipolar cycloaddition mechanism of a 1,3-dipole and a dipolarophile.  
 
  
a
b c
R R
cis-alkene:
1,3-dipole:
HOMOdipole
LUMOalkene
cba
R R
cis-product
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1.1.2: Azomethine Ylides in Dipolar Cycloaddition Reactions 
 
Azomethine ylides are a powerful class of reactive nitrogen centered 1,3-dipoles that are difficult to 
isolate and hence are commonly generated in-situ. They are generated from a variety of sources 
including; condensation between an aldehyde and a secondary amino acid or amino ester (Table 1.2, 
eq. 1), N-metalation of imino esters (Table 1.2, eq. 2), from deprotonation of iminium salts (Table 1.2, 
eq. 3), desilylation of an amine (Table 1.2, eq. 4), and thermal ring-opening of aziridines (Table 1.2, 
eq. 5). Furthermore, azomethine ylides can be sundered into two sub-classes known as stabilised or 
non-stabilised. The stabilised azomethine ylides commonly contain electron-withdrawing group 
substitutions that help stabilise the carbanion of the dipole, while non-stabilised azomethine ylides 
lack a substitution on the carbanion.3 
 
Table 1.2: Common methods for the generation of azomethine ylides. 
1) Condensation of Amino acids or Amino esters with Aldehydes 
 
2) N-Metalation of Imino Esters 
 
3) Deprotonation of Iminium Salts 
 
4) Desilylation of Amines 
 
5) Thermal Ring-opening of Aziridines 
 
 
 
R
O
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H
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Nitrogen-centered 1,3-dipoles can be used as an expedient method to prepare nitrogen-
containing heterocycles. Specifically, the 1,3-dipolar cycloaddition reaction between an azomethine 
ylide 1 and an alkene 2 is a powerful route towards the construction of pyrrolidines 3 and has been 
extensively investigated over the past three decades (Scheme 1.3, A).7  Much less commonly, 
azomethine ylides have also been shown to react with aromatic C=C bonds in the form of indoles 4 
(Scheme 1.3, B).8 However, pairing with all-carbon aromatic carbocycles 6 (arenes) has seen limited 
exploration (Scheme 1.3, C).9 
 
 
Scheme 1.3: [3 + 2] Cycloaddition of azomethine ylides with olefins and aromatic dipolarophiles can 
generate N-containing heterocycles. 
 
The difficulty in promoting azomethine ylide cycloaddition with heteroaromatics and arenes 
is due to inherent stability imparted via aromaticity, therefore it is essential to activate the aromatic 
C=C bonds, usually via substitution with strongly electron-withdrawing groups (i.e. NO2), in order to 
promote reactivity. The substitution with a very strongly electron-withdrawing group lowers the 
orbital coefficients at the reacting atoms of the LUMOdipolarophile leading to a decrease in energy 
difference of the reacting FMOs allowing for a more efficient HOMO-LUMO interaction and hence 
increased propensity for reactivity (Figure 1.2).10 While there are many reported methods for the 
preparation of monocyclic pyrrolidines via the combination of an azomethine ylide and an alkene, 
there have been only a handful of reports exploring 1,3-dipolar cycloaddition involving arenes for the 
synthesis of complex polycyclic structures. This is an important area for exploration as arenes 
represent a cheap and widely available chemical feedstock and can provide routes to heterocycles that 
are sp3-rich with multiple stereocentres thus potentially providing higher-quality lead compounds for 
drug discovery.11 Now will be discussed the few previous literature reports of existing methods 
involving the [3 + 2] cycloaddition of azomethine ylides with aromatic systems. 
N
R1
R2
R3 N
R1
R2 R3
well known
N
R1
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N
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1 6
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Figure 1.2: The change in frontier orbitals by substitution of the dipolarophile with electron-
withdrawing groups (EWG).  
1,3-dipole dipolarophile dipoarophile-EWG
energy
LUMO
LUMO
LUMO
HOMO
HOMO
HOMO
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1.1.3: 1,3-Dipolar Cycloaddition of Azomethine Ylides with Heteroaromatics 
 
In 2007, Gribble and co-workers were the first to report a successful 1,3-dipolar cycloaddition 
reaction of an azomethine ylide with a heteroaromatic system in the form of indole 11 (Scheme 1.4, 
A).12 Utilising simple in-situ generated azomethine ylides 10 derived via the condensation between 
amino acids 9 and paraformaldehyde 8 in combination with the highly electron-deficient species 3-
nitroindole 11, they observed successful [3 + 2] cycloaddition for the formation of corresponding cis-
fused pyrrolo-[3,4-b]indoles 12 in good to high yields. They also demonstrated the sulfonyl-protected 
constitutional isomer, 2-nitroindole 13, under the same conditions undergoing successful 
cycloaddition forming the corresponding cycloadduct 14 in good to high yields. This result 
demonstrated the facile dearomative [3 + 2] cycloaddition towards an activated heteroaromatic π-bond 
in the form of the highly electron-deficient 3-nitroindole system, albeit with limited exploration of 
substrate scope. Arai et al. recently described a highly efficient asymmetric [3 + 2] cycloaddition of a 
stabilised azomethine ylides derived via the N-metalation of α-imino esters 15 with 3-nitroindoles 16 
under copper-catalysed conditions in the presence of a chiral PyBidine ligand yielding the pyrrolo-
3,4-b-indole framework 17 in excellent yield, dr, and ee (Scheme 1.4, B).8c 
 
 
Scheme 1.4: Dearomative [3 + 2] cycloaddition of an azomethine ylide with nitroindoles. 
N
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B) Arai et al. 2014
15 16
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8
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In 2011, Piettre and co-workers published a significant report, in which, expanding upon the 
work of Gribble et al., they reported the dearomative [3 + 2] cycloaddition of an expanded series of 5-
membered aromatic heterocycles 20 with symmetrical azomethine ylide 10b forming 
hexahydropyrrolo[3,4-b]indole cycloadducts 21 in good to high yields (Scheme 1.5).8b Crucially, they 
were able to generate a highly reactive non-stabilised azomethine ylide 10b via the desilylation of 
hemiaminal 18 at 0 °C, thereby negating the use of the harsh thermal conditions used by Gribble and 
co-workers. Additionally, other nitro-substituted heteroaromatics were trialled, including 3-nitrofuran, 
3-nitropyrrole, 3-nitroimidazole and 2-nitrothiophene, which all gave the corresponding fused 
pyrrolidine cycloadducts 22-25 respectively in good to high yields. 
 
 
Scheme 1.5: Dearomative [3 + 2] cycloaddition of azomethine ylides towards a range of 5-membered 
heteroaromatic systems. 
 
Critically, when they applied the above method towards mono-nitrated 6-membered 
heterocycles in the form of 3-nitropyridine 26 and quinoline-N-oxide 27, they observed no reaction – 
highlighting the need for multiple electron-withdrawing groups for these particular arenes (Scheme 
1.6, pathway a.). However, the corresponding di-nitrated substrate 3,5-nitropyridine 28, and mono-
nitrated 4-nitroquinoline-N-oxide 29, underwent successful cycloaddition to give the corresponding 
pyrrolidine fused cycloadducts 30 and 31 respectively (Scheme 1.6, pathway b.). Importantly, these 
highly activated nitrated heterocycles saw uncontrolled multiple cycloaddition for the formation of 
completely saturated cycloadducts at the aromatic C–C–NO2 and C–N bonds. Most interestingly, in 
the case of 4-nitroquinoline-N-oxide 29, an unexpected [3 + 3] cycloaddition at the N-oxide moiety 
yielded a 6-membered fused oxadiazinane ring further demonstrating the high reactivity of the 
symmetrical non-stabilised azomethine ylides 19. This can be explained by the fact that after the first 
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cycloaddition had occurred, the resulting product is of reduced aromaticity, therefore represents a 
more reactive substrate than the original starting material, hence the observation of multiple 
cycloadditions. In contrast, the cycloaddition towards the indole substrates, leaves an intact benzene 
ring after the first cycloaddition and hence only undergoes a single cycloaddition process. 
 
 
 
Scheme 1.6: Dearomative [3 + 2] cycloaddition of azomethine ylide 10b towards 6-membered 
heterocycles. 
 
The above reactions exemplify the power of non-stabilised azomethine ylides in 
cycloaddition reactions for the construction of fused pyrrolidine structures, especially with 5-
membered containing heterocycles. However, there were difficulties in the methods application 
towards 6-membered heterocycles including limited substrate scope and uncontrolled multiple 
cycloadditions.  
 
As can be seen from the aforementioned literature, nitro-activated heterocyclic aromatic 
systems exhibit increased reactivity towards dearomative [3 + 2] cycloaddition with azomethine 
ylides. Therefore, dearomative [3 + 2] cycloaddition of an all-carbon benzenoid aromatic system, with 
increased aromatic stability poses a challenging obstacle. The use of an all-carbon benzenoid system 
substituted with a fused electron-withdrawing hetero-substituent in the form of azoles could be a 
potential system to help increase reactivity towards azomethine ylides - this is due to the strongly π-
deficient nature of fused azoles.13 Shevelev et al. reported the first example of a [3 + 2] cycloaddition 
of an azomethine ylide to heterocyclic-fused dinitrobenzenoids (Scheme 1.7).14 They utilised the 
highly reactive non-stabilised azomethine ylide 10a, derived from the condensation between sarcosine 
9a and paraformaldehyde 8, with meta-dinitrobenzene fused azoles 32 affording 
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decahydropyrrolo[3,4-e]isoindole cycloadducts 33 in moderate yields. The reaction was noted to be 
diastereoselective forming only cis-fused bis-cycloadducts in an anti-relative relationship. 
Noteworthy, a unique double cycloaddition was observed with mono-nitrotriazolo[1,5-a]pyrimidine 
34, yielding bis-cycloadduct 35 in 41% yield demonstrating a cycloaddition between the azomethine 
ylide 10a and the heteroaromatic C=N bond. 
 
 
Scheme 1.7: Dearomative [3 + 2] cycloaddition of azomethine ylides towards heterocyclic fused 
benzenoids. 
 
Starosotnikov et al. then further expanded on their above result by focusing on achieving 
azomethine ylide cycloaddition with mono-nitrobenzazoles 36/38 (Scheme 1.8). 15  They were 
successful in achieving this by utilising mono-nitrated benzenoid fused indazoles 34 and isoxazoles 
38 obtaining cycloadducts 37 and 39 respectively with selective mono-addition in moderate to high 
yields. In contrast, when less electron-withdrawing groups were installed in the form of a bulkier 
sulfonyl at the 4-position of benzenoid 40, they observed the product 42 resulting from exclusive 
addition to the C=C–NO2 bond followed by loss of nitrous acid (HNO2). Critically, if an electron-
donating group was substituted on the heteroaromatic side of the molecule, (i.e., R2 = OMe, OPh, 
SPh), no reaction was observed, highlighting the need for the strongly electron-withdrawing groups to 
promote cycloaddition, presumably via the lowering of the LUMO. 
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Scheme 1.8: Dearomative [3 + 2] mono-cycloaddition of azomethine ylide towards heterocyclic fused 
benzenoids. 
 
The same group then went onto further explore other benzenoid-fused pyridine derivatives 
(quinolines) due to their prominence in bioactive molecules (Scheme 1.9). 16  Using 5,7-
dinitroquinoline, a highly unstable cycloadduct was noted, but when the 8-position was substituted 
with a heteroatom, selective mono-cycloaddition resulted. However, when 8-SR-substituted 
derivatives 43 were trialled, successful [3 + 2] cycloaddition with azomethine ylides 10 yielded re-
aromatised cycloadduct 44 in moderate to good yields. When 8-NR2-substituted derivatives 45 were 
trialled, they also observed successful cycloaddition towards cycloadducts 46 in moderate to high 
yields, except when amine R2 = Me where loss of HNO2 formed re-aromatised cycloadduct 47 in 33% 
yield. Reaction time was also noted to have a significant effect on the nature of the cycloadducts 
formed. If exposed to thermal conditions, as is required for the condensation between sarcosine 9a 
and paraformaldehyde 8 to generate azomethine ylide 10a, it was discovered that prolonged heating 
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and consequent re-aromatisation occurred yielding the corresponding tetracycles 55 in low to 
moderate yield. 
 
 
Scheme 1.9: [3 + 2] Cycloaddition of azomethine ylides with di-nitrated benzenoid-fused pyridine 
derivatives. 
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Piettre et al. also reported [3 + 2] cycloaddition of a non-stabilised azomethine ylide 
towards a suite of mono-nitrated polycyclic heteroaromatics (Scheme 1.10). 17 ,8b This method 
generated the N-benzyl azomethine ylide 10b, by the milder TFA catalysed desilylation of amine 56. 
They achieved mono-cycloaddition with polycyclic nitro-heteroaromatics 57 generating dearomatised 
cycloadducts 58-63 in generally high yields. This result contrasts to aforementioned work in which 
uncontrolled bis-cycloaddition with a similar quinoline systems was observed, most likely due to the 
milder reaction conditions.  
 
 
Scheme 1.10: [3 + 2] Cycloaddition of azomethine ylides with mono-nitrated benzenoid-fused 
heterocycle derivatives. 
 
Despite the work by the above researchers, the dearomative [3 + 2] cycloaddition of 
azomethine ylides towards an undecorated all-carbon aromatic system still remained a significant 
challenge. Piettre et al. conducted a thorough investigation into [3 + 2] cycloaddition of the 
symmetrical N-benzyl azomethine ylide 10b towards a suite of electron-deficient naphthalenes 64 and 
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cycloadducts were found to be cis-fused, with the newly formed pyrrolidine rings in an anti-
relationship to each other. As expected, when a carbonyl group was present, such as in 68, there was 
found to be a preferential cycloaddition of the azomethine ylide 10b with the carbonyl over the nitro-
aromatic for the formation of an oxazolidine 69. The dearomative method was applicable to a wide 
range of arene systems, however, it was noted to be very limited due to its formation of bis-
cycloadducts when 6-membered benzene-derivatives were utilised. 
 
 
Scheme 1.11: [3 + 2] Cycloaddition of azomethine ylides with electron-deficient arenes. 
 
There still also remained the challenge of achieving mono-cycloaddition of azomethine 
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cycloadduct underwent loss of nitrous acid (HNO2) resulting in rearomatisation, which is in contrast 
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aromaticity in the final product could likely be explained by use of higher temperatures. Steric 
interactions can also not be discounted. However, in order for the initial cycloaddition to occur, the 
reaction required multi-nitrated arenes as starting materials. In particular, the use of tri-nitrated arene 
substrates is not ideal due to potential shock induced explosions that would prohibit the further 
applications of these systems towards large scale synthesis. 
 
Scheme 1.12: [3 + 2] Cycloaddition of azomethine ylides with highly activated 6-membered 
aromatics.  
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1.1.4: Intramolecular 1,3-Dipolar Cycloaddition of Azomethine Ylides with Aromatics 
 
The intramolecular 1,3-dipolar cycloaddition of an azomethine ylide with a tethered dipolarophile is a 
powerful procedure for the synthesis of structurally complex fused pyrrolidine containing 
heterocycles. However, of the potential dipolarophile reaction partners, the overwhelming majority of 
examples reported in the literature use olefins 75 as the 2-π dipolarophile (Scheme 1.13, A).7b 
Intramolecular cycloaddition towards aromatic dipolarophiles 78 have received scant attention but 
could be a powerful method for controlling the multiple cycloadditions observed in the previous 
section. Using a tethered arene in the context of intramolecular [3 + 2] cycloaddition would also 
provide expedient method for the rapid construction of complex fused heterocycles such as 80/81. 
(Scheme 1.13, B). 
 
Scheme 1.13: Intramolecular [3 + 2] cycloaddition of azomethine ylides with pendent dipolarophiles. 
 
One of the earliest examples of dearomatisation of an aromatic system via azomethine ylides 
was a single intramolecular example by Tsuge and co-workers in 1984 (Scheme 1.14).19 Via the in-
situ tautomerisation of imino ester 82, they were able to generate the stabilised azomethine ylide 83, 
which underwent an intramolecular [3 + 2] cycloaddition towards a pendent furan to give the 
dearomatised cycloadduct 84 in 9% yield. The use of high temperatures saw the formation of a 
complex mixture of side products which meant that only a low yield of the cycloadduct was obtained. 
It should be noted that furan has relatively low aromaticity.  
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Scheme 1.14: Intramolecular [3 + 2] cycloaddition of an in situ generated azomethine ylide towards 
a tethered furan. 
 
In 1992, Heathcock et al. reported an unexpected intramolecular [3 + 2] cycloaddition of a 
non-stabilised azomethine ylide towards a pendent 6-membered arene (Scheme 1.15).20 Utilising flash 
vacuum pyrolysis (FVP) conditions to ring-open aziridine 85 to give intermediate azomethine ylide 
86, they observed formation of a dearomatised cycloadduct 87 in moderate yields. This result 
demonstrated the first reported intramolecular dearomative cycloaddition of an azomethine ylide with 
a benzene moiety without the need for electron-withdrawing substituents. However, again harsh 
thermal conditions were required for the reaction to proceed, limiting its potential application in 
synthesis.  
 
 
Scheme 1.15: Intramolecular [3 + 2] cycloaddition of thermal ring-opened aziridine towards an 
arene. 
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1.1.5: Project 1 Aims  
 
As can be seen from the above literature, relatively few examples of [3 + 2] cycloaddition of 
azomethine ylides with aromatic systems are reported in the literature with only one intramolecular 
cycloaddition example towards all-carbon aromatic systems. It is therefore clearly evident there is an 
opportunity to explore azomethine ylide cycloaddition intramolecularly towards arenes. It should also 
be noted that the combination of a tethered arene and reduced aromaticity are key to increasing 
reactivity but also avoid multiple cycloadditions from occurring. Therefore, an approach was designed 
that employed an intramolecular [3 + 2] cycloaddition of an in-situ generated azomethine ylide 90 
with a tethered nitro-arene system (Scheme 1.16). The efforts and results towards this goal will be 
discussed in full within Chapter 2 of this thesis. 
 
 
Scheme 1.16: Proposed intramolecular [3 + 2] cycloaddition of an azomethine ylide with a tethered 
nitro-arene system. 
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Of particular benefit with this approach is the inclusion of embedded bioactive benzo-fused 
heterocycles, such as benzoxepine, benzoazepine and isoindolines into the skeletons 91-93.21,22,23 For 
example; Combrestastin analogues, a benzoxepine derivative, are known to exhibit anticancer 
properties; 24  Clomipramine, a benzoazepine derivative, representative of important tricyclic 
antidepressants; 25  and Lenalidomide, an isoindoline derivative, an important anti-cancer drug 
(Scheme 1.17).26 The combination of these skeletons, representative of a common pharmacologically 
active motifs that exhibit distinct and different biological effects, could constitute a beneficial strategy 
to access novel compounds that inherit characteristic elements for the generation of potential new 
bioactivities.27  
 
 
Scheme 1.17: Representative examples of bioactive molecules containing benzoxepine, benzoazepine, 
and isoindoline moieties.  
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1.2: Three-Membered Rings as Precursors to Zwitterionic 1,3-Dipoles 
 
There are multiple methods to access 1,3-dipoles, however, the use of 3-membered rings (100) as 
zwitterionic 1,3-dipole reaction partners has recently gained considerable attention.28 These reactive 
three-atom systems offer unique reaction pathways due to their labile ring-opening under transition-
metal or Lewis acid catalysis to afford a zwitterionic 1,3-dipole 100′. These dipoles have been 
investigated in [3 + 2] cycloaddition reactions with various 2-π dipolarophiles (Scheme 1.18, pathway 
b.). However, the use of aromatic dipolarophiles is not well investigated. In addition to cycloaddition 
reactions, they can undergo nucleophilic attack or rearrangement reactions yielding a diverse range of 
products (Scheme 1.18, pathway a.). 29  Of interest to the synthesis of saturated 6-membered 
heterocycles is the under-explored reactivity of these zwitterionic 1,3-dipoles with another 
zwitterionic 1,3-dipole in a [3 + 3] cycloaddition pathway (Scheme 1.18, pathway c.).30 The [3 + 3] 
cycloaddition method involving an aziridine and cyclopropanes offers a powerful alternative 
formation of 6-membered systems and importantly, a complementary method to the powerful hetero 
[4 + 2] Diels–Alder cycloaddition. However, the use of hetero-dienes in the context of cycloaddition 
chemistry is restrictive due to the limited functional group tolerability, use of thermal conditions and 
often side reactions due to high reactivity or volatility. Therefore, complementary methods to directly 
synthesise 6-membered heterocycles remains an important area of research. In this section, both the [3 
+ 2] cycloaddition (pathway b.) and [3 + 3] cycloaddition (pathway c.) reactions and their equivalent 
processes will be discussed. 
 
 
Scheme 1.18: Potential reaction pathways involving zwitterionic 1,3–dipoles derived from 3-
membered rings. 
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1.2.1: Pd(0)-Catalysed Reactivity of Vinylaziridines 
 
Vinylaziridines are strained 3-membered ring systems that have unique reactivity patterns in the 
presence of transition metals. Under Pd(0)-catalysed conditions, vinylaziridines 101 can form a Pd p-
allyl complex causing C–N bond cleavage ring-opening to form a zwitterionic 1,3-dipole 102. In the 
context of [3 + 2] cycloaddition reactions, the reactivity then typically involves initial nucleophilic 
attack of the nitrogen anion towards an electrophilic acceptor, usually an electron deficient p-bond 
(103), forming anion 104 that can then undergo ring-closure and expulsion of Pd(0) to generate 
cycloadduct 105 (Scheme 1.19). The types of dipolarophiles used in these [3 + 2] cycloaddition 
reactions are at this stage limited to heterocumulenes and olefins – the key examples of which are 
now discussed.  
 
 
Scheme 1.19: Pd(0)-catalysed ring opening of vinylaziridines and [3 + 2] cycloaddition with a 
dipolarophile to form 5-membered nitrogen-containing heterocycles. 
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1.2.2: Pd(0)-Catalysed [3 + 2] Cycloaddition of Vinylaziridines With Heterocumulenes 
 
The first reported use of a Pd(0)-catalysed cycloaddition of a vinylaziridine as a 1,3-dipole was 
reported by Alper et al. in 2000 who described the [3 + 2] cycloaddition of N-alkyl protected geminal 
substituted vinylaziridines 106 with a variety of heterocumulenes 107 forming imidazolidinones, 
imidazolidinethiones, and imidazolidineimines 108 respectively in good to high yields, but as a 
mixture of 2:1 cis:trans diastereomers (Scheme 1.20, A). 31  The authors attributed the low 
diastereoselectivity due to a facile interconversion of the Pd-intermediate via η3-η1-η3 isomerisation, 
before the initial nitrogen attack. This effectively meant that the nucleophilic ring-closure can occur 
of either face of the Pd p-allyl intermediate yielding cis:trans mixtures. Trost et al. then reported the 
first dynamic kinetic asymmetric transformation (DYKAT – the transformation of 100% racemic 
compound into an enantiopure product) in the context of a cycloaddition of singly substituted 
vinylaziridines 109 to isocyanates 110 under Pd(0)-catalysis (Scheme 1.20, B).32 Using enantiopure 
Trost ligand ((R,R)-DACH-napthyl Trost ligand), they were able to form imidazolidin-2-ones 111 in 
high yields and enantioselectivity. The high enantioselectivity was attributed to the AcOH additive, 
which protonated the nitrogen intermediate slowing the rate of addition to the isocyanate and thereby 
allowing interconversion of the Pd p-allyl intermediate via η3-η1-η3 mechanism to occur, permitting 
enantio-discriminating cyclisation to arise. Alper and Dong then developed an asymmetric 
cycloaddition of racemic vinylaziridines 112 with isocyanates 110 under Pd(0)-catalysis and chiral 
BINAP ligands (Scheme 1.20, C). 33  They discovered that Pd2(dba)3·CHCl3/(S)-BINAP in 
combination with CeCl3 as an additive significantly increased the enantioselectivity from 75% ee to 
83% ee. The CeCl3 was postulated to possibly increase η3-η1-η3 interconversion of the Pd p-allyl 
intermediate/chiral ligand complex, leading to the formation of the enantiomeric imidazolidin-2-ones 
113.  
 
	 31 
 
Scheme 1.20: Pd(0)-catalysed [3 + 2] cycloaddition of racemic vinylaziridines with various 
heterocumulenes for the construction of 5-membered heterocycles. 
 
Aggarwal et al. then described the Pd(0)-catalysed carboxylative addition of trans-
vinylaziridines 114 using CO2 as a carbonyl dipolarophile under pressure to yield trans-
vinyloxazolidinones 115 in moderate to high yield (Scheme 1.21).34 Importantly, it was noted if a cis-
vinylaziridine was used, then cis-geometry 	was also returned, leading to cis-vinyloxazolidinones. 
This finding of conserved relative stereochemistry strongly suggested that Pd(0)-mediated η3-η1-η3 
isomerisation was suppressed under the reaction conditions in the presence of additive TBAT 
(tetrabutylammonium difluorotriphenylsilicate) at 0 °C by preventing ion pairing between the amide 
anion and cationic Pd complex, allowing for rapid cycloaddition and hence conserved selectivity. 
 
 
Scheme 1.21: Pd(0)-catalysed [3 + 2] cycloaddition of trans-vinylaziridines to carbon dioxide to 
yield vinyloxazolidinones. 
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1.2.3: Pd(0)-Catalysed [3 + 2] Cycloaddition of Vinylaziridines With Olefins 
 
While exploring the palladium-catalysed aminoallylation of activated olefins, Yamamoto et al.  
fortuitously discovered a [3 + 2] cycloaddition of a vinylaziridine 116 to an activated olefin 117, 
successfully forming the corresponding pyrrolidine 118 in high yields, albeit with low 
diastereoselectivity (Scheme 1.22, A).35 Aggarwal et al. subsequently noted the poor selectivity of 
above reaction and sought to develop a method to control the stereochemical outcome (Scheme 1.22, 
B). 36  By using mono-activated electron-poor vinylketones 121, trans-vinylaziridines 119, and 
introducing n-Bu4NCl as an additive, they were able to successfully form the corresponding 
pyrrolidine cycloadducts 122 in moderate yield with good to high diastereoselectivity. They 
uncovered that the quaternary amine salt, n-Bu4NCl, in combination with pentane/TBME solvent 
mixture was critical for high dr as it disrupted the potential self-ion pairing between the nitrogen 
anion and the cationic Pd complex 120. This allowed for increased nucleophilicity of the nitrogen 
anion towards the low reactivity of the olefin, and hence results in conserved selectivity in a similar 
mechanism to above (see Scheme 1.21). Hou et al. inspired by Aggarwal’s work, developed an 
enantioselective variant utilising vinylketones 124 and racemic N-tosylvinylaziridines 123 (Scheme 
1.22, C).37  They uncovered chiral ferrocene-based SIOCPhox ligands as inducers of excellent 
diastereo- and enantioselectivity towards the construction of pyrrolidines 126. It is of note that the 
KBr additive and a bulky substituent at the C2 position of the aziridine allyl group was vital in 
promoting high dr. In the proposed mechanism, it is thought that the enolate, formed by the attack of 
the amine anion on the vinylketone, interacts with the OH substituent from the chiral SIOCPhox 
chiral ligand through hydrogen-bonding, as shown in intermediate 125, dictating the favoured 
orientation for the subsequent stereo controlled ring-closure.  
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Scheme 1.22: Pd(0)-catalysed [3+2] cycloaddition of vinylaziridines with various olefins. 
 
These above examples exemplify the power of Pd(0)-catalysed [3 + 2] cycloaddition of 
vinylaziridines towards the direct synthesis of functionalised heterocycles. The requirement for an 
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Enantioenriched products were obtained via the use of chiral ligands and/or use of initial enantiopure 
vinylaziridine starting materials. Diastereoselectivity was highly influenced by the introduction of 
additive salts such as n-Bu4NCl or KBr as these were postulated to suppress self-ion pairing within 
the ring-opened zwitterion intermediate, allowing for increased nucleophilicity of the amine and 
hence increase in rapid attack thereby limiting η3-η1-η3 isomerisation of the Pd complex. In light of 
the impressive advances of the above chemistry, there still remained a gap in the exploration with 
other dipolarophiles, especially common dipolarophiles such as carbonyls and aromatic systems. The 
utilisation of a heteroaromatic π-system, such as with indoles explored in the first section of this 
introduction with azomethine ylides (Scheme 1.4), represent a promising reaction partner for 
vinylaziridines.  
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As discussed in the previous section, the use of azomethine ylides with indoles as 
dipolarophile partners has been previously established by Gribble et al. and Arai et al. (Scheme 1.4). 
It is of note, however that the installation of the nitrogen from the symmetrical azomethine ylide 128 
is at the 2-position of the newly formed pyrrolidine ring 129 (Scheme 1.23). Complementary to this, 
the recent use of an activated aryl aziridines 130 as a reaction partner with electron-rich indoles 127 
(when R2 = alkyl) in [3 + 2] cycloaddition delivering the nitrogen at the 1-postion, has provided a 
route to the highly desirable pyrroloindoline system 131, with the nitrogen in the more biologically 
relevant position. It is important to note that in order for cycloaddition to proceed with azomethine 
ylides, electron-deficient indoles are required in which the C3-postion bears a strongly electron-
withdrawing group (e.g. 3-NO2). In contrast, the formal [3 + 2] cycloaddition of Lewis acid activated 
aryl-aziridines 130 require the use of electron-rich indoles. The use of Pd(0)-derived zwitterionic 1,3-
dipole 132 accessed from vinylaziridines, would operate with highly electron-deficient indoles and 
allow access to functionalised pyrroloindolines 133, specifically containing the versatile vinyl 
moieties, however, this has not been achieved to date. The importance of the pyrroloindoline system 
and methods for accessing them will now be discussed below in the next section, in particular 
introducing the use of aryl-aziridines in formal [3 + 2] cycloaddition with indoles to prepare the 
skeleton.  
 
 
Scheme 1.23: General approaches dipole cycloaddition with indoles for the formation of 
cycloadducts 129, 131, and 133.  
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1.2.4: Current Methods for the Synthesis of Pyrroloindolines 
 
The pyrroloindoline motif is found in many important biologically active systems and at its core is 
made up of an indoline fused with a pyrrolidine (shown in blue in Figure 1.3). Natural products 
containing pyrroloindolines exhibit a wide range of biological effects including; anticholinesterase 
properties for the treatment of Alzheimer’s disease (physostigmine), 38  antibacterial properties 
(psychotrimine and (+)-pestalazine B),39,40 and anticancer properties (gliocladin C)41 (Figure 1.3). 
Because of their wide application in biological systems, methods to access pyrroloindolines have 
gained considerable attention in recent years.42 
 
 
Figure 1.3: Examples of natural products featuring the pyrroloindoline moiety (highlighted in blue). 
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There are three main synthetic approaches towards the construction of the pyrroloindoline 
core; the biomimetic approach via the electrophilic attack at the indole C3-position followed by ring 
closure of tryptophan or tryptamine (Scheme 1.24, A),43 the 2-oxindole approach via alkylation at C3-
position followed by amination and reduction (Scheme 1.24, B),44 and the dearomative [3 + 2] 
cycloaddition of indoles using aziridines under Lewis acid catalysis (Scheme 1.24, C).45  The 
following section entails a literature overview concerning access of pyrroloindolines via the formal [3 
+ 2] cycloaddition route between aziridines and indoles, which are the most pertinent to this thesis 
and also represent the most convergent route to the skeleton.  
 
 
Scheme 1.24: Three main synthetic routes towards to the construction of pyrroloindolines. 
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1.2.5: Formal [3 + 2] Cycloaddition between Aziridines and Indoles 
 
While the use of vinylaziridine-derived Pd-stabilised zwitterionic 1,3-dipoles in [3 + 2] cycloaddition 
with aromatic dipolarophiles, such as indoles, has yet to be investigated, the formal [3 + 2] 
cycloaddition of aziridines under Lewis acid catalysis to indoles for the synthesis of pyrroloindolines 
has gained some interest in recent years (Scheme 1.25). The binding of a Lewis acid to the N-
protecting group of an aziridine 140 causes polarisation of the strained C–N bond, generating an 
activated aziridine species 140′, making the C2 or C3 positions susceptible to attack from an 
introduced nucleophile (Scheme 1.25, A).46 The site of attack favours the site of least steric hindrance. 
However, if the aziridine is substituted with an aryl group, then preferential C–N bond cleavage at the 
C2 position will occur.28a,47 In this type of aziridine system (R = Ar), the benzylic moiety helps 
stabilise the partial positive charge, while the N-protecting accepting group, usually an N-sulfonyl or 
electron-withdrawing group, stabilise the nitrogen partial negative charge. Lewis acid activated 
aziridines 140′ have been demonstrated to undergo formal [3 + 2] cycloadditions with a variety of 
dipolarophiles 141 including alkynes, nitriles, alkenes, and carbonyls, generating 5-membered 
nitrogen containing heterocycles. In 2000, Nakagawa and co-workers reported a seminal paper where 
they examined the [3 + 2] cycloaddition of 1,3-dimethylindole 143 with an N-benzyloxycarbonyl 
aziridine 144 under Sc(OTf)3 Lewis acid catalysed conditions at −30 °C generated the corresponding 
pyrroloindoline 145 in high yield in the presence of TMSCl (Scheme 1.25, B).45 However, this 
method required the use of stoichiometric amounts of expensive and hazardous reagents, which is not 
particularly advantageous. It was not until a number of years later that the potential of this 
foundational work was built upon. In 2014, Wang et al. reported an enantioselective 
desymmetrisation of meso-N-(2-picolinoyl)aziridines 147 with 3-methylindoles 146 to yield 
pyrroloindolines 148 in high dr and ee, via a chiral BINOL/organomagnesium complex catalysed [3 + 
2] cycloaddition process (Scheme 1.25, C).48 Wang et al. then reported the Lewis acid Cu(I)-catalysed 
kinetic resolution of N-sulfonylaziridines 150 with electron-rich indoles 149 providing access to 
enantiopure pyrroloindolines 151 in high dr and ee induced through the use of a chiral (R)-XylBINAP 
ligand (Scheme 1.25, D).49 Ghorai and co-workers then reported a further exploration of the Lewis 
acid LiClO4 catalysed formation of pyrroloindolines via the use of enantiopure N-tosylarylaziridines 
153 with 3-substituted indoles 152 (Scheme 1.23, E).50  They were successful in forming the 
enantiopure cycloadduct 154 with expanded substrate scope and with the formation of up to three-
contiguous stereogenic centres in high yield with conservation of stereoselectivity, albeit with limited 
diastereoselectivity. It is noteworthy that they were able to perform a cyclisation and detosylation 
using Na/naphthalene conditions in a one-pot reaction to give the unprotected pyrroloindolines. In all 
of the above examples, activation of the aziridine is achieved under Lewis acid catalysis promoting 
attack from the electron-rich indole followed by annulation. 
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Scheme 1.25: Lewis acid catalysed [3 + 2] cycloaddition between electron-rich indoles and 
aziridines for the formation of pyrroloindolines. 
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Concurrent with the above studies, the Hyland group have shown that Pd(II) can catalyse a 
C3-selective Friedel–Crafts reaction of electron-rich indoles 156 with N-tosylarylaziridines 155 
generating a series of tryptamine derivatives 158 and also demonstrating that 3-methylindole under 
the same conditions undergoes formal [3 + 2] cycloaddition to the corresponding pyrroloindoline 157 
in high yield and good dr (Scheme 1.26, A).51 At the same time, Zhou et al. and others reported 
similar chemistry, generating enantiopure pyrroloindolines 161 from enantioenriched N-tosyl 
arylaziridines 159 and electron-rich indoles 160 catalysed by Pd(II) Lewis acid conditions without the 
need of complex chiral ligands in high yield and selectivity (Scheme 1.26, B).52  
 
 
Scheme 1.26: Lewis acid catalysed [3 + 2] cycloaddition between N-tosylaziridines with electron-
rich indoles. 
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preserves the free N–H group in the product and also negates the need for aziridines (or oxiranes) 
activation by Lewis acid catalysts. It is also the first example of a controlled dearomative 
cycloaddition of vinylaziridines to electron-rich indoles.  
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Scheme 1.27: [3 + 2] Cycloaddition of 3-substituted indoles with vinylaziridines and vinylepoxides 
via the in-situ activation of indoles. 
 
Although the above procedures provide direct routes towards the important pyrroloindoline 
skeleton, each case is restricted by the C3a-position having to bear a carbon-based group, such as a 
methyl group, which is extremely difficult to further manipulate. In contrast, methods for providing 
pyrroloindolines bearing nitrogen or hydrogen at the quaternary C3a position are desperately needed 
as aminopyrroloindolines in particular possess important bioactivities.54 For example, psychotrimine 
and (+)-pestalazine B exhibit antibacterial properties (Figure 1.3). The current methods for the 
construction of aminopyrroloindolines rely on aminative cyclisation of tryptamine skeletons 166 via 
O-(2,4-dinitrophenyl)hydroxylamine (DPH) 167 to give aminopyrroloindolines 168 (Scheme 1.28).55 
However, the introduction of substituents around the newly formed ring of 168 has not been 
investigated and would require the synthesis of complex tryptamine derivative precursors in 
enantioenriched form. Furthermore, the use of DPH 167 produces a nitro-phenol byproduct causing 
the reaction to exhibit poor atom efficiency.  
 
 
Scheme 1.28: Lewis acid catalysed aminative cyclisation of tryptamines initiated via DPH for 
construction of C3a-NH2 containing pyrroloindolines.  
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1.2.6: Project 2 Aims 
 
While there exist several methods for the synthesis of pyrroloindolines, there are limited methods to 
synthesise the highly desirable 3a-aminopyrroloindoline system. Specifically, there are restricted 
approaches that deliver the pyrroloindoline system containing versatile functional groups. Based on 
combining nitroaromatics with aziridines, it was thought that the [3 + 2] cycloaddition between an 
aziridine and a 3-nitroindole route would provide an alternate and direct access to 3a-
aminopyrroloindoline system that overcome the non-convergent nature of aminative cyclisation of 
tryptamines. All of the aforementioned work concerning the formation of pyrroloindolines exploits 
the nucleophilicity about the C3-position of electron-rich indoles towards activated aziridines 
(Scheme 1.29, A). However, less explored in the context of [3 + 2] cycloaddition reactions are 
electron-deficient indoles. This type of system is analogous to the use of electron-deficient olefins 
which have been shown as highly successful reaction partners with Pd(0)-catalysed ring-opened 
aziridines (refer to Scheme 1.22). The strongly electron-withdrawing nature of a nitro substituent at 
the C3-position of an indole polarises the C2-position to behave as an electrophile and thereby 
making it susceptible to initial nucleophilic attack opening up a wide range of reaction pathways 
(Scheme 1.29, B). Vinylaziridines under Pd(0)-catalysed conditions ring-open to the zwitterionic 1,3-
dipole represent an ideal nucleophilic partner as the nitrogen anion is poised to attack the electrophilic 
C2-position of a 3-nitroindole. Conversely, arylaziridines are incompatible as they cannot produce a 
N-nucleophile as Lewis acid coordination activates them to behave as electrophiles. 
 
 
Scheme 1.29: A) Electron-rich indoles act as nucleophiles. B) Electron-deficient indoles act as 
electrophiles. 
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The use of 3-nitroindoles as a reaction partner in cycloaddition reactions has only recently 
begun to be explored. Gribble et al. and Arai et al. have previously demonstrated 3-nitroindoles 
participating in dearomative [3 + 2] cycloaddition via 1,3-dipoles in the form of azomethine ylides 
(refer Scheme 1.4). However, the use of a vinylaziridine-derived 1,3-dipole has never been explored 
but would give both the biologically relevant pyrroloindoline and provide a versatile vinyl substituent 
on the newly formed ring. However, such dipoles represent a less reactive reaction partner than an 
azomethine ylide and therefore constitutes a potentially challenging proposition. It is promising 
however that Trost and co-workers recently demonstrated the utility of 3-nitroindoles 170 with the all-
carbon trimethylenemethane precursor 171 under Pd(0)-catalysed conditions generating 
cyclopenta[b]indoline cycloadduct 172 in quantitative yields (Scheme 1.30, A).56  This method 
demonstrates the power of Pd p-allyl complexes in its ease of operation, however, it should be noted 
the difficulty in making analogues of the TMM precursor to introduce additional substituents around 
the newly formed carbocycle and cannot provide the pyrroloindoline skeleton. Inspired by the work 
shown above, it was envisaged that a method to access the significant aminopyrroloindoline motif 
could be devised containing a versatile and important nitrogen at the C3a-position (Scheme 1.30, B). 
Envisaged towards this goal was a reaction design incorporating [3 + 2] cycloaddition of a ring-
opened vinylaziridine 173′ under Pd(0)-catalysis in combination with the highly electron-deficient 3-
nitroindole 174 system for the formation of highly functionised pyrroloindoline cycloadducts 175. 
Crucially, the use of 3-nitroindole comprising of a pre-installed nitrogen functionality would install a 
nitro group at the C3a position of the pyrroloindoline product, constituting a highly versatile moiety 
that could be reduced to provide a C3a-aminopyrroloindoline 176. In addition, the installed vinyl 
group would allow further manipulation previously not possible with aryl-derived aziridines. 
Furthermore, the use of a vinylaziridine derived 1,3-dipole represents a weaker nucleophile then the 
previously establish carbanion of the Pd-TMM complex developed by Trost and co-workers. 
Therefore, if conditions could be found for its cycloaddition to an electron-deficient indole, it would 
constitute a significant advance. The efforts and results towards this goal will be discussed in full 
detail within Chapter 3 of this thesis. 
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Scheme 1.30: A) Pd(0)-catalysed [3+2] cycloaddition between Pd-TMM-complex and 3-nitroindoles. 
B) Proposed Pd(0)-catalysed [3+2] cycloaddition of vinylaziridines with electron-deficient 3-
nitroindoles for the formation of pyrroloindolines. 
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1.3: Aziridines as Reaction Partners in [3 + 3] Cycloaddition Reactions 
 
Previously in Section 1.2.1, it was shown that zwitterionic 1,3-dipoles can be obtained from 
vinylaziridines under Pd(0)-catalysis. The ability of donor-acceptor aziridines 180 to form reactive 
activated systems under Lewis acid catalysis and behave as formal 1,3-dipoles in [3 + 3] 
cycloadditions will now be discussed (Scheme 1.31). As previously described in Section 1.2.5, the 
binding of a Lewis acid to an aziridine 180 causes polarisation of the strained C–N bond, generating 
an activated aziridine species 180′, promoting the C2 or C3 positions as susceptible to attack from an 
introduced reaction partner. The site of attack is highly dependent on the substituents on the aziridine, 
the nature of the reactant, and the type of Lewis acid utilised.46 In the previous examples shown (refer 
to Scheme 1.25) described the use of aryl-substituted aziridines which underwent reaction pathway at 
the C2 position due to the stabilising influence of the benzylic moiety. While the pairing with 
dipolarophiles has led to the formal [3 + 2] cycloaddition with a variety of partners including alkynes, 
nitriles, alkenes, carbonyls, and indoles to generate 5-membered nitrogen containing heterocycles, 
less known however, is aziridine cycloaddition with another activated/ring-opened aziridine or 
cyclopropane 181 in a [3 + 3] fashion to nitrogen-containing 6-membered rings 182 (Scheme 1.31). 
 
 
Scheme 1.31: Potential cycloaddition reaction pathways involving aziridines. 
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1.3.1: Formal [3 + 3] Cycloaddition of 1,3-Dipoles with Aziridines 
 
Aziridines have only recently begun to be explored in [3 + 3] reactions with traditional 1,3-dipoles 
such as with air stable nitrones. Selender and co-workers disclosed an efficient process of oxiranes 
186 undergoing successful cycloaddition with nitrones 185 using the Lewis acid, AlCl3, to generate 
trans-1,4,2-dioxazinanes 187 operating via an SN2 like mechanism (Scheme 1.32).57 When they 
switched to aziridines 188 as reaction partners they found that InCl3 was the superior Lewis acid 
catalyst favouring the formation of trans-1,2,4-oxadiazinane cycloadducts 189 in high yield. It is 
important to note that N-tosyl protected aziridines were unreactive under the conditions used, to 
explain which the authors propose the idea of Lewis acid incompatibility with the tosyl group. 
 
 
Scheme 1.32: [3 + 3] cycloaddition of air-stable nitrones with Lewis acid activated oxiranes and 
aziridines. 
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Scheme 1.33: Enantioselective [3 + 3] cycloaddition between 3-isothiocyanato oxindoles and 
symmetrical aziridines generating cycloadducts 193. 
 
In addition to Lewis acid activated aziridines, recently Zhang et al. reported the first 
example of a Rh-catalysed vinylaziridine 195 undergoing [3 + 3] cycloaddition with an air-stable 
azomethine imine 196 (Scheme 1.34).59 Using Rh-catalysed conditions in the presence of a Ag-salt, 
they observed the formation of fused 1,2,4-triazinane cycloadducts 197 in moderate to high yields 
with moderate to high chiral transfer in favour of the trans diastereoisomer. In the mechanistic 
proposal, Rh is postulated to coordinate via a δ–π interaction to the nitrogen and pendent olefin of the 
ring-opened aziridine with retention of stereochemistry 198. The authors then propose attack of the 
nitrogen of the ring-opened aziridine, or either attack of the N-acyl moiety towards the rhodium 
complex followed by subsequent ring-closure. 
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Scheme 1.34: Rh-catalysed [3 + 3] cycloaddition between enantiopure vinylaziridines and C,N-cyclic 
azomethine imines forming fused 1,2,4-triazinane cycloadducts. 
 
In addition to the use of Lewis acid and Rh-activated aziridines, in-situ generated 1,3-dipoles 
in the form of a palladium-trimethylenemethane complex (Pd-TMM) represent a potent reaction 
partner in formal [3 + 3] cycloaddition. A seminal report in 1989 by Bambal and Kemmitt found that 
Pd-TMM complexes 201 and non-activated aziridine 200 can undergo a formal [3 + 3] cycloaddition 
for the direct construction of piperidines 203 (Scheme 1.35).60 They proposed that the in-situ formed 
TMM-Pd complex 201 acts as a nucleophile towards the less hindered carbon of the activated 
aziridine 200 causing C–N bond cleavage generating intermediate 202 and then consequent ring-
closure forming the corresponding piperidine cycloadduct 203. Note that in this case however, no 
activation of the aziridine is required due to the highly nucleophilic nature of the Pd-TMM complex. 
 
 
Scheme 1.35: Formation of piperidines via formal [3 + 3] cycloaddition reaction. 
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Harrity et al. then disclosed an enantioselective procedure of the above method through the 
use of enantiopure aziridines (Scheme 1.36).61 Initially, they used the same reaction conditions from 
Bambal and Kemmitt but saw no transformation, but when Pd(OAc)2, a phosphite ligand and n-BuLi 
as a reductant were utilised, they saw efficient cycloaddition between enantiopure aziridine 204 and 
TMM precursor 199 forming the corresponding piperidines 205 in good to high yields. Again, the 
aziridines underwent attack at the less sterically hindered position to give the products in 
enantiomerically pure form. Importantly, when 2-phenyltosylaziridine 205b was used, a mixture of 
regioisomeric products 205b and 206b were obtained likely due to ease of ring-opening due to the 
phenyl groups ability to stabilise an incipient positive charge. 
 
 
Scheme 1.36: Enantioselective [3 + 3] cycloaddition of piperidines from enantiopure aziridines. 
 
Harrity and co-workers, in separate publications, further explored the above result by 
expanding substrate scope through the use of spirocyclic aziridine substrates 207 forming 
cycloadducts 208 in moderate yields (Scheme 1.37).62 They then went onto demonstrate the utility of 
this process as a key step in the synthesis of Nuphar alkaloids 209.63 However, they noted the 
limitation inherent of using the TMM-Pd complex 199 as the reaction partner as the products obtained 
were restricted by the formation of a single exocyclic methylene group and the requirement of 
relatively high temperatures. 
 
 
Scheme 1.37: Application of spirocyclic aziridines and TMM-Pd for the construction of cycloadduct 
towards the total synthesis of Nuphar alkaloids. 
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The founding efforts of Harrity and co-workers demonstrated the power of using aziridines 
in a formal [3 + 3] cycloaddition process. But due to the limitations of TMM-Pd complex 189, the 
reactions lacked atom-efficiency and often require harsh reaction conditions to proceed. However, in 
each case above, the aziridine partakes in the process as a non-activated electrophilic partner without 
activation by a Lewis acid.  
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1.3.2: Donor-Acceptor Cyclopropanes in [3 + 3] Cycloaddition Reactions 
 
The above examples demonstrate some of the substrates aziridines can pair within the context of 
formal [3 + 3] cycloaddition processes (i.e. TMM-Pd complexes, heterocumulenes, nitrones and 
azomethine imines), but there are still only limited examples within the literature. However, the 
previous examples mostly afford heterocycles containing two or more heteroatoms. The use of an all-
carbon synthon is greatly appealing as a reaction partner with aziridines in [3 + 3] cycloaddition 
reactions as this would generate piperidine heterocycles that are widely located in bioactive 
compounds. Cyclopropanes are an all-carbon analogue of aziridines, having strained-ring character 
resulting in similar reactivity patterns.28b When a donor-acceptor cyclopropane 210 is exposed to a 
Lewis acid catalyst it can further polarise the C–C bond activating the system (210′) and promote 
reversible ring-opening to form zwitterionic 1,3-dipole 211. In this reactive zwitterionic intermediate 
system, the positive charge is stabilised by an electron-donating group, usually an aryl group, and the 
negative charge is stabilised by an electron-withdrawing group, commonly an ester moiety. This 
zwitterionic 1,3-dipole has been demonstrated to successfully undergo formal cycloaddition reactions 
for the generation of a wide variety of cycloadducts,64 and specifically undergo formal [3 + 3] 
cycloaddition with other 1,3-dipoles 212 generating 6-membered ring structures 213 (Scheme 1.38).  
 
 
Scheme 1.38: Ring-opening of donor-acceptor cyclopropanes via Lewis acid catalysis generating 
zwitterionic 1,3-dipole and consequent [3 + 3] cycloaddition with a 1,3-dipole forming 6-membered 
rings. 
 
Donor-acceptor cyclopropanes in [3 + 3] cycloaddition reactions have been established, 
spearheaded, and thoroughly investigated by Kerr and others, in which they demonstrated the 
reactions with air-stable 1,3-dipoles in the form of nitrones 215 generating oxazines 216, all of which 
are Lewis acid catalysed.65 This result mirrors Selender and co-worker’s efforts with [3 + 3] 
cycloaddition between aziridines and nitrones under Lewis acid catalysed conditions (refer to Scheme 
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1.32). As of 2018, there are currently 18 papers published on [3 + 3] cycloaddition between nitrones 
and donor-acceptor cyclopropanes.66  Presented below are four seminal examples demonstrating 
donor-acceptor cyclopropanes undergoing [3 + 3] cycloaddition reactions. Kerr et al. in 2003 were the 
first to disclose a donor-acceptor cyclopropane 214 reacting with a nitrone 215 in a [3 + 3] fashion 
under Lewis acid catalysed conditions yielding oxazine cycloadducts 216 in high yields (Scheme 
1.39).66a A suite of common Lewis acids were successful, but Yb(OTf)3 was found to be the superior 
catalyst. The product formed exclusively the cis diastereoisomer implying that a concerted process 
occurs via a chair-like dipole-dipole interaction, although a stepwise mechanism could not be 
excluded.  
 
 
Scheme 1.39: Formation of oxazines via the [3 + 3] cycloadditions between donor-acceptor 
cyclopropanes and nitrones. 
 
Charette et al. had previously explored the reactivity of air-stable azomethine imines and 
they envisaged reacting them with activated cyclopropanes to form tricyclic scaffolds 
(hexahydropyridazines) (Scheme 1.40).67 Using Ni(ClO4)2 catalysed conditions they successfully 
paired donor-acceptor cyclopropanes 217 with N-iminoquinolinium derived azomethine imines 218 in 
a [3 + 3] fashion to form 6-membered cycloadducts 219 in good to high yields with cis 
diastereoisomer favoured in ratio up to 6.6:1. They also attempted using N-iminoquinolinium 220 and 
observed formation of 221 as a single diasteroisomer and regioisomer, albeit with low yield. The lack 
of diastereomeric control was attributed to a long-lived intermediate before ring-closure resulting in 
both diastereomers formed. 
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Scheme 1.40: [3 + 3] Cycloaddition between donor-acceptor cyclopropanes and cyclic N,C-
azomethine imines.  
 
In 2009, Kerr et al. in the course of their extensive [3 + 3] cycloaddition of cyclopropanes 
with nitrone chemistry became interested in using an all-carbon 1,3-dipole for the formation of 
cyclohexanes.68 Initial trials using TMM-Pd complexes with donor-acceptor cyclopropanes failed to 
form the desired cycloadduct suggesting that the activated TMM-Pd complex was not reactive enough 
to attack the donor-acceptor cyclopropane. They instead opted to use the related substrate, 
chloromethylallylsilane 223, in the presence of TiCl4, causing activation of cyclopropane 223 and 
attack from 223 via a silyl-stabilised carbocation and loss of trimethylsilyl group generating 
intermediate 225, followed by a simple intramolecular Michael addition process, yielding the desired 
cyclohexane 226 in great to high yields (Scheme 1.41). They then went onto utilise the cycloadduct 
for the total synthesis of Iboga indole alkaloids.  
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Scheme 1.41: Synthesis of functionalised cyclohexanes 223 via the combination of donor/acceptor-
cyclopropane and a TMM-Pd complex. 
 
Kerr et al. then went onto develop a Zn(NTf2)2 catalysed two-step one-pot tandem ring-
opening/Conia-ene cyclisation method between cyclopropanes 227 and propargyl amines 228 yielding 
piperidines 229 in excellent yield (Scheme 1.42).69 A 1:1 ratio of diastereomers was observed when R2 = 
Me, but when employing enantiomerically pure cyclopropanes and amines the chirality was conserved in 
the product without erosion of ee. The N-Boc and N-Ts protected amine derivative attempts were 
unsuccessful highlighting the requirement for electron-rich N-groups in order to render the propargyl 
amine sufficiently nucleophilic.  
 
 
Scheme 1.42: The formal [3 + 3] cycloaddition between donor-acceptor cyclopropanes and 
propargyl amines to generate poperidines. 
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The use of cyclopropanes and aziridines has also been applied for the formation of 7- and 9-
membered rings. Hayashi et al. described 1,1-dicyanocyclopropanes and N-tosylaziridines 230 
undergoing [4 + 3] cycloaddition with aryl-substituted ɣ-methylidene-δ-valerolactones 231 via a 
palladium-catalysed decarboxylative pathway for the formation of 7-membered cycloadduct 232 
(Scheme 1.43, pathway a.). 70  When alkyl-substituted ɣ-methylidene-δ-valerolactones 231 were 
utilised, a divergent non-decarboxylative [6 + 3] cycloaddition pathway was observed for the 
formation of 9-membered cycloadducts 233 (Scheme 1.43, pathway b.). In both cases, the formed 
zwitterionic dipoles 234 and 235 proceeded to attack the non-activated strained 3-membered ring. 
 
 
Scheme 1.43: Divergent [4 + 3] or [6 + 3] cycloaddition between cyclopropanes or aziridines with 
ɣ-methylidene-δ-valerolactones for the formation of 7 and 9-membered rings. 
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1.3.3: Project 3 Aims 
 
As can be seen from the above literature, there are several [3 + 3] cycloaddition transformations 
possible utilising three-membered rings, with most pairing air-stable 1,3-dipoles, such as nitrones, 
with aziridines/cyclopropanes under Lewis acid or Pd(0) activation. However, there is currently a gap 
concerning further exploration of [3 + 3] cycloadditions between two 3-membered rings to access 6-
membered heterocycles. Such a route would provide a complementary route to well established 
methods such as the hetero Diels–Alder reaction, with the added benefit of direct access to fully 
saturated and potentially stereo defined systems. A project was therefore developed that utilises the 
well-known ring-opening of vinylaziridines and vinylcyclopropanes 236 under Pd(0)-catalysed 
conditions to generate the corresponding zwitterionic 1,3-dipoles 236′ that can then pair with another 
activated arylaziridine or arylcyclopropane-1,1-dicarboxylate 237 (Scheme 1.44). Such a reaction 
would allow the preparation of highly functionalised saturated N-containing heterocycles and the 
content towards this goal pertains as the focus of Chapter 4 of this thesis. Some potential challenges 
include; the compatibility of Lewis acids and transition-metals, the nucleophilicity of the ring-opened 
anion towards attack and ring-opening of the strained 3-membered ring, and if so the use of Lewis 
acid co-catalysts to further activate these systems. Furthermore, two potential regioisomers are 
predicted to arise, in which cycloadduct 238 is favoured if a Lewis acid is included (Scheme 1.44, 
pathway a.), or favouring of cycloadduct 239 in the absence of a Lewis acid (Scheme 1.44, pathway 
b.).  
 
 
Scheme 1.44: Proposed Pd(0)-catalysed ring-opening of a 3-membered rings generating a 1,3-dipole 
and potential cycloaddition pathways for the generation of 6-membered heterocycles  
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Chapter 2: Intramolecular [3 + 2] Cycloadditions to Electron-
poor Aromatics 
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2.1: Research Proposal 
 
The research plan to harness the reactivity of an azomethine ylide and a pendent nitro-arene in an 
intramolecular [3 + 2] manner is summarised in Scheme 2.2. The proposed intramolecular design of 
the reaction should increase the likelihood of reactivity and prevent unwanted bis-cycloaddition 
towards nitroaromatics as observed in the work of Piettre et al. (Scheme 2.1, A).1 This project is also 
partly inspired by the work of Tsuge and co-workers in the 1980s, where an intramolecular [3 + 2] 
cycloaddition of an azomethine ylide to a pendent furan was reported, to yield a dearomatised 
cycloadduct, albeit in low yield and with a single example (Scheme 2.1, B).2 It was also considered, 
given that intramolecular reactions onto benzenoid aromatics have only been observed under high 
temperature FVP conditions,3 could the presence of a nitro group allow this transformation to occur at 
lower temperatures, obtainable with standard laboratory equipment. 
 
 
Scheme 2.1: A) [3 + 2] bis-cycloaddition of azomethine ylides with electron-deficient arenes. B) 
Intramolecular [3 + 2] cycloaddition of an in-situ generated azomethine ylide towards a tethered 
furan. 
 
Firstly, an α-amino acid 251 will be used for generating an azomethine ylide in-situ via a 
condensation reaction with aldehyde 250. The addition of amino acid 251 to an aldehyde 250 is 
known to generate intermediates of type 252, which can generate intermediate 253 via a proton 
transfer. This could subsequently be protonated by the neighbouring carboxylic acid moiety forming 
intermediate 254, before water elimination via an intramolecular attack to give the oxazolidinone 
intermediate 255.4 The oxazolidinone would then undergo cycloreversion, resulting in spontaneous 
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decarboxylation to generate azomethine ylide 256, ready for cycloaddition to the pendent nitro-
decorated benzenoid ring. Cycloaddition could be predicted to proceed via a concerted process to the 
nitroarene for the formation of three potential isomeric cycloadducts: 257, 258, or 259. Due to the 
torsional strain of the theoretical structures of 257 and 259, the 7-membered cycloadduct 258 is 
predicted to be the favoured product. It is anticipated that the position of the nitro-substituent on the 
pendent aromatic ring may alter where on the ring cycloaddition occurs, therefore different positional 
isomers will be prepared, and their reactions investigated. The nature of the tether will be explored 
through different heteroatom linkers will be trialled (X = O, NTs), in addition to variations about the 
R substituent of the benzenoid, and exploration of alternate sources of amino acids. Some of the 
proposed cycloadduct structures contain a fused combination of benzoxepine or benzoazepine, and 
isoindoline scaffolds in a new tetracyclic combination, which may be useful scaffolds in medicinal 
chemistry given their occurrence in bioactive molecules.5   
	 64 
 
Scheme 2.2: Overall research plan for generation of an azomethine ylide and consequent 
intramolecular dearomative [3 + 2] cycloaddition to a pendent nitro-arene. 
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2.2: Results and Discussion 
2.2.1: Synthesis of O-Tethered Starting Materials 
 
In order to investigate the proposed intramolecular [3 + 2] cycloaddition reaction, O-tethered 
cycloaddition precursors 262 were initially prepared (Table 2.1). The O-tethered aldehydes 262 were 
easily accessed via an SN2 reaction under basic conditions between readily available commercial 
salicylaldehydes 260 and substituted benzyl (or pyridylmethyl) chloride 261 (Table 2.1). For the 
benzyl derivatives, various strongly electron-withdrawing substituents were chosen, including 2-, 3-, 
4-nitro 262aa-ac and 3,5-dinitro 262ad-262fd, as well as 3,5-difluoro- and 3,5-bis(trifluoromethyl) 
262ae and 262af respectively – as discussed above, these are anticipated to facililate the 
cycloaddition. Low isolated yields of 262ad and 262fd were attributed to low solubility from 
purification by crystallisation. In addition to these, pyridylmethyl tethered examples (262ag and 
262ah) were synthesised as these types of systems tend to have reduced aromaticity compared to 
benzene-derivatives, so might more readily undergo a dearomative cycloaddition. In each case, novel 
compound structures were confirmed via 1H NMR, 13C NMR, HRMS and IR analyses: in each case 
the benzylic CH2 group gave a distinctive singlet within the δ 5.62-5.12 ppm region of the 1H 
spectrum and a corresponding resonance within the δ 71.2-63.8 ppm region of the 13C spectrum. In 
addition, each compound exhibited distinctive 1H NMR (δ 10.60-10.49 ppm), 13C NMR (δ 189.7-
188.9 ppm), and IR (1697-1668 cm-1) signals indicative of the aldehyde. High-resolution mass 
spectrometric analysis confirmed the molecular weight of each compound. Importantly, the synthesis 
of the aforementioned compounds could be prepared on 1-gram scale with relatively easy purification 
by recrystallisation. 
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Table 2.1: Synthesis of O-tethered cycloaddition substrates.a 
 
 
262aa - 82% 
 
262ab - 33% 
 
262ac - 71% 
 
262ad - 77% 
 
262bd – 52% 
 
262cd – 62% 
 
262dd – 47% 
 
262ed – 23% 
 
262fd – 40% 
 
262ae - 71% 
 
262af - 68% 
 
262ag - 74% 
 
262ah - 64% 
 
a Conditions used: 1.0 equiv. of 260, 1.2 equiv. of 261 and 1.3 equiv. of Cs2CO3. Purification 
typically via recrystallisation from 1:1 CHCl3:n-hexanes. 
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2.2.2: Intramolecular [3 + 2] Cycloaddition 
 
With the O-tethered substrates 262 in hand, investigations of the [3 + 2] cycloaddition with the simple 
α-amino acid sarcosine 263 was attempted (Table 2.2). Sarcosine was chosen first as it is a cheap and 
readily accessible amino acid that has previously been shown to participate in intramolecular [3 + 2] 
cycloaddition reactions of similar aldehyde starting materials with olefins.6,7,8,9,10,11 The first attempts 
utilising mono-substituted nitro-aromatics 262aa-ac unfortunately led to only recovery of the starting 
aldehyde after workup, implying the need for additional electron-withdrawing substituents – which is 
consistent with previous observations in the literature for intermolecular dearomative cycloadditions 
(Table 2.2, entries 1-3). Therefore, the 3,5-dinitro substrate 262ad was subjected to the same reaction 
conditions and, gratifyingly, complete consumption of the aldehyde was observed, accompanied by 
the formation 265ad in 30% yield (Table 2.2, entry 4). Interestingly, the isolated product appeared to 
be the rearomatised structure, which was presumably formed via the loss of nitrous acid (HNO2) from 
the initially formed cycloadduct (Figure 2.1). The assignment of this structure was made based on the 
1H NMR spectrum, which showed two 1H singlet resonances at δ 7.92 and 7.74 ppm, representative 
of a re-aromatised tetrasubstituted nitro-aryl ring. Furthermore, the benzylic methylene group adjacent 
to the oxygen appeared as doublets at δ 5.46 and 4.95 ppm, while the methylene of the isoindoline 
system appeared as doublet of doublets at δ 4.55 and 3.96 ppm. Furthermore, the isolated isoindoline 
CH was a distinctive singlet resonance at 5.42 ppm. The N-Me proton appeared as a singlet resonance 
at δ 2.74 ppm, clearly indicating incorporation of the sarcosine N-Me into the product. Furthermore, 
the 13C NMR spectrum showed the expected 12 sp2 and 4 sp3 resonances (Figure 2.1). High-resolution 
mass-spectrometric analysis detected a mass ion of 283.1086 and was assigned as [M + H]+ 
correlating to the proposed structure. Further confirmation of the assigned structure came through X-
ray crystallographic analysis of a crystalline analogue (see later). It was not possible to obtain an X-
ray quality crystal of 265ad, however, the C8-Cl analogue (265bd – refer to table 2.6) was able to be 
successfully crystallised thereby confirming the structure of this series of compounds (Figure 2.2).  
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Figure 2.1: 1H and 13C NMR spectra of product 265ad. 
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Figure 2.2: X-ray crystal structure for product 265bd obtained by M Gardiner from the University of 
Tasmania. 
 
With the reactivity of the dinitrophenyl substrate 262ad established, the analogous 3,5-
difluorophenyl and 3,5-bis(trifluoromethyl)phenyl systems 262ae and 262af were then investigated 
(Table 2.2). It is important to note that the proposed cycloadduct from 3,5-difluoro system 262ae may 
be able to lose HF and concomitantly rearomatise, however, the 3,5-bis(trifluoromethyl)phenyl 
system 262af would presumably be incapable of losing HCF3 and as such be unable to rearomatise. 
Unfortunately, the 3,5-difluoro substrate 262ae failed to convert to the desired cycloadduct and 3,5-
bis(trifluoromethyl)phenyl substrate 262af underwent low conversion towards an unstable product 
that could not be isolated (Table 2.1, entries 5 & 6). The use of the pyridine tethered systems in the 
form of 262ag and 262ah was also trialled, but both gave no conversion under the reaction conditions, 
indicating that the strongly electron-withdrawing 3,5-dinitro substituted groups were essential to 
promote the intramolecular cycloaddition reaction (Table 2.2, entries 7 & 8). 	  
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Table 2.2: Exploration of intramolecular [3 + 2] cycloaddition with O-tethered electron-
deficient aromatics.a 
 
Entry 262, R Conversion  Yield 265 
1 
262aa 
No rxn - 
2 
262ab 
No rxn - 
3 
262ac 
No rxn - 
4 
262ad 
100% 
 
265ad - 30% 
5 
262ae 
No rxn - 
6 
262af 
Incomplete 
conversion 
 
Complex mixture. 
Unidentified & unstable 
product 
7 
262ag 
No rxn - 
8 
262ah 
No rxn - 
a Conditions: 1.0 equiv. compound 262 with 2.0 equiv. 263 in 0.1M PhMe solvent. Reactions 
monitored via TLC for consumption of 262. 
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With the success of the intramolecular [3 + 2] cycloaddition with the 3,5-dinitrophenyl 
substrate 262ad established, optimisation of the reaction conditions was initiated (Table 2.3). An 
increase in the molar equivalents of sarcosine 263 in the reaction mixture was predicted to encourage 
the formation of the azomethine ylide. Indeed, 6.0 equivalents of sarcosine 263 resulted in the 
isolation of product 265ad in 43% yield (Table 2.3, entry 2). However, when the reaction was 
repeated, a dramatic lowering in the isolated yield of 265ad (6%) was uncovered. When the initial 
conditions were repeated (Table 2.3, entry 1), a similar variability in the isolated yield was observed, 
indicating the capricious nature of the reaction. Interestingly, when 10.0 equivalents of 263 was used, 
a shorter reaction time was noted, but a lower yield (25%) of 265ad was obtained (Table 2.3, entry 3). 
It was considered that the nitrous acid generated in-situ may be imposing a detrimental effect on the 
stability of the product. Consequently, the introduction of an organic base in the form of triethylamine 
(Et3N) or diisopropylethylamine (DIPEA) was added to neutralise the in-situ generated nitrous acid, 
however, no increase in yield was observed (Table 2.3, entries 4 and 5). Reducing to 1.2 molar 
equivalents of sarcosine 263 saw an incomplete conversion to the product (Table 2.3, entry 6). It was 
also suspected because in-situ generation of water occurs during the formation of the azomethine 
ylide that the ylide formation was reversible – potentially hindering the cycloaddition. Therefore, 
activated 4Å molecular sieves were introduced to remove in-situ generated water and furnished the 
product in 26% yield (Table 2.3, entry 9). While this was not the highest yield obtained, the reaction 
with molecular sieves occurred in a more consistent and reproducible manner. It was also speculated 
that the extended reaction time may be detrimental to the isolated yield as the product could be 
undergoing decomposition: therefore, a reduction in reaction time to 6 hours was trialled but gave 
incomplete conversion towards 265ad (Table 2.3, entry 10). This result highlighted the requirement 
for extended reaction times to ensure complete conversion towards the product. A larger scale 
reaction (200 mg of 262ad) was carried out but saw no improvement in yield (Table 2.3, entry 11). 
Furthermore, precautions were undertaken to avoid oxygen contact, such as sparging of solvent with 
N2 and purging the reaction vessel with N2. Given that the 1H NMR of the crude reaction material 
showed predominantly only the desired product 265ad, the potential instability of the product during 
purification was also considered as responsible for the low isolated yields. Therefore, purification via 
neutral alumina in place of silica gel was also attempted as it was thought that the product might 
display instability towards weakly acidic silica leading to a low isolated yield, however, this approach 
did not result in an increased yield (Table 2.3, entry 12). Various recrystallisation methods were also 
attempted but were unsuccessful. Analysis of previous synthetic methods show that the isoindoline 
fragment is most commonly prepared with electron-withdrawing substituents, particularly on the 
nitrogen and adjacent carbons, in order to increase stability.12 The generated isoindoline structure 
formed in product 265ad lack these stabilising substituents, and this potentially contributes to its 
instability. Isoindoline instability is also potentially due to oxidation towards the corresponding 
isoindole, which has been previously observed in similar types of heterocycles.13,14 It is also possible 
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that the nitroarene starting material could be an oxidant which has been proposed in previous 
intermolecular examples with polynitro compounds.9 
 
Table 2.3: Selected optimisation results with sarcosine as the amino acid.a 
 
Entry 263 equiv. Conditions Conversion Yield 265ad (%) 
1 2.0 120 °C, overnight 100% 4 – 30b 
2 6.0 120 °C, overnight 100% 6 – 43b 
3 10.0 120 °C, 5 h 100% 25 
4 6.0 120 °C, overnight, Et3N 100% 18 
5 6.2 120 °C, 6 h, DIPEA 100% 26 
6 1.2 120 °C, overnight Incomplete - 
9 2.1 120 °C, overnight, 4Å MS 100% 18 – 26b 
10 2.0 120 °C, 6 h, 4Å MS Incomplete 15 
11c 2.0 120 °C, overnight, 4Å MS 100% 17 
12d 2.0 120 °C, overnight, 4Å MS 100% 13 
Conditions: a 1.0 equiv. 262ad, 0.1M in PhMe. b Variable isolated yields. c 200 mg scale.           
d Purification performed on alumina.  
 
An LC-MS study was then conducted on the reaction of sarcosine with the starting material 
262ad under similar conditions presented in Table 2.1, entry 10. It was found that within 2 hours of 
heating at 120 °C, a signal correlating to the formation of the isoindoline 265ad (m/z 283.05) was 
beginning to emerge, in addition to peaks correlating to hydrated azomethine ylide (m/z 347.98), 
oxidised starting material (m/z 318.06), and a trace of cycloadduct 264ad (m/z 330.07). After 3 hours, 
the emergence of a peak correlating to the isoindole 265ad′ (m/z 281.07) was first observed, along 
with increasing formation of cycloadduct 265ad. After 4-5 hours, a further increase in isoindoline 
265ad was uncovered, with a corresponding decrease in starting material. After 5-7 hours of heating 
at 120 °C, many overlapping peaks were observed. This result was indicative of the cycloadduct 
instability under the prolonged heating at 120 °C. After 7 hours the reaction was ceased, and the LC-
MS analysis indicated ~60% unreacted starting material. After purification, 265ad was then isolated 
in 14% yield. 
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A proposed mechanism for the formation of 265ad is shown below in Scheme 2.3. The 
reaction begins with initial amino acid 263 addition to the aldehyde 262ad, generating intermediate I. 
As previously established in the literature,15 the resulting anion then undergoes a proton-transfer, 
forming intermediate II, followed by a second proton-transfer from the carboxylic acid generating 
intermediate III. This then undergoes an intramolecular condensation forming an unstable 
oxazolidinone ring IV which then quickly decarboxylates via a cycloreversion forming the highly 
reactive azomethine ylide V. The azomethine ylide V then undergoes an intramolecular [3 + 2] 
cycloaddition with the 2,3 C=C bond of the 3,5-dinitrophenyl aromatic group form cycloadduct 
264ad. Under the elevated reaction temperatures, 264ad undergoes elimination of nitrous acid with 
concomitant rearomatisation to afford the isolated product 265ad.9,11 Auto-oxidation of isoindoline 
265ad towards the corresponding isoindole 265ad′ is also possible. It should also be noted that when 
the experiment was repeated below temperatures of 80 °C, no conversion of the starting material was 
observed. In contrast, when the reaction was repeated at 80 °C for extended reaction times (24 hours) 
a low yield of previously identified product 265ad was obtained. These results are consistent with the 
elimination of nitrous acid from the cycloadduct 264ad occurring at faster rates then the 
intramolecular cycloaddition to form 264ad. The low yield of 265ad under these conditions could be 
due to slow formation of the azomethine ylide or slow cycloaddition rate at this temperature and in 
the meantime these intermediates are prone to side-reactions, e.g. with the in-situ generated water, 
eventually leading to the reformation of the initial aldehyde 262ad. 
 
 
Scheme 2.3: Mechanism for the generation of azomethine ylide V and intramolecular [3 + 2] 
cycloaddition, and subsequent rearomatisation via loss of nitrous acid. 
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Due to the inconsistent results observed with the use of sarcosine, it was anticipated that an 
alternative amino acid substrate might return superior results as previous groups have demonstrated 
success with N-benzylated azomethine ylides in [3 + 2] cycloadditions towards nitro-arenes.1b,16 
Therefore, N-benzyl glycine hydrochloride 266, was employed, with the addition of an organic base 
Et3N to liberate the free amine (Table 2.4). When the reaction was performed using 2.1 equivalents of 
266, gratifyingly, 100% conversion to the corresponding isoindoline 267 was observed within 2 hours 
with product isolated in 47% yield (Table 2.4, entry 1). Spectroscopic analysis supported the proposed 
structure with the 1H and 13C NMR spectra being very similar to that of 265ad, though the isoindoline 
CH2 resonances now appeared upfield in comparison to the precursor (Figure 2.3). Of significant 
difference was the isoindoline CH singlet which was shifted downfield to 5.75 ppm. Furthermore, the 
diastereotopic benzyl O-CH2 moiety exhibited as a pair of doublets at 5.49 and 4.98 ppm with a 
coupling constant of 16.0 Hz were shifted downfield. High-resolution mass spectrometric analysis 
detected a mass ion of 381.1227 and was assigned as [M + Na]+ correlating to the predicted product. 
By increasing the molar equivalents of 266 to 4.1, an increased yield of product 267 was obtained 
(53%), whilst 6.1 mole equivalents of 266 saw no further increase in yield (Table 2.4, entries 2 & 3). 
Next, a series of different polar aprotic solvents were trialled. Interestingly, the use of THF saw a 
reduction in the yield of 267 even with the extended reaction times, likely due to less efficient 
cycloaddition at the lower reaction temperature of 80 °C (Table 2.4, entry 4). Similarly, the use of 
DCE saw a low isolated yield of 13%, while MeCN saw the return of unreacted starting materials 
(Table 2.4, entries 5 & 6). Interestingly, when the reaction was repeated at 120 °C in PhMe, a drastic 
decrease in the yield was noted. This result was unexpected, as the previous result (Table 2.4, entry 2) 
had shown an isolated yield of 53%. However, this capricious behavior was similar to that observed 
with sarcosine (Table 2.3, entries 1 & 2). It was again thought that the in-situ generated water may be 
interfering with the reaction, therefore, the reaction was repeated in the presence of 4Å MS. 
Satisfyingly, a reproducible and consistent result was observed, albeit in a lower yield of 21% (Table 
2.4, entry 7). It was then suspected that high temperatures were influencing the formation of the 
cycloadduct. When the reaction was conducted at 80 °C, a significant increase in reaction time was 
necessary, requiring more the 12 hours to ensure 100% conversion but with a lower isolated yield of 
27% (Table 2.4, entry 8). At 100 °C, complete conversion to the product 267 was noted in 35% yield 
within 2 hours (Table 2.4, entry 9). The observed effects of temperature on the formation of the 
desired product uncovered several trends. Prolonged heating at 120 °C was likely detrimental to the 
stability of product 267, whilst heating at 80 °C required extended reaction times, indicating that 
prolonged heating was detrimental to the product stability. Heating at 100 °C constituted the optimum 
conditions for efficient formation of the azomethine ylide and consequent cycloaddition within a short 
reaction time. Several organic bases in the form of pyridine, DABCO and DBU were also trialled, 
however, each returned low yield or incomplete reactions (Table 2.4, entries 10-12). 
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Figure 2.3: 1H and 13C NMR spectra of cycloadduct 267.  
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Table 2.4: Selected optimisation results with N-Bn amino acid.a 
 
Entry 266 
equiv. 
Baseb Conditions Conversion Yield (%) 
267 
1  2.1 Et3N PhMe, 120 °C, 2 h 100% 9 - 47 
2  4.1 Et3N PhMe, 120 °C, 2 h 100% 5 - 53 
3  6.1 Et3N PhMe, 120 °C, 1 h 100% 4 - 52 
4  4.1 Et3N THF, 80 °C, overnight 100% 9 
5 4.9 Et3N DCE, 80 °C, 7 h 100% 13 
6 4.0 Et3N MeCN, 80 °C, 4 h Incomplete 0 
7 2.0 Et3N PhMe, 120 °C, 4Å MS, 2 h 100% 20 - 21 
8 4.0 Et3N PhMe, 80 °C, 4Å MS, overnight 100% 27 
9 4.0 Et3N PhMe, 100 °C, 4Å MS, 2 h 100% 31 - 35 
10 4.0 Pyridine PhMe, 100 °C, 4Å MS, 2 h Incomplete - 
11 4.0 DABCO PhMe, 100 °C, 4Å MS, 2 h 100% 17 
12 4.0 DBU PhMe, 100 °C, 4Å MS, 2 h 100% 0 
Notes: a 1.0 equiv. 262ad, 0.1M solvent concentration. b 1.5-2.0 equiv. base added with 
respect to amine 266. 
 
An LC-MS analysis was then conducted on the reaction of N-benzyl glycine 266 with the 
starting material 262ad. After heating at 80 °C for ~4 hours, it was uncovered that the predicted 
cycloadduct 267 was forming (m/z 359.13). However, when the temperature was raised to 120 °C for 
1.5 hours, almost complete consumption of starting material 262ad was noted, but with significant 
formation of the corresponding isoindole 267′ (m/z 357.07) along with an increase the number of 
components, most likely a result of product decomposition. This result showed that prolonged heating 
of the isoindoline 267 under the reaction conditions resulted in product decomposition.		
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With the success of the N-benzyl glycine, other N-protected amino acids were then employed 
utilising the optimised conditions (Table 2.5, entry 9) (Scheme 2.4). When N-phenylglycine 269 was 
utilised, analysis of the 1H NMR spectra of the crude material indicated a complex mixture. The use 
of electron-withdrawing N-substituted amino acids such as N-tosylglycine 270 and N-tosylalanine 271 
resulted in no conversion under the reaction conditions, even when the temperature was increased to 
120 °C. In each of these cases the reduced nucleophilicity of the amine likely hindered initial 
aldehyde attack, thereby preventing azomethine ylide formation. 
 
 
Scheme 2.4: Limitations of certain amino acids derivatives in intramolecular [3 + 2] cycloaddition. 
 
In contrast, when the cyclic amino acid proline 272 was utilised, 100% conversion of 262ad 
was observed with isolation of the corresponding isoindole 274 in 18% yield (Scheme 2.5). Trace 
formation of the corresponding isoindoline precursor 273 was noted, but this unable to be isolated. It 
was noteworthy that the product 274 was found to be unstable and underwent slow decomposition 
when dissolved in d-chloroform (Scheme 2.5). The low isolated yield of 274 and trace observation of 
isoindoline 273 could suggest a faster reaction where the initially formed 273 has a longer time period 
compared to other systems to decompose under the high temperature of the reaction.13,14  
 
 
Scheme 2.5: Intramolecular cycloaddition with use of cyclic amino acid proline.  
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The substrate scope about the benzenoid ring of the O-tethered substrate was then briefly 
explored on a set of previously prepared of 5-substituted starting materials 262bd-fd (Table 2.6). 
Substitutions about the 5-position were chosen due to commercial availability. Halogens at the 5-
position in the form of 5-Cl 262bd and 5-Br 262cd gave the corresponding products 265bd (5% 
yield) and 265cd (15% yield) respectively. When the 5-position was substituted with the strongly 
electron-withdrawing NO2 group (262dd), a very low yield of the isolated product 265dd was 
observed (2% yield). Conversely, the electron-donating analogue 5-Me 262ed saw the formation of 
the corresponding product 265ed in 23% yield, and the 5-OMe substrate 262fd saw the isolation of 
the corresponding product 265fd in 11% yield.  
 
Table 2.6: Substrate scope using sarcosine 263.a 
 
 
265bd 
Yield - 5% 
 
265cd 
Yield – 15% 
 
265dd 
Yield – 2% 
 
265ed 
Yield – 23% 
 
265fd 
Yield – 11% (unstable) 
a Conditions: 1.0 equiv. 262bd-fd, 2.0 equiv. 263, heated at 100 °C overnight, in 0.1M in PhMe.  
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2.2.3: Synthesis of N-Tethered Starting Materials 
 
The above examples revealed the inherent instability of the O-tethered substrate, reflected in the 
consistently low isolated yields of the corresponding O-tethered cycloadducts. Therefore, in efforts to 
design a more stable substrate while exploring heteroatom versatility at the benzylic tether position, 
the synthesis of an N-tethered substrate 280 was undertaken (Scheme 2.6). The design of a N-Ts tether 
was also theorised to increase steric bulk, reduce conformational rotation, and may	 lead	 to	 the	
conformer	required	 for	 cyclisation	being	populated	 to	a	greater	degree.17 Cheap and readily available 
anthranilic acid 275 was reduced to the corresponding alcohol 276 via LiAlH4 reduction. The free 
amino moiety was then protected with tosyl chloride (TsCl) in the presence of pyridine, yielding 277. 
Selective oxidation of the benzyl alcohol moiety within compound 277 with PCC yielded the 
corresponding aldehyde 278.18 Subsequent N-alkylation with 3,5-dinitrobenzyl chloride 261d under 
basic conditions afforded the desired N-tethered system 280. Spectroscopic analysis was carried out to 
confirm the structure of 280. The 1H NMR found contained a singlet at δ 10.10 ppm, in addition to 
peaks at δ 8.92 and 8.43 ppm arising from the nitro-aryl group containing an integration of 3H. 
Curiously, the benzylic CH2 was found to have split into two doublets at δ 5.21 and 4.70 ppm sharing 
a coupling constant of 13.0 Hz with an integration of 2H. This diastereotopic splitting pattern is 
speculated to arise via restricted rotation of the tosyl group with the nitro-aryl moiety, or perhaps by 
an intramolecular π-stacking interaction rendering the neighbouring benzylic CH2 protons non-
equivalent. Although outside the scope of this project, additional NMR and X-ray crystal analyses 
will need to be conducted to further elucidate this curious observation. Furthermore, the tosyl CH3 
group was found as a singlet at δ 2.49 ppm. Analysis of the 13C NMR spectrum revealed 17 peaks 
expected from the desired compound. 2D NMR experiments such as of gCOSY and gHSQC further 
supported the proposed structure. High-resolution mass spectrometric analysis detected a mass ion of 
478.06776 and was assigned as [M + Na]+ correlating to the predicted product. Furthermore, the 
synthesis of compounds 276, 277, and 278 were amenable to large scale (up to 4.5 grams) with 
purification easily performed via recrystallisation. 
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Scheme 2.6: Multistep synthesis for the formation of the N-tethered substrate 280.  
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2.2.4: Intramolecular [3 + 2] Cycloaddition with N-Tethered Substrates 
 
With the N-tethered substrate 280 obtained, it was treated with sarcosine under the same reaction 
conditions described for the previous cycloaddition (Table 2.4, entry 1). Gratifyingly, the first attempt 
at 120 °C for 15 hours saw the complete consumption of starting material 280 and the formation of 
two products: isoindoline 281 and isoindole 281′ in a ratio of 53:47 respectively (Table 2.7, entry 1). 
Isoindoline 281 was isolated in 35% yield and isoindole 281′ isolated in 32% yield. This result 
contrasted with that obtained for the O-tethered substrate in that 281 appeared to have undergone in-
situ oxidation to form isoindole 281′. Unfortunately, isoindole 281′ was observed to decompose in 
solution after purification, making characterisation extremely difficult. The isoindoline 281 was 
successfully isolated in 35% yield and the structure was confirmed via spectroscopic methods (Figure 
2.4). The 1H NMR spectrum contained a pair of doublets at δ 5.53 and 4.38 ppm sharing a coupling 
constant of 18.0 Hz assigned to the CH2 adjacent to the N-Ts group, while a pair of doublet signals at 
δ 4.51 and 3.86 ppm with a coupling constant of 13.5 Hz were assigned to the CH2 adjacent to the N-
Me group. A singlet at δ 5.01 ppm was assigned to the isolated CH group. Furthermore, the protons 
belonging to the nitro-aromatic ring were assigned the singlets at δ 7.92 and 7.85 ppm. Analysis of the 
13C NMR spectrum demonstrated 21 signals consistent with the predicted structure. High-resolution 
mass spectrometric analysis detected a mass ion of 436.1335 and was assigned as [M + H]+ 
correlating to the predicted product. The inherent instability of isoindole 281′ made conclusive 
structure elucidation arduous. However, analysis of the 1H NMR spectrum correlated to a total proton 
integration of 19 protons, corresponding to a loss of 2 protons from 281 (Figure 2.5). The five-
membered ring CH2 and CH protons were no longer observed, nor in the 13C NMR spectrum as the 
signals were due to the two CH2 carbons. The CH2 doublet signals assigned to the protons adjacent to 
the N-Ts group were shifted slightly upfield (relative to isoindoline 281) to δ 5.41 and 4.41 ppm. The 
N-Me signal was found at δ 3.87 ppm, downfield relative to the corresponding signals for 281, 
reflective of its part in the aromatic isoindole system. Intriguingly, the CHAr proton signals associated 
with the tosyl group were shifted upfield to δ 6.76 and 6.56 pm as was the tosyl Me to δ 2.10 ppm. 
The formation of the isoindole 281′ is proposed to form via an autoxidation dehydrogenation 
mechanism presented below in Scheme 2.7.19 When the isoindoline 281 is exposed to molecular 
oxygen, a CH-insertion at the alpha position on the pyrroline ring is able to generate intermediate A. 
Formation of a transient imine expels a hydrogen peroxide anion, forming intermediate B, which 
consequently reacts with the acidic hydrogen alpha to the imine nitrogen, driving expulsion of 
hydrogen peroxide and formation of isoindole 281′.  
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Figure 2.4: 1H and 13C spectra of isoindoline 281.  
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Figure 2.5: 1H NMR spectrum of isoindole 281′. 
 
  
unstable 
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With it understood that the side-product was due to an oxidative process, an attempt was 
made to optimise the reaction to select for either the oxidised isoindole or isoindoline. Initially it was 
thought that extended reaction times may be contributing towards oxidation of the cycloadduct, 
therefore, the reaction time was extended to 42 hours, which saw a small increase in the ratio 
281:281′ observed (Table 2.7, entry 2). Exposure of the reaction to the open air further increased the 
formation of isoindole 281′, suggesting that prolonged heating and exposure to air promote the 
oxidation of 281 towards the isoindole (Table 2.7, entry 3). It has been well documented that 
isoindoles are unstable,20 indeed, the isoindole 281′ was observed to convert to another unidentified 
species in solution as evidenced by the 1H NMR spectrum. When a lower reaction temperature of 80 
°C was used, a significant reduction in the formation of the oxidised isoindole 281′ was observed, 
albeit with incomplete conversion and as such similar isolated yield as Table 2.7, entry 1 (Table 2.7, 
entry 4). Conducting the reaction at 100 °C for 27 hours saw complete conversion of the starting 
material but returned a ratio of 54:46 of 281:281′ respectively (Table 2.7, entry 5). Excitingly, when 
the reaction was repeated at 100 °C, but monitored closely via TLC analysis, the reaction was found 
to be complete after ~7 hours with a ratio of 95:5 (281:281′), favouring the desired isoindoline 281 
and allowing an isolated yield of 59%, representing the highest yield observed for the intramolecular 
cycloadditions across all attempted systems (Table 2.7, entry 6). Other groups have previously 
demonstrated success of microwave-promoted [3 + 2] cycloaddition involving azomethine ylides,21 
however, exposure of 280 to sarcosine under microwave conditions for 1 hour resulted in only 40% 
conversion with a 96:4 ratio of isoindoline 281 and 281′, in addition to the formation of an intensely 
coloured and insoluble material that excluded this method from further exploration as it hindered 
purification (Table 2.7, entry 7). Lastly, increasing the molar equivalents of sarcosine to 5.0 saw the 
reaction progress to completion within 3 hours, however a reduced isolated yield of 47% was obtained 
(Table 2.7, entry 8).  
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Table 2.7: Optimisation of conditions for the intramolecular [3 + 2] cycloaddition of an azomethine 
ylide towards a N-tethered nitroaromatic.a 
 
Entry Conditions Conversion Ratio (281:281′) b Yield 281 (%) 
1  120 °C, 15 h  100% 53:47 35 (281′ decomposed) 
2  120 °C, 42 h  100% 51:49 Not isolated 
3c 120 °C, 27 h  100% 47:53 Not isolated 
4 80 °C, 23 h ~90% 78:22 34  
5 100 °C, 27 h 100% 54:46 Not isolated 
6  100 °C, 7 h 100% 95:5 59 
7d  100 °C, 1 h  ~40% 96:4 Not isolated 
8e 100 °C, 3 h  100% 96:4 47 
a Conditions: 1.0 equiv. 280, 2.0 equiv. sarcosine 263 under N2 atm. b Ratio determined via 1H NMR 
integration of the crude material. c Open air. d Microwave conditions. e 5.0 equiv. sarcosine 263 used. 
 
 
Scheme 2.7: Proposed oxidation mechanism of isoindoline 281 for the formation of isoindole 281′.  
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With reaction conditions for the N-tethered substrate with sarcosine optimised, an exploration 
of different amino acids was attempted (Table 2.8). When N-benzylglycine hydrochloride 266 was 
subjected to the reaction conditions, the corresponding isoindoline 282 was formed cleanly and 
isolated in a yield of 70% (Table 2.8, entry 2). When N-phenylglycine 268 was utilised, no reaction 
was observed, mirroring a similar result for the O-tethered substrate, with the incompatibility likely 
due to reduced nucleophilicity of the amino acid (Table 2.8, entry 3). To see if diastereoselectivity 
could be induced, the use of α-substituted amino acids in the form of N-methylalanine 286 and N-
methylphenylalanine 287 were utilised and led to the formation of the corresponding isoindoline 
cycloadducts 284 and 285 in 23% and 64% yield, respectively (Table 2.8, entry 4 and 5). Of note, 284 
and 285 were obtained as single diastereoisomers via 1H NMR analysis of the crude reaction material. 
Compound 285 was crystallised and an X-ray crystal analysis was performed by A/Professor Michael 
G. Gardiner from the University of Tasmania. The X-ray crystal analysis showed the pyrrolidine ring 
H’s to be in a cis-relationship (Figure 2.6). The isolation of 285 in 64% yield also suggested a positive 
trend for a benzylic group to form a stable cycloadduct. Also attempted was an amino ester variant in 
the form of 288, as previous groups had shown success using these model amines in an intramolecular 
[3 + 2] fashion with pendent olefins.22 The potential cycloadduct formed would also contain the added 
functionality of an ester moiety for future transformations. Unfortunately, no reaction was observed 
under these conditions. This result also highlighted the requirement for a more reactive non-stabilised 
azomethine ylides in order to promote cycloaddition to the relatively unreactive aromatic ring.  
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Table 2.8: Substrate scope of secondary amino acids.a 
 
 
281 
59%, 95:5 
 
282c 
70%, 100:0 
 
268 
no cycloaddition 
 
284 
23%, 100:0 
(single diastereomer) 
 
285c 
64%, 100:0 
(single diastereomer) 
 
288 
no cycloaddition 
Conditions: a 1.0 equiv. 180, 2.0 equiv. amino acid under N2 atm for 2-3 hours. b 266 and 287 
as the corresponding hydrochloride salt. c 1.5-2.0 equiv. Et3N added with respect amino acid. 
	
	
Figure	 2.6:	X-ray crystal analysis of 285 performed by A/Professor Michael G. Gardiner from the 
University of Tasmania. 	 	
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With the success of N-benzyl glycine as the amino acid in giving a high isolated yield of the 
cycloadduct, the substrate scope with respect to the benzenoid component of the N- tethered starting 
materials 280a-i was next investigated. The appropriate starting materials were synthesised and the 
structures of each were confirmed via spectroscopic 1H and 13C NMR analysis, 2D NMR techniques, 
and molecular weights confirmed for novel substrates via both low and high-resolution mass 
spectrometry (Table 2.9). 
	
Table 2.9: Synthesis of N-tethered starting materials 280a-i.a  
 
Entry R Yield 276 (%) Yield 277 (%) Yield 278 (%) Yield 280 (%) 
1 a, R = H 62  77  84  64  
2 b, R = 4-F 78  78  96  79  
3 c, R = 3-Cl 57  47  99  17  
4 d, R = 4-Cl 78  91  88  81  
5 e, R = 5-Cl 69  97  86  54  
6 f, R = 6-Cl 37  58  47  55  
7 g, R = 4-Br 97  88  90 84  
8 h, R = 4-Me 98 88  91  79  
9 i, R = 5-OMe 90 99  56  71  
a Conditions: a) LiAlH4 (2.2 equiv.), THF, 0 oC to rt, overnight. b) TsCl (1.1 equiv.), pyridine 
(1.2 equiv.), DCM, 0 oC to rt, overnight. c) PCC (1.2 equiv.), DCM, rt, ~1 hour. d) 3,5-
dinitrobenzylchloride 279 (1.2 equiv.), Et3N (1.6 equiv.), MeCN, reflux, overnight. 
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With the necessary starting materials prepared, the task of exploring the substrate scope with 
respects to the benzenoid component was conducted. Firstly, a substitution at the 3-position was 
trialed in the form of 3-Cl 280c, however a complex 1H NMR spectrum of the crude material was 
observed, returning mixture of unreacted starting material and indistinct signals after 24 hours. This 
result is likely attributed to steric influences at the position ortho to the aldehyde, potentially 
hindering initial attack of the amine to the corresponding azomethine ylide. Substitutions about the 4-
position were next explored. The use of 4-F 280b initially resulted in an incomplete reaction with the 
formation of a mixture of products and ~20% unreacted starting material. Interestingly, when the 
reaction was repeated, the limiting starting material was consumed and formation of a single product 
was evidenced upon analysis of the crude material. However, after flash column chromatography, 
significant loss of material was observed and a mixture of new signals in the 1H NMR spectrum not 
present in that of the crude material, indicating a further transformation upon silica had occurred, with 
apparent isolation of isoindole 282b′ in 25% yield. The use of 4-Cl (280d) and 4-Br (280e) 
derivatives gave complete conversion to the corresponding isoindolines 282d and 282e isolated in 
42% and 49% yield, respectively. Next, substrates with the electron-donating substituents, 4-Me 
(280f) and 4-MeO (280g) were investigated and gave the desired isoindoline 282f and 282g with good 
yields of 61% and 62%, respectively. The 5-position and 6-positions were then briefly investigated 
via the corresponding 5-Cl (280h) and 6-Cl (280i) analogues, both of which underwent complete 
conversion providing the desired isoindolines 282h and 282i isolated in 54% and 61% yields, 
respectively. These results demonstrate the tolerance of both electron-withdrawing and donating 
substitutions about the benzenoid ring, allowing access to functionalised fused polycyclic systems. 
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Table 2.11: Substrate scope with respect to the benzenoid component.a 
 
 
282a 
70% 
282b′ 
25% (unstable) 
 
280c 
no cycloaddition 
282d 
42% 
282e 
49% 
282f 
61% 
282g 
62% 
282h 
54% 
 
282i 
61% 
a Conditions: 1.0 equiv. 280, 2.0 equiv. 266, 2.5 equiv. Et3N under N2 atm in 0.1M PhMe. 
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Due to time constraints, manipulation of the isoindoline cycloadduct 282 was unfortunately 
unable to be performed. Another goal of this work was to test the products for biological activity as 
they contain scaffolds of pharmacological relevance. With the current substrates in hand, they will be 
sent for biological testing (for antibacterial properties). Furthermore, expanded substrate scope, 
specifically with other secondary amino acids, was unable to be elucidated, also due to time 
constraints. In addition to further investigating expanded substrate scope about the amino acid 
position, other types of product manipulations can be envisaged. These include: nitro reduction, 
expanded tether length in order to achieve 8- or 9-membered products, destosylation to reveal the free 
amine in addition to other protecting groups/heteroatoms, and coupling reactions about the benzenoid 
ring (Figure 2.7). Moreover, the expected divergent manipulation of 282 could provide multiple 
access to even more potentially bioactive highly functionalised products. 
 
 
Figure 2.7: Potential product manipulation.  
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2.3: Conclusions 
 
In summary, the intramolecular [3 + 2] cycloaddition reaction between an in-situ generated 
azomethine ylide and a pendent 3,5-dinitrophenyl group has been developed. The initially formed 
dearomatised cycloadducts rapidly lost nitrous acid with concomitant rearomatisation to form 
tetracyclic isoindolines. Prolonged heating was found to impose a detrimental effect on the 
isoindolines formed, with oxidation of the isoindoline skeleton providing the unstable isoindole. 
Control of the formation of the isoindoline cycloadduct was regulated via strict heating at no greater 
than 100 °C under anhydrous conditions. The pendent aromatic was found to require substitution with 
strongly electron-withdrawing groups, with reactions only observed when substituted with a 3,5-
dinitro moiety. The utilisation of an O-tethered starting material was found to return the isoindoline 
product in low yields, while the utilisation of an N-tethered starting material was found to form the 
isoindoline in higher yields with greater tolerability for a range of substrates. The favourable reaction 
with the N-tethered starting materials is likely due an increase of the reaction rate via the Thorpe-
Ingold effect. Substitution patterns about the benzenoid component of the starting material was well 
tolerated, with 4-, 5-, 6-, and 7-substitions all returning the desired cycloadduct in moderate yields. 
However, substitution of the 3-position was found to disfavor cycloaddition, likely due to steric 
influences. Notably, the use of α-amino acids was found to be critical towards the formation of the 
desired products. Conversely, amino esters were found to not undergo cycloaddition, most likely due 
to the stabilising influences the ester group imparts on the in-situ generated azomethine ylide, 
disfavoring cycloaddition towards the relatively unreactive pendent nitro-aromatic. Branched amino 
acids were found to undergo successful condensation-cycloaddition process producing the cis-
diastereomer. Importantly, these new compounds have the potential to be varied at multiple sites to 
allow further product variations. Future directions of this project are to be focused on further 
expansion of the substrate scope of N-Ts tethered starting material and exploration of product 
manipulations to demonstrate the potential utility of the developed method. In addition, the use of 
other electron-deficient aromatic systems will be explored in efforts to expand the versatility of the 
pendent aromatic group.  
  
	 93 
2.4: Cycloaddition of an Azomethine Ylide to Electron-Deficient Isatoic Anhydrides 
 
With our continued interest in the reactivity of azomethine ylides with aromatic dipolarophiles within 
the context of dearomatisation, an additional project was carried out alongside that described above to 
explore the reactivity of a non-stabilised azomethine ylide with aromatic ring in the form of isatoic 
anhydride derivatives. Previous work at CSIRO in the group of Dr. Jack Ryan had uncovered non-
stabilised azomethine ylide such as 279′ generated in-situ from reagent 279 reacting with a wide 
range of substituted isatoic anhydrides 289 to afford novel 1,3-benzodiazepin-5-one derivatives 291.23 
Mechanistically, cycloaddition occurs to the carbonyl group providing transient spectroscopically 
observable oxazolidine intermediates 290 which underwent a  ring-opening, decarboxylation, and 
ring-closing cascade process to yield the 1,3-benzodiazepin-5-one cycloadducts 291 in generally 
excellent yield (Scheme 2.8).  
 
 
Scheme 2.8: 1,3-Dipolar cycloaddition/decarboxylation reaction between a non-stabilised 
azomethine ylide and isatoic anhydrides for the formation of benzodiazepinones. 
 
Importantly, it was noted that electron-withdrawing substituents on the benzenoid component 
(R2) of the isatoic anhydride resulted in increased rates of transformation. Therefore, in order to 
further explore the influence of electron-withdrawing substituents on these type of systems in 
different positions on the aryl ring, nitro-substituted anhydrides 289a and 289b were prepared 
(Scheme 2.9). Selective nitration at the 6-position of isatoic anhydride 287 was carried out via 
exposure to NaNO3/H2SO4 at 0 °C for 1 hour, forming 288a in 80% yield. Next, N-methylation was 
performed on 6-nitro isatoic anhydride 288a and commercial 7-nitro isatoic anhydride 288b using 
MeI in the presence of DIPEA to yield the corresponding products 289a/289b in low to moderate 
yields on a ~2.5 g scale. 
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Scheme 2.9: Preparation of nitro-substituted isatoic anhydrides. 
 
Initial trial reactions of N-methyl-7-nitroisatoic anhydride 289b with azomethine ylide 279′ 
generated in-situ from 279 under LiF or TFA catalysed conditions, gratifyingly saw the efficient 
transformation towards the corresponding nitro-substituted cycloadduct 291b in 46-62% yield and 57-
83% yield respectively (Scheme 2.10). The use of LiF conditions saw the reaction progress within 3.5 
hours, however, the use of TFA catalysed conditions required ~15 hours stirring at room temperature 
to ensure 100% conversion. 
 
 
Scheme 2.10: Cycloaddition of 289b towards 291b. Conditions (i): LiF, 4Å MS, MeCN, 35–40 °C, 3.5 
h. Conditions (ii): TFA (0.05 equiv.), 3Å MS, CH2Cl2, 0 °C to room temperature, 16 h. 
 
In contrast, when N-methyl-6-nitroisatoic anhydride 289a was reacted with azomethine ylide 
279′ generated from 279 under LiF conditions, interestingly, low conversion towards the expected 
benzo-1,3-diazepin-5-one 291a (7% yield) was observed. Most curiously, new aliphatic peaks were 
observed in the crude material 1H NMR spectra that had not been observed before as the major 
component. MS analysis of this major component material returned a peak at [488+] correlating to a 
bis-cycloadduct indicating 289a had undergone cycloaddition twice with 279′. When the reaction was 
repeated on a larger scale with excess azomethine ylide 289, benzo-1,3-diazepin-5-one 289a was 
observed in slight increased yield of 20%, and isolation of the major bis-cycloadducts 292a and 292a′ 
were found in 46% and 28% respectively (Scheme 2.11). When the reaction was repeated under TFA-
catalysed conditions, similar conversion towards the corresponding benzo-1,3-diazepin-5-one 291a 
was observed (23% yield), however, the major bis-cycloadduct 292a was found in reduced yield (8%) 
and minor bis-cycloadduct 292a′ in 7% yield. It should be noted that extended reactions times (i.e., 
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>3 hours) and/or heating above 40 °C resulted in the return of complex crude 1H NMR spectra 
indicative of decomposition highlighting the delicate nature of the products. 
 
 
Scheme 2.11: Utilisation of N-methyl-6-nitroisatoic anhydride 289a with azomethine ylide 286 
resulting in formation of benzo-1,3-diazepin-5-one 291a and bis-cycloadducts 292/292a′. Conditions 
(i): LiF, 4Å MS, MeCN, 35–40 °C, 3.5 h. Conditions (ii): TFA (0.05 equiv.), 3Å MS, CH2Cl2, 0 °C to 
room temperature, 16 h. 
 
Full characterisation and structural elucidation of the bis-cycloadducts 292/292a′ were 
conducted by Asha M. D’Souza from CSIRO Manufacturing in which NMR and IR data supported 
bis-cycloaddition promoted on the nitro-substituted benzenoid ring with the anhydride component 
intact.24 
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Mechanistically, the preference for 6-nitro substituted isatoic anhydride 289a to undergo bis-
cycloaddition with the non-stabilised azomethine ylide 279′ can be rationalised via analysis of 
resonances effects and changes in frontier molecular orbital interactions (Scheme 2.12). Generally, 
1,3-dipolar cycloaddition rates increase with smaller HOMO-LUMO energy gaps,25 therefore, in 6-
nitroisatoic anhydride 289a, the nitro group permits resonance contributors otherwise not possible in 
7-nitroisatoic anhydride 289b. Furthermore, the propensity for the formation of bis-cycloadducts 292 
indicates a rapid selective second cycloaddition process due to the activated bond. 
 
 
Scheme 2.12: Resonance effects of 6-nitroisatoic anhydride 289a and 7-nitroisatoic anhydride 289b.  
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2.4: Future Directions 
	
2.4.1: Trapping the Isoindole via a [4 + 2] Diels-Alder Reaction 
 
During the optimisation of the intramolecular [3 + 2] cycloaddition of the N-tethered substrate 280, a 
side product was tentatively identified as the corresponding isoindole 281′ due to oxidative processes 
(Scheme 2.6, A). The oxidised side product was not conclusively identified due to its inherent 
instability and decomposition.26 Due to this instability, previous research groups have employed the 
trapping of analogous in-situ generated isoindoles 294 in a Diels–Alder [4 + 2] cycloaddition reaction 
to yield the more stable product 296 (Scheme 2.15, B).27 It is therefore proposed that cycloadduct 282 
could be subjected to oxidation conditions to favour the formation of the unstable isoindole 282′, and 
then consequently introduce a well-known dienophile, such as N-methylmaleimide 295, under [4 + 2] 
cycloaddition conditions to deliver cycloadduct 297 (Scheme 2.15, C). 
	
 
Scheme 2.15: A) Formation of unstable over-oxidised cycloadduct 281′. B) Trapping of the in-situ 
generated isoindole 294 with dieneophile 295 for the generation of stable product 296. C) Proposed 
reaction design to trap the unstable isoindole 282′ with a dienophile 295 in a Diels-Alder reaction for 
the formation of stable products 297. 
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2.4.2: Exploration of the 3,5-(Bis)trifluoromethyl Pendent Aromatic Substrate 
 
During the course of trialling different electron-deficient pendent aromatic systems, the 3,5-
(bis)trifluoromethyl pendent aromatic substrate 262k was found to return some starting material and 
partial conversion to an unidentified material (Table 2.2, entry 6). However, analysis of the 1H NMR 
spectrum of the crude material was found be messy indicating multiple products and also underwent 
an apparent change after flash column chromatography indicative of product instability. When the 
reaction was repeated with 10 equivalents of sarcosine present, the full consumption of the starting 
material and formation of promising new peaks in the 1H NMR spectrum was uncovered. Analysis of 
the 1H NMR spectrum saw doublet signals at 4.53 and 4.49 ppm sharing a J-coupling of 5.0 Hz, and a 
doublet of doublets signals at 3.41 and 2.77 ppm sharing a J-coupling of 11.3 and 7.0 Hz, indicative 
of a cyclic product containing two CH2 groups. Furthermore, a singlet resonance at 2.50 ppm likely 
correlated to a N-CH3 group, perhaps supporting evidence for the newly formed pyrrolidine ring. 
However, it was noted that the material slowly transformed after one-week indicative of product 
instability. Due to time constraints, unfortunately further investigations were deferred. The 
exploration of the 3,5-trifluoromethyl pendent aromatic substrate 298 merits further investigations. 
This approach is particularly interesting considering the potential cycloadduct 299 to have undergone 
true dearomatisation due to the low likelihood of HCF3 elimination (Scheme 2.16). 
 
 
Scheme 2.16: Intramolecular [3 + 2] cycloaddition towards a pendent aromatic substituted with the 
highly electron-withdrawing 3,5-(bis)trifluoromethyl groups. 
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2.5: Experimental Section 
 
General Experimental Details: 
 
Unless stated specifically, all chemicals were purchased from commercial suppliers and used without 
purification. All reactions were conducted in oven-dried glassware under nitrogen atmosphere. The 
reaction solvents were dried by passing through a column of activated alumina and then stored over 4 
Å or 3 Å molecular sieves. The progress of reactions was tracked by TLC which was performed on 
aluminium backed silica gel sheets (Grace Davison, UV254). TLC plates were visualised under UV 
lamp at 254 nm and/ or by treatment with one of the following TLC stains: phosphomolybdic acid 
(PMA) stain; PMA (10 g), absolute EtOH (100 mL); potassium permanganate stain: KMnO4 (1.5 g), 
10% NaOH (1.25 mL), water (200 mL); vanillin stain: Vanillin (15 g), concentrated H2SO4 (2.5 mL), 
EtOH (250 mL). For NMR spectroscopy, analytes were dissolved in deuterated chloroform or stated 
otherwise. NMR spectra for each compound were collected from one of the following instruments: a 
Mercury 2000 spectrometer operating at 500 and 125 MHz for 1H and 13C NMR respectively; a 
Bruker spectrometer operating at 400, 100, and 470 MHz for 1H, 13C, and 19F NMR, respectively. 
NMR data are expressed in parts per million (ppm) and referenced to the solvent (7.26 ppm for 1H 
NMR and 77.16 ppm for 13C NMR). The following abbreviations are used to assign the multiplicity of 
the 1H NMR signal: s = singlet; bs = broad singlet; d = doublet; t = triplet; q = quartet; p = pentet; 
quin = quintet; dd = doublet of doublets; dt = doublet of triplets; m = multiplet. NMR assignments 
were made on the basis of COSY, HSQC, HMBC, and DEPT experiments. For mass spectrometry, 
analytes were dissolved in HPLC grade methanol, acetonitrile or dichloromethane. High-resolution 
mass spectra were collected from a Waters Xevo G1 QTOF mass spectrometer. Infrared spectra were 
obtained from a Shimadzu IRAffinity-1 Fourier transform infrared spectrophotometer with ATR 
attachment. Melting point measurements were performed using a Buchi M-560.  
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2.5.1: Synthesis of O-Tethered Substrates 
	
 
 
General Procedure A: 
Method adapted from: J. Am. Chem. Soc., 2012, 134, 11153. 
In a round bottom flask equipped with condenser under a flow of N2 was loaded the 
halomethyl(nitro)benzene 261 (1.0 equiv.), the 2-hydroxybenzaldehyde (or derivative) 260 (2.0 
equiv.), and Cs2CO3 (1.0 equiv.) in MeCN (0.5 M wr 261). The resultant mixture was heated to reflux 
and monitored via TLC (typically 1-2 hours). After which, the reaction was cooled to room 
temperature, filtered through a sintered glass funnel, the solid residue washed generously with 
CH2Cl2, and the filtrate was concentrated under reduced pressure. The crude material was then diluted 
with H2O (equal to reaction volume) and extracted thrice using CH2Cl2, the combined organic phases 
were dried over Na2SO4, filtered and concentrated under reduced pressure. The product was then 
purified via recrystallisation or flash column chromatography to reveal to afford the benzylated 
salicylaldehyde 262.  
 
General Procedure B: 
Method adapted from: J. Am. Chem. Soc., 2012, 134, 11153. 
In a round bottom flask equipped with condenser under a flow of N2 was loaded the 
halomethyl(nitro)benzene 261 (1.0 equiv.), the 2-hydroxybenzaldehyde (or derivative) 260 (2.0 
equiv.), and Cs2CO3 (1.0 equiv.) in MeCN (0.5 M wr 261). The resultant mixture was heated to reflux 
and allowed to stir typically overnight. After which, the reaction was cooled to room temperature, the 
crude material was then diluted with H2O (equal to reaction volume) and extracted thrice using 
CH2Cl2, the combined organic phases were dried over Na2SO4, filtered and concentrated under 
reduced pressure. The product was then purified via recrystallisation or flash column chromatography 
to reveal to afford the benzylated salicylaldehyde 262. 
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2-((2-Nitrobenzyl)oxy)benzaldehyde (262aa) 
The title compound was prepared using General Procedure A. The product 
was recrystallised from MeOH to afford the title compound as a beige solid 
(0.211 g, 82% yield). Mp: 137-140 °C. 1H NMR (400 MHz, CDCl3): δ 10.59 
(s, 1H, CHO), 8.21 (d, J = 8.2 Hz, 1H, CHAr), 7.96 (d, J = 7.8 Hz, 1H, CHAr), 
7.88 (d, J = 7.5 Hz, 1H, CHAr), 7.74 (t, J = 7.5 Hz, 1H, CHAr), 7.59-7.52 (m, 2H, overlapping CHAr), 
7.13-7.06 (m, 2H, overlapping CHAr), 5.62 (s, 2H, O-CH2) ppm. 13C NMR (100 MHz, CDCl3): δ 
189.4 (CHO), 160.2 (CAr), 146.9 (CAr), 136.2 (CHAr), 134.5 (CHAr), 133.0 (CAr), 129.6 (CHAr), 128.8 
(CHAr), 128.5 (CHAr), 125.3 (CHAr), 121.7 (CHAr), 113.1 (CHAr), 67.4 (O-CH2), one signal obscured 
ppm. HRMS (ESI): calcd for C14H12NO4 [M + H]+ 258.0766, found 258.0760. IR (ATR, cm-1): ṽ = 
2800 (w), 2700 (w), 1682 (m), 1597 (m), 1517 (m), 1482 (m), 1457 (m), 1400 (w), 1376 (w), 1338 
(s), 1288 (m), 1240 (s), 1188 (m), 1158 (m), 1101 (m), 1049 (m), 1024 (s), 861 (m), 849 (m), 791 (m), 
757 (s), 725 (s), 649 (s).  
 
2-((3-Nitrobenzyl)oxy)benzaldehyde (262ab) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title compound as a 
beige solid (0.087 g, 33% yield). Mp: 118-120 °C. 1H NMR (400 MHz, 
CDCl3): δ 10.55 (s, 1H, CHO), 8.32 (s, 1H, CHAr), 8.22 (dd, J = 9.5, 1.3 
Hz, 1H, CHAr), 7.88 (dd, J = 7.7, 1.8 Hz, 1H, CHAr), 7.82 (dd, J = 7.7, 0.8 Hz, 1H, CHAr), 7.61 (t, J = 
8.0 Hz, 1H, CHAr), 7.59-7.54 (m, 1H, CHAr), 7.10 (t, J = 7.5 Hz, 1H, CHAr), 7.03 (d, J = 8.4 Hz, 1H, 
CHAr), 5.29 (s, 2H, O-CH2) ppm. 13C NMR (100 MHz, CDCl3): δ 189.4 (CHO), 160.4 (CAr), 148.6 
(CAr), 138.3 (CAr), 136.1 (CHAr), 133.2 (CHAr), 130.0 (CHAr), 129.2 (CHAr), 125.3 (CAr), 123.4 (CHAr), 
122.2 (CHAr), 121.8 (CHAr), 112.9 (CHAr), 69.3 (O-CH2-Ar) ppm. HRMS (ESI): calcd for C14H12NO4 
[M + H]+ 258.0766, found 258.0768. IR (ATR, cm-1): ṽ = 2850 (w), 1679 (m), 1597 (m), 1526 (m), 
1482 (m), 1461 (m), 1386 (m), 1340 (s), 1285 (m), 1238 (s), 1169 (m), 1092 (m), 1026 (m), 882 (w), 
846 (w), 827 (m), 802 (s), 753 (s), 730 (s), 688 (s), 668 (m).  
 
2-((4-Nitrobenzyl)oxy)benzaldehyde (262ac) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title compound as a 
beige solid (0.182 g, 71% yield). Mp: 114-117 °C. 1H NMR (400 MHz, 
CDCl3): δ 10.56 (s, 1H, CHO), 8.27 (d, J = 8.5 Hz, 2H, CHAr), 7.87 (d, J 
= 7.7 Hz, 1H, CHAr), 7.64 (d, J = 8.6 Hz, 2H, CHAr), 7.57-7.53 (m, 1H, CHAr), 7.09 (t, J = 7.5 Hz, 1H, 
CHAr), 7.01 (d, J = 8.4 Hz, 1H, CHAr), 5.31 (s, 2H, O-CH2) ppm. 13C NMR (100 MHz, CDCl3): δ 
189.3 (CHO), 160.3 (CAr), 147.9 (CAr), 143.5 (CAr), 136.1 (CHAr), 129.3 (CHAr), 127.7 (2 x CHAr), 
125.3 (CAr), 124.1 (2 x CHAr), 121.8 (CHAr), 112.9 (CHAr), 69.2 (O-CH2) ppm. HRMS (ESI): calcd 
CHO
O
NO2
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O NO2
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O
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for C14H12NO4 [M + H]+ 258.0766, found 258.0763. IR (ATR, cm-1): ṽ = 2880 (w), 2700 (w), 1684 
(s), 1595 (m), 1517 (s), 1484 (w), 1449 (w), 1342 (s), 1298 (m), 1242 (s), 1189 (w), 1103 (m), 1049 
(m), 840 (s), 752 (s), 736 (s). 
 
2-((3,5-Dinitrobenzyl)oxy)benzaldehyde (262ad) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title compound as a 
white solid (0.272 g, 77% yield). Mp: 173-176 °C. 1H NMR (400 MHz, 
CDCl3): δ 10.54 (s, 1H, CHO), 9.06 (s, 1H, CHAr), 8.71 (s, 2H, CHAr), 
7.92 (d, J = 7.6 Hz, 1H, CHAr), 7.61 (t, J = 7.8 Hz, 1H, CHAr), 7.17 (t, J 
= 7.3 Hz, 1H, CHAr), 7.04 (d, J = 8.3 Hz, 1H, CHAr), 5.40 (s, 2H, O-CH2-Ar) ppm. 13C NMR (100 
MHz, CDCl3): δ 188.9 (CHO), 159.5 (CAr), 149.0 (CAr), 140.8 (CAr), 136.2 (CHAr), 130.2 (CHAr), 
127.2 (two overlapping CHAr), 125.5 (CAr), 122.5 (CHAr), 118.8 (CHAr), 112.7 (CHAr), 68.4 (O-CH2-
Ar) ppm. HRMS (ESI): calcd for C14H11N2O6 [M + H]+ 303.0617, found 303.0608. IR (ATR, cm-1): 
ṽ = 3110 (w), 2890 (w), 2770 (w), 1685 (s), 1597 (m), 1534 (s), 1492 (w), 1344 (s), 1287 (w), 1186 
(w), 1154 (w), 908 (w), 870 (w), 763 (s), 728 (s), 649 (s). 
 
5-Chloro-2-((3,5-dinitrobenzyl)oxy)benzaldehyde (262bd) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title compound 
as a pale brown solid (0.809 g, 52% yield). Mp: 197-199 °C. 1H 
NMR (500 MHz, CDCl3): δ 10.47 (s, 1H, CHO), 9.07 (s, 1H, 
CHAr), 8.69 (s, 2H, CHAr), 7.87 (d, J = 1.5 Hz, 1H, CHAr), 7.55 (dd, 
J = 8.8, 2.7 Hz, 1H, CHAr), 7.01 (d, J = 8.9 Hz, 1H, CHAr), 5.38 (s, 2H, CH2) ppm. 13C NMR (125 
MHz, CDCl3): δ 187.5 (C=O), 158.0 (CAr), 149.1 (CAr), 140.3 (CAr), 135.7 (CHAr), 129.6 (CHAr), 
128.3 (CAr), 127.2 (CHAr), 126.4 (CAr), 119.0 (CHAr), 114.4 (CHAr), 68.8 (CH2) ppm. HRMS (ESI): 
calcd for C14H8ClN2O6 [M - H]- 335.0071, found 335.0063. IR (ATR, cm-1): ṽ = 3096 (w), 2863 (w), 
2749 (w), 1697 (s), 1594 (w), 1533 (s), 1486 (m), 1343 (s), 1282 (s), 1181 (s), 1047 (m), 911 (s), 808 
(s), 725 (s), 690 (m).  
 
5-Bromo-2-((3,5-dinitrobenzyl)oxy)benzaldehyde (262cd) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title compound 
as a pale brown solid (0.656 g, 62% yield). Mp: 198-200 °C. 1H 
NMR (500 MHz, CDCl3): δ 10.45 (s, 1H, CHO), 9.07 (s, 1H, 
CHAr), 8.69 (s, 2H, CHAr), 8.01 (d, J = 2.5 Hz, 1H, CHAr), 7.69 (dd, 
J = 8.8, 2.5 Hz, 1H, CHAr), 6.95 (d, J = 8.8 Hz, 1H, CHAr), 5.37 (s, 2H, CH2) ppm. 13C NMR (125 
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MHz, CDCl3): δ 187.4 (C=O), 158.4 (CAr), 149.1 (CAr), 140.2 (CAr), 138.6 (CHAr), 132.6 (CHAr), 
127.2 (CHAr), 126.7 (CAr), 119.0 (CHAr), 115.4 (CAr), 114.7 (CHAr), 68.8 (CH2) ppm. HRMS (ESI): 
calcd for C14H8N2O6Br [M – H]- 378.9566, found 378.9567. IR (ATR, cm-1): ṽ = 3118 (w), 3066 (w), 
2853 (w), 2741 (w), 1690 (s), 1591 (w), 1535 (s), 1485 (m), 1341 (s), 1280 (s), 1159 (m), 1043 (s), 
904 (s), 828 (s), 727 (s).  
 
2-((3,5-Dinitrobenzyl)oxy)-5-nitrobenzaldehyde (262dd) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title 
compound as an orange solid (0.573 g, 47% yield). Mp: 209-212 
°C. 1H NMR (400 MHz, d-DMSO): δ 10.39 (s, 1H, CHO), 8.87 
(d, J = 2.1Hz, 2H, CHAr), 8.83-8.82 (m, 1H, CHAr), 8.56 (dd, J = 
9.2, 3.0 Hz, 1H, CHAr), 8.50 (d, J = 2.8 Hz, 1H, CHAr), 7.56 (d, J = 9.2 Hz, 1H, CHAr), 5.70 (s, 2H, 
CH2) ppm. 13C NMR (100 MHz, d-DMSO): δ 188.2 (CHO), 163.7 (CAr), 148.2 (CAr), 141.3 (CAr), 
139.9 (CAr), 130.9 (CHAr), 128.2 (CHAr), 124.4 (CAr), 124.3 (CHAr), 118.3 (CHAr), 115.0 (CHAr), 68.9 
(CH2) ppm. HRMS (ESI): calcd for C14H8N3O8 [M – H]- 346.0311, found 346.0301. IR (ATR, cm-
1): ṽ = 3085 (m), 3072 (m), 2872 (w), 1687 (s), 1612 (s), 1587 (m), 1532 (s), 1493 (m), 1343 (s), 1284 
(s), 1186 (m), 1104 (m), 1035 (m), 921 (m), 841 (m), 789 (m), 748 (s), 730 (s).  
 
2-((3,5-Dinitrobenzyl)oxy)-5-methylbenzaldehyde (262ed) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title compound 
as a beige solid (0.129 g, 23% yield). Mp: 226-228 °C. 1H NMR 
(500 MHz, d-DMSO): δ 10.42 (s, 1H, CHO), 8.80 (s, 3H, CHAr), 
7.56 (s, 1H, CHAr), 7.51 (d, J = 8.5 Hz, 1H, CHAr), 7.24 (d, J = 8.5 
Hz, 1H, CHAr), 5.52 (s, 2H, CH2), 2.30 (s, 3H, Ar-CH3) ppm. 13C NMR (125 MHz, d-DMSO): δ 
189.3 (CHO), 157.8 (CAr), 148.2 (CAr), 141.1 (CAr), 136.8 (CHAr), 130.6 (CAr), 128.5 (CHAr), 127.8 
(CHAr), 124.2 (CAr), 118.0 (CHAr), 114.0 (CHAr), 67.9 (CH2), 19.8 (Ar-CH3) ppm. HRMS (ESI): 
calcd for C15H11N2O6 [M – H]- 315.0617, found 315.0631. IR (ATR, cm-1): ṽ = 3107 (w), 3085 (w), 
2852 (w), 2734 (w), 1682 (s), 1576 (w), 1532 (s), 1499 (m), 1342 (s), 1287 (s), 1233 (s), 1147 (s), 907 
(s), 770 (m), 726 (s).  
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2-((3,5-Dinitrobenzyl)oxy)-5-methoxybenzaldehyde (262fd) 
The title compound was prepared using General Procedure A. The 
product was recrystallised from MeOH to afford the title 
compound as a yellow solid (0.238 g, 40% yield). Mp: 193-195 
°C. 1H NMR (500 MHz, d-DMSO): δ 10.41 (CHO), 8.79 (s, 3H, 
CHAr), 7.30-7.28 (m, 2H, CHAr), 7.23 (dd, J = 2.7, 0.9 Hz, 1H, 
CHAr), 5.49 (s, 2H, CH2), 3.77 (s, 3H, O-CH3) ppm. 13C NMR (125 MHz, d-DMSO): δ 189.0 (CHO), 
154.3 (CAr), 153.7 (CAr), 148.2 (CAr), 141.2 (CAr), 127.8 (CHAr), 125.1 (CAr), 122.8 (CHAr), 118.0 
(CHAr), 116.0 (CHAr), 111.1 (CHAr), 68.5 (CH2), 55.6 (O-CH3) ppm. HRMS (ESI): calcd for 
C15H11N2O7 [M – H]- 331.0566, found 331.0572. IR (ATR, cm-1): ṽ = 3093 (w), 2885 (w), 1668 (s), 
1587 (w), 1537 (s), 1494 (m), 1342 (s), 1255 (m), 1218 (s), 1171 (s), 1112 (m), 1052 (s), 893 (m), 723 
(s), 596 (m).  
 
2-((3,5-Difluorobenzyl)oxy)benzaldehyde (262ae) 
The title compound was prepared using General Procedure A. The product 
was recrystallised from MeOH to afford the title compound as a white solid 
(0.450 g, 76% yield). Mp: 100-105 oC. 1H NMR (400 MHz, CDCl3) δ: 
10.56 (d, J = 0.6 Hz, 1H, CHO), 7.87 (dd, J = 7.7, 1.8 Hz, 1H, CHAr), 7.57-
7.52 (m, 1H, CHAr), 7.08 (t, J = 7.5 Hz, 1H, CHAr), 7.00-6.95 (m, 3H, 
overlapping CHAr), 6.81-6.76 (m, 1H, CHAr), 5.17 (s, 2H, O-CH2-Ar) ppm. 13C NMR (100 MHz, 
CDCl3) δ: 189.4 (CHO), 163.4 (2 x CAr-F), 160.4 (CAr), 140.2 (CAr), 136.1 (CHAr), 129.1 (CHAr), 
125.3 (CAr), 121.7 (CHAr), 112.9 (CHAr), 109.9 (CHAr), 103.8 (CHAr), 69.2 (O-CH2-Ar) ppm. HRMS 
(ESI): calcd for C14H10O2F2 [M]+ 248.0643, found 248.0642. IR (ATR, cm-1): ṽ = 3110 (w), 2870 
(w), 1685 (s), 1597 (m), 1534 (s), 1492 (w), 1344 (s), 1287 (w), 1186 (w), 1154 (w), 908 (w), 870 
(w), 763 (s), 728 (s), 649 (s). 
 
2-((3,5-Bis(trifluoromethyl)benzyl)oxy)benzaldehyde (262af) 
The title compound was prepared using General Procedure A. The 
product was purified by dry vacuum column chromatography to afford 
the title compound as a white solid (0.386 g, 68% yield). Rf: 0.20 in 
10:90 ethyl acetate:petroleum spirit. Mp: 120-125 °C. 1H NMR (400 
MHz, CDCl3): δ 10.54 (s, 1H, CHO), 7.94 (s, 2H, CHAr), 7.91-7.89 (m, 
2H, overlapping CHAr), 7.59 (t, J = 8.0 Hz, 1H, CHAr), 7.13 (t, J = 7.5 Hz, 1H, CHAr), 7.03 (d, J = 8.0 
Hz, 1H, CHAr), 5.30 (s, 2H, O-CH2-Ar) ppm. 13C NMR (100 MHz, CDCl3): δ 189.2 (CHO), 160.2 
(CAr), 138.9 (CHAr), 136.1 (CHAr), 132.5 (CAr), 132.3 (CAr), 129.5 (CHAr), 127.4 (q, J = 13.5 Hz, C-
CF3), 125.4 (CHAr), 122.4 (t, J = 15.5 Hz, CF3), 122.0 (CHAr), 112.8 (CHAr), 69.2 (O-CH2-Ar) ppm. 
HRMS (ESI): calcd for C16H10O2F6 [M]+ 348.0580, found 348.0577. IR (ATR, cm-1): ṽ = 2850 (w), 
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2750 (w), 1685 (s), 1597 (m), 1534 (s), 1492 (w), 1344 (s), 1287 (w), 1186 (w), 1154 (w), 908 (w), 
870 (w), 763 (s), 728 (s), 649 (s). 
 
2-(Pyridin-2-ylmethoxy)benzaldehyde (262ag) 
The title compound was prepared using General Procedure A. The product was 
recrystallised from MeOH to afford the title compound as a beige solid (0.160 
g, 74% yield). Mp: 64-66 °C. 1H NMR (400 MHz, CDCl3): δ 10.60 (s, 1H, 
CHO), 8.60 (d, J = 4.8 Hz, 1H, CHAr), 7.85 (d, J = 7.6 Hz, 1H, CHAr), 7.74 (t, 
J = 7.7 Hz, 1H, CHAr), 7.55-7.49 (m, 2H, overlapping CHAr), 7.26-7.23 (m, 1H, CHAr), 7.07-7.02 (m, 
2H, overlapping CHAr), 5.31 (s, 2H, O-CH2-Ar) ppm. 13C NMR (100 MHz, CDCl3): δ 189.7 (CHO), 
160.7 (CAr), 156.4 (CAr), 149.5 (CHAr), 137.1 (CHAr), 136.1 (CHAr), 128.9 (CHAr), 125.2 (CAr), 123.1 
(CHAr), 121.4 (2 overlapping CHAr), 113.1 (CHAr), 71.2 (O-CH2-Ar) ppm. HRMS (ESI): calcd for 
C13H12O2N [M + H]+ 214.0868, found 214.0856. IR (ATR, cm-1): ṽ = 2865 (w), 1684 (m), 1592 (m), 
1486 (m), 1458 (m), 1434 (m), 1398 (w), 1376 (m), 1298 (m), 1244 (s), 1194 (m), 1172 (m), 1106 
(m), 1032 (s), 851 (m), 751 (s), 666 (s).  
 
2-(Pyridin-3-ylmethoxy)benzaldehyde (262ah) 
The title compound was prepared using General Procedure A. The product 
was recrystallised from MeOH to afford the title compound as a beige solid 
(0.134 g, 64% yield). Mp: 51-54 °C. 1H NMR (400 MHz, CDCl3): δ 10.49 
(s, 1H, CHO), 8.69 (s, 1H, CHAr), 8.60 (d, J = 4.6 Hz, 1H, CHAr), 7.86-7.85 
(m, 1H, CHAr), 7.80-7.78 (m, 1H, CHAr), 7.56-7.52 (m, 1H, CHAr), 7.34 (dd, J = 7.8, 4.9 Hz, 1H, 
CHAr), 7.07-7.04 (m, 2H, CHAr), 5.19 (s, 2H, O-CH2-Ar) ppm. 13C NMR (100 MHz, CDCl3): δ 189.4 
(CHO), 160.6 (CAr), 149.9 (CHAr), 148.9 (CHAr), 136.0 (CHAr), 135.3 (CHAr), 131.7 (CAr), 128.9 
(CHAr), 128.2 (CAr), 123.8 (CHAr), 121.5 (CHAr), 112.8 (CHAr), 68.1 (O-CH2-Ar) ppm. HRMS (ESI): 
calcd for C13H12O2N [M + H]+ 214.0868, found 214.0860. IR (ATR, cm-1): ṽ = 2858 (w), 1680 (s), 
1597 (s), 1577 (m), 1487 (m), 1447 (m), 1428 (m), 1396 (m), 1304 (m), 1286 (s), 1244 (s), 1193 (m), 
1158 (m), 1104 (m), 1045 (m), 1031 (s), 849 (m), 784 (s), 763 (s), 706 (s), 668 (m).  
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2.5.2: Synthesis of N-Tethered Substrates 
 
General Procedure C - Reduction: 
 
 
 
Method adapted from Chem. Commun., 2017, 53, 216-219. 
To a solution of the corresponding anthranilic acid (1.0 equiv.) in anhydrous THF (~1.0 M) cooled to 
0 °C was added a solution of LiAlH4 (2.2 equiv.) in anhydrous THF (~3.0 M) drop wise. After 
complete addition the reaction mixture was allowed to slowly warm to room temperature and stirred 
overnight. The next day, the reaction mixture was cooled to 0 °C, treated with crushed ice (slowly), 
then by addition of 15% NaOH solution (2 mL) forming a gel-like suspension which was stirred for 
15 minutes, then MgSO4 added and then the mixture was stirred for a further 15 minutes. The crude 
mixture was then filtered, extracted generously with EtOAc and the extract concentrated under 
reduced pressure. The product was then precipitated from small amount of hot EtOAc and excess n-
pentane, filtered and washed with cold n-pentane to reveal the corresponding alcohol.  
 
(2-Aminophenyl)methanol (276a) 
The title compound was prepared using General Procedure C to afford the title 
compound as a pale brown solid (1.115 g, 62% yield). 1H NMR (500 MHz, CDCl3): 
δ 7.12 (td, J = 7.7, 1.3 Hz, 1H, CHAr), 7.04 (dd, J = 7.4, 0.5 Hz, 1H, CHAr), 6.71 (td, 
J = 7.4, 0.9 Hz, 1H, CHAr), 6.68 (d, J = 7.9 Hz, 1H, CHAr), 4.62 (s, 3H, overlapping OH & CH2), 3.43 
(bs, 2H, NH2) ppm. 13C NMR (125 MHz, CDCl3): δ 146.1 (CAr-NH2), 129.5 (CHAr), 129.3 (CHAr), 
125.0 (CAr-CH2), 118.3 (CHAr), 116.2 (CHAr), 64.4 (CH2-OH) ppm. NMR data match known literature 
values: J. Org. Chem., 2010, 75, 4887-4890. 
 
(2-amino-5-fluorophenyl)methanol (276b) 
The title compound was prepared using General Procedure C to afford the title 
compound as a beige solid (1.647 g, 78% yield). 1H NMR (400 MHz, CDCl3): δ 
6.86-6.81 (m, 2H, CHAr), 6.65-6.60 (m, 1H, CHAr), 4.62 (s, 2H, CH2) ppm. 13C 
NMR (125 MHz, CDCl3): δ 156.0 (d, J = 235.1 Hz, CAr), 141.9 (CAr), 126.3 (d, J = 6.3 Hz, CAr), 
117.0 (d, J = 7.4 Hz, CHAr), 115.6 (d, J = 22.1 Hz, 2 x CHAr), 63.9 (CH2) ppm. NMR data match 
known literature values: Synlett., 2017, 28, 1724-1728. 
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(2-amino-6-chlorophenyl)methanol (276c) 
The title compound was prepared using General Procedure C to afford the title 
compound as a brown crystalline solid (1.347 g, 57% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.01 (t, J = 8.0 Hz, 1H, CHAr), 6.76 (dd, J = 8.0, 0.5 Hz, 1H, CHAr), 6.58 
(d, J = 8.0 Hz, 1H, CHAr), 4.88 (s, 2H, CH2-OH), 4.28 (bs, 2H, NH2), 1.66 (bs, 1H, 
CH2-OH) ppm. 13C NMR (125 MHz, CDCl3): δ 148.2 (CAr), 134.3 (CAr), 129.8 (CHAr), 122.2 (CAr), 
119.2 (CHAr), 114.8 (CHAr), 59.7 (CH2) ppm. NMR data match known literature values: Bioorg. Med. 
Chem., 2012, 20, 5810-5831. 
 
(2-amino-5-chlorophenyl)methanol (276d) 
The title compound was prepared using General Procedure C to afford the title 
compound as a pale yellow solid (1.827 g, 78% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.09-7.05 (m, 2H, 2x CHAr), 6.62 (d, J = 8.0 Hz, 1H, CHAr), 4.61 (s, 
2H, CH2), 4.17 (bs, 1H, NH2), 1.61 (bs, 1H, OH) ppm. 13C NMR (125 MHz, CDCl3): δ 144.7 (CAr), 
129.1 (CHAr), 128.9 (CHAr), 126.2 (CAr), 122.7 (CAr), 117.2 (CHAr), 64.0 (CH2) ppm. NMR data match 
known literature values: Synlett., 2017, 28, 1724-1728. 
 
(2-amino-4-chlorophenyl)methanol (276e) 
The title compound was prepared using General Procedure C to afford the title 
compound as a beige solid (1.618 g, 69% yield). 1H NMR (500 MHz, CDCl3): 
δ 6.97 (d, J = 8.0 Hz, 1H, CHAr), 6.69-6.66 (m, 2H, 2x CHAr), 4.64 (s, 2H, CH2), 
4.27 (bs, 2H, NH2), 1.58 (bs, 1H, OH) ppm. 13C NMR (125 MHz, CDCl3): δ 147.4 (CAr), 134.9 (CAr), 
130.3 (CHAr), 123.1 (CAr), 118.0 (CHAr), 115.7 (CHAr), 64.0 (CH2) ppm. NMR data match known 
literature values: Synlett., 2017, 28, 1724-1728. 
 
(2-amino-3-chlorophenyl)methanol (276f) 
The title compound was prepared using General Procedure C to afford the title 
compound as a white “needle-like” solid (1.012 g, 43% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.23 (d, J = 8.0 Hz, 1H, CHAr), 6.97 (d, J = 7.0 Hz, 1H, CHAr), 6.33 (t, J = 
7.5 Hz, 1H, CHAr), 4.67 (s, 2H, CH2), 4.65 (bs, 2H, NH2), 1.72 (bs, 1H, OH) ppm. 13C NMR (125 
MHz, CDCl3): δ 142.8 (CAr), 129.5 (CHAr), 127.6 (CHAr), 125.8 (CAr), 120.1 (CAr), 118.0 (CHAr), 
64.6 (CH2) ppm. NMR data match known literature values: Bioorg. Med. Chem., 2012, 70, 5810-
5831. 
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(2-amino-5-bromophenyl)methanol (276g) 
The title compound was prepared using General Procedure C to afford the title 
compound as a bright yellow solid (2.926 g, 97% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.22-7.18 (m, 2H, CHAr), 6.57 (d, J = 8.4 Hz, 1H, CHAr), 4.60 (s, 2H, 
CH2), 4.16 (bs, 2H, NH2), 1.76 (bs, 1H, OH) ppm. 13C NMR (125 MHz, CDCl3): δ 145.2 (CAr), 
132.0 (CHAr), 131.7 (CHAr), 126.7 (CAr), 117.7 (CHAr), 109.7 (CAr), 63.9 (CH2) ppm. NMR data match 
known literature values: Tetrahedron Lett., 2017, 58, 3795-3799. 
 
(2-amino-5-methylphenyl)methanol (276h) 
The title compound was prepared using General Procedure C to afford the title 
compound as an orange/yellow solid (2.011 g, 98% yield). 1H NMR (500 MHz, 
CDCl3): δ 6.94 (dd, J = 8.0, 2.0 Hz, 1H, CHAr), 6.88 (s, 1H, CHAr), 6.61 (d, J = 
8.0 Hz, 1H, CHAr), 4.61 (s, 2H, CH2), 2.23 (s, 3H, CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 143.5 
(CAr), 129.93 (CHAr), 129.89 (CHAr), 127.6 (CAr), 125.2 (CAr), 116.4 (CHAr), 64.5 (CH2), 20.5 (CH3) 
ppm. NMR data match known literature values: Tetrahedron Lett., 2017, 58, 3795-3799. 
 
(2-amino-5-methoxyphenyl)methanol (276i) 
The title compound was prepared using General Procedure C to afford the title 
compound as an orange/brown solid (2.066 g, 90% yield). 1H NMR (500 
MHz, CDCl3): δ 6.72 (dd, J = 8.5, 2.8 Hz, 1H, CHAr), 6.69-6.68 (m, 1H, 
CHAr), 6.64 (d, J = 8.5 Hz, 1H, CHAr), 4.61 (s, 2H, CH2), 3.74 (s, 3H, OCH3) ppm. 13C NMR (100 
MHz, CDCl3): δ 152.7 (CAr), 139.3 (CAr), 126.7 (CAr), 117.5 (CHAr), 115.1 (CHAr), 114.6 (CHAr), 
64.2 (CH2), 55.9 (OCH3) ppm. NMR data match known literature values: Bioorg. Med. Chem., 2012, 
20, 5810-5831. 
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General Procedure D - N-Tosylation: 
 
 
 
Method adapted from Chem Commun., 2017, 53, 216-219. 
To a solution of corresponding amino 276 (1.0 equiv.) in anhydrous CH2Cl2 (0.3 M) was added 
pyridine (1.5 equiv.). The resultant solution was cooled to 0 °C before addition of TsCl (1.1 equiv.). 
The resultant reaction mixture was then allowed to warm to room temperature and allowed to stir 
overnight. The reaction was then quenched using sat. aq. NaHCO3 (30 mL), the aqueous layer was 
extracted using CH2Cl2 (3 x 20 mL) and the solvent removed under reduced pressure. The crude 
material was then dissolved in EtOAc (30 mL), washed thrice using 2M HCl solution (30 mL), and 
then concentrated under reduced pressure to reveal the corresponding N-tosylated product. The 
corresponding N-tosylated product was then clean enough to be used in the next reaction or purified 
via recrystallisation if required. 
 
N-(2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277a) 
The title compound was prepared using General Procedure D to afford the title 
compound as a pale-yellow solid (1.911 g, 77% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.90 (s, 1H, NH), 7.65 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.43 (d, J = 8.0 Hz, 
1H, CHAr), 7.26-7.23 (m, 1H, CHAr), 7.21 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.09-7.06 (m, 2H, CHAr), 
4.39 (s, 2H, CH2), 2.38 (s, 3H, CH3 Tosyl), 2.21 (bs, 1H, OH) ppm. 13C NMR (125 MHz, CDCl3): δ 
143.9 (CHAr-NH), 137.1 (CAr), 136.5 (CAr), 131.8 (CAr), 129.8 (CHAr Tosyl), 129.4 (CHAr), 129.2 
(CHAr), 127.2 (CHAr Tosyl), 125.5 (CHAr), 123.6 (CHAr), 64.0 (CH2), 21.7 (CH3 Tosyl) ppm. NMR data 
match known literature values: Org. Lett., 2016, 18, 642-645. 
 
N-(4-fluoro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277b)  
The title compound was prepared using General Procedure D to afford the title 
compound as a yellow/orange solid (2.956 g, 86% yield). Mp: 150-153 °C. 1H 
NMR (500 MHz, CDCl3): δ 7.60 (d, J = 8.5 Hz, 2H, CHAr Tosyl), 7.31 (dd, J = 9.0, 
5.0 Hz, 1H, CHAr), 7.23 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 6.96 (ddd, J = 9.0, 8.0, 3.0 Hz, 1H, CHAr), 6.89 
(dd, J = 8.5, 3.0 Hz, 1H, CHAr), 4.32 (s, 2H, CH2), 2.40 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, 
CDCl3): δ 160.5 (d, J = 232.8 Hz, CAr), 144.2 (CAr Tosyl), 136.5 (CAr Tosyl), 135.7 (d, J = 7.3 Hz, CAr), 
131.7 (d, J = 3.0 Hz, CAr), 129.9 (CHAr Tosyl), 127.2 (CHAr Tosyl), 127.0 (d, J = 8.3 Hz, CHAr), 116.0 (d, 
J = 22.8 Hz, CHAr), 115.8 (d, J = 22.1 Hz, CHAr), 63.2 (d, J = 1.0 Hz, CH2), 21.7 (CH3 Tosyl) ppm. 
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HRMS (ESI): calcd for C14H13FNO3S [M - H]- 294.0606, found 294.0608. IR (ATR, cm-1): ṽ 3446 
(m), 3080 (m), 1595 (w), 1491 (m), 1323 (s), 1154 (s), 918 (m), 880 (m), 663 (s), 554 (s). 
 
N-(3-chloro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277c)   
The title compound was prepared using General Procedure D to afford the title 
compound as a brown solid (1.256 g, 47% yield). Mp: 115-120 °C. 1H NMR (400 
MHz, CDCl3): δ 7.66 (d, J = 8.4 Hz, 2H, CHAr Tosyl), 7.32 (dd, J = 5.8, 3.4 Hz, 1H, 
CHAr), 7.24 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.15-7.14 (m, 2H, CHAr), 4.65 (s, 2H, 
CH2), 2.39 (s, 3H, CH3 Tosyl) ppm. 13C NMR (100 MHz, CDCl3): δ 144.2 (CAr), 138.3 (CAr), 136.8 
(CAr), 133.9 (CAr), 129.9 (CHAr Tosyl), 129.65 (CAr), 129.55 (CHAr), 127.2 (CHAr Tosyl), 126.7 (CHAr), 
122.2 (CHAr), 59.8 (CH2), 21.7 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C14H13ClNO3S [M - H]- 
310.0305, found 310.0316. IR (ATR, cm-1): ṽ 3450 (w), 3356 (m), 3250 (m), 3064 (w), 2922 (m), 
1671 (s), 1457 (s), 995 (s), 771 (s).  
 
N-(4-chloro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277d) 
The title compound was prepared using General Procedure D to afford the title 
compound as a yellow solid (3.272 g, 91% yield). 1H NMR (400 MHz, 
CDCl3): δ 7.95 (s, 1H, NH), 7.63 (d, J = 6.8 Hz, 2H, CHAr Tosyl), 7.36 (d, J = 6.8 
Hz, 1H, CHAr), 7.23 (d, J = 6.4 Hz, 2H, CHAr Tosyl), 7.22-7.19 (m, 1H, CHAr), 7.09 (d, J = 2.0 Hz, 1H, 
CHAr), 4.33 (s, 2H, CH2), 2.39 (s, 3H, CH3 Tosyl), 1.60 (bs, 1H, OH) ppm. 13C NMR (125 MHz, 
CDCl3): δ 144.2 (CAr), 136.6 (CAr), 134.9 (CAr), 133.8 (CAr), 130.8 (CAr), 129.9 (CHAr Tosyl), 129.1 (2 x 
CHAr), 127.2 (CHAr Tosyl), 125.2 (CHAr), 63.3 (CH2), 21.7 (CH3 Tosyl) ppm. NMR data match known 
literature values: Org. Lett., 2006, 8, 2257-2260. 
 
N-(5-chloro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277e) 
The title compound was prepared using General Procedure D to afford the title 
compound d as a yellow solid (3.098 g, 97% yield). 1H NMR (400 MHz, 
CDCl3): δ 8.14 (bs, 1H, NH), 7.67 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.47 (d, J = 
2.0 Hz, 1H, CHAr), 7.24 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.03-6.98 (m, 2H, CHAr), 4.37 (s, 2H, CH2), 
2.49 (bs, 1H, OH), 2.39 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 144.3 (CAr), 137.7 
(CAr), 136.6 (CAr), 134.8 (CAr), 130.1 (CHAr), 129.9 (CHAr Tosyl), 129.5 (CAr), 127.1 (CHAr Tosyl), 125.1 
(CHAr), 122.8 (CHAr), 63.4 (CH2), 21.7 (CH3) ppm. NMR data match known literature values: 
Tetrahedron, 2004, 60, 3017-3035. 
 
 
 
 
NHTs
Cl
OH
NHTs
Cl OH
NHTsCl
OH
	 111 
N-(6-chloro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277f) 
The title compound was prepared using General Procedure D to afford the title 
compound as a yellow solid (1.017 g, 58% yield). 1H NMR (400 MHz, CDCl3): δ 
7.53 (dd, J = 7.8, 1.4 Hz, 1H, CHAr), 7.50 (d, J = 8.4 Hz, 2H, CHAr Tosyl), 7.27-7.18 
(m, 4H, overlapping CHAr & CHAr Tosyl), 6.48 (bs, 1H, NH), 4.86 (s, 2H, CH2), 2.24 (s, 3H, CH3 Tosyl) 
ppm. 13C NMR (125 MHz, CDCl3): δ 144.6 (CAr), 142.6 (CAr), 135.8 (CAr), 132.2 (CAr), 130.8 (CAr), 
130.1 (CHAr), 129.7 (CHAr Tosyl), 129.1 (CHAr), 129.0 (CHAr), 127.8 (CHAr Tosyl), 62.0 (CH2), 21.8 (CH3 
Tosyl) ppm. NMR data match known literature values: Tetrahedron, 2011, 67, 1501-1505. 
 
N-(4-bromo-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277g) 
The title compound was prepared using General Procedure D to afford the title 
compound as a yellow solid (4.578 g, 88% yield). 1H NMR (500 MHz, CDCl3): 
δ 7.64 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.38-7.31 (m, 2H, CHAr), 7.24-7.23 (m, 
3H, overlapping CHAr & CHAr Tosyl), 4.34 (s, 2H, CH2), 2.39 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 
MHz, CDCl3): δ 144.2 (CAr), 136.8 (CAr), 135.6 (CAr), 133.8 (CAr), 132.2 (CHAr), 132.0 (CHAr), 129.9 
(CHAr Tosyl), 127.2 (CHAr Tosyl), 125.2 (CHAr), 118.5 (CAr), 63.4 (CH2), 21.7 (CH3) ppm. NMR data 
match known literature values: Org Lett., 2010, 12, 1084-1087. 
 
N-(2-(hydroxymethyl)-4-methylphenyl)-4-methylbenzenesulfonamide (277h) 
The title compound was prepared using General Procedure D to afford the title 
compound as an orange solid (3.746 g, 88% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.63 (bs, 1H, NH), 6.61 (d, J = 8.5 Hz, 2H, CHAr Tosyl), 7.23-7.20 (m, 
3H, overlapping CHAr & CHAr Tosyl), 7.04 (dd, J = 8.0, 1.5 Hz, 1H, CHAr), 6.93 (d, J = 1.5 Hz, 1H, 
CHAr), 4.33 (s, 2H, CH2), 2.38 (s, 3H, CH3 Tosyl), 2.27 (s, 3H, CH3) ppm. 13C NMR (125 MHz, 
CDCl3): δ 143.8 (CAr), 137.0 (CAr), 135.8 (CAr), 133.4 (CAr), 132.8 (CAr), 130.0 (CHAr), 129.8 (CHAr), 
129.7 (CHAr Tosyl), 127.2 (CHAr Tosyl), 124.5 (CHAr), 63.7 (CH2), 21.7 (CH3 Tosyl), 20.9 (CH3) ppm. NMR 
data match known literature values: Org. Lett., 2006, 8, 2257-2260. 
 
N-(2-(hydroxymethyl)-4-methoxyphenyl)-4-methylbenzenesulfonamide (277i) 
The title compound was prepared using General Procedure D to afford the title 
compound as a brown solid (4.150 g, 99% yield). 1H NMR (500 MHz, 
CDCl3): δ 7.57 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.33 (bs, 1H, NH), 7.21 (d, J = 
8.0 Hz, 2H, CHAr Tosyl), 7.11 (d, J = 8.5 Hz, 1H, CHAr), 6.74-6.71 (m, 2H, CHAr), 4.30 (s, 2H, CH2), 
3.76 (s, 3H, O-CH3), 2.39 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 158.1 (CAr), 143.9 
(CAr), 136.7 (CAr), 136.6 (CAr), 129.7 (CHAr Tosyl), 128.0 (CAr), 127.6 (CHAr), 127.3 (CHAr Tosyl), 114.8 
(CHAr), 114.0 (CHAr), 63.2 (CH2), 55.6 (O-CH3), 21.7 (CH3) ppm. NMR data match known literature 
values: Tetrahedron, 2004, 60, 3017-3035. 
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General Procedure E – Oxidation: 
 
 
 
Method adapted from Chem Commun., 2017, 53, 216-219. 
To a solution of the corresponding alcohol 277 (1.0 equiv.) in anhydrous CH2Cl2 (0.1 M) at room 
temperature was added PCC (1.2 equiv.). The resultant reaction solution was stirred at room 
temperature and monitored via TLC (typically 1-2 hours). To the reaction mixture was then added 
MgSO4 to form an easily to handle suspension that was then directly filtered through a sintered glass 
funnel, with the residue washed generously with extra CH2Cl2. The solvent was removed under 
reduced pressure to afford crude material that was then purified via recrystallisation or flash column 
chromatography to reveal the corresponding aldehyde. 
 
N-(2-formylphenyl)-4-methylbenzenesulfonamide (278a) 
The title compound was prepared using General Procedure E to afford the title 
compound as a white solid (1.585 g, 84% yield). 1H NMR (500 MHz, CDCl3): δ 
10.79 (bs, 1H, NH), 9.82 (s, 1H, CHO), 7.77 (d, J = 8.3 Hz, 2H, CHAr Tosyl), 7.68 (d, J 
= 8.4 Hz, 1H, CHAr), 7.59 (dd, J = 7.6, 0.6 Hz, 1H, CHAr), 7.52-7.49 (m, 1H, CHAr), 7.24 (d, J = 8.1 
Hz, 2H CHAr Tosyl), 7.16 (t, J = 7.5, Hz, 1H, CHAr), 2.36 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, 
CDCl3): δ 195.1 (C=O), 144.3 (CAr), 140.0 (CAr), 136.5 (CAr), 136.2 (CHAr), 135.9 (CHAr), 129.9 
(CHAr Tosyl), 127.4 (CHAr Tosyl), 123.1 (CHAr), 122.0 (CAr), 117.8 (CHAr), 21.6 (CH3 Tosyl) ppm. NMR 
data match known literature values: Eur. J. Org. Chem., 2016, 22, 17808-17812. 
 
N-(4-fluoro-2-formylphenyl)-4-methylbenzenesulfonamide (278b) 
The title compound was prepared using General Procedure E to afford the title 
compound as a brown solid (2.785 g, 96% yield). Mp: 135-137 °C. 1H NMR (500 
MHz, CDCl3): δ 10.45 (s, 1H, CHO), 9.76 (s, 1H, NH), 7.74-7.71 (m, 3H, 
overlapping CHAr & CHAr Tosyl), 7.29-7.26 (m, 2H, overlapping CHAr), 7.24 (d, J = 8.0 Hz, 2H, CHAr 
Tosyl), 2.37 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 193.7 (CHO), 158.3 (d, J = 244.4 
Hz, CAr), 144.4 (CAr Tosyl), 136.2 (CAr Tosyl), 136.2 (d, J = 2.4 Hz, CAr), 129.9 (CHAr Tosyl), 127.3 (CHAr 
Tosyl), 123.21 (d, J = 22.6 Hz, CHAr), 123.2 (CAr), 121.3 (d, J = 22.4 Hz, CHAr), 120.7 (d, J = 7.0 Hz, 
CHAr), 21.7 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C14H11FNO3S [M - H]- 292.0449, found 
292.0451. IR (ATR, cm-1): ṽ = 3713 (w), 3072 (w), 2873 (w), 1670 (s), 1588 (m), 1495 (s), 1342 
(m), 1159 (s), 905 (s), 770 (s), 542 (s). 
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N-(3-chloro-2-formylphenyl)-4-methylbenzenesulfonamide (278c) 
The title compound was prepared using General Procedure E to afford the title 
compound as a white solid (1.844 g, 99% yield). 1H NMR (500 MHz, CDCl3): δ 
11.33 (bs, 1H, NH), 10.45 (s, 1H, CHO), 7.77 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.62 (d, 
J = 8.5 Hz, 1H, CHAr), 7.39 (t, J = 8.0 Hz, 1H, CHAr), 7.26 (d, J = 7.5 Hz, 2H, CHAr 
Tosyl), 7.08 (dd, J = 8.0, 1.0 Hz, 1H, CHAr), 2.38 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): 
δ 193.9 (CHO), 144.6 (CAr), 142.4 (CAr), 140.5 (CAr), 136.5 (CHAr), 136.3 (CAr), 130.0 (CHAr Tosyl), 
127.4 (CHAr Tosyl), 124.6 (CHAr), 117.7 (CAr), 116.8 (CHAr), 21.7 (CH3 Tosyl) ppm. NMR data match 
known literature values: J. Org. Chem., 2017, 82, 4497-4503. 
 
N-(4-chloro-2-formylphenyl)-4-methylbenzenesulfonamide (278d) 
The title compound was prepared using General Procedure E to afford the title 
compound as a brown solid (2.848 g, 88% yield). 1H NMR (500 MHz, CDCl3): 
δ 10.62 (bs, 1H, NH), 9.77 (s, 1H, CHO), 7.75 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 
7.68 (d, J = 9.0 Hz, 1H, CHAr), 7.56 (s, 1H, CHAr), 7.46 (d, J = 8.5 Hz, 1H, CHAr), 7.25 (d, J = 8.5 Hz, 
2H, CHAr Tosyl), 2.38 (CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 193.9 (CHO), 144.6 (CAr), 
138.6 (CAr), 136.2 (CAr), 135.8 (CHAr), 135.3 (CHAr), 130.0 (CHAr Tosyl), 128.5 (CAr), 127.4 (CHAr Tosyl), 
123.0 (CAr), 119.7 (CHAr), 21.7 (CH3 Tosyl) ppm. NMR data match known literature values: 
Tetrahedron, 2004, 60, 3017-3035. 
 
N-(5-chloro-2-formylphenyl)-4-methylbenzenesulfonamide (278e) 
The title compound was prepared using General Procedure E to afford the title 
compound as a brown solid (2.591 g, 86% yield). 1H NMR (500 MHz, CDCl3): 
δ 10.88 (s, 1H, NH), 9.79 (s, 1H, CHO), 7.79 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.72 
(s, 1H, CHAr), 7.51 (d, J = 8.0 Hz, 1H, CHAr), 7.28 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.12 (d, J = 8.0 Hz, 
1H, CHAr), 2.39 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 194.0 (CHO), 144.7 (CAr), 
142.7 (CAr), 141.1 (CAr), 137.2 (CHAr), 136.2 (CAr), 130.1 (CHAr Tosyl), 127.4 (CHAr Tosyl), 123.3 (CHAr), 
120.2 (CAr), 117.8 (CHAr), 21.7 (CH3 Tosyl) ppm. NMR data match known literature values: Org. Lett., 
2016, 18, 4924-4927. 
 
N-(6-chloro-2-formylphenyl)-4-methylbenzenesulfonamide (278f) 
The title compound was prepared using General Procedure E to afford the title 
compound as a yellow solid (0.478 g, 47% yield). Mp: 143-146 °C.1H NMR (400 
MHz, CDCl3): δ 10.32 (d, J = 0.8 Hz, CHO), 7.92 (dd, J = 7.6, 1.6 Hz, 1H, CHAr), 
7.49 (dd, J = 8.0, 1.6 Hz, 1H, CHAr), 7.43 (d, J = 8.4 Hz, 2H, CHAr Tosyl), 7.34 (td, J = 
7.8, 0.8 Hz, 1H, CHAr), 7.20 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 2.41 (s, 3H, CH3 Tosyl) ppm. 13C NMR (100 
MHz, CDCl3): δ 189.2 (CHO), 144.9 (CAr), 135.5 (CAr), 134.92 (CAr), 134.85 (CAr), 134.3 (CHAr), 
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131.6 (CAr), 129.8 (CHAr Tosyl), 128.3 (CHAr), 128.1 (CHAr), 127.6 (CHAr Tosyl), 21.8 (CH3 Tosyl) ppm. 
HRMS (ESI): calcd for C14H12ClNO3SNa [M + Na]+ 332.0124, found 332.0132. IR (ATR, cm-1): ṽ 
= 3366 (w), 3102 (w),2895 (w), 1671 (s), 1466 (m), 1395 (s), 1163 (s), 883 (m), 796 (s), 721 (s), 576 
(s). 
 
N-(4-bromo-2-formylphenyl)-4-methylbenzenesulfonamide (278g) 
The title compound was prepared using General Procedure E to afford the title 
compound as a yellow solid (4.116 g, 90% yield). Mp: 135-139 °C. 1H NMR 
(500 MHz, CDCl3): δ 10.64 (s, 1H, NH), 9.76 (s, 1H, CHO), 7.75 (d, J = 8.0 Hz, 
2H, CHAr Tosyl), 7.70 (d, J = 2.0 Hz, 1H, CHAr), 7.63-7.58 (m, 2H, CHAr), 7.25 (d, J = 8.0 Hz, 2H, CHAr 
Tosyl), 2.38 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 193.7 (CHO), 144.6 (CAr), 139.0 
(CAr), 138.6 (CHAr), 138.2 (CHAr), 136.2 (CAr), 130.0 (CHAr Tosyl), 127.3 (CHAr Tosyl), 123.3 (CAr), 119.9 
(CHAr), 115.5 (CAr), 21.7 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C14H11BrNO3S [M - H]- 351.96485, 
found 351.96505. IR (ATR, cm-1): ṽ = 3126 (w), 3049 (w), 2865 (w), 1669 (m), 1479 (s), 1375 (s), 
1159 (s), 856 (s), 684 (s). 
 
N-(2-formyl-4-methylphenyl)-4-methylbenzenesulfonamide (278h) 
The title compound was prepared using General Procedure E to afford the title 
compound as a yellow solid (3.398 g, 91% yield). 1H NMR (500 MHz, CDCl3): 
δ 10.59 (s, 1H, NH), 9.77 (s, 1H, CHO), 7.74 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.60 
(d, J = 8.5 Hz, 1H, CHAr), 7.37-7.36 (m, 1H, CHAr), 7.32 (dd, J = 8.5, 1.5 Hz, 1H, CHAr), 7.22 (d, J = 
8.5 Hz, 2H, CHAr Tosyl), 2.36 (s, 3H, CH3 Tosyl), 2.32 (s, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3): 
δ 195.1 (CHO), 144.0 (CAr), 137.5 (CAr), 136.6 (CHAr), 136.5 (CAr), 136.3 (CHAr), 132.9 (CAr), 129.7 
(CHAr Tosyl), 127.3 (CHAr Tosyl), 122.1 (CAr), 118.3 (CHAr), 21.6 (CH3 Tosyl), 20.4 (CH3) ppm. NMR data 
match known literature values: J. Org. Chem., 2017, 82, 4497-4503. 
 
N-(2-formyl-4-methoxyphenyl)-4-methylbenzenesulfonamide (278i) 
The title compound was prepared using General Procedure E to afford the title 
compound as a yellow solid (2.323 g, 56% yield). 1H NMR (500 MHz, 
CDCl3): δ 10.22 (s, 1H, NH), 9.74 (dd, J = 0.5 Hz, 1H, CHO), 7.68 (d, J = 8.5 
Hz, 2H, CHAr Tosyl), 7.68-7.67 (m, 1H, CHAr), 7.20 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.09 (dd, J = 9.0, 3.0 
Hz, 1H, CHAr), 7.05 (d, J = 3.0 Hz, 1H, CHAr), 3.81 (s, 3H, O-CH3), 2.35 (s, 3H, CH3 Tosyl) ppm. 13C 
NMR (100 MHz, CDCl3): δ 194.6 (CHO), 155.9 (CAr), 144.1 (CAr), 136.5 (CAr), 133.1 (CAr), 129.8 
(CHAr Tosyl), 127.4 (CHAr Tosyl), 123.7 (CAr), 122.2 (CHAr), 121.2 (CHAr), 119.5 (CHAr), 55.9 (O-CH3), 
21.7 (CH3 Tosyl) ppm. NMR data match known literature values: Tetrahedron, 2004, 60, 3017-3035. 
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General Procedure F - N-Benzylation: 
	
 
 
In a round bottom flask equipped with condenser under a flow of N2 was loaded 1-(chloromethyl)-
3,5-dinitrobenzene 279 (1.0 equiv.), corresponding aldehyde 278 (1.2 equiv.) and Et3N (1.5 – 1.8 
equiv.) in anhydrous MeCN (0.5 M). The resultant reaction mixture was heated to reflux and allowed 
to stir typically overnight. After which time, the reaction was cooled to room temperature and the 
solvent was removed under reduced pressure. The crude material was then diluted with water (equal 
to reaction volume), extracted thrice using CH2Cl2, then the combined organic phases were dried over 
Na2SO4, filtered and concentrated under reduced pressure. The crude product was then purified via 
recrystallisation or flash column chromatography to reveal to corresponding N-benzylated product. 
 
N-(3,5-Dinitrobenzyl)-N-(2-formylphenyl)-4-methylbenzenesulfonamide (280a) 
The title compound was prepared using General Procedure F to afford 
the title compound as a white solid (1.683 g, 89% yield). Mp: 156-160 
°C. Rf: 0.21 in 40:60 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 
10.10 (s, 1H, CHO), 8.92 (s, 1H, CHAr), 8.43 (d, J = 2.0 Hz, 2H, CHAr), 
7.90 (dd, J = 7.8, 1.7 Hz, 1H, CHAr), 7.53-7.52 (m, 1H, CHAr), 7.52 (d, J 
= 8.5 Hz, 2H, CHAr Tosyl), 7.48 (t, J = 7.5 Hz, 1H, CHAr) 7.34 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 6.89 (d, J 
= 8.0 Hz, 1H, CHAr), 5.21 (d, J = 13.5 Hz, 1H, CH2), 4.70 (d, J = 13.0 Hz, 1H, CH2), 2.49 (s, 3H, CH3 
Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 188.8 (CHO), 148.8 (CAr), 145.3 (CAr), 140.3 (CAr), 140.1 
(CAr), 135.4 (CAr), 134.8 (CHAr), 133.9 (CAr), 130.19 (CHAr), 130.16 (CHAr Tosyl), 129.6 (CHAr), 128.8 
(CHAr), 128.4 (CHAr), 128.1 (CHAr Tosyl), 118.8 (CHAr), 54.7 (CH2), 21.8 (CH3 Tosyl) ppm. HRMS 
(ESI): calcd for C21H17N3O7SNa [M + Na]+ 478.06849, found 478.06776. IR (ATR, cm-1): ṽ = 3310 
(w), 3085 (w), 2982 (w), 1691 (m), 1595 (m), 1495 (s), 1339 (s), 1270 (m), 1161 (s), 1089 (m), 909 
(m), 822 (s), 808 (s), 777 (m), 664 (s), 569 (s).  
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N-(3,5-dinitrobenzyl)-N-(4-fluoro-2-formylphenyl)-4-methylbenzenesulfonamide (280b)  
The title compound was prepared using General Procedure F to 
afford the title compound as a yellowish solid (0.828 g, 79% yield). 
Mp: 170-174 °C. Rf: 0.26 in 40:60 EtOAc:n-hexanes. 1H NMR (500 
MHz, CDCl3): δ 10.04 (d, J = 2.8 Hz, 1H, CHO), 8.93 (t, J = 2.1 Hz, 
1H, CHAr), 8.43 (d, J = 2.1 Hz, 2H, CHAr), 7.56 (dd, J = 8.2, 3.1 Hz, 
1H, CHAr), 7.53 (d, J = 8.3 Hz, 2H, CHAr Tosyl), 7.36 (d, J = 7.8 Hz, 2H, CHAr Tosyl), 7.21 (ddd, J = 
8.2, 7.2, 3.1 Hz, 1H, CHAr), 6.85 (dd, J = 8.8, 4.4 Hz, 1H, CHAr), 5.24 (d, J = 14.9 Hz, 1H, CH2), 4.63 
(d, J = 14.8 Hz, 1H, CH2), 2.49 (s, 3H, CH3 tosyl) ppm. 13C NMR (100 MHz, CDCl3): δ 187.5 
(CHO), 162.4 (d, J = 252.2 Hz, CAr), 148.7 (CAr), 145.5 (CAr), 140.0 (CAr), 137.5 (d, J = 6.9 Hz, CAr), 
136.1 (d, J = 3.4 Hz, CAr), 133.6 (CAr), 130.319 (d, J = 7.7 Hz, CHAr), 130.306 (CHAr tosyl), 128.8 
(CHAr), 128.1 (CHAr tosyl), 121.9 (d, J = 23.2 Hz, CHAr), 118.4 (CHAr), 116.4 (d, J = 23.3 Hz, CHAr), 
54.9 (CH2), 21.8 (CH3 tosyl) ppm. HRMS (ESI): calcd for C21H15N3O7FS [M-H]- 472.0615, found 
472.0622. IR (ATR, cm-1): ṽ 3097 (w), 2876 (w), 1691 (m), 1541 (s), 1488 (m), 1342 (s), 1261 (m), 
1151 (s), 1057 (s), 883 (s), 771 (s), 674 (s), 577 (m), 535 (s). 
 
N-(3-chloro-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280c) 
The title compound was prepared using General Procedure F to afford 
the title compound as a yellow solid (0.171 g, 17% yield). Mp: 192-195 
°C. Rf: 0.36 in 40:60 EtOAc:n-hexanes. 1H NMR (400 MHz, CDCl3): δ 
10.15 (s, 1H, CHO), 8.94 (t, J = 2.0 Hz, 1H, CHAr), 8.39 (d, J = 2.0 Hz, 
2H, CHAr), 7.51 (d, J = 8.4 Hz, 2H, CHAr Tosyl), 7.46 (dd, J = 8.0, 1.2 Hz, 
1H, CHAr), 7.39 (t, J = 8.0 Hz, 1H, CHAr), 7.32 (d, J = 8.0 Hz, 2H, CHAr 
Tosyl), 6.90 (d, J = 7.6 Hz, 1H, CHAr), 4.96 (s, 2H, CH2), 2.47 (s, 3H, CH3 Tosyl) ppm. 13C NMR (100 
MHz, CDCl3): δ 189.3 (CHO), 148.7 (CAr), 145.0 (CAr), 140.7 (CAr), 138.7 (CAr), 137.4 (CAr), 134.8 
(CAr), 133.9 (CAr), 133.4 (CHAr), 131.7 (CHAr), 130.1 (CHAr Tosyl), 129.3 (CHAr), 129.1 (CHAr), 128.0 
(CHAr Tosyl), 118.6 (CHAr), 55.2 (CH2), 21.8 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C21H15N3O7S [M 
- H]- 488.03247, found 488.03282. IR (ATR, cm-1): ṽ = 3121 (w), 3088 (w), 2918 (w), 2772 (w), 
1702 (m), 1585 (s), 1449 (m), 1341 (s), 1156 (s), 1087 (m), 905 (m), 828 (m), 726 (s), 657 (s), 578 
(s).  
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N-(4-chloro-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280d) 
The title compound was prepared using General Procedure F to 
afford the title compound as a yellow solid (0.832 g, 81% yield). Rf: 
0.36 in 40:60 EtOAc:n-hexanes. Mp: 180-182 °C. 1H NMR (500 
MHz, CDCl3): δ 10.07 (s, 1H, CHO), 8.93 (t, J = 2.0 Hz, 1H, 
CHAr), 8.44 (d, J = 2.0 Hz, 2H, CHAr), 7.85 (d, J = 2.5 Hz, 1H, 
CHAr), 7.52 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.47 (dd, J = 8.5, 2.5 Hz, 1H, CHAr), 7.37 (d, J = 8.0 Hz, 
2H, CHAr Tosyl), 6.80 (d, J = 8.5 Hz, 1H, CHAr), 5.24 (d, J = 14.0 Hz, 1H, CH2), 4.62 (d, J = 13.0 Hz, 
1H, CH2), 2.49 (s, 3H, CHAr Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 187.4 (CHO), 148.8 (CAr), 
145.6 (CAr), 140.0 (CAr), 138.5 (CAr), 136.6 (CAr), 136.1 (CAr), 134.6 (CHAr), 133.4 (CAr), 130.3 (CHAr 
Tosyl), 129.9 (CHAr), 129.4 (CHAr), 128.7 (CHAr), 128.1 (CHAr Tosyl), 119.0 (CHAr), 54.6 (CH2), 21.9 
(CH3 Tosyl) ppm. HRMS (ESI): calcd for C21H15ClN3O7S [M - H]- 488.03247, found 488.03289. IR 
(ATR, cm-1): ṽ = 3093 (w), 2905 (w), 1689 (m), 1539 (s), 1447 (m), 1337 (s), 1211 (m), 1161 (s), 
1090 (m), 909 (m), 857 (m), 725 (s), 630 (s), 570 (s).  
 
N-(5-chloro-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280e) 
The title compound was prepared using General Procedure F to 
afford the title compound as a white solid (0.552 g, 54% yield). 
Mp: 197-200 °C. Rf: 0.33 in 40:60 EtOAc:n-hexanes. 1H NMR 
(500 MHz, CDCl3): δ 10.06 (CHO), 8.94 (s, 1H, CHAr), 8.45 (d, J = 
2.0 Hz, 2H, CHAr), 7.86 (d, J = 8.3 Hz, 1H, CHAr), 7.54 (d, J = 8.3 
Hz, 2H, CHAr Tosyl), 7.46 (dd, J = 8.3, 1.9 Hz, 1H, CHAr), 7.39 (d, J = 7.9 Hz, 2H, CHAr Tosyl), 6.83 (d, J 
= 1.9 Hz, 1H, CHAr), 5.21 (bs, 1H, CH2), 4.61 (bs, 1H, CH2), 2.51 (s, 3H, CH3 Tosyl) ppm. 13C NMR 
(125 MHz, CDCl3): δ 187.6 (CHO), 148.9 (CAr), 145.7 (CAr), 141.4 (CAr), 140.7 (CAr), 139.9 (CAr), 
133.9 (CAr), 133.4 (CAr), 131.2 (CHAr), 130.3 (CHAr Tosyl), 130.1 (CHAr), 128.7 (CHAr), 128.5 (CHAr), 
128.2 (CHAr Tosyl), 119.0 (CHAr), 54.7 (CH2), 21.9 (CH3 Tosyl) ppm. HRMS (ESI): calcd for 
C21H15ClN3O7S [M - H]- 488.03247, found 488.03285. IR (ATR, cm-1): ṽ = 3112 (w), 3086 (w), 
2872 (w), 1691 (m), 1539 (s), 1344 (s), 1154 (s), 1086 (m), 915 (m), 725 (s), 668 (s), 545 (s). 
 
N-(2-chloro-6-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280f) 
The title compound was prepared using General Procedure F to afford 
the title compound as a yellow solid (0.300 g, 55% yield). Mp: 189-191 
°C. Rf: 0.34 in 40:60 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 
9.75 (s, 1H, CHO), 8.97 (d, J = 1.5 Hz, 1H, CHAr), 8.44 (d, J = 1.5 Hz, 
2H, CHAr), 7.84 (d, J = 7.5 Hz, 1H, CHAr), 7.67-7.63 (m, 3H, 
overlapping CHAr & CHAr Tosyl), 7.49 (t, J = 8.0 Hz, 1H, CHAr), 7.35 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 
5.29 (d, J = 15.5 Hz, 1H, CH2), 4.83 (d, J = 15.5 Hz, 1H, CH2), 2.49 (s, 3H, CH3 Tosyl) ppm. 13C NMR 
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(125 MHz, CDCl3): δ 188.2 (CHO), 148.6 (CAr), 145.2 (CAr), 139.6 (CAr), 138.1 (CAr), 136.6 (CAr), 
136.5 (CHAr), 135.9 (CAr), 134.8 (CAr), 130.9 (CHAr), 130.3 (CHAr Tosyl), 129.7 (CHAr), 128.3 (CHAr), 
127.8 (CHAr Tosyl), 119.1 (CHAr), 53.4 (CH2), 21.9 (CH3 Tosyl) ppm. HRMS (ESI): calcd for 
C21H16ClN3O7SNa [M + Na]+ 512.0295, found 512.0284. IR (ATR, cm-1): ṽ = 3095 (w), 2879 (w), 
1685 (s), 1537 (s), 1449 (m), 1343 (s), 1243 (m), 1158 (s), 1086 (s), 918 (m), 856 (s), 727 (s), 658 (s), 
565 (s).  
 
N-(4-bromo-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280g) 
The title compound was prepared using General Procedure F to 
afford the title compound as a white solid (0.819 g, 84% yield). 
Mp: 171-172 °C. 1H NMR (500 MHz, CDCl3): δ 10.07 (s, 1H, 
CHO), 8.94 (s, 1H, CHAr), 8.44 (d, J = 1.5 Hz, 2H, CHAr), 8.01 (s, 
1H, CHAr), 7.62 (dd, J = 8.5, 2.0 Hz, 1H, CHAr), 7.52 (d, J = 8.0 Hz, 
2H, CHAr Tosyl), 7.37 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 6.73 (d, J = 8.5 Hz, 1H, CHAr), 5.23 (d, J = 13.5 
Hz, 1H, CH2), 4.61 (d, J = 13.5 Hz, 1H, CH2), 2.50 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, 
CDCl3): δ 187.3 (CHO), 148.9 (CAr), 145.6 (CAr), 139.9 (CAr), 139.0 (CAr), 137.6 (CHAr), 136.7 (CAr), 
133.5 (CAr), 133.0 (CHAr), 130.3 (CHAr Tosyl), 129.6 (CHAr), 128.7 (CHAr), 128.1 (CHAr Tosyl), 124.0 
(CAr), 119.0 (CHAr), 54.6 (CH2), 21.9 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C21H16BrN3O7SNa [M 
+ Na]+ 555.9790, found 555.9799. IR (ATR, cm-1): ṽ = 3122 (w), 3089 (w), 2866 (w), 1696 (m), 
1538 (s), 1475 (m), 1343 (s), 1253 (m), 1161 (s), 1089 (m), 846 (s), 723 (s), 680 (s), 567 (s). 
 
N-(3,5-dinitrobenzyl)-N-(2-formyl-4-methylphenyl)-4-methylbenzenesulfonamide (280h) 
The title compound was prepared using General Procedure F to 
afford the title compound as a white solid (0.814 g, 79% yield). 
Mp: 180-183 °C. 1H NMR (500 MHz, CDCl3): δ 10.06 (s, 1H, 
CHO), 8.91 (d, J = 2.0 Hz, 1H, CHAr), 8.43 (s, 2H, CHAr), 7.68 (s, 
1H, CHAr), 7.53 (d, J = 7.0 Hz, 2H, CHAr Tosyl), 7.34 (d, J = 8.0 Hz, 
2H, CHAr Tosyl), 7.34-7.31 (m, 1H, CHAr), 6.76 (d, J = 14.5 Hz, 1H, CHAr), 5.21 (d, J = 14.5 Hz, 1H, 
CH2), 4.66 (d, J = 14.5 Hz, CH2), 2.49 (s, 3H, CH3 Tosyl), 2.38 (s, 3H, CH3) ppm. 13C NMR (125 MHz, 
CDCl3): δ 189.1 (CHO), 148.7 (CAr), 145.1 (CAr), 140.4 (CAr), 140.1 (CAr), 137.5 (CAr), 135.5 (CHAr), 
134.9 (CAr), 134.0 (CAr), 130.4 (CHAr), 130.1 (CHAr Tosyl), 128.9 (CHAr), 128.107 (overlapping CHAr & 
CHAr Tosyl), 118.7 (CHAr), 54.7 (CH2), 21.8 (CH3 Tosyl), 21.2 (CH3) ppm. HRMS (ESI): calcd for 
C22H19N3O7SNa [M + Na]+ 492.0841, found 492.0858. IR (ATR, cm-1): ṽ = 3086 (w), 2866 (w), 
1688 (s), 1540 (s), 1340 (s), 1087 (m), 942 (m), 857 (s), 696 (s), 666 (s), 571 (s).  
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N-(3,5-dinitrobenzyl)-N-(2-formyl-4-methoxyphenyl)-4-methylbenzenesulfonamide (280i) 
The title compound was prepared using General Procedure F to 
afford the title compound as a white solid (0.729 g, 71% yield). 
Mp: 215-217 °C. 1H NMR (400 MHz, CDCl3): δ 10.02 (s, 1H, 
CHO), 8.93 (t, J = 2.0 Hz, 1H, CHAr), 8.42 (d, J = 2.0 Hz, 2H, 
CHAr), 7.54 (d, J = 8.4 Hz, 2H, CHAr Tosyl), 7.35-7.33 (m, 3H, 
overlapping CHAr & CHAr Tosyl), 7.02 (dd, J = 8.8, 3.2 Hz, 1H, CHAr), 6.75 (d, J = 8.8 Hz, 1H, CHAr), 
5.21 (d, J = 14.4 Hz, 1H, CH2), 4.62 (d, J = 14.8 Hz, 1H, CH2), 3.84 (s, 3H, O-CH3), 2.48 (s, 3H, CH3 
Tosyl) ppm. 13C NMR (100 MHz, CDCl3): δ 188.7 (CHO), 160.0 (CAr), 148.8 (CAr), 145.1 (CAr), 140.4 
(CAr), 136.5 (CAr), 134.1 (CAr), 132.7 (CAr), 130.2 (CHAr Tosyl), 129.6 (CHAr), 128.9 (CHAr), 128.1 
(CHAr Tosyl), 121.9 (CHAr), 118.8 (CHAr), 112.5 (CHAr), 56.0 (O-CH3), 55.0 (CH2), 21.8 (CH3 Tosyl) 
ppm. HRMS (ESI): calcd for C22H19N3O8SNa [M + Na]+ 508.0791, found 508.0793. IR (ATR, cm-
1): ṽ = 3118 (w), 3089 (w), 2973 (w), 2866 (w), 1693 (s), 1597 (m), 1539 (s), 1495 (m), 1341 (s), 
1277 (m), 1161 (s), 853 (s), 699 (s), 573 (s).  
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2.5.3: Synthesis of Glycines 
	
 
 
General Procedure G: 
Procedure adapted from: Adv. Synth. Catal., 2016, 358, 1968-1974. 
To a solution of the corresponding glycine (1.3 equiv.) in H2O (5.0 M) was added 50 mL of 2N NaOH 
solution portion wise. The solution was cooled to 0 °C before addition of tosyl chloride (1.0 equiv.) 
and then allowed to stir at room temperature overnight, maintaining pH ~12. After this time, the 
reaction mixture was analysed via TLC to ensure limiting reagent was consumed and then the reaction 
was acidified using 5N HCl solution to pH ~2 whereby a white precipitate formed. The precipitate 
was collected via Buchner filtration, washed generously with cold H2O (100 mL), air-dried then 
further dried over self-indicating silica under vacuum overnight, affording the corresponding N-tosyl 
protected acid.  
 
N-Tosylglycine (269) 
The title compound was prepared using General Procedure G to afford the title 
compound as a white solid (5.872 g, 33% yield). 1H NMR (500 MHz, d-DMSO): 
δ 12.69 (bs, 1H, CO2H), 7.95 (t, J = 11.5 Hz, 1H, N-H), 7.68 (d, J = 8.2 Hz, 2H, CHAr Tosyl), 7.38 (d, J 
= 7.9 Hz, 2H, CHAr Tosyl) 3.55 (d, J = 6.1 Hz, 2H, CH2), 2.38 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 
MHz, d-DMSO): δ 170.2 (C=O), 142.6 (CAr Tosyl), 137.8 (CAr Tosyl), 129.5 (CHAr Tosyl), 126.6 (CHAr 
Tosyl), 43.8 (CH2), 21.0 (CH3 Tosyl) ppm. NMR data match known literature values: Adv. Synth. Catal., 
2016, 358, 1968-1974. 
 
N-Tosylalanine (270) 
The title compound was prepared using General Procedure G to afford the title 
compound as a white solid (3.687 g, 38% yield). 1H NMR (500 MHz, d-DMSO): 
δ 12.62 (bs, 1H, CO2H), 8.03 (d, J = 7.6 Hz, 1H, N-H), 7.67 (d, J = 8.0 Hz, 2H, 
CHAr Tosyl), 7.36 (d, J = 9.0 Hz, 2H, CHAr Tosyl) 3.76-3.70 (m, 1H, CH), 2.37 (s, 3H, CH3 Tosyl), 1.13 (d, J 
= 7.1 Hz, 3H, CH3-CH) ppm. 13C NMR (125 MHz, d-DMSO): δ 173.2 (C=O), 142.5 (CAr Tosyl), 138.5 
(CAr Tosyl), 129.5 (CHAr Tosyl), 126.5 (CHAr Tosyl), 51.1 (CH), 20.9 (CH3 Tosyl), 18.4 (CH3-CH) ppm. NMR 
data match known literature values: Adv. Synth. Catal., 2016, 358, 1968-1974. 
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2.5.4: Intramolecular [3 + 2] Cycloaddition 
 
 
 
General Procedure H: 
A reaction vial was loaded with the corresponding aldehyde (1.0 equiv.), the corresponding amino 
acid (2.0 equiv.), and 4 ÅMS in anhydrous toluene (0.1 M) then heated to 100 °C and the reaction 
progress was monitored via TLC. The reaction mixture was then cooled to room temperature, filtered 
via sintered glass funnel, and the solvent was removed under reduced pressure. The crude product was 
then purified via flash column chromatography to afford the corresponding isoindoline product. 
 
General Procedure I: 
A reaction vial was loaded with the corresponding aldehyde (1.0 equiv.), the corresponding amino 
acid (2.0 equiv.), and 4 ÅMS in anhydrous toluene (0.1 M). To this was then added dry Et3N (2.0-2.5 
equiv.) before heating to 100 °C and the reaction progress was monitored via TLC. The reaction 
mixture was then cooled to room temperature, filtered via sintered glass funnel, and the solvent was 
removed under reduced pressure. The crude product was then purified via flash column 
chromatography to afford the corresponding isoindoline product. 
 
10-Methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265ad) 
The title compound was prepared using General Procedure H from 262d 
to afford the title compound as a orange/pink solid (30.0 mg, 30% yield). 
Rf: 0.40 in 20:80 EtOAc:n-hexanes. Mp: 125-129 oC. 1H NMR (500 
MHz, CDCl3): δ 7.92 (s, 1H, CHAr), 7.74 (s, 1H, CHAr), 7.49 (d, J = 7.5 
Hz, 1H, CHAr), 7.29 (dt, J = 7.5, 1.0 Hz, 1H, CHAr), 7.23-7.18 (m, 2H, CHAr), 5.46 (d, J = 16.5 Hz, 
1H, O-CH2-C), 5.42 (s, 1H, C-CH-N), 4.95 (d, J = 16.0 Hz, 1H, O-CH2-C), 4.55 (dd, J = 13.0, 1.0 Hz, 
1H, N-CH2-C), 3.96 (dd, J = 13.0, 2.5 Hz, 1H, N-CH2-C), 2.74 (s, 3H, N-CH3) ppm. 13C NMR (125 
MHz, CDCl3): δ 156.9 (CAr), 148.0 (CAr), 145.2 (CAr), 141.4 (CAr), 136.5 (CAr), 135.6 (CAr), 128.8 
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(CHAr), 125.5 (CHAr), 125.3 (CHAr), 121.7 (CHAr), 119.1 (CHAr), 116.0 (CHAr), 72.1 (OCH2C), 68.3 
(NCHC)), 60.6 (NCH2C), 42.0 (NCH3) ppm. HRMS (ESI): calcd for C16H15N2O3 [M + H]+ 283.1083, 
found 283.1086.  IR (ATR cm-1): ṽ = 1700 (m), 1534 (m), 1483 (w), 1343 (s), 1264 (s), 1047 (m), 
895 (m), 732 (s), 702 (s). 
 
8-chloro-10-methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265bd) 
 The title compound was prepared using General Procedure H from 
262e to afford the title compound as a pale brown residue (2.5 mg, 
5% yield). Rf: 0.28 in 20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, 
CDCl3): δ 7.94 (s, 1H, CHAr), 7.76 (s, 1H, CHAr), 7.47 (d, J = 1.5 Hz, 
1H, CHAr), 7.24 (dd, J = 8.5, 2.5 Hz, 1H, CHAr), 7.12 (d, J = 8.5 Hz, 1H, CHAr), 5.46 (d, J = 16.0 Hz, 
1H, O-CH2), 5.41 (s, 1H, CH), 4.93 (d, J = 16.0 Hz, 1H, O-CH2), 4.56 (dd, J = 13.5, 1.0 Hz, 1H, N-
CH2), 3.98 (dd, J = 13.5, 2.0 Hz, 1H, N-CH2), 2.74 (s, 3H, CH3) ppm. Insufficient amount of material 
to obtain full characterisation data. 
 
8-bromo-10-methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265cd) 
The title compound was prepared using General Procedure H from 
262f to afford the title compound as a pale red residue (7.1 mg, 15% 
yield). Rf: 0.30 in 20:80 EtOAc:n-hexanes. 1H NMR (400 MHz, 
CDCl3): δ 7.93 (s, 1H, CHAr), 7.75 (s, 1H, CHAr), 7.61 (dd, J = 2.3, 
1.1 Hz, 1H, CHAr), 7.39 (dd, J = 8.4, 2.3 Hz, 1H, CHAr), 7.06 (d, J = 8.4 Hz, 1H, CHAr), 5.46 (d, J = 
16.0 Hz, 1H, OCH2), 5.41 (s, 1H, CH), 4.93 (d, J = 16.0 Hz, 1H, OCH2), 4.56 (dd, J = 13.7, 2.3 Hz, 
1H, NCH2), 3.97 (d, J = 23.6 Hz, 1H, NCH2), 2.73 (s, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3): 
δ 155.9 (CAr), 148.2 (CAr), 144.3 (CAr), 141.5 (CAr), 139.0 (CAr), 135.2 (CAr), 131.8 (CHAr), 128.6 
(CHAr), 123.6 (CHAr), 119.2 (CHAr), 118.8 (CAr), 116.1 (CHAr), 72.1 (OCH2), 68.1 (CH), 60.5 (NCH2), 
41.9 (CH3) ppm. HRMS (ESI): calcd for C16H14N2O3Br [M + H]+ 361.0188, found 361.0185.  IR 
(ATR cm-1): ṽ = 1700 (m), 1534 (m), 1483 (w), 1343 (s), 1264 (s), 1047 (m), 895 (m), 732 (s), 702 
(s). 
 
10-methyl-2,8-dinitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265dd) 
The title compound was prepared using General Procedure H from 
262g to afford the title compound as a yellow residue (0.9 mg, 2% 
yield). Rf: 0.19 in 20:80 EtOAc:n-hexanes. 1H NMR (400 MHz, 
CDCl3): δ 8.39 (s, 1H, CHAr), 8.18 (dd, J = 8.7, 2.9 Hz, 1H, CHAr), 
7.96 (s, 1H, CHAr), 7.78 (s, 1H, CHAr), 7.31 (d, J = 8.7 Hz, 1H, CHAr), 5.57 (d, J = 16.0 Hz, 1H, 
OCH2), 5.46 (s, 1H, CH), 4.99 (d, J = 16.1 Hz, 1H, OCH2), 4.62 (d, J = 13.7 Hz, 1H, NCH2), 4.03 (d, 
J = 13.6 Hz, 1H, NCH2), 2.77 (s, 3H, CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 161.8 (CAr), 143.7 
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(CAr), 141.7 (CAr), 139.0 (CAr), 134.4 (CAr), 131.5 (CAr), 124.8 (CHAr), 122.9 (CHAr), 121.7 (CHAr), 
119.2 (CHAr), 118.7 (CAr), 116.5 (CHAr), 72.2 (OCH2), 68.0 (CH), 60.6 (NCH2), 41.8 (CH3) ppm. 
HRMS (ESI): calcd for C16H14N3O5 [M + H]+ 328.0933, found 328.0930.  IR (ATR cm-1): ṽ = 1700 
(m), 1534 (m), 1483 (w), 1343 (s), 1264 (s), 1047 (m), 895 (m), 732 (s), 702 (s). 
 
8,10-dimethyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265ed) 
The title compound was prepared using General Procedure H from 
262h to afford the title compound as a pale orange residue (11.4 mg, 
23% yield). Rf: 0.29 in 20:80 EtOAc:n-hexanes. 1H NMR (500 
MHz, CDCl3): δ 7.92 (s, 1H, CHAr), 7.75 (s, 1H, CHAr), 7.28 (s, 1H, 
CHAr), 7.11-7.04 (m, 2H, CHAr), 5.45-5.41 (m, 2H, overlapping CH & OCH2), 4.93 (d, J = 15.8 Hz, 
1H, OCH2), 4.56 (d, J = 13.5 Hz, 1H, NCH2), 3.96 (dd, J = 13.5, 2.3 Hz, 1H, NCH2), 2.75 (s, 3H, N-
CH3), 2.35 (s, 3H, Ar-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 154.7 (CAr), 148.0 (CAr), 145.3 
(CAr), 141.4 (CAr), 136.1 (CAr), 135.8 (CAr), 135.1 (CAr), 129.2 (CHAr), 125.8 (CHAr), 121.4 (CHAr), 
119.2 (CHAr), 115.9 (CHAr), 72.2 (OCH2), 68.4 (CH), 60.6 (NCH2), 42.1 (NCH3), 21.3 (Ar-CH3) ppm. 
HRMS (ESI): calcd for C17H17N2O3 [M + H]+ 297.1239, found 297.1235.  IR (ATR cm-1): ṽ = 1700 
(m), 1534 (m), 1483 (w), 1343 (s), 1264 (s), 1047 (m), 895 (m), 732 (s), 702 (s). 
 
8-methoxy-10-methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265fd) 
The title compound was prepared using General Procedure H from 
262i to afford the title compound as a pale orange residue (5.0 mg, 
11% yield). Rf: 0.27 in 30:70 EtOAc:n-hexanes. 1H NMR (500 
MHz, CDCl3): δ 7.92 (s, 1H, CHAr), 7.75 (s, 1H, CHAr), 7.11 (d, J 
= 8.5 Hz, 1H, CHAr), 7.06 (d, J = 2.5 Hz, 1H, CHAr), 6.77 (dd, J = 8.5, 3.0 Hz, 1H, CHAr), 5.44-5.41 
(m, 2H, overlapping O-CH2 & CH), 4.92 (d, J = 15.5 Hz, 1H, O-CH2), 4.56 (d, J = 12.5 Hz, 1H, N-
CH2), 3.96 (d, J = 13.0 Hz, 1H, N-CH2), 3.80 (s, 3H, O-CH3), 2.74 (s, 3H, N-CH3) ppm. Insufficient 
amount of sample to obtain full characterisation data. 
 
10-Benzyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (267) 
The title compound was prepared using General Procedure I from 262d to 
afford the title compound as a pale-yellow solid (58.6 mg, 53% yield). Rf: 
0.46 in 20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.85 (s, 
1H, NO2CHAr), 7.75 (s, 1H, NO2CHAr), 7.71 (d, J = 7.5 Hz, 1H, CHAr), 
7.56 (d, J = 7.5 Hz, 2H, CHAr), 7.43 (t, J = 7.5 Hz, 2H, CHAr), 7.36-7.29 (m, 2H, CHAr), 7.25-7.21 (m, 
2H, CHAr), 5.75 (s, 1H, N-CH-C), 5.49 (d, J = 16.0 Hz, 1H, O-CH2-C), 4.98 (d, J = 16.0 Hz, 1H, O-
CH2-C), 4.45-4.39 (m, 2H, N-CH2-C and N-CH2-Ph), 3.86 (d, J = 14.0 Hz, 1H, N-CH2-Ph), 3.74 (d, J 
= 13.5 Hz, 1H, N-CH2-C) ppm. 13C NMR (125 MHz, CDCl3): δ 156.9 (NO2CAr), 148.0 (CAr), 144.6 
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(CAr), 141.1 (CAr), 138.6 (CAr), 136.7 (CAr), 135.6 (CAr), 129.0 (CHAr), 128.9 (CHAr), 128.4 (CHAr), 
127.6 (CHAr), 125.5 (CHAr), 125.2 (CHAr), 121.8 (CHAr), 119.1 (CHAr), 116.1 (CHAr), 72.1 (O-CH2-
C), 66.7 (N-CH-C), 59.2 (N-CH2-C), 58.0 (N-CH2-Ph) ppm. HRMS (ESI): calcd for C22H18N2O3Na 
[M + Na]+ 381.1215, found 381.1227. IR (ATR cm-1): ṽ = 3056 (w), 1701 (m), 1529 (s), 1481 (m), 
1343 (s), 1266 (m), 1222 (m), 1045 (m), 895 (m), 773 (m), 734 (s), 699 (s). 
 
2-Nitro-4,9b,11,12,13,13a-hexahydrobenzo[6,7]oxepino[5,4,3-cd]pyrrolo[2,1-a]isoindole (274) 
The title compound was prepared using General Procedure I from 262d to 
afford the title compound as a red residue (8.9 mg, 18%). Rf: 0.29 in 
40:60 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.55 (d, J = 2.0 
Hz, 1H, CHAr), 7.63 (d, J = 7.4 Hz, 1H, CHAr), 7.51 (d, J = 1.9 Hz, 1H, 
CHAr), 7.25-7.13 (m, 3H, CHAr), 5.15 (s, 2H, O-CH2), 4.64 (t, J = 7.1 Hz, 
2H, N-CH2), 3.31 (t, J = 7.4 Hz, 2H, C-CH2), 2.78 (p, J = 7.2 Hz, 2H, CH2-CH2-CH2) ppm. 13C NMR 
(125 MHz, CDCl3): δ 157.7 (CAr), 141.7 (CAr), 136.5 (CAr), 133.8 (CAr), 126.93 (CAr), 126.84 (CAr), 
126.5 (CHAr), 125.7 (Q), 124.52 (CHAr), 124.49 (CHAr), 123.1 (CHAr), 119.4 (CHAr), 115.0 (Q), 110.9 
(CHAr), 75.5 (O-CH2), 50.1 (CH2), 27.8 (CH2), 24.0 (CH2) ppm. LRMS found 306+. Due to product 
instability a HRMS was inconclusive. 
 
10-methyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole (281) 
The title compound was prepared using General Procedure H from 280a 
to afford the title compound as a pale orange solid (28.7 mg, 59% yield). 
Rf: 0.55 in 50:50 EtOAc:n-hexanes. Mp: 193-99 °C. 1H NMR (500 
MHz, CDCl3): δ 7.91 (s, 1H, CHAr), 7.84 (s, 1H, CHAr), 7.72 (d, J = 8.4 
Hz, 2H, CHAr Tosyl), 7.57 (d, J = 7.8 Hz, 1H, CHAr), 7.39 (td, J = 7.6, 1.4 
Hz, 1H, CHAr), 7.32 (d, J = 7.6 Hz, 2H, CHAr Tosyl), 7.28-7.24 (m, 1H, CHAr), 7.16 (dd, J = 7.8, 1.3 Hz, 
1H, CHAr), 5.53 (d, J = 17.8 Hz, 1H, NTs-CH2-C), 5.01 (s, 1H, C-CH-NMe), 4.51 (dd, J = 13.6, 2.2 
Hz, 1H, MeN-CH2-C), 4.38 (d, J = 18.2 Hz, 1H, NTs-CH2-C), 3.86 (dd, J = 13.5, 3.2 Hz, 1H, MeN-
CH2-C), 2.58 (s, 3H, N-CH3), 2.46 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 148.1 
(CAr), 144.4 (CAr), 144.0 (CAr), 141.9 (CAr), 141.7 (CAr), 138.5 (CAr), 137.5 (CAr), 134.4 (CAr), 130.0 
(CHAr Tosyl), 129.6 (CHAr), 128.6 (CHAr), 128.5 (CHAr), 127.2 (CHAr Tosyl), 126.2 (CHAr), 120.5 (CHAr), 
116.1 (CHAr), 69.0 (C-CH-NMe), 60.3 (NMe-CH2-C), 50.7 (NTs-CH2-C), 41.7 (N-CH3), 21.7 (CH3 
Tosyl) ppm. HRMS (ESI): calcd for C23H22N3O4S [M + H]+ 436.1331, found 436.1335. IR (ATR cm-
1): ṽ = 2821 (w), 2847 (w), 2787 (w), 1684 (w), 1532 (s), 1482 (w), 1341 (s), 1117 (s), 1089 (s), 1017 
(w), 888 (m), 783 (m), 681 (s), 572 (s). 
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10-benzyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole (282a) 
The title compound was prepared using General Procedure I from 280a to 
afford the title compound as a pale brown solid (40.2 mg, 70% yield). Rf: 
0.38 in 30:70 EtOAc:n-hexanes. Mp: 121-125 °C. 1H NMR (500 MHz, 
CDCl3): δ 7.89 (d, J = 5.0 Hz, 2H, CHAr), 7.80 (d, J = 8.0 Hz, 1H, CHAr), 
7.75 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.52 (d, J = 7.5 Hz, 2H, CHAr), 7.44-
7.34 (m, 3H, overlapping CHAr), 7.28 (t, J = 7.5 Hz, 1H, CHAr), 7.18 (d, J = 8.0 Hz, 1H, CHAr), 5.57 
(d, J = 17.5 Hz, 1H, NTs-CH2-C), 5.40 (s, 1H, C-CH-NBn), 4.43-4.36 (m, 2H, overlapping N-CH2-Ph 
& N-CH2-C), 4.28 (d, J = 14.0 Hz, 1H, NTs-CH2-C), 3.78 (d, J = 13.5 Hz, 1H, N-CH2-Ph), 3.56 (d, J 
= 14.0 Hz, 1H, NTs-CH2-C), 2.50 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 148.1 
(CAr), 144.1 (CAr), 143.8 (CAr), 141.9 (CAr), 141.6 (CAr), 138.5 (CAr), 138.4 (CAr), 137.5 (CAr), 134.5 
(CAr), 130.1 (CHAr Tosyl), 129.6 (CHAr), 128.9 (CHAr), 128.64 (CHAr), 128.61 (CHAr), 128.4 (CHAr), 
127.6 (CHAr), 127.3 (CHAr Tosyl), 126.0 (CHAr), 120.5 (CHAr), 116.3 (CHAr), 67.7 (C-CH-NBn), 59.2 
(NTs-CH2-C), 57.8 (N-CH2-Ph), 50.7 (NBn-CH2-C), 21.8 (CH3 Tosyl) ppm. HRMS (ESI): calcd for 
C29H26N3O4S [M + H]+ 512.16440, found 512.16374. IR (ATR cm-1): ṽ = 3099 (w), 3030 (w), 2922 
(w), 2829 (w), 1598 (w), 1526 (s), 1482 (m), 1342 (s), 1159 (s), 1091 (s), 895 (s), 785 (s), 702 (s), 572 
(s). 
 
10-benzyl-8-fluoro-2-nitro-5-tosyl-5,10-dihydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole (282b′) 
The title compound was prepared using General Procedure I from 280b 
to afford the title compound as a pale brown solid (14.4 mg, 25% 
yield). Mp: 150-154 °C. Rf: 0.37 in 30:70 EtOAc:n-hexanes. 1H NMR 
(500 MHz, CDCl3): δ  8.45 (d, J = 2.0 Hz, 1H, CHAr), 8.14 (d, J = 1.9 
Hz, 1H, CHAr), 7.83 (d, J = 8.4 Hz, 2H, CHAr tosyl), 7.57 (d, J = 7.2 
Hz, 2H, CHAr benzyl), 7.45 (d, J = 8.1 Hz, 2H, CHAr tosyl), 7.37-7.28 (m, 3H, CHAr benzyl), 6.98-6.90 
(m, 2H, CHAr), 6.77 (dd, J = 8.9, 4.4 Hz, 1H, CHAr), 5.93 (d, J = 17.4 Hz, 1H, NTs-CH2-C), 5.28 (s, 
1H, CH), 5.07 (d, J = 15.3 Hz, CH2 benzyl), 4.95 (d, J = 15.3 Hz, 1H, CH2 benzyl), 4.46 (d, J = 17.4 
Hz, 1H, NTs-CH2-C), 2.52 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 166.4 (CAr), 
162.3 (d, J = 251.6 Hz, CAr), 149.6 (CAr), 148.5 (CAr), 145.3 (CAr), 142.9 (d, J = 7.6 Hz, CAr), 137.1 
(CAr), 136.9 (CAr), 134.7 (CAr), 133.1 (CAr), 132.6 (d, J = 3.4 Hz, CAr), 131.0 (d, J = 8.8 Hz, CHAr), 
130.6 (CHAr tosyl), 128.9 (CHAr benzyl), 128.7 (CHAr benzyl), 127.8 (CHAr benzyl), 127.6 (CHAr 
tosyl), 125.6 (CHAr), 117.8 (CHAr), 117.7 (d, J = 22.4 Hz, CHAr), 113.8 (d, J = 25.5 Hz, CHAr), 90.5 
(CH), 51.0 (NTs-CH2-C), 45.8 (N-CH2-Ph), 21.9 (CH3 tosyl) ppm. LRMS found peak at 524+. IR 
(ATR cm-1): ṽ = 3393 (w), 3067 (w), 2922 (w), 2852 (w), 1680 (s), 1596 (w), 1536 (s), 1486 (s), 
1340 (s), 1271 (m), 1158 (s), 1090 (s), 788 (s), 664 (s), 541 (s). 
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10-benzyl-8-chloro-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282d) 
The title compound was prepared using General Procedure I from 
280d to afford the title compound as an orange solid (24.1 mg, 42% 
yield). Rf: 0.38 in 30:70 EtOAc:n-hexanes. Mp: 218-221 °C. 1H 
NMR (500 MHz, CDCl3): δ 7.853 (s, 1H, CHAr), 7.847 (s, 1H, 
CHAr), 7.78 (d, J = 2.0 Hz, 1H, CHAr), 7.73 (d, J = 8.0 Hz, 2H, CHAr 
Tosyl), 7.49 (d, J = 7.5 Hz, 2H, CHAr Benzyl), 7.43 (d, J = 7.5 Hz, 2H, CHAr Benzyl), 7.37-7.34 (m, 3H, 
overlapping CHAr Tosyl & CHAr Benzyl), 7.25 (dd, J = 8.8, 2.5 Hz, 1H, CHAr), 7.11 (d, J = 8.5 Hz, 1H, 
CHAr), 5.56 (d, J = 17.5 Hz, 1H, NTs-CH2-C), 5.33 (C-CH-N), 4.40-4.34 (m, 2H, overlapping BnN-
CH2-C & NTs-CH2-C), 4.19 (d, J = 13.5 Hz, 1H, N-CH2-Ph), 3.80 (dd, J = 13.8, 2.3 Hz, 1H, BnN-
CH2-C), 3.54 (d, J = 13.5 Hz, 1H, N-CH2-Ph), 2.49 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, 
CDCl3): δ 148.3 (CAr), 144.3 (CAr), 144.0 (CAr), 143.0 (CAr), 141.5 (CAr), 138.1 (CAr), 138.0 (CAr), 
135.83 (CAr), 135.78 (CAr), 134.2 (CAr), 130.20 (CHAr), 130.17 (CHAr Tosyl), 129.0 (CHAr Benyl), 128.7 
(CHAr), 128.6 (CHAr Benzyl), 127.8 (CHAr Benzyl), 127.3 (CHAr Tosyl), 126.6 (CHAr), 120.6 (CHAr), 116.4 
(CHAr), 67.4 (C-CH-N), 59.3 (N-CH2-Ph), 57.8 (BnN-CH2-C), 50.6 (NTs-CH2-C), 21.8 (CH3 Tosyl) 
ppm. HRMS (ESI): calcd for C29H25N3O4SCl [M + H]+ 546.1254, found 546.1230. IR (ATR cm-1): ṽ 
= 3081 (w), 3030 (m), 2922 (w), 2801 (w), 1718 (w), 1523 (s), 1350 (m), 1324 (s), 1268 (m), 1154 
(s), 1090 (s), 813 (s), 722 (s), 658 (s), 578 (s), 544 (s). 
 
10-benzyl-7-chloro-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282e) 
The title compound was prepared using General Procedure I from 
280e to afford the title compound as a yellow solid (30.7 mg, 54% 
yield). Rf: 0.39 in 30:70 EtOAc:n-hexanes. Mp: 161-162 °C. 1H 
NMR (400 MHz, CDCl3): δ 7.85 (s, 2H, CHAr), 7.75 (d, J = 8.4 Hz, 
2H, CHAr Tosyl), 7.73 (d, J = 8.4 Hz, 1H, CHAr), 7.49 (d, J = 7.2 Hz, 
2H, CHAr), 7.42 (d, J = 7.2 Hz, 2H, CHAr), 7.39-7.34 (t, J = 2H, CHAr), 7.37 (d, J = 8.0 Hz, 2H, CHAr 
Tosyl), 7.18 (d, J = 2.0 Hz, 1H, CHAr), 5.23 (d, J = 18.0 Hz, 1H, NTs-CH2-C), 5.40 (s, 1H, C-CH-N), 
4.41-4.36 (m, 2H, overlapping, NTs-CH2-C & BnN-CH2-C), 4.21 (d, J = 14.0 Hz, 1H, N-CH2-Ph), 
3.78 (dd, J = 13.8, 2.6 Hz, 1H, BnN-CH2-C), 3.56 (d, J = 13.6 Hz, 1H, N-CH2-Ph), 2.50 (s, 3H, CH3 
Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 148.2 (CAr), 144.2 (CAr), 143.2 (CAr), 141.5 (CAr), 140.7 
(CAr), 138.4 (CAr), 138.2 (CAr), 138.0 (CAr), 134.1 (CAr), 133.6 (CAr), 130.2 (CHAr Tosyl), 129.8 (CHAr), 
129.0 (CHAr), 128.9 (CHAr), 128.4 (CHAr), 127.7 (CHAr), 127.3 (CHAr Tosyl), 127.2 (CHAr), 120.5 
(CHAr), 116.4 (CHAr), 67.4 (C-CH-N), 59.1 (N-CH2-Ph), 57.8 (BnN-CH2-C), 50.5 (NTs-CH2-C), 21.8 
(CH3 Tosyl) ppm. HRMS (ESI): calcd for C29H25N3O4SCl [M + H]+ 546.1254, found 546.1238. IR 
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(ATR cm-1): ṽ = 3062 (w), 2922 (m), 2852 (w), 1715 (w), 1547 (s), 1431 (w), 1343 (s), 1131 (s), 
1027 (w), 913 (s), 744 (s), 697 (s), 582 (s), 539 (s). 
 
10-benzyl-6-chloro-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282f) 
The title compound was prepared using General Procedure I from 280f to 
afford the title compound as a yellow solid (34.1 mg, 61%). Rf: 0.36 in 
30:70 EtOAc:n-hexanes. Mp: 229-230 °C. 1H NMR (500 MHz, CDCl3): 
δ 7.855 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.855 (s, 2H, CHAr), 7.77-7.74 (m, 
1H, CHAr), 7.54 (d, J = 7.2 Hz, 2H, CHAr), 7.43 (t, J = 7.2 Hz, 2H, CHAr), 
7.37-7.33 (m, 5H, CHAr & CHAr Tosyl), 5.85 (s, 1H, C-CH-N), 5.30 (d, J = 18.4 Hz, 1H, NTs-CH2-C), 
4.44-4.38 (m, 2H, overlapping NTs-CH2-C & NBn-CH2-C), 4.37 (d, J = 14.4 Hz, 1H, N-CH2-Ph), 
3.84 (dd, J = 13.8, 2.6 Hz, 1H, NBn-CH2-C), 3.73 (d, J = 14.0 Hz, 1H, N-CH2-Ph), 2.48 (s, 3H, CH3 
Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 148.2 (CAr), 145.9 (CAr), 144.2 (CAr), 143.6 (CAr), 141.8 
(CAr), 138.3 (CAr), 137.9 (CAr), 134.9 (CAr), 134.8 (CAr), 134.7 (CAr), 130.7 (CHAr), 129.8 (CHAr Tosyl), 
129.5 (CHAr), 128.9 (CHAr), 128.5 (CHAr), 127.9 (CHAr Tosyl), 127.6 (CHAr), 124.7 (CHAr), 120.5 
(CHAr), 116.4 (CHAr), 68.2 (C-CH-N), 59.1 (N-CH2-Ph), 57.8 (NBn-CH2-C), 49.8 (NTs-CH2-C), 21.8 
(CH3 Tosyl) ppm. HRMS (ESI): calcd for C29H25N3O4SCl [M + H]+ 546.1254, found 546.1251. IR 
(ATR cm-1): ṽ = 3094 (w), 3032 (w), 2922 (m), 2852 (w), 2903 (w), 1737 (w), 1597 (s) 1452 (s), 
1341 (s), 1157 (s), 1088 (s), 909 (s), 776 (s), 677 (s), 567 (s). 
 
10-benzyl-8-bromo-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282g) 
The title compound was prepared using General Procedure I from 
280g to afford the title compound as a yellow solid (27.4 mg, 49% 
yield). Rf: 0.44 in 30:70 EtOAc:n-hexanes. Mp: 207-209 °C. 1H 
NMR (500 MHz, CDCl3): δ 7.94 (d, J = 2.0 Hz, 1H, CHAr), 7.850 (s, 
1H, CHAr), 7.845 (s, 1H, CHAr), 7.73 (d, J = 8.5 Hz, 2H, CHAr Tosyl), 
7.49 (d, J = 7.5 Hz, 2H, CHAr), 7.43 (t, J = 7.5 Hz, 2H, CHAr), 7.42-7.39 (m, 1H, CHAr), 7.37-7.36 (m, 
1H, CHAr), 7.35 (d, J = 8.5 Hz, 2H, CHAr Tosyl), 7.04 (d, J = 8.5 Hz, 1H, CHAr), 5.57 (d, J = 17.5 Hz, 
1H, NTs-CH2-C), 5.34 (s, 1H, C-CH-N), 4.40-4.34 (m, 2H, overlapping NTs-CH2-C & NBn-CH2-C), 
4.19 (d, J = 13.5 Hz, 1H, N-CH2-Ph), 3.81 (dd, J = 13.8, 2.3 Hz, 1H, NBn-CH2-C), 3.54 (d, J = 13.5 
Hz, 1H, N-CH2-Ph), 2.48 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 148.3 (CAr), 144.3 
(CAr), 144.2 (CAr), 143.0 (CAr), 141.5 (CAr), 138.1 (CAr), 138.0 (CAr), 136.4 (CAr), 134.2 (CAr), 131.7 
(CHAr), 130.5 (CHAr), 130.2 (CHAr Tosyl), 129.6 (CHAr), 129.0 (CHAr), 128.6 (CHAr), 127.8 (CHAr), 
127.3 (CHAr Tosyl), 124.0 (CAr), 120.6 (CHAr), 116.4 (CHAr), 67.4 (C-CH-N), 59.3 (N-CH2-Ph), 57.8 
(NBn-CH2-C), 50.5 (NTs-CH2-C), 21.8 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C29H25N3O4SBr [M 
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+ H]+ 590.0749, found 590.0762. IR (ATR cm-1): ṽ = 3078 (w), 3030 (w), 2921 (m), 2851 (w), 2787 
(w), 1751 (w), 1523 (s), 1453 (m), 1336 (s), 1154 (s), 1095 (s), 864 (s), 767 (s), 687 (s), 575 (s). 
 
10-benzyl-8-methyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282h) 
The title compound was prepared using General Procedure I from 
280h to afford the title compound as a yellow solid (35.4mg, 61% 
yield). Rf: 0.43 in EtOAc:n-hexanes. Mp: 205-209 °C. 1H NMR 
(500 MHz, CDCl3): δ 7.841 (s, 1H, CHAr), 7.835 (s, 1H, CHAr), 7.74 
(d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.60 (s, 1H, CHAr), 7.52 (d, J = 7.5 
Hz, 2H, CHAr), 7.43 (t, J = 7.5 Hz, 2H, CHAr), 7.36-7.33 (m, 1H, CHAr), 7.34 (d, J = 8.5 Hz, 2H, CHAr 
Tosyl), 7.08-7.03 (d, 2H, CHAr), 5.54 (d, J = 17.5 Hz, 1H, NTs-CH2-C), 5.36 (s, 1H, C-CH-N), 4.41-
4.34 (m, 2H, overlapping NTs-CH2-C & NBn-CH2-C), 4.26 (d, J = 13.5 Hz, 1H, N-CH2-Ph), 3.77 (dd, 
J = 13.8, 2.8 Hz, 1H, NBn-CH2-C), 3.54 (d, J = 13.5 Hz, 1H, N-CH2-Ph), 2.48 (s, 3H, CH3 Tosyl), 2.36 
(s, 3H, Ar-CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 148.1 (CAr), 143.96 (CAr), 143.95 (CAr), 
141.55 (CAr), 141.52 (CAr), 139.7 (CAr), 138.6 (CAr), 138.5 (CAr), 134.8 (CAr), 134.7 (CAr), 130.0 (CHAr 
Tosyl), 129.1 (CHAr), 128.9 (CHAr), 128.53 (CHAr), 128.47 (CAr), 127.6 (CHAr), 127.3 (CHAr Tosyl), 126.6 
(CHAr), 120.5 (CHAr), 116.3 (CHAr), 67.6 (C-CH-N), 59.3 (N-CH2-Ph), 57.8 (NBn-CH2-C), 50.8 
(NTs-CH2-C), 21.8 (CH3 Tosyl), 21.7 (Ar-CH3) ppm. HRMS (ESI): calcd for C30H28N3O4S [M + H]+ 
526.1801, found 526.1812. IR (ATR cm-1): ṽ = 3034 (w), 2921 (m), 2852 (w), 2795 (w), 1599 (w), 
1528 (s), 1496 (m), 1342 (s), 1157 (s), 1116 (s), 866 (s), 746 (s), 695 (s), 612 (s), 537 (s). 
 
10-benzyl-8-methoxy-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282i) 
The title compound was prepared using General Procedure I from 
280i to afford the title compound as a beige solid (34.4 mg, 62% 
yield). Rf: 0.38 in EtOAc:n-hexanes. Mp: 216-218 °C. 1H NMR 
(500 MHz, CDCl3): δ 7.85 (s, 1H, CHAr), 7.84 (s, 1H, CHAr), 7.73 
(d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.51 (d, J = 7.5 Hz, 2H, CHAr), 7.42 
(t, J = 7.0 Hz, 2H, CHAr), 7.36-7.33 (m, 2H, CHAr), 7.33 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.07 (d, J = 8.5 
Hz, 1H, CHAr), 6.76 (dd, J = 9.0, 3.0 Hz, 1H, CHAr), 5.57 (d, J = 18.0 Hz, 1H, NTs-CH2-C), 5.31 (s, 
1H, C-CH-C), 4.42-4.36 (m, 2H, overlapping NTs-CH2-C & NBn-CH2-C), 4.24 (d, J = 13.5 Hz, 1H, 
N-CH2-Ph), 3.79-3.77 (m, 1H, NBn-CH2-C), 3.77 (s, 3H, O-CH3), 3.54 (d, J = 14.0 Hz, 1H, N-CH2-
Ph), 2.48 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 160.5 (CAr), 148.1 (CAr), 143.9 
(CAr), 143.7 (CAr), 143.6 (CAr), 141.5 (CAr), 138.6 (CAr), 138.5 (CAr), 134.7 (CAr), 130.02 (CHAr Tosyl), 
129.99 (CHAr), 129.6 (CAr), 128.9 (CHAr), 128.3 (CHAr), 127.6 (CHAr), 127.3 (CHAr Tosyl), 120.6 
(CHAr), 116.3 (CHAr), 113.7 (CHAr), 111.3 (CHAr), 67.8 (C-CH-N), 59.8 (N-CH2-Ph), 57.9 (NBn-CH2-
N
N
Bn
NO2
Ts
Me
N
N
Bn
NO2
Ts
MeO
	 129 
C), 55.6 (O-CH3), 50.9 (NTs-CH2-C), 21.8 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C30H27N3O5SNa 
[M + Na]+ 564.1569, found 564.1567. IR (ATR cm-1): ṽ = 3068 (w), 3031 (w), 2921 (m), 2851 (m), 
2798 (w), 1725 (w), 1600 (m), 1523 (s), 1491 (s), 1334 (s), 1091 (s), 902 (s), 839 (s), 810 (s), 667 (s), 
525 (s). 
 
10,11-dimethyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole 
(284) 
 The title compound was prepared using General Procedure H from 280a 
to afford the title compound as a yellow solid (11.8 mg, 23% yield). Rf: 
0.32 in 20:80 EtOAc:n-hexanes. Mp: 186-188 °C. 1H NMR (500 MHz, 
CDCl3): δ 7.85 (s, 1H, CHAr), 7.83 (s, 1H, CHAr), 7.72 (d, J = 8.0 Hz, 2H, 
CHAr Tosyl), 7.57 (d, J = 7.5 Hz, 1H, CHAr), 7.38 (td, J = 7.5, 1.0 Hz, 1H, 
CHAr), 7.31 (d, J = 8.0 Hz, 2H, CHAr Tosyl), 7.26 (td, J = 7.5, 1.0 Hz, 1H, 
CHAr), 7.16 (dd, J = 4.0, 1.0 Hz, 1H, CHAr), 5.55 (d, J = 17.5 Hz, 1H, NTs-CH2-C), 5.00 (s, 1H, C-
CH-N), 4.39 (d, J = 17.5 Hz, 1H, NTs-CH2-C), 3.92-3.88 (m, 1H, N-CH-CH3), 2.54 (s, 3H, N-CH3), 
2.46 (s, 3H, CH3 Tosyl), 1.52 (d, J = 6.5 Hz, 3H, CH-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 148.3 
(CAr), 146.4 (CAr), 144.0 (CAr), 143.5 (CAr), 142.0 (CAr), 138.5 (CAr), 137.5 (CAr), 134.2 (CAr), 130.0 
(CHAr  Tosyl), 129.5 (CHAr ), 128.5 (CHAr ), 128.4 (CHAr ), 127.2 (CHAr  Tosyl), 126.3 (CHAr ), 120.6 (CHAr 
), 115.9 (CHAr ), 68.7 (C-CH-N), 65.1 (N-CH-CH3), 50.7 (NTs-CH2-C), 39.6 (N-CH3), 21.7 (CH3 
Tosyl), 19.8 (CH-CH3) ppm. HRMS (ESI): calcd for C24H24N3O4S [M + H]+ 450.1488, found 
450.1489. IR (ATR cm-1): ṽ = 3065 (w), 2963 (w), 2921 (w), 2845 (w), 2789 (w), 2598 (w), 1523 (s), 
1482 (m), 1341 (s), 1115 (s), 915 (m), 811 (s), 776 (s), 705 (s), 651 (s), 568 (s). 
 
11-benzyl-10-methyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (285) 
The title compound was prepared using General Procedure I from 280a to 
afford the title compound as a beige solid (37.2 mg, 64% yield). Rf: 0.46 
in 30:70 EtOAc:n-hexanes. Mp: 181-184 °C. 1H NMR (500 MHz, 
CDCl3): δ 7.83 (s, 1H, CHAr), 7.72 (s, 1H, CHAr), 7.69 (d, J = 8.5 Hz, 2H, 
CHAr Tosyl), 7.55 (d, J = 7.5 Hz, 1H, CHAr), 7.37 (t, J = 7.5 Hz, 1H, CHAr), 
7.32-7.28 (m, 6H, CHAr), 7.26-7.21 (2H, CHAr), 7.16 (d, J = 8.0 Hz, 1H, CHAr), 5.56 (d, J = 18.0 Hz, 
1H, NTs-CH-C), 5.01 (s, 1H, C-CH-N), 4.37 (d, J = 17.5 Hz, 1H, NTs-CH-C), 4.25-4.22 (m, 1H, N-
CH-Bn), 3.22-3.09 (m, 2H, CH-CH2-Ph), 2.43 (s, 3H, CH3 Tosyl), 2.04 (s, 3H, N-CH3) ppm. 13C NMR 
(125 MHz, CDCl3): δ 148.1 (CAr), 144.6 (CAr), 144.0 (CAr), 143.5 (CAr), 142.3 (CAr), 138.4 (CAr), 
137.9 (CAr), 137.2 (CAr), 134.1 (CAr), 129.98 (CHAr Tosyl), 129.98 (CHAr Tosyl), 129.5 (CHAr), 128.59 
(CHAr), 128.55 (CHAr), 128.4 (CHAr), 127.2 (CHAr Tosyl), 126.7 (CHAr), 126.1 (CHAr), 120.7 (CHAr), 
116.6 (CHAr), 70.8 (N-CH-Bn), 69.2 (C-CH-N), 50.6 (NTs-CH2-C), 42.1 (CH-CH2-Ph), 40.8 (N-
N
N
Me
NO2
Ts
H
H
Me
N
N
Me
NO2
Ts
H
H
Bn
	 130 
CH3), 21.7 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C30H28N3O4S [M + H]+ 5266.1801, found 
526.1779. IR (ATR cm-1): ṽ = 3088 (w), 3064 (w), 3028 (w), 2920 (w), 2854 (w), 2800 (w), 1702 
(w), 1525 (s), 1341 (s), 1161 (s), 1010 (m), 787 (s), 701 (s), 648 (s), 584 (s). 
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General Procedure J - N-Methylation of Isatoic Anhydride: 
 
 
 
To a solution of nitro-isatoic anhydride 288 (1.0 equiv.) in dry DMF (0.35 M) was added DIPEA (2.0 
equiv.) drop wise and the mixture was stirred a room temperature for ~10 minutes. Next, MeI (4.0 
equiv.) was slowly added and the mixture was allowed to stir overnight. The reaction was then 
quenched via the careful addition of 0.5 M HCl solution (~30 mL). The aqueous phase was then 
extracted sing EtOAc (10 x 30 mL), the organic phase was collected and the solvent was removed 
under reduced pressure. The crude material was the purified via recrystallisation from warm MeOH 
(~20 mL) to reveal the corresponding product. 
 
1-Methyl-6-nitro-2H-benzo[d][1,3]oxazine-2,4(1H)-dione (289a) 
The title compound was prepared using General Procedure J to afford the title 
compound as a brown/orange solid (0.138 g, 27% yield). 1H NMR (400 
MHz, CDCl3): δ 9.02 (d, J = 2.8 Hz, 1H, CHAr), 8.61 (dd, J = 9.2, 2.8 Hz, 
1H, CHAr), 7.25 (d, J = 9.2 Hz, 1H, CHAr), 3.68 (s, 3H, N-CH3) ppm. 13C 
NMR (100 MHz, CDCl3): δ 156.5 (CAr), 147.0 (C=O), 146.2 (CAr), 143.7 (C=O), 131.9 (CHAr), 
126.9 (CHAr), 115.1 (CHAr), 112.2 (CAr), 32.9 (N-CH3) ppm. NMR data match known literature 
values: RNA, 2013, 19, 1857. 
 
1-Methyl-7-nitro-2H-benzo[d][1,3]oxazine-2,4(1H)-dione (289b)  
The title compound was prepared using General Procedure J to afford the title 
compound as a yellow solid (1.093 g, 75% yield). 1H NMR (400 MHz, 
CDCl3): δ 8.38 (d, J =8.4 Hz, 1H, CHAr), 8.12 (dd, J = 8.4, 2.0 Hz, 1H, 
CHAr), 8.05 (d, J = 1.6 Hz, 1H, CHAr), 3.69 (s, 3H, N-CH3) ppm. 13C NMR 
(100 MHz, CDCl3): δ 156.0 (CAr), 153.2 (C=O), 147.1 (C=O), 143.1 (CAr), 
132.8 (CHAr), 118.4 (CHAr), 116.1 (CAr), 109.5 (CHAr), 32.6 (N-CH3) ppm. NMR data match known 
literature values: RNA, 2013, 19, 1857. 
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General Procedure K - LiF Promoted Cycloaddition: 
 
 
A flame-dried schlenk flask was loaded with the appropriate nitroisatoic anhydride 289 (1.0 equiv.), 
N-benzyl-1-methoxy-N-((trimethylsilyl)methyl)-methanamine 285 (3.0 equiv.), lithium fluoride (1.4 
equiv.) and 3 ÅMS. The flask was then purged with a positive flow of nitrogen for several minutes 
before anhydrous MeCN (0.1 M) was added. The flask was then sealed and sonicated at ~35 °C for 3 
hours after which the dark orange reaction mixture was concentrated in vacuo (temperature kept 
below 40 °C). The crude material was then loaded with a minimal amount of CH2Cl2 onto neutralised 
(1% Et3N) silica gel flash column chromatography and eluted through with EtOAc:n-hexanes to 
afford the corresponding product 291. 
 
General Procedure L - TFA Catalysed Cycloaddition: 
 
 
A reaction vial was loaded the appropriate nitroisatoic anhydride 289 (1.0 equiv.), N-benzyl-1-
methoxy-N-((trimethylsilyl)methyl)-methanamine 285 (2.0 equiv.) and 3 ÅMS. The vial was then 
purged with a positive flow of nitrogen for several minutes before the addition of anhydrous CH2Cl2 
(0.2M) after which time it was cooled to 0 °C. Meanwhile, a solution of 0.1M TFA solution in 
anhydrous CH2Cl2 was prepared in an oven-dried schlenk flask under nitrogen atmosphere and 
allowed to stir at room temperature before use. Then the 0.1M TFA solution (0.05 equiv.) was added 
to the cold reaction mixture. The resultant reaction mixture was then allowed to warm to room 
temperature and then stirred at room temperature overnight. In the morning, the reaction progress was 
monitored via TLC to ensure the reaction gone to completion before the reaction mixture was 
concentrated in vacuo (temperature kept below 40 °C). The crude material was then loaded with 
minimal amount CH2Cl2 onto neutralized (1% Et3N) silica gel flash column chromatography and 
eluted through via gradient EtOAc:n-hexanes to reveal the corresponding compound. 
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3-Benzyl-1-methyl-7-nitro-1,2,3,4-tetrahydro-5H-benzo[d][1,3]diazepin-5-one (291a) 
The title compound was prepared using General Procedure K and L to 
afford the title compound as an orange solid (0.123 g, 83% yield). Rf: 0.33 
in 70:30 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.70 (d, J = 
2.8 Hz, 1H, CHAr), 8.21 (dd, J = 9.3, 2.8 Hz, 1H, CHAr), 7.38-7.29 (m, 5H, 
overlapping CHAr), 6.89 (d, J = 9.3 Hz, 1H, CHAr), 4.25 (s, 2H, NMe-CH2-
NBn), 3.89 (s, 2H, NBn-CH2-C=O), 3.62 (s, 2H, N-CH2-Ar), 3.24 (s, 3H, N-CH3) ppm. 13C NMR 
(125 MHz, CDCl3): δ 196.8 (C=O), 156.2 (CAr), 139.2(CAr), 137.0 (CAr), 128.93 (CHAr), 128.86 
(CHAr), 128.03 (CHAr), 127.95 (CHAr), 127.4 (CHAr), 125.3 (CAr), 113.5 (CHAr), 75.9 (NMe-CH2-
NBn), 64.6 (Ar-CH2-N), 58.6 (BnN-CH2-C=O), 40.5 (N-CH3) ppm. HRMS (ESI): calcd for 
C17H17N2O3 [M]+ 311.1264, found 311.1267. IR (ATR cm-1): ṽ = 3096,	3062,	2957,	2910,	2821,	
1675,	1598,	1573,	1506,	1491,	1451,	1423,	1386,	1324,	1289,	1266,	1255,	1196,	1165,	1151,	
1112,	1081,	1151,	1112,	1081,	1067,	1015,	987,	928,	869,	824,	776,	744, 700, 645, 597, 519, 474. 
 
3-Benzyl-1-methyl-8-nitro-1,2,3,4-tetrahydro-5H-benzo[d][1,3]diazepin-5-one (291b) 
The title compound was prepared using General Procedure K and L to 
afford the title compound as a yellow solid (10.9 mg, 23% yield). Rf: 0.36 
in 20:80 EtOAc:n-hexanes. 1H NMR (400 MHz, CDCl3): δ 7.90 (d, J = 
8.6 Hz, 1H, CHAr), 7.73 (s, 1H, CHAr), 7.63 (dd, J = 8.6, 1.8 Hz, 1H, 
CHAr), 7.39-7.31 (m, 5H, CHAr), 4.16 (s, 2H, CH2), 3.88 (s, 2H, CH2), 3.57 
(s, 2H, CH2), 3.24 (s, 3H, N-CH3) ppm. 13C NMR (100 MHz, CDCl3): δ 197.6 (C=O), 153.1 (CAr), 
150.7 (CAr), 137.2 (CAr), 131.5 (CHAr), 130.4 (CAr), 129.0 (CHAr), 128.8 (CHAr), 127.9 (CHAr), 112.6 
(CHAr), 108.6 (CHAr), 76.5 (CH2), 64.2 (CH2), 58.6 (CH2), 40.2 (N-CH3) ppm. HRMS (ESI): calcd 
for C17H17N2O3 [M]+ 311.1264, found 311.1260. IR (ATR cm-1): ṽ = 1673 (s), 1611 (m), 1522 (s), 
1489 (m), 1446 (m), 1345 (s), 1316 (m), 1289 (m), 1273 (m), 1197 (m), 1068 (m), 967 (w), 909 (m), 
880 (s), 698 (s). 
 
  
N
N
O
Me
Bn
O2N
N
N
O
Me
Bn
O2N
	 134 
2.6: References 
																																																								
1 (a) Lee, S.; Chataigner, I.; Piettre, S. R. Angew. Chem., Int. Ed. Engl. 2010, 50 (2), 472. (b) Lee, S.; 
Diab, S.; Queval, P.; Sebban, M.; Chataigner, I.; Piettre, S. R. Chem. Eur. J. 2013, 19 (22), 7181. 
2 Tsuge, O.; Ueno, K.; Kanemasa, S. Chem. Lett. 1984, No. 2, 285. 
3 Henke, B. R.; Kouklis, A. J.; Heathcock, C. H. J. Org. Chem. 1992, 57 (26), 7056. 
4 Grigg, R.; Idle, J.; McMeekin, P.; Vipond, D. J. Chem. Soc., Chem. Commun. 1987, (2), 49. 
5 (a) Coelho Filho, J. M. J.; Birks, J. Physostigmine For Dementia Due to Alzheimer’s Disease; 
Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD001499. (b) Schallenberger, M. A.; 
Newhouse, T.; Baran, P. S.; Romesberg, F. E. J. Antibiot. 2010, 63 (11), 685. (c) Ding, G.; Jiang, L.; 
Guo, L.; Chen, X.; Zhang, H.; Che, Y. J. Nat. Prod. 2008, 71 (11), 1861. (d) Bertinetti, B. V.; 
Rodriguez, M. A.; Godeas, A. M.; Cabrera, G. M. J. Antibiot. 2010, 63 (11), 681. 
6 Bastrakov, M. A.; Starosotnikov, A. M.; Pechenkin, S. Y.; Kachala, V. V.; Glukhov, I. V.; Shevelev, 
S. A. J. Heterocyl. Chem. 2010, 47 (4), 893.  
7 Konstantinova, L. S.; Bastrakov, M. A.; Starosotnikov, A. M.; Glukhov, I. V.; Lysov, K. A.; Rakitin, 
O. A.; Shevelev, S. A. Mendeleev Commun. 2010, 20 (6), 353. 
8 Starosotnikov, A. M.; Bastrakov, M. A.; Pechenkin, S. Y.; Leontieva, M. A.; Kachala, V. V.; 
Shevelev, S. A. J. Heterocycl. Chem. 2011, 48 (4), 824. 
9 Starosotnikov, A.; Bastrakov, M.; Kachala, V.; Belyakov, P.; Fedyanin, I.; Shevelev, S. Synlett 
2012, 23 (16), 2400. 
10 Bastrakov, M. A.; Leonov, A. I.; Starosotnikov, A. M.; Fedyanin, I. V.; Shevelev, S. A. Russ. 
Chem. Bull. 2014, 62 (4), 1052. 
11 Bastrakov, M. A.; Starosotnikov, A. M.; Kachala, V. V.; Fedyanin, I. V.; Shevelev, S. A. Asian J. 
Org. Chem. 2015, 4 (2), 146. 
12 (a) Solé, D.; Serrano, O. J. Org. Chem. 2010, 75 (18), 6267. (b) Pandey, G.; Varkhedkar, R.; 
Tiwari, D. Org. Biomol. Chem. 2015, 13 (15), 4438. 
13 For reported examples of isoindole instability, see: (a) Solé, D.; Serrano, O. J. Org. Chem. 2010, 75 
(18), 6267. (b) Jeffrey, J. L.; Bartlett, E. S.; Sarpong, R. Angew. Chem., Int. Ed. Engl. 2013, 52 (8), 
2194. 
14 For studies on the auto-oxidation of isoindolines, see: (a) Kopecký, J.; Shields, J. E.; Bornstein, J. 
Tetrahedron Lett. 1967, 8 (38), 3669. (b) Kricka, L. J.; Vernon, J. M. J. Chem. Soc. C 1971, 2667. (c) 
Ahmed, I.; Chesseman, G. W. H.; Jaques, B. Tetrahedron 1979, 35 (9), 1145. 
15 Grigg, R.; Idle, J.; McMeekin, P.; Vipond, D. J. Chem. Soc., Chem. Commun. 1987, (2), 49. 
16 Roy, S.; Kishbaugh, T. L. S.; Jasinski, J. P.; Gribble, G. W. Tetrahedron Lett. 2007, 48 (8), 1313.  
17 (a) Allinger, N. L.; Zalkow, V. J. Org. Chem. 1960, 25 (5), 701. (b) Kaneti, J.; Kirby, A. J.; 
Koedjikov, A. H.; Pojarlieff, I. G. Org. Biomol. Chem. 2004, 2 (7), 1098. 
18 Cao, B.; Simaan, M.; Marek, I.; Wei, Y.; Shi, M. Chem. Commun. 2016, 53 (1), 216. 
	 135 
																																																																																																																																																																												
19 Kochi, J. K.; Singleton, E. A. Tetrahedron 1968, 24 (13), 4649. 
20 Ahmed, I.; Chesseman, G. W. H.; Jaques, B. Tetrahedron 1979, 35 (9), 1145. 
21 Parmar, N. J.; Pansuriya, B. R.; Barad, H. A.; Kant, R.; Gupta, V. K. Bioorg. Med. Chem. Lett. 
2012, 22 (12), 4075. 
22 Parmar, N. J.; Pansuriya, B. R.; Labana, B. M.; Kant, R.; Gupta, V. K. RSC Adv. 2013, 3 (38), 
17527. 
23 Spiccia, N.; Basutto, J.; Jokisz, P.; Wong, L. S. M.; Meyer, A. G.; Holmes, A. B.; White, J. M.; 
Ryan, J. H. Org. Lett. 2011, 13 (3), 486. 
24 D’Souza, A. M.; Rivinoja, D. J.; Mulder, R. J.; White, J. M.; Meyer, A. G.; Hyland, C. J. T.; Ryan, 
J. H. Aust. J. Chem. 2018, 71 (9), 690. 
25 Sustmann, R. Pure Appl. Chem. 1974, 40 (4), 569. 
26 Kopecký, J.; Shields, J. E.; Bornstein, J. Tetrahedron Lett. 1967, 8 (38), 3669. 
27 Fan, W.; Yuan, W.; Ma, S. Nat. Commun. 2014, 5 (1), 3884.	
	 136 
Chapter 3: Pd(0)-Catalysed Dearomative [3 + 2] Cycloaddition of 
Vinylaziridines with Electron-deficient Indoles. 
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3.1: Research Proposal 
 
Inspired by the work shown above concerning the zwitterionic 1,3-dipoles derived from aziridines 
(Section 1.2.3), a project was developed in an effort to design a more efficient method to access the 
biologically important C3a-aminopyrroloindoline structure. Envisaged towards this goal was a reaction 
design incorporating [3 + 2] cycloaddition of a ring-opened vinylaziridine under Pd(0)-catalysis in 
combination with the highly electron-deficient 3-nitroindole system for the formation of highly 
functionalised pyrroloindoline cycloadducts (Scheme 3.1). Firstly, an N-tosyl protected vinylaziridine 
300 will be prepared and subjected to a Pd(0) source with a supporting ligand as the catalyst system to 
initiate oxidative C–N bond addition and ring-opening to the zwitterionic 1,3-dipole 301. This dipole 
will then be reacted with an electron-deficient N-protected 3-nitroindole 302, which have previously 
only undergone dearomative cycloadditions with more strongly nucleophilic species, such as 
azomethine ylides. It is anticipated that nucleophilic attack of the sulfonamide anion to the highly 
electrophilic C2 carbon of indoles 302 will take place, followed by a ring-closure step from the C3 
nitro-enolate carbon. This would then release the active Pd(0)-catalyst to re-enter the catalytic cycle, 
with concomitant yielding of the desired pyrroloindoline system 303. 
 
In order to probe the viability of the proposed reaction, various Pd(0) sources in combination 
with phosphine and nitrogen-based ligands will be explored along with analysis of standard reaction 
parameters such as solvent, temperature and time. As three stereogenic centres will be created in the 
proposed [3 + 2] cycloaddition, the diastereoselectivity will be carefully monitored and optimised. In 
addition, to demonstrate the synthetic value of the formed pyrroloindolines, several sites for further 
transformations will be explored. These may include a cross-coupling with the olefin handle, a 
reduction of the nitro group attached to the C3a carbon and couplings about the benzenoid component.  
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Scheme 3.1: Proposal of Pd(0)-catalysed [3+2] cycloaddition of vinylaziridines with electron-deficient 
3-nitroindoles for the formation of pyrroloindolines.  
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3.2: Results and Discussion 
3.2.1 Synthesis of Starting Materials 
 
To explore the proposed cycloaddition reaction, N-tosylvinylaziridine and a range of 3-nitroindoles 
were synthesised. The N-tosyl protected vinylaziridine 300 was chosen due to its ease of synthesis and 
stability at room temperature. The synthesis of the N-tosylvinylaziridine 300 starting material was 
carried out on large scale by bubbling 1,3-butadiene gas 304 through a solution of Chloramine-T 305 
as the limiting reagent in MeCN in the presence of catalytic phenyltrimethylammonium tribromide 
(PhNMe3Br3) (Scheme 3.2).1 The product was able to be isolated via recrystallisation in up to 58% 
yield, rendering this an efficient method for preparing the required aziridine in a single step from 
commercially available materials. Spectroscopic analysis using 1H NMR confirmed the desired 
compound was indeed isolated as evident by the terminal olefin CH2 signals at δ 5.42 and 5.23 ppm, 
internal olefin CH resonance at δ 5.55-5.48 ppm, along with CH and CH2 signals of the 3-membered 
ring at δ 3.26, 2.77 and 2.21 ppm respectively, and presence of the indicative signal of the tosyl CH3 at 
δ 2.43 ppm. Inspection of the 13C NMR spectrum further supported the isolation of the desired 
compound with indicative resonances of the CH and CH2 carbons found at δ 41.0 and 34.2 ppm 
respectively, and terminal and internal CH2 and CH olefin signals found at δ 120.3 and 133.0 ppm 
respectively. In total, nine resonances were found correlating to the number of expected carbon nuclei. 
The data matched the literature values.2  
 
 
Scheme 3.2: Synthesis of N-tosylvinylaziridine 300. 
 
The mechanism of PhNMe3Br3 catalysed aziridination is presented in Scheme 3.3. 3  It is 
suggested to begin via the combination of olefin 367 and an electrophilic bromine source 373 forming 
brominium ion 368. The brominium ion intermediate then undergoes ring-opening by attack of the 
Chloramine-T 305 forming intermediate 370, followed by a presumed attack of bromide forming anion 
371. Elimination and intramolecular cyclisation then provide the desired aziridine and concomitant 
generation of bromide that can react with 370 to regenerate the electrophilic bromine source 373 – 
rendering the reaction catalytic in PhNMe3Br3. 
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Scheme 3.3: Proposed mechanism for the formation of vinylaziridines 300. 
 
The majority of the 3-nitroindole substrates 308 were prepared from commercially available 
N–H indoles 306 (Table 3.1). N-Sulfonyl protection was conducted on indoles 306a and 306i-x via a 
base-induced deprotonation followed by introduction of the corresponding sulfonyl chloride in the 
presence of 10 mol% n-Bu4NHSO4 (phase transfer catalyst) in MeCN at room temperature, delivering 
clean and efficient conversion to the corresponding N-sulfonyl protected indoles 307. Noteworthy, N-
tosylindole-7-methylcarboxylate 307o was prepared in a low isolated yield (31%) and return of 
unreacted starting material, perhaps likely due to the bulky 7-position hindering attack towards TsCl. 
In addition, the N-tosyl-3-cyanoindole 307x returned an extremely low isolated yield of 5%, potential 
due to side reactions of the CN group. Spectroscopic analysis confirmed the formation of N-tosyl 
protected indoles 307a and 307i-x as evidenced by inspection of the 1H NMR spectra, revealing 
distinctive singlet resonances between δ 2.38-2.28 ppm indicative of the tosyl CH3 moiety. The 
carbamate-protected indoles 307d and 307f were synthesised from the corresponding acyl chlorides 
under the same conditions. Spectroscopic 1H and 13C NMR analysis confirmed the formation of indole 
307f, with indicative resonances at δ 4.49 ppm with an integration of 2H, and δ 1.47 ppm with an 
integration of 3H sharing a coupling constant of 7.1 Hz, both corresponding to the ethyl group of the 
ester. Synthesis of N-Boc protected indole 307g was the exception, which was accessed using DMAP 
and Boc-anhydride in THF at room temperature. Spectroscopic 1H and 13C NMR analysis in this case 
confirmed the formation of indole 307g, revealing an indicative CH doublet resonance at δ 6.56 ppm 
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with an integration of 1H, and singlet signal at δ 1.66 ppm with an integration of 9H, correlating to the 
Boc moiety.  
 
With the corresponding N-protected indoles in hand, selective C3 nitration was next 
performed using in-situ generated acetyl nitrate under strict temperature-controlled conditions to yield 
the corresponding 3-nitroindole 308 in a large range of yields (Table 3.1).4 Isolation for most of the 3-
nitroindoles 308 was quickly and easily conducted via recrystallisation from methanol or flash column 
chromatography performed if multiple nitration was observed. It should also be highlighted that the 
nitration step required a thorough workup procedure to ensure all residual acetic acid was completely 
removed as its presence has the potential to compromise the cycloaddition reaction through quenching 
of the sulfonamide anion. The mechanism of this nitration involves acetic anhydride 310 reacting with 
nitric acid 309, generating the highly electrophilic acetyl nitrate 311 species along with acetic acid 
(Scheme 3.4). This highly reactive intermediate is then slowly introduced to the corresponding N-
protected indole 307 at −70 oC. Temperatures above this can lead to unwanted, and potentially unstable, 
multi-nitrated species due to uncontrolled nitratation on the benzenoid ring.4 However, some substrates 
were noted to proceed slowly under the reaction conditions and required gradual warming to −20 oC in 
order to observe successful C3 nitration. Even under strict temperature control, multiple nitrated 
products were noted and corresponded to the low yields of some 3-nitroindole products, i.e. with the 
electron-rich indole species 308r-t (16-20% isolated yield). Spectroscopic analysis confirmed the 
formation of indoles 308a-t as evidenced by the presence of distinctive singlet resonances at δ 8.69-
8.49 ppm with an integration of 1H indicative of the C2 proton, and disappearance of the C3 proton 
doublet resonance at δ 6.81-6.56 ppm. The known compounds were confirmed via comparison to the 
literature values, and novel compounds were confirmed via spectroscopic analysis (1H NMR, 13C NMR, 
IR, and HMRS). 
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Table 3.1: Two-step synthesis of 3-nitroindoles 308. 
 
R1, R2 Product 307 Yield (%) Product 308 Yield (%) 
H, Ts 307a 88 308a 81 
H, Ns 307b 32 308b 57 
H, Ac 307c -b 308c 43 
H, Bz 307d 33 308d 11 
H, CO2Me 307e -b 308e 41 
H, CO2Et 307f 91 308f 58 
H, Boc 307g 93a 308g 28 
H, Me 307h -b 308h 28 
5-Cl, Ts 307i 87 308i 44 
6-Cl, Ts 307j 72 308j 43 
7-Cl, Ts 307k 82 308k 64 
5-Br, Ts 307l 90 308l 79 
4-CO2Me, Ts 307m 71 308m 33 
5-CO2Me, Ts 307n 68 308n 62 
7-CO2Me, Ts 307o 31 308o 36 
5-CN, Ts 307p 51 308p 59 
5-NO2, Ts 307q 88 308q 60 
4-Me, Ts 307r -c 308r 16 
5-Me, Ts 307s 90 308s 19 
5-MeO, Ts 307t 76 308t 20 
H, Ts, 3-Me 307u 99 -  
H, Ts, 3-Ac 307v 65 -  
H, Ts, 3-CO2Me 307w 56 -  
H, Ts, 3-CN 307x 5 -  
Notes: a From 0.1 equiv. DMAP and 2.3 equiv. Boc2O in 0.1 M THF at rt used. b Commercially 
available c Material used without further purification. 
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Scheme 3.4: Mechanism for the in-situ generation of acetyl nitrate 311 and selective C3 nitration of N-
protected indoles. 
 
An alternate method for the preparation of 3-nitroindoles via initial C3 nitration of the N–H 
indole was also attempted, however extremely poor yield (<10%) of 312 and indistinct decomposition 
material rendered this approach inefficient for the general synthesis of the 3-nitroindoles (Scheme 3.5). 
This was likely a result of the N-H moiety propensity to facilitate uncontrolled nitrations at multiple 
sites of the molecule.4,5 
 
 
Scheme 3.5: Unsuccessful alternate approach to form 3-nitroindoles from N-H indoles via acetyl 
nitrate. 
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The common soluble and air-stable Pd(0) sources of Pd2(dba)3, Pd2(dba)3·CHCl3, and Pd2(dba-
OMe)3·CHCl3 were chosen for screening the catalytic conditions and were synthesised from 
commercially available Pd(OAc)2 using the method reported by Ananikov and Zalesskiy (Scheme 3.6).6 
High purity was essential but can be challenging to achieve due to the labile nature of the dba ligands, 
requiring succesive recrystallisations to obtain >90% purity. Purity was determined via 1H NMR 
analysis by comparing the integrals of the major and minor isomers of Pd2(dba)3 with those of free dba.  
 
 
Scheme 3.6: Synthesis of Pd(0)-catalysts, where dba = dibenzylideneacetone.  
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3.2.2: Dearomative [3 + 2] Cycloaddition Reaction Development 
 
With the materials in hand to begin the project, N-tosylvinylaziridine 300 and 3-nitro-N-tosylindole 
308a were exposed to a range of different ligands in the presence of catalytic Pd2dba3·CHCl3 (Table 
3.2). Phosphine ligands have been previously demonstrated as successful in promoting Pd(0)-catalysed 
ring–opening of vinylaziridines and were therefore initially investigated.7,8,9,10,11 However, using the 
Pd(0) source of Pd2dba3·CHCl3 (5 mol%) in the presence of PPh3 (15 mol%) in MeCN, no reaction was 
observed, returning predominantly unreacted starting materials. In addition, a small amount of indistinct 
baseline signals were found in the 1H NMR analysis of the crude material, likely due to aziridine 
decomposition products formed via polymerisation, which is a known process (Table 3.2, entry 1).12 
When the reaction was heated above 40 oC, a white insoluble precipitate was noted, indicative of 
polymerisation/decomposition of the vinylaziridine 300. It was suspected that choice of the solvent may 
play a key role, as polar organic solvents, such as MeCN, are noted to increase the rate of 
polymerisation.13 Furthermore, previous literature examples had shown success with non-polar solvents 
such as PhMe. Interestingly, PPh3 in PhMe resulted in the complete decomposition of the vinylaziridine 
at room temperature and return of unreacted indole without any trace of the desired cycloadduct (Table 
3.2, entry 2). Next a bidentate phosphine ligand in the form of dppe, also in PhMe, was deployed and 
gratifiyingly saw 100% consumption of the vinylaziridine and isolation of the desired pyrroloindoline 
cycloadduct 313a in 22% yield with a dr of 79:21 (Table 3.2, entry 3). The low yield was likely a result 
of a competitive process of vinylaziridine decomposition via polymerisation as no vinylaziridine was 
observed in the 1H NMR spectrum of the crude reaction material, however, the starting 3-nitroindole 
was not fully consumed. Importantly, the major diastereoisomer could be isolated via flash column 
chromatography with a dr of >99:1 – the determination of the relative stereochemistry and 
spectroscopic analysis of pyrroloindoline cycloadducts 313a and 313′ will be discussed below. Also 
attempted was the use of a chiral Trost ligand L3, as Trost et al. had demonstrated success with this 
class of ligands in promoting [3 + 2] cycloaddition towards isocyanates,14 however, decomposition of 
the vinylaziridine 300 was observed (Table 3.2, entry 4). Curiously, Johnson and co-workers had 
previously demonstrated bidentate amine ligands successfully promoting [3 + 2] cycloaddition of the 
analogous vinylcyclopropane system with carbonyls for the formation of tetrahydrofurans.15 Therefore, 
Phen L4 was trialled under the reaction conditions with PhMe as the solvent at room temperature 
overnight (Table 3.2, entry 5). Excitingly, the reaction achieved 93% conversion with the formation of 
desired pyrroloindoline cycloadduct 313a as a mixture of trans:cis isomers in a diastereomeric ratio of 
74:26, respectively. With this result in hand, attempts to increase the dr were made. Aggarwal et al. and 
Hou et al. had previously described the positive effect that the addition of ionic salts (n-Bu4NCl and 
KBr) exhibit on vinylaziridine cycloaddition by increasing amide reactivity as a result of disrupting 
self-ion paring between the amide anion and the cationic Pd complex.11,16 Therefore, the inclusion of a 
quaternary amine salt additive in the form of n-Bu4NCl, in combination with Phen as the ligand, was 
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next attempted in anticipation of observing an improvement in yield and/or dr. However, it was found 
that the reaction returned an incomplete conversion of 68% of the limiting vinylaziridine and the crude 
material was returned as a complex mixture of desired cycloadduct and unidentified side-products 
(Table 3.2, entry 6). Switching the solvent back to MeCN in the absence of any additive saw 100% 
conversion and a concurrent increase in dr up to 91:9 with isolation of 313a in 72% yield (Table 3.2, 
entry 7). With the success of Phen in MeCN, a series of analagous diamine ligands were subsequently 
trialled. Bipy L5 gave the same yield (72%) but saw an increase in dr (93:7), while neocuproine L6 
saw a slight decline in yield and severe reduction in dr (55:45) (Table 3.2, entries 8 & 9). When Bphen 
L7 was utilised, a significant improvement in yield up to 81% was observed with a high selectivity of 
93:7 in favour of the trans isomer 313a (Table 3.2, entry 10). Phendione L8 was also tested in the 
reaction but no reaction was observed in this case (Table 3.2, entry 11). Lowering the loading of 
Pd2dba3·CHCl3/Bphen to 2.5/7.5 mol% respectively led to incomplete conversion and low isolated yield 
(Table 3.2, entry 12). The above results demonstrate the trend of bidentate amine ligands favouring the 
cycloaddition process with 3-nitroindole. Importantly, while all reactions displayed good to high 
selectivity for the trans isomer, after flash column purification the major isomer was able to be isolated 
as a single diastereoisomer – highlighting the practical utility of this process.  
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Table 3.2. Synthesis of pyrroloindolines via Pd(0)-catalysed [3 + 2] cycloaddition between 3-
nitroindole and vinylaziridines.a 
 
Entry Ligand Conversion (%) Yield 313ab (%) 313a:313a′ 
(trans:cis) c 
1 L1 - PPh3 0 - - 
2d L1 - PPh3  Decomp. 300 - - 
3d L2 - dppe  100 22 79:21 
4d L3 - Trost ligand  Decomp. 300 - - 
5d L4 – Phen 93 73 74:26 
6d,e L4 - Phen 68 - 76:24 
7 L4 - Phen 100 72 91:9 
8 L5 - Bipy 100 72 93:7 
9 L6 - Neocuproine 100 70 55:45 
10 L7 - Bphen 100 81 93:7 
11 L8 - Phendione 0 - - 
12f L7 - Bphen  40 29 89:11 
a Reactions were carried out at 0.1 M in MeCN, rt with 5 mol% Pd2(dba)3·CHCl3, 15 mol% 
ligand, 1.0 equiv. 308a and 1.2 equiv. 300. b Isolated yields. c Measured from the 1H NMR 
spectrum of the crude reaction material. d Conducted in 0.1 M PhMe. e 1.0 equiv. n-Bu4NHCl.   
f 2.5 mol % Pd2(dba)3·CHCl3 and 7.5 mol% Bphen.  
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Spectroscopic analysis of the major isolated cycloadduct 313a supported the proposed 
structure (Figure 3.1). The 1H NMR sprectrum revealed signals indicative of terminal olefin protons at 
δ 5.28 and 5.49-5.42 ppm. Additionally, the C8a proton signal was found as a distinctive singlet at δ 
7.07 ppm and the two tosyl CH3 resonances appeared at δ 2.45 and 2.36 ppm. The aliphatic C2 proton 
resonances adjacent to the vinyl group were found to have split into a doublet of doublets and a triplet 
at δ 3.92 and 2.80 ppm respectively, while the aliphatic C3 proton signal was found at δ 3.10 ppm as a 
doublet of triplets. Analysis of gCOSY and gHSQC NMR spectra confirmed that C2 and C3 proton 
signals were coupled in addition to the C3 proton next to the internal olefin signals providing evidence 
of the newly formed pyrrolidine ring. The aromatic region was found to contain an integration of 12 H 
corresponding to the benzenoid and tosyl aromatic protons. In addition, 13C NMR and gHSQC analysis 
of 313a confirmed the presence of 22 signals supporting the structure proposed. Indicative resonances 
at δ 101.7 and 84.6 ppm correlated to the C3a quaternary carbon bearing the nitro group, and the C8 
carbon, respectively. Furthermore, two overlapping CH3 signals were found at δ 21.8 ppm from the two 
tosyl groups. High-resolution mass spectrometric analysis detected a mass ion of 562.1091 and was 
assigned as [M + Na]+ correlating to the predicted structure. The major isomer 313a was also able to be 
crystallised allowing for X-ray crystal analysis, conclusively confirming the trans relative 
stereochemistry between the NO2 and vinyl substituent of the major isomer (Figure 3.2). 
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Figure 3.1: 1H NMR and 13C NMR spectra for major trans-isomer 313a.  
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Figure 3.2: X-ray structure of major isomer 313a confirmed as the trans diastereoisomer. Performed 
by A/Professor Michael G. Gardiner from the University of Tasmania. 
 
Spectroscopic analysis of the isolated minor cis isomer 313a′ was also conducted via NMR 
techniques, uncovering very similar 1H and 13C NMR signals compared to the major trans isomer, but 
with slight changes in chemical shift (Figure 3.3). The internal olefin CH signal was shifted downfield 
to δ 5.86 ppm (compared to δ 5.49-5.42 ppm in the major trans diastereoisomer), while the terminal 
olefin CH2 resoances were unchanged. The C8a singlet signal was upshifted to δ 6.99 ppm. The aliphatic 
C2 protons were split into a doublet, and doublet of doublet at δ 3.93 and 3.06 ppm respectively, while 
the C3 proton signal was upshift to δ 3.25 ppm as a doublet of doublets. This was a notable change from 
the observed multiplicities and chemical shifts of the previous isomer 313a. High-resolution mass 
spectrometric analysis detected a mass ion of 540.1260 amd was assigned as [M + H]+ correlating to 
the predicted product. 
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Figure 3.3: 1H NMR and 13C NMR spectra for minor cis-isomer 313a′.  
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The success of bidentate amine ligands for promoting the successful [3 + 2] cycloaddition 
between N-tosylvinylaziridine 300 and 3-nitroindole 308a for the formation of cycloadduct 313 is quite 
notable (Table 3.2, entries 7-10). Conversely, the phosphine ligands trialled were found to be generally 
unsuccessful, observing no reaction and even decomposition of the vinylaziridine at elevated 
temperatures (Table 3.2, entries 1, 2, 4). This interesting preference in reactivity can perhaps be 
rationalised via consideration of the zwitterionic 1,3-dipole complex and its propensity for 
polymerisation.12 It is postulated that bidentate amine ligands such as Bipy and Bphen impart a 
stabilsing influence on the Pd π-allyl complex of the intermediate zwitterionic dipole 301, allowing it 
to remain ring-opened long enough and attack the electrophilic indole. In addition, it is thought that 
these ligands prevent polymerisation by making the π-complex more electron-rich and therefore less 
likely to undergo side reactions. In contrast, phosphine ligands are better π-acceptors, so are likely to 
render the Pd π-allyl complex of the zwitterionic dipole more electrophilic in nature, meaning that it 
could more readily undergo polymerisation through self-reaction, rather than productive attack on the 
nitro-indole. Furthermore, the use of amine-based ligands represent increased air-stability and lower 
cost compared to phosphine-based ligands. 
  
With this initial result, it was then decided to explore different solvents in an attempt to 
improve dr and yield of the pyrroloindoline cycloadduct 313a (Table 3.3). The use of DCM as the 
solvent saw an incomplete conversion with consequent reduction in yield (56%) and dr (76:24) (Table 
3.3, entry 2). DCE was next trialled which saw complete conversion with an isolated yield of 52%, but 
with a dr of 76:24 (Table 3.3, entry 3). The use of THF provided no reaction, while PhMe saw 93% 
conversion of the limiting vinylaziridine with a slight increase in yield to 73%, but a reduction in dr to 
74:26 (Table 3.3, entries 4 & 5). The polar aprotic solvent DMSO was next used but in this case no 
reaction was observed, while the non-polar aprotic solvent n-pentane saw 53% conversion with 40% 
yield and 75:25 dr (Table 3.3, entries 6 & 7). The solvent scope investigation therefore demonstrated 
MeCN as the optimal solvent yielding the best dr and was used as the solvent of choice for further 
optimisation reactions.  
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Table 3.3: Solvent optimisation for the synthesis of pyrroloindolines via Pd(0)-catalysed [3 
+ 2] cycloaddition between 3-nitroindole and vinylaziridine. a 
 
Entry Solvent % Conversion Yield 313a (%)b dr (trans:cis)c 
1 MeCN  100 81 93:7 
2  DCM 88 56 76:24 
3  DCE 100 52 76:24 
4  THF 0 - - 
5  PhMe 93 73 74:26 
6 DMSO 0 - - 
7  n-pentane 53 40 75:25 
a Reactions carried out at 0.1 M concentration, rt with 5 mol% Pd2dba3·CHCl3, 15 mol% 
Bphen, 1.2 equiv. of indole 308a and 1.0 equiv. vinylaziridine 300. b Isolated yield.  
c Measured from the 1H NMR spectrum of the crude reaction material. 
 
It is important to note at this point that the purity of the 1-tosyl-3-nitro-indole is critical to the 
success of the reaction. Often trace amounts of AcOH remain after purification following the nitration 
steo and this can quench the sulfonamide anion of the zwitterionic dipole 301. In cases where material 
contaminated with AcOH is used, no reaction is observed.  
 
The use of an alternative source of Pd(0) in the form of the more electron-rich Pd2(MeO-
dba)3·CHCl3 (5 mol%) was also investigated, as reports have shown that dba ligands substituted with 
electron-rich substituents significantly increase catalytic activity via faster dissociation of the alkene 
ligand.17,18 When the reaction was conducted under the conditions presented in Table 3.3, entry 1, but 
replacing Pd2(dba)3·CHCl3 with Pd2(MeO-dba)3·CHCl3, a faster reaction time was observed (~3 hours 
vs. ~15 hours) but with slightly increased yield of the desired cycloadduct 313a (87%, Scheme 3.7). 
Most importantly, a lower dr of 10.9:1 was observed, compared to a dr of 13.6:1 for the optimised 
conditions. Therefore, it was decided to progress with Bphen as the ligand of choice in combination 
with Pd2(dba)3·CHCl3 as the Pd(0)-source, as this combination returned consistently high yields with 
the highest dr in favour of the trans isomer. 
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Scheme 3.7: Use of Pd2(MeO-dba)3·CHCl3 as the Pd(0) source. 
 
An alternate N-protected vinylaziridine was next employed in the form of N-phthalimide 
vinylaziridine 314. When the reaction was conducted under the same conditions as above, no reaction 
was observed, even when the catalyst loading was increased, returning unreacted starting materials, 
potentailly due to the weaker leaving group ability of the N-NPhth compared to the N-Ts (Scheme 3.8). 
 
 
Scheme 3.8: The unsuccessful use of N-phthalimide vinylaziridine 314 in the [3 + 2] cycloaddition 
reaction 
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With the optimal conditions determined, attention was shifted to exploring the substrate scope 
of the indole about the N1 and C3 positions in order to determine the range of electron-withdrawing 
groups that could be used. Firstly, the different N–protected indoles 307a-h – synthesis described above 
– were investigated (Table 3.4, products 308a-f). N–Nosylated 3-nitroindole 307b provided the 
corresponding cycloadduct 313b in low isolated yield and only 65% conversion despite an increased 
catalyst loading (10 mol%). This result was most likely caused by the observed poor solubility of the 
N–nosyl-3-nitroindole 308b in the reaction solvent. Interestingly, N–acetyl 308c and N–benzoyl 308d 
protected 3-nitroindoles showed no reaction with the vinylaziridine 300 under the optimised conditions. 
However, N–methyl and N–ethyl carbamate 3-nitroindoles 308e and 308f facilitated the cycloaddition 
reaction as did the N–Boc 3-nitroindole 308g, all allowing the formation of pyrroloindolines 313e, 313f 
and 313g respectively in good yield and with high dr. As anticipated, N–methyl protected 3-nitroindole 
308h saw no reaction likely due to the significant decrease in electrophilicity at the indole C2 position. 
These results demonstrated that the indole nitrogen required a significantly strong electron-withdrawing 
protecting group in order to promote attack from the vinylaziridine. Next, a range of differing 3-
substituted N–tosylindoles 307u-v – synthesis described above – were trialled (Table 3.4). As expected, 
N–tosylindole-3-methyl 307u saw no reaction. Curiously, when the nitro substituent was replaced with 
a milder electron-withdrawing groups at the C3 position, such as 3–acetyl 307v, 3–methylcarboxylate 
307w and 3–cyano 307x N–tosylindoles, no reaction was observed, even with 10 mol % catalyst 
loading. These results reinforce the critical requirement for a strongly electron-withdrawing group in 
the form of a nitro group at the C3 position in combination with a strongly electron-withdrawing group 
on the nitrogen.  
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Table 3.4: Variation of N–electron-withdrawing group and C3 electron-withdrawing 
group of the indole.a 
 
 
313a: 81% yield 
93:7 (>98:2) dr 
 
313b: 48% yieldb 
84:16 (>98:2) dr 
 
308c: no reaction 
 
308d: no reaction 
 
313e: 66% yield 
96:4 (>98:2) dr 
 
313f: 75% yield 
89:11 (>98:2) dr 
 
313g: 73% yield 
91:9 (>98:2) dr 
 
308h: no reactionb 
 
307u: no reactionb 
 
307v: no reactionb 
 
307w: no reactionb 
 
307x: no reactionb 
a Reactions carried out at 0.1 M in MeCN, rt with 5 mol % Pd2dba3·CHCl3, 15 mol% Bphen, 
1.2 equiv. of indole 308a and 1.0 equiv. vinylaziridine 300. Reported isolated yields. dr 
(trans:cis) measured from 1H NMR spectrum of the crude reaction material after workup. 
Isolated dr given in parentheses measured from the 1H NMR spectrum of the purified 
material. b 10 mol% Pd2(dba)3·CHCl3 and 25 mol% Bphen used; 65% conversion only for 
308b. 
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The previously accessed indoles (refer Table 3.1) with variations about the benzenoid-indole 
ring were then investigated (Table 3.5). Chlorine and bromine substitutions about the 5-, 6- and 7-
positions (313i-l) of the starting indoles (308i-l) were all well tolerated, giving high yields and dr of the 
pyrroloindoline cycloadducts (313i-l, Table 3.5). Introducing the moderately electron-withdrawing 
methylcarboxylate group at the 5- and 7-positions also provided the desired products in excellent yields 
and dr (313n and 313o). Strongly electron-withdrawing groups were also trialled at the 5-positon, in 
the form of 5–cyano and 5–nitro substituents, returning excellent dr and high yields of the cycloadduct 
(313p and 313q). When the mildly electron-donating 5-methyl group 313s was trialled, a similar result 
as the parent N-tosyl-3-nitroindole 313a was observed, returning a yield of 88% with 96:4 dr. However, 
when the strongly mesomerically-donating 5–methoxy group was installed 308t, the reaction did not 
proceed, instead seeing the return of unreacted indole and vinylaziridine, again most likely due to 
reduction of indole electrophilicity. Interestingly, when the 4-position was occupied by a methyl group 
308r, a switch in diastereoselectivity (34:66) in favour the cis isomer 313r′ was observed, albeit in low 
selectivity. Pleasingly, both isomers were able to be isolated and fully characterised. The major cis 
isomer of 313r′ was compared to that isolated for the previous cis isomer 313a′, sharing similar 
distinctive signals in the 1H and 13C NMR spectra. The olefin resonances were found at δ 5.88-5.80 and 
5.26-5.22 ppm representing the internal and terminal olefin protons respectively. The CH resonance 
adjacent to the olefin of the newly formed pyrrolidine ring was found at δ 3.53 ppm as a doublet of 
doublets with a coupling constant of 4.5 Hz, and the CH2 resonances were found at δ 3.84 and 3.23 ppm 
as a doublet and a doublet of doublets, respectively, sharing a coupling constant of 10.9 and 4.5 Hz. 
When the 4-position was occupied with the bulkier methylcarboxylate group, astonishingly a complete 
switch in selectivity was observed in absolute favour of the cis isomer 313m′ (>2:98). The above results 
demonstrate the wide range of substitutions tolerated in this reaction with all substrates returning a dr 
≥ 96:4, with the exception of substitutions about the 4-position that caused an unprecedented switch in 
dr. 
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Table 3.5: Variation of substituents on the benzenoid-indole ring.a 
 
 
313i: 78% yield 
94:6 (>98:2) dr 
 
313j: 81% yield 
86:14 (>98:2) dr 
 
313k: 70% yield 
84:16 (97:3) dr 
 
313l: 91% yield 
92:8 (98:2) dr 
 
313n: 88% yield 
94:6 (>98:2) dr 
 
313o: 94% yield 
84:16 (88:12) dr 
 
313p: 75% yield 
96:4 (>98:2) dr 
 
313q: 82% yield 
98:2 (98:2) dr 
 
313s 88% yield 
93:7 (96:4) dr 
 
308t: no reaction  
313r′: 85% yield 
34:66 (>98:2  
for each isomer) dr 
 
313m′: 82% yield 
>2:98 (2:98) dr 
 
 a Reactions carried out at 0.1 M, rt with 5 mol % Pd2dba3·CHCl3, 15 mol% Bphen, 1.2 equiv. 
of indole 308i-t and 1.0 equiv. vinylaziridine 300. Isolated yields. dr (trans:cis) measured from 
1H NMR spectrum of the crude reaction material after workup. Isolated dr given in parentheses 
measured from the 1H NMR spectrum of the purified material.  
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The major cis isomer 313m′ was successfully crystallised as a pure diastereomer, allowing for 
X-ray crystal analysis which conclusively confirmed the relative stereochemistry between the nitro and 
olefin groups as cis (Figure 3.4). This interesting switch in diastereoselectivity will be further discussed 
in the mechanism section of this chapter.  
 
 
Figure 3.4: X-ray structure of major cis isomer 313m′. Thermal ellipsoids of non-hydrogen atoms are 
drawn at the 50% probability level. Performed by A/Professor Michael G. Gardiner from the University 
of Tasmania.  
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3.2.3: Proposed Mechanism 
	
A proposed mechanistic model that explains the diastereoselectivity for the dearomative [3 + 2] 
cycloaddition reaction between N-tosylvinylaziridine 300 and electron-deficent 3-nitroindoles 308 is 
proposed below in Scheme 3.9. Initially, the palladium(0)-Bphen catalyst system coordinates with the 
alkene component of the vinylaziridine forming an η2 Pd(0)-complex I. Oxidative addition then occurs 
in which the strained aziridine ring-opens, forming an η3 Pd(II) p-allyl complex II. This ring-opened 
complex is now considered a zwitterionic 1,3-dipole intermediate as the charges of the nitrogen anion 
and p-allyl complex cation are separated via the neutral CH2 moiety. This Pd(II) p-allyl complex is then 
able to undergo a Pd-mediated isomerisation in which the η3 complex II can interconvert to an η1 
complex III via C–C bond rotation then back to isomeric η3 complex IV. In the presence of the 3-
nitroindole substrate 308, it is proposed that the nitrogen anion of the zwitterionic 1,3-dipole attacks 
the highly electrophilic C2 position of the indole, indiscriminately from either the si or re face of the 
indole, in a reversible manner. The resulting nitro-enolate intermediate anion V can then attack the 
electrophilic Pd p-allyl complex in an irreversible ring-closure. It is in this ring-closure step in which 
diastereoselectivity is determined. Before the ring-closure operation, two potential transition states are 
predicted to arise. In one scenario, the Pd p-allyl complex can stack on top of the aromatic benzenoid 
component of the indole in a favourable cation-p-interaction (TS1).19 In the second scenario, the p-allyl 
complex can be orientated up and away from the aromatic group due to steric influences or an electronic 
interruption (TS2). In either case, there is potential for an η3-η1-η3 isomerisation event of the p-allyl 
moiety between TS1 and TS2 before the irrevsible ring-closure.9,11 The ring-closure via TS1 leads to 
the trans diastereomer, while the ring-closure of the less hindered TS2 gives the cis diastereomer. Based 
upon the experimental results observed, it can be tentatively inferred that when substrates C4 = H are 
utilised, TS1 is favoured, giving rise to the trans cycloadduct 313. However, when C4 ≠ H, the p-
stacking interaction is disrupted, potentialy due to a steric clash between the Pd p-allyl complex and the 
C4 substituent favouring the cis cycloadduct 313′. It is important to note the TS1/TS2 precursors can 
interconvert via an η3-η1-η3 isomerisation event. The steric argument for the switch in selectivity is 
further supported by the use of 308r (C4 = Me) where the less bulky methyl group resulted in a mixture 
of diastereoisomers (34:66 in favour cis). But when the larger 308m (C4 = CO2Me) was utilised, a 
complete switch in selectivity in favour of the cis diastereomer 313m′ occured. However, an electronic 
effect cannot be fully discounted in which the C4 = CO2Me moiety and the Pd p-allyl complex 
favourably interact.  
 
The intriguing effect of solvent in determining the dr was also considered. Solvent influences 
on dr have been explored and commented on by numerous research groups, in particular with 
cycloaddition type reactions.20 It is postulated that polar media such as MeCN stabilise zwitterionic 
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intermediates and further facilitate asynchronous addition.21 The use of MeCN in the above examples 
is thought to help facilitate η3-η1-η3 interconversion towards the most favoured transition state, in this 
case TS1, and also potentially help facilitate the reversible Micheal addition step. This is further evident 
when non-polar solvents, such as PhMe or n-pentane were used, and erosion of dr was observed (Table 
3.3 entries 5 & 7). Furthermore, a favourable cation-π-interaction is theorised to arise between the Pd 
π-allyl/ligand intermediate and the aromatic benzenoid component of the indole. This is further 
supported in Table 3.2, entry 9, in which the use of neocuproine saw a dr of 55:45 most likely as a result 
of the sterically bulky neocuprione ligand disrupting the cation-π-interaction leading to TS1 and TS2 
having similar energies. 
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Scheme 3.9: Proposed mechanism for the diastereoselective formation of pyrroloindolines 313 and 
313′. 
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3.2.4: Pyrroloindoline Transformations 
 
A critical goal of this project was to demonstrate the utility of the developed synthesis towards further 
product transformations in order to justify the skeletons as useful pyrroloindoline precursors. Most 
previous syntheses of pyrroloindolines suffer from a lack of synthetic utility due to the inherent starting 
material restrictions, with most focusing on simple couplings about the indole benzenoid ring. The 
method developed in this work, with the pre-installed nitro and vinyl substituents, allows for significant 
transformations about the newly constructed pyrrolidine ring, in addition to the indole benzenoid, 
thereby allowing expedient access to derivatives (Scheme 3.10).  
 
The nitro group at the C3a position of 313a was easily reduced in the presence of excess 
Zn/TMSCl, yielding the valuable 3a-amino-pyrroloindoline 315 skeleton commonly found in natural 
products, such as in psychotrimine which exhibits antibacterial properties (Scheme 3.10, A). It is 
important to note that this reduction reaction had to be conducted at 0 oC to obtain the single 
diastereomer as erosion of dr occured at room temperature. A radical denitration at the C3a position 
was conducted on 313a using Bu3SnH and AIBN and this fully reduced 313a to the pyrroloindoline 
316 in 62% yield (Scheme 3.10, B). Importantly, both reduction conditions were able to yield single 
diastereisomers. The utility of the vinyl component was also demonstrated by conducting a Pd(0)-
catalysed Heck reaction of cycloadduct 313a with iodobenzene 317 to give compound 318 in 90% yield 
(Scheme 3.10, C). The N-Boc protecting pyrroloindoline 313g was quantitatively removed under in-
situ generated acidic conditions (TMSCl/MeOH) furnishing the free N-H pyrroloindoline 319 (Scheme 
3.10, D). Fellow PhD student, Yi Sing Gee, contributed experiments for the transformations yielding 
315 and 316. 
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Scheme 3.10: Pyrroloindoline transformations. 
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3.3: Conclusion 
 
In summary, a Pd(0)-catalysed [3 + 2] cycloaddition reaction between N-tosylvinylaziridine 300 and 
various electron-deficient 3-nitroindoles 308 has been developed for an efficient and diastereoselective 
synthesis of pyrroloindolines 313. A series of diverse cycloadducts were prepared in good to high 
yields. Importantly, the cycloadduct formed contained the pharmaceutically relevant nitrogen at the C3a 
position: a functionality found in many antibacterial agents. It was also demonstrated that bidentate 
amine ligands such as Bphen were found to promote high selectivity for the trans diastereomer. When 
a 4-substituent was present on the 3-nitroindole, a switch in diastereoselectivity was observed in favour 
of the cis diasteroisomer. Furthermore, the use of amide-based ligands contain the added advantage of 
increased air-stability and represent cheaper ligand source. Mechanistically, the combination of a 
bidentate amine ligand and use of the polar solvent MeCN is postulated to help stabilise a cation-p 
interaction that highly favours TS1 in which the stereochemical outcome is the trans diastereomer. The 
favoured TS1 is disrupted when C4 ≠ H presumably due to steric interactions, promoting TS2 and 
consequently generating the cis diastereomer. Importanly, the pyrroloindolines formed were highly 
open to further functionalisation demonstrating the potential utility of this procedure for access to 
medicinally relevent compounds, specifically with respects to the C3a position. Furthermore, the 
development of an enantioselective variant was also considered. However, very recently, methods of 
catalytic asymmetric dearomative [3 + 2] cycloaddition of 3-nitroindoles and vinylaziridines have 
emerged providing access to optically active pyrroloindolines inspired by the work developed in this 
lab.22 
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3.4: Future Directions 
	
3.4.1: Pd(0)-Catalysed Dearomative [3 + 2] Cycloaddition of Vinylcyclopropanes with Electron-
Deficient Indoles 
 
With the success of the Pd(0)-catalysed vinylaziridine cycloaddition to 3-nitroindoles, other 
zwitterionic 1,3-dipole derivatives were imagined as reaction partners. The use of a vinylcyclopropane 
320 would offer an attractive all-carbon analogue and allow expedient access towards the 
cyclopenta[b]indoline core, a common motif found in many bioactive molecules.23 Initial reactions 
were trialled concurrently as the N-tosylvinylaziridine substrate and selected results are shown below 
in Table 3.6. However, while the yield was high for the desired product, the reactions had very poor 
diastereoselectivity. Due to time constraints this reaction could not be optimised further in this thesis.24 
 
Table 3.6: Selected results for the Pd(0)-catalysed [3 + 2] cycloaddition between 3-nitroindole 
and vinylcyclopropane.a 
 
Entry Ligand Solvent Yield 321a (%)b drc 
1  PPh3 PhMe 0 - 
2  PBu3 PhMe 40 53:47 
3  (R)-BINAP PhMe 37 52:48 
4  Bipy PhMe 23 53:47 
5  Phen PhMe 41 53:47 
6  Phen DCM 88 57:43 
7  Phen DCE 89 58:42 
8  Phen THF 76 52:48 
9 Phen 1,3-dioxane 83 48:52 
10  Phen MeCN 98 58:42 
11  Neocuproine MeCN 87 54:46 
12  Bphen MeCN 99 56:54 
Notes: a 1.2 equiv. 3-nitroindole 308a, 1.0 equiv. vinylcyclopropane 320, 0.1 M solvent 
concentration. b Isolated yield. c Determined via integration from crude 1H NMR spectrum. 
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3.5.2: Carbonyls as the Dipolarophile in Pd(0)-Catalysed [3 + 2] Cycloaddition with 
Vinylaziridines 
 
In addition to other zwitterionic 1,3-dipoles, the Pd(0)-catalysed reactivity of vinylaziridines can be 
applied to other dipolarophiles utilising the method developed as part of this project. The use of 
carbonyl dipolarophiles would provide direct access to oxazolidine systems. Previously, the use of 
donor-acceptor aziridines 322/326 in [3 + 2] cycloadditions towards carbonyls 323 has been applied in 
the formation of functionalised oxazolidines 325/327 (Scheme 3.11, A and B).25,26 However, these 
reported methods are all limited to the use of Lewis acid catalysts and are presumed to react via an SN2 
type mechanism in which the Lewis acid-activated aziridine is initially attacked by the oxygen from the 
carbonyl. The mechanism is supported by the best reported yields arising from electron-rich carbonyl 
substrates and, conversely, typically poorer results observed when electron-deficient carbonyl systems 
were utilised. The use of vinylaziridines under Pd(0)-catalysis has not been explored in such reactions 
and would provide a complementary synthesis of functionalised oxazolidines, via an inverted 
mechanism with respects to polarity. The pairing of the analagous vinylcyclopropane system 328 under 
Pd(0)-catalysed conditions with aldehydes 329 for the formation of tetrahydrofurans 330 has previously 
been reported by Johnson and co-workers (Scheme 3.11, C).15 Drawing inspiration from this literature 
precedent, it is proposed that N-tosylvinylaziridine 300 could react with carbonyl dipolarophiles under 
Pd(0)-catalyst, for example with aldehydes and/or ketones 331, for the formation of densely 
functionalised oxazolidines 332 (Scheme 3.11, D). The proposed oxazolidines would contain two 
stereogenic centres, as well as the incorporation of the versatile olefin moiety for further 
transformations. This proposed route contains several advantages including excellent atom-efficiency, 
versatile cycloadduct transformations and, most crucially, the potential to control diastereoselectivity. 
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Scheme 3.11: Proposed Pd(0)-catalysed [3 + 2] cycloaddition between vinylaziridine and carbonyl 
dipolarophiles for the construction of oxazolidines. 
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3.5.3: Imines as the Dipolarophile in Pd(0)-Catalysed [3 + 2] Cycloadditions with Vinylaziridines 
 
The use of imines as a dipolarophile reaction partner represents a significant gap in the existing 
literature. To the best of our knowledge, there are only two exisiting reported methods that pair imines 
and aziridines undergoing [3 + 2] cycloaddition. Both reported methods utilised donor-acceptor 
aziridines 333 undergoing C–C bond cleavage under Lewis acid catalysis to the corresponding ring-
opened dipole, and consequent [3 + 2] cycloaddition with imines 334 for the generation of trans-
imidazolidines 335 (Scheme 3.12, A).27,28 A Ni(0)-catalysed process has been reported by Matsubara et 
al. in which vinylcyclopropane 328 and imines 336 generate densely functionalized pyrrolidines 337 in 
high yields in favour of the cis diastereoisomer (Scheme 3.12, B).29 However, the use of Pd(0) cataylsis 
with vinylaziridines 300 and imines 338 remains unexplored and would provide access to 
imidazolidines 339 (Scheme 3.12, C). 
 
 
 
Scheme 3.12: Proposed Pd(0)-catalysed [3 + 2] cycloaddition between vinylaziridine and imine 
dipolarophiles for the construction of imidazolidines. 
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3.5.4: Nitro-aromatics as the Dipolarophile in Pd(0)-Catalysed [3 + 2] Cycloadditions with 
Vinylaziridines 
 
With the success of the developed Pd(0)-catalysed dearomative [3 + 2] cycloaddition to electron-
deficient indoles, the use of other related electron-deficient aromatic dipolarophiles would be highly 
desirable. Pietrre et al. have demonstrated the use of nitro-arenes 341 as successful reaction partners in 
the dearomative [3 + 2] cycloaddition with non-stabilised azomethine ylides 340 and have applied this 
to a wide range of nitro-aromatic and nitro-heteroaromatic systems.30 Unfortunately, these systems 
suffer from lack of cycloaddition control, often giving undesirable bis-cycloadducts 342 due to the 
highly reactive nature of the in-situ generated azomethine ylide 340 (Scheme 3.13, A). Through the use 
of N-heterocycles such as nitroquinolines 343, control of the cycloaddition process was possible, 
forming mono-cycloadducts 344 (Scheme 3.13, A). Furthermore, in Chapter 2, the intramolecular [3 + 
2] cycloaddition reaction between an in-situ generated azomethine ylide 345 and a pendent 3,5-
dinitrophenyl group was developed allowing for the formation of a mono-cycloadduct 346 (Scheme 
3.13, B). The reaction of three-membered rings, such as vinylaziridines/vinylcyclopropanes 348 with 
N-heterocycles 347 under Pd(0) catalysis, could provide a complementary method to access 
dearomatised mono-cycloadducts 349, with the formation of the constitutional isomer, as the location 
of the N-atom would be shifted (Scheme 3.13, C). Furthermore, this process would provide a more 
atom-efficient process, milder reaction conditions, and increased potential for product manipulation. 
The cycloadduct would also form the important biologically relevant motif, pyrroloquinolines. 
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Scheme 3.13: Proposed dearomative Pd(0)-catalysed [3 + 2] cycloaddition between 
vinylaziridines/vinylcyclopropanes and highly electron-deficient aromatic dipolarophiles. 
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3.5: Experimental Section 
	
General Experimental Details: 
 
Unless stated specifically, all chemicals were purchased from commercial suppliers and used without 
purification. All reactions were conducted in oven-dried glassware under nitrogen atmosphere. The 
reaction solvents were dried by passing through a column of activated alumina and then stored over 4 
Å or 3 Å molecular sieves. The progress of reactions was tracked by TLC which was performed on 
aluminium backed silica gel sheets (Grace Davison, UV254). TLC plates were visualised under UV 
lamp at 254 nm and/ or by treatment with one of the following TLC stains: phosphomolybdic acid 
(PMA) stain; PMA (10 g), absolute EtOH (100 mL); potassium permanganate stain: KMnO4 (1.5 g), 
10% NaOH (1.25 mL), water (200 mL); vanillin stain: Vanillin (15 g), concentrated H2SO4 (2.5 mL), 
EtOH (250 mL). For NMR spectroscopy, analytes were dissolved in deuterated chloroform or stated 
otherwise. NMR spectra for each compound were collected from one of the following instruments: a 
Mercury 2000 spectrometer operating at 500 and 125 MHz for 1H and 13C NMR respectively; a Bruker 
spectrometer operating at 400, 100, and 470 MHz for 1H, 13C, and 19F NMR, respectively. NMR data 
are expressed in parts per million (ppm) and referenced to the solvent (7.26 ppm for 1H NMR and 77.16 
ppm for 13C NMR). The following abbreviations are used to assign the multiplicity of the 1H NMR 
signal: s = singlet; bs = broad singlet; d = doublet; t = triplet; q = quartet; p = pentet; quin = quintet; dd 
= doublet of doublets; dt = doublet of triplets; m = multiplet. NMR assignments were made on the basis 
of COSY, HSQC, HMBC, and DEPT experiments. For mass spectrometry, analytes were dissolved in 
HPLC grade methanol, acetonitrile or dichloromethane. High-resolution mass spectra were collected 
from a Waters Xevo G1 QTOF mass spectrometer. Infrared spectra were obtained from a Shimadzu 
IRAffinity-1 Fourier transform infrared spectrophotometer with ATR attachment. Melting point 
measurements were performed using a Buchi M-560.  
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3.5.1: Synthesis of N-Tosyl-2-vinylaziridine (300) 
 
 
 
Method adapted from: Org. Biol. Chem., 2014, 12, 9113. 
To a solution of chloramine-T trihydrate (2.8486 g, 10.1125 mmol, 1.0 equiv.) and PTAB 0.3888 g, 
1.0342 mmol, 10 mol%) in dry MeCN (40 mL, 0.25 M) was gently bubbled in 1,3-butadiene gas for 30 
minutes. The reaction vessel was then sealed and allowed to stir at room temperature. After 5 hours, 
another batch of 1,3-butadiene was bubbled into the reaction solution for 30 minutes, sealed shut and 
allowed to stir at room temperature overnight. The reaction solution was then passed through a short 
plug of silica gel (approx. 3 cm), washed with MeCN (100 mL) and solvent removed under reduced 
pressure. The crude was then purified via flash column chromatography to reveal the title compound 
300 as a beige solid (0.829 g, 37% yield), Rf: 0.29 in 20:80 EtOAc:n-hexanes, 1H NMR (500 MHz, 
CDCl3) δ 7.82 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.33 (d, J = 8.0 Hz, 2H, CHAr tosyl), 5.55-5.48 (m, 1H, 
CH-CH=CH2), 5.42 (d, J = 17.1, 1H, CH=CH2), 5.23 (d, J = 10.0 Hz, 1H, CH=CH2), 3.26 (td, J = 7.2, 
4.6 Hz, 1H, CH-CH=CH2), 2.77 (d, J = 7.1 Hz, 1H, CH2-CH), 2.43 (s, 3H, CH3 tosyl), 2.21 (d, J = 4.5 
Hz, 1H, CH2-CH) ppm. 13C NMR (CDCl3, 125 MHz): δ 144.6 (CAr tosyl), 135.2 (CAr tosyl), 133.0 
(CH=CH2), 129.8 (CHAr tosyl), 127.9 (CHAr tosyl), 120.3 (CH=CH2), 41.0 (CH-CH=CH2), 34.2 (NTs-
CH2-CH), 21.7 (CH3 tosyl) ppm. NMR data matches known literature values: Tetrahedron Lett., 2005, 
46, 2539–2542. 
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3.5.2: General procedure A - N-protection of indoles 
	
 
 
To a solution of the corresponding N-H indole 306 (1.0 equiv.) in anhydrous DCM (0.1 M) was added 
n-Bu4NHSO4 (0.1 equiv.) followed by addition of freshly powdered NaOH (4.0 equiv.) at 0 °C. The 
resultant solution was allowed to stir at room temperature for 10 minutes before addition of 
corresponding protecting group (1.5-2.0 equiv.) and then allowed to stir at room temperature (monitored 
via TLC – typically 1-2 hours). After which, the reaction was quenched with H2O (equal to reaction 
solvent volume), the organic phase collected, and the aqueous phase extracted three times with CH2Cl2 
(equal to reaction volume). The combined organic phases were then dried over MgSO4, filtered and 
solvent removed under reduced pressure. The crude material was then purified via flash column 
chromatography to reveal the corresponding N-protected indole 307.  
 
1-Tosyl-1H-indole (307a) 
The title compond was prepared using General Procedure A to afford the title compound 
as a beige solid (1.036 g, 88% yield), Rf: 0.41 in 30:70 EtOAc:n-hexanes, 1H NMR (300 
MHz, CDCl3): δ 7.99 (d, J = 8.3 Hz, 1H, CHAr), 7.76 (d, J = 8.2 Hz, 2H, CHAr tosyl), 
7.56 (d, J = 3.6 Hz, 1H, NTs-CH=CH), 7.52 (d, J = 7.7 Hz, 1H, CHAr), 7.30 (dd, J = 8.2, 
7.4 Hz, 1H, CHAr), 7.23-7.20 (m, 3H, overlapping CHAr tosyl & CHAr), 6.64 (d, J = 3.6 Hz, 1H, NTs-
CH=CH), 2.33 (s, 3H, CH3 tosyl) ppm. 13C NMR (75 MHz, CDCl3): δ 145.0 (CAr), 135.5 (CAr), 135.0 
(CAr), 130.9 (CAr), 129.9 (CHAr tosyl), 126.9 (CHAr tosyl), 126.5 (NTs-CH=CH), 124.7 (CHAr), 123.4 
(CHAr), 121.5 (CHAr), 113.7 (CHAr), 109.1 (NTs-CH=CH), 21.6 (CH3 tosyl) ppm. NMR data match 
known literature values: Chem. Eur. J., 2010, 16, 9676-9685.  
 
1-((4-Nitrophenyl)sulfonyl)-1H-indole (307b) 
The title compond was prepared using General Procedure A. The product was further 
recrystallised from hot methanol afford the title compound as a white solid (0.101 g, 
32% yield). Rf: 0.25 in 20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.25 
(d, J = 8.5Hz, 2H, CHAr nosyl), 8.03 (d, J = 8.5 Hz, 2H, CHAr nosyl), 7.98 (d, J = 8.4 Hz, 1H, CHAr), 
7.54-7.53 (m, 2H, overlapping NTs-CH=CH & CHAr), 7.34 (t, J = 7.8 Hz, 1H, CHAr), 7.26 (t, J = 7.5 
Hz, 1H, CHAr), 6.72 (d, J = 3.6 Hz, 1H, NTs-CH=CH) ppm. 13C NMR (125 MHz, CDCl3): δ 150.8 
(CAr), 143.5 (CAr), 134.9 (CAr), 131.0 (CAr), 128.2 (CHAr nosyl), 126.1 (NTs-CH=CH), 125.4 (CHAr), 
N
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124.6 (CHAr nosyl), 124.2 (CHAr), 121.9 (CHAr), 113.6 (CHAr), 110.8 (NTs-CH=CH) ppm. NMR data 
matches known literature values: Chem. Eur. J., 2010, 16, 9676-9685. 
 
(1H-Indol-1-yl)(phenyl)methanone (307d) 
The title compond was prepared using General Procedure A to afford the title compound 
as a colourless oil (0.141 g, 33% yield). Rf: 0.32 in 20:80 EtOAc:n-hexanes. 1H NMR 
(500 MHz, CDCl3): δ 8.40 (d, J = 8.3 Hz, 1H, CHAr), 7.73-7.71 (m, 2H, CHAr), 7.59 (t, 
J = 7.3 Hz, 2H, CHAr), 7.51 (t, J = 7.5 Hz, 2H, CHAr), 7.39-7.36 (m, 1H, CHAr), 7.32-7.28 (m, 2H, 
overlapping CHAr & CH=CH-N), 6.60 (d, J = 3.7 Hz, 1H, CH=CH-N) ppm. 13C NMR (125 MHz, 
CDCl3): δ 168.8, 136.2, 134.7, 132.0, 130.9, 129.3, 128.7, 127.7, 125.1, 124.1, 121.0, 116.5, 108.9 
ppm. NMR data matches known literature values: J. Org. Chem., 2010, 75, 8410-8415. 
 
Ethyl 1H-indole-1-carboxylate (307f) 
The title compond was prepared using General Procedure A to afford the title 
compound as a colourless oil (0.355 g, 91% yield), Rf: 0.95 in 5:95 EtOAc:n-
hexanes, 1H NMR (500 MHz, CDCl3): δ 8.18 (d, J = 7.5 Hz, 1H, N-CH=CH), 7.62 
(d, J = 3.1 Hz, 1H, CHAr), 7.56 (d, J = 7.8 Hz, 1H, CHAr), 7.33 (t, J = 7.7 Hz, 1H, CHAr), 7.25 – 7.22 
(m, 1H, CHAr), 6.59 (d, J = 3.7 Hz, 1H, N-CH=CH), 4.49 (q, J = 7.1 Hz, 2H, CO2-CH2-CH3), 1.47 (t, J 
= 7.1 Hz, 3H, CO2-CH2-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 151.2, 135.4, 130.7, 125.7, 124.5, 
123.0, 121.1, 115.3, 108.1, 63.3, 14.6 ppm. NMR data match known literature values: Chem. Commun., 
2015, 51, 13898-13901.  
 
tert-Butyl 1H-indole-1-carboxylate (307g) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.202 g, 93% yield). Rf: 0.52 in 20:80 EtOAc:n-hexanes. 
1H NMR (500 MHz, CDCl3): δ 8.15 (d, J = 6.7 Hz, 1H, CHAr), 7.59 (s, 1H, NBoc-
CH=CH), 7.55 (d, J = 7.7 Hz, 1H, CHAr), 7.30 (t, J = 7.7 Hz, 1H, CHAr), 7.21 (t, J = 7.5 Hz, 1H, CHAr), 
6.56 (d, J = 1.3 Hz, 1H, NBoc-CH=CH), 1.66 (s, 9H, 3 x CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 
149.9 (C=O), 135.3 (CAr), 130.7 (CAr), 126.0 (NBoc-CH=CH), 124.3 (CHAr), 122.7 (CHAr), 121.0 
(CHAr), 115.3 (CHAr), 107.4 (NBoc-CH=CH), 83.7 (CO2-C-(Me)3), 28.3 (3 x CH3) ppm. NMR data 
match known literature values: Chem. Commun., 2012, 48, 3239. 
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5-Chloro-1-tosyl-1H-indole (307i) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.266 g, 87% yield). Rf: 0.41 in 30:70 EtOAc:n-
hexanes. 1H NMR (500 MHz CDCl3): δ 7.91 (d, J = 6.5 Hz, 1H, CHAr), 7.73 (d, J 
= 5.1 Hz, 2H, CHAr tosyl), 7.57 (s, 1H, NTs-CH=CH), 7.45 (s, 1H, CHAr), 7.24 (d, J = 6.7 Hz, 1H, 
CHAr), 7.18 (d, J = 5.3 Hz, 2H, CHAr tosyl), 6.56 (s, 1H, NTs-CH=CH), 2.29 (s, 3H, CH3 tosyl) ppm. 
13C NMR (125 MHz, CDCl3): δ 145.3 (CAr tosyl), 135.0 (CAr tosyl), 133.2 (CAr), 132.0 (CAr), 130.0 
(CHAr tosyl), 129.1 (CAr), 127.8 (NTs-CH=CH), 126.8 (CHAr tosyl), 124.8 (CHAr), 121.0 (CHAr), 114.6 
(CHAr), 108.5 (NTs-CH=CH), 21.6 (CH3 tosyl) ppm. NMR data match known literature values: J. Org. 
Chem., 2015, 80, 12659-12667. 
 
6-Chloro-1-tosyl-1H-indole (307j) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.224 g, 72% yield). Rf: 0.30 in 20:80 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 8.01 (s, 1H, CHAr), 7.76 (d, J = 7.9 Hz, 
2H, CHAr tosyl), 7.54 (d, J = 3.1 Hz, 1H, NTs-CH=CH), 7.42 (d, J = 8.4 Hz, 1H, CHAr), 7.24 (d, J = 8.1 
Hz, 2H, CHAr tosyl), 7.19 (d, J = 8.3 Hz, 1H, CHAr), 6.61 (d, J = 3.3 Hz, 1H, NTs-CH=CH), 2.35 (s, 
3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 145.4 (CAr), 135.33 (CAr), 135.28 (CAr), 130.7 
(CAr), 130.2 (CHAr tosyl), 129.3 (CAr), 127.05 (NTs-CH=CH), 126.96 (CHAr tosyl), 124.1 (CHAr), 122.2 
(CHAr), 113.9 (CHAr), 108.8 (NTs-CH=CH), 21.7 (CH3 tosyl) ppm. NMR data match known literature 
values: J. Org. Chem., 2006, 71, 4255. 
 
7-Chloro-1-tosyl-1H-indole (307k) 
The title compond was prepared using General Procedure A to afford the title compound 
as a white solid (0.254 g, 82% yield). Mp: 95-98 °C. Rf: 0.29 in 10:90 EtOAc:n-hexanes. 
1H NMR (500 MHz, CDCl3): δ 7.90 (d, J = 3.5 Hz, 1H, NTs-CH=CH), 7.68 (d, J = 8.1 
Hz, 2H, CHAr tosyl), 7.45 (d, J = 7.7 Hz, 1H, CHAr), 7.23 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.19 (d, J = 
7.7 Hz, 1H. CHAr), 7.10 (t, J = 7.7 Hz, 1H, CHAr), 6.69 (d, J = 3.7 Hz, 1H, NTs-CH=CH), 2.36 (s, 3H, 
CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 144.8 (CAr), 137.3 (CAr), 134.8 (CAr), 131.8 (CAr), 
130.5 (NTs-CH=CH), 129.8 (CHAr tosyl), 127.2 (CHAr tosyl), 126.9 (CHAr), 124.2 (CHAr), 120.2 
(CHAr), 119.1 (CAr), 107.6 (NTs-CH=CH), 21.7 (CH3 tosyl) ppm. HRMS (ESI): calcd for 
C15H13ClNO2S [M + H]+ 306.03555, found 306.03523. IR (ATR, cm-1): ṽ 3150 (w), 1595 (w), 1470 
(m), 1401 (m), 1369 (s), 1252 (m), 1190 (s), 1174 (s), 1127 (s), 1090 (s), 982 (m), 936 (m), 811 (s), 790 
(s), 720 (s), 672 (s), 651 (s). 
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5-Bromo-1-tosyl-1H-indole (307l) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.323 g, 90% yield). Rf: 0.29 in 10:90 diethyl ether:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 7.86 (d, J = 8.8 Hz, 1H, CHAr), 7.73 (d, J 
= 8.2 Hz, 2H, CHAr tosyl), 7.64 (s, 1H, CHAr), 7.55 (d, J = 3.6 Hz, 1H, CH=CH-NTs), 7.38 (d, J = 8.8 
Hz, 1H, CHAr), 7.21 (d, J = 7.9 Hz, 2H, CHAr tosyl), 6.58 (d, J = 3.7 Hz, 1H, C-CH=CH-NTs), 2.32 (s, 
3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 145.4 (CAr tosyl), 135.0 (CAr tosyl), 133.6 (CAr), 
132.6 (CAr), 130.1 (CHAr tosyl), 127.6 (CH=CH-NTs), 127.5 (CHAr), 126.9 (CHAr tosyl), 124.1 (CHAr), 
116.9 (CBrAr), 115.0 (CHAr), 108.4 (CH=CH-NTs), 21.7 (CH3 tosyl) ppm. NMR data match known 
literature values: J. Org. Chem., 2004, 69, 6812-6820. 
 
Methyl 1-tosyl-1H-indole-4-carboxylate (307m) 
The title compond was prepared using General Procedure A to afford the title compound 
as a beige solid (0.233 g, 71% yield). Mp: 140-142 °C. Rf: 0.38 in 30:70 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 8.20 (d, J = 8.2 Hz, 1H, CHAr), 7.95 (d, J = 7.6 
Hz, 1H, CHAr), 7.74 (d, J = 7.1 Hz, 2H, CHAr tosyl), 7.694-7.690 (m, 1H, NTs-CH=CH), 
7.36-7.33 (m, 2H, overlapping CHAr & NTs-CH=CH), 7.19 (d, J = 8.0 Hz, 2H, CHAr tosyl), 3.93 (s, 3H, 
CO2CH3), 2.30 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 167.0 (C=O), 145.3 (CAr), 
135.5 (CAr), 135.1 (CAr), 130.8 (CAr), 130.0 (CHAr tosyl), 128.3 (NTs-CH=CH), 126.9 (CHAr tosyl), 
126.2 (CHAr), 124.0 (CHAr), 122.7 (C-CO2Me), 118.1 (CHAr), 109.8 (NTs-CH=CH), 52.1 (CO2CH3), 
21.6 (CH3 tosyl) ppm. HRMS (ESI): calcd for C17H16NO4S [M + H]+ 330.0800, found 330.0793. IR 
(ATR, cm-1): ṽ 3117 (w), 2950 (w), 2362 (w), 1718 (s), 1594 (w), 1436 (m), 1358 (m), 1271 (s), 1166 
(s), 1100 (s), 1023 (m), 730 (s), 704 (s), 679 (s). 
 
Methyl 1-tosyl-1H-indole-5-carboxylate (307n) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.231 g, 68% yield). Mp: 145-158 °C. Rf: 0.24 in 
20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.25 (s, 1H, CHAr), 
8.01-8.00 (m, 2H, 2 x overlapping CHAr), 7.77 (d, J = 8.4 Hz, 2H, CHAr tosyl), 7.62 (d, J = 3.7 Hz, 1H, 
NTs-CH=CH), 7.23 (d, J = 8.1 Hz, 2H, CHAr tosyl), 6.72 (d, J = 3.7 Hz, 1H, NTs-CH=CH), 3.91 (s, 
3H, CO2CH3), 2.33 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 167.3 (C=O), 145.5 (CAr), 
137.4 (CAr), 135.1 (CAr), 130.6 (CAr), 130.1 (CHAr tosyl), 127.7 (NTs-CH=CH), 126.9 (CHAr tosyl), 
125.9 (CHAr), 125.5 (CAr), 123.8 (CHAr), 113.3 (CHAr), 109.5 (NTs-CH=CH), 52.2 (CO2CH3), 21.7 
(CH3 tosyl) ppm. HRMS (ESI): calcd for C17H16NO4S [M + H]+ 330.08000, found 330.07971. IR 
(ATR, cm-1): ṽ 1718 (m), 1436 (w), 1366 (w), 1290 (m), 1264 (m), 1190 (m), 1125 (m), 1089 (m), 992 
(w), 815 (w), 734 (s), 705 (s), 667 (m). 
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Methyl 1-tosyl-1H-indole-7-carboxylate (307o) 
The title compond was prepared using General Procedure A to afford the title compound 
as a beige solid (0.101 g, 31% yield). Mp: 129-130 °C. Rf: 0.38 in 30:70 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 7.56 (d, J = 8.3 Hz, 3H, overlapping CHAr & 
CHAr tosyl), 7.50 (dd, J = 7.4, 0.6 Hz, 1H, CHAr), 7.47 (d, J = 3.6 Hz, 1H, NTs-CH=CH), 
7.27 (t, J = 7.6 Hz, 1H, CHAr), 7.14 (d, J = 8.0 Hz, 2H, CHAr tosyl), 6.66 (d, J = 3.7 Hz, 1H, NTs-
CH=CH), 3.93 (s, 3H, CO2CH3), 2.31 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 169.1 
(C=O), 144.9 (CAr), 135.0 (CAr), 133.0 (CAr), 132.0 (CAr), 130.0 (NTs-CH=CH), 129.6 (CHAr tosyl), 
126.9 (CHAr tosyl), 125.7 (CHAr), 124.1 (CHAr), 123.9 (CHAr), 122.7 (C-CO2CH3), 111.6 (NTs-
CH=CH), 52.7 (CO2CH3), 21.7 (CH3 tosyl) ppm. HRMS (ESI): calcd for C17H15NO4SNa [M + Na]+ 
352.0619, found 352.0627. IR (ATR, cm-1): ṽ 3107 (w), 2961 (w), 1717 (s), 1593 (w), 1429 (m), 1369 
(m), 1288 (s), 1169 (s), 1074 (m), 968 (m), 785 (s), 748 (s), 685 (s), 650 (s). 
 
1-Tosyl-1H-indole-5-carbonitrile(307p) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.208 g, 51% yield). Rf: 0.40 in 40:60 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 8.07 (d, J = 8.6 Hz, 1H, CHAr), 7.87 (s, 
1H, CHAr), 7.77 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.69 (d, J = 3.6 Hz, 1H, NTs-CH=CH), 7.55 (d, J = 8.6 
Hz, 1H, CHAr), 7.26 (d, J = 8.2 Hz, 2H, CHAr tosyl), 6.71 (d, J = 3.6 Hz, 1H, NTs-CH=CH), 2.36 (s, 
3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 145.9 (CAr), 136.6 (CAr), 134.9 (CAr), 130.8 (CAr), 
130.3 (CHAr tosyl), 128.6 (NTs-CH=CH), 127.6 (CHAr), 127.0 (CHAr tosyl), 126.5 (CHAr), 119.4 (CAr), 
114.4 (CHAr), 108.6 (NTs-CH=CH), 107.1 (C-CN), 21.7 (CH3 tosyl) ppm. NMR data match known 
literature values: Chemistry Letters, 2011, 40, 555-557. 
 
5-Nitro-1-tosyl-1H-indole (307q) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.280 g, 88% yield). Rf: 0.31 in 20:80 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 8.46 (d, J = 1.6 Hz, 1H, CHAr), 8.20 (dd, 
J = 9.1, 1.7 Hz, 1H, CHAr), 8.08 (d, J = 9.1 Hz, 1H, CHAr), 7.79 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.74 
(d, J = 3.6 Hz, 1H, NTs-CH=CH), 7.28 (d, J = 8.2 Hz, 2H, CHAr tosyl), 6.81 (d, J = 3.6 Hz, 1H, NTs-
CH=CH), 2.36 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 146.0 (C-NO2), 144.3 (CAr 
tosyl), 137.7 (CAr), 134.8 (CAr tosyl), 130.6 (CAr), 130.3 (CHAr tosyl), 129.3 (NTs-CH=CH), 127.0 (CHAr 
tosyl), 119.9 (CHAr), 117.9 (CHAr), 113.7 (CHAr), 109.5 (NTs-CH=CH), 21.7 (CH3 tosyl) ppm. NMR 
data match known literature values: Org. Lett., 2015, 17, 1296-1299. 
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5-Methyl-1-tosyl-1H-indole (307s) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.281 g, 90% yield). Rf: 0.33 in 20:80 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 7.86 (d, J = 8.5 Hz, 1H, CHAr), 7.73 (d, J 
= 8.2 Hz, 2H, CHAr tosyl), 7.50 (d, J = 3.5 Hz, 1H, NTs-CH=CH), 7.29 (s, 1H, CHAr), 7.18 (d, J = 8.0 
Hz, 2H, CHAr), 7.11 (d, J = 8.5 Hz, 1H, CHAr), 6.56 (d, J = 3.5 Hz, 1H, NTs-CH=CH), 2.38 (s, 3H, C-
CH3), 2.31 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 144.9 (CAr), 135.6 (CAr), 133.3 
(CAr), 133.0 (CAr), 131.2 (CAr), 129.9 (CHAr tosyl), 126.9 (CHAr tosyl), 126.6 (NTs-CH=CH), 126.1 
(CHAr), 121.4 (CHAr), 113.4 (CHAr), 109.0 (NTs-CH=CH), 21.6 (CH3 tosyl), 21.4 (Ar-CH3) ppm. NMR 
data match known literature values: Tetrahedron, 2015, 71, 451-456. 
 
5-Methoxy-1-tosyl-1H-indole (307t) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.275 g, 90% yield). Rf: 0.31 in 20:80 EtOAc:n-
hexanes. 1H NMR (500 MHz, CDCl3): δ 7.87 (d, J = 9.0 Hz, 1H, CHAr), 7.71 (d, 
J = 8.1 Hz, 2H, CHAr tosyl), 7.50 (d, J = 3.5 Hz, 1H, NTs-CH=CH), 7.16 (d, J = 8.2 Hz, 2H, CHAr 
tosyl), 6.94 (d, J = 2.1, 1H, CHAr), 6.91 (dd, J = 9.0, 2.1 Hz, 1H, CHAr), 6.56 (d, J = 3.6 Hz, 1H, NTs-
CH=CH), 3.77 (s, 3H, O-CH3), 2.28 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 156.5 
(C-OMe), 144.9 (CAr tosyl), 135.2 (CAr tosyl), 131.8 (CAr), 129.9 (CHAr tosyl), 129.6 (CAr), 127.2 (NTs-
CH=CH), 126.8 (CHAr tosyl), 114.4 (CHAr), 113.7 (CHAr), 109.3 (NTs-CH=CH), 103.7 (CHAr), 55.7 
(O-CH3), 21.6 (CH3 tosyl) ppm. NMR data match known literature values: Angew. Chem. Int. Ed., 2002, 
41, 4732. 
 
3-Methyl-1-tosyl-1H-indole (307u) 
The title compond was prepared using General Procedure A to afford the title compound 
as a white solid (0.298 g, 99% yield). Rf: 0.24 in 10:90 EtOAc:n-hexanes. 1H NMR (500 
MHz, CDCl3): δ 7.98 (d, J = 8.3 Hz, 1H, CHAr), 7.72 (d, J = 8.3 Hz, 2H, CHAr tosyl), 
7.42 (d, J = 7.7 Hz, 1H, CHAr), 7.31-7.28 (m, 2H, overlapping CHAr & NTs-CH=C), 
7.22 (t, J = 7.4 Hz, 1H, CHAr), 7.15 (d, J = 8.0 Hz, 2H, CHAr tosyl), 2.28 (s, 3H, CH3 tosyl), 2.22 (s, 
3H, CH=C-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 144.7 (CAr), 135.5 (CAr), 135.4 (CAr), 131.9 
(CAr), 129.8 (CHAr tosyl), 126.1 (CHAr tosyl), 124.6 (CHAr), 123.16 (NTs-CH=C), 123.07 (CHAr), 119.5 
(CHAr), 118.7 (CAr), 21.6 (CH3 tosyl), 9.8 (CH=C-CH3) ppm. NMR data match known literature values: 
Tetrahedron, 2007, 63, 8250-8254. 
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1-(1-Tosyl-1H-indol-3-yl)ethan-1-one (307v) 
The title compond was prepared using General Procedure A to afford the title compound 
as a white solid (0.203 g, 65% yield). Rf: 0.36 in 40:60 EtOAc:n-hexanes. 1H NMR (500 
MHz, CDCl3): δ 8.32 (d, J = 7.8 Hz, 1H, CHAr), 8.22 (s, 1H, NTs-CH-C-Ac), 7.92 (d, 
J = 7.7 Hz, 1H, CHAr), 7.83 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.37-7.31 (m, 2H, 
overlapping CHAr), 7.26 (d, J = 8.0 Hz, 2H, CHAr tosyl), 2.56 (s, 3H, COCH3), 2.34 (s, 3H, CH3 tosyl) 
ppm. 13C NMR (125 MHz, CDCl3): δ 193.5 (C=O), 146.0 (CAr), 135.0 (CAr), 134.6 (CAr), 132.3 (NTs-
CH=C-Ac), 130.3 (CHAr tosyl), 127.6 (CAr), 127.2 (CHAr tosyl), 125.8 (CHAr), 124.9 (CHAr), 123.2 
(CHAr), 121.7 (CAr), 113.1 (CHAr), 27.9 (COCH3), 21.7 (CH3 tosyl) ppm. NMR data match known 
literature values: Tetrahedron., 2011, 67, 3997-4001. 
 
Methyl 1-tosyl-1H-indole-3-carboxylate (307w) 
The title compond was prepared using General Procedure A to afford the title 
compound as a white solid (0.188 g, 56% yield). Rf: 0.35 in 30:70 EtOAc:n-
hexanes. Mp: 170-173 °C. 1H NMR (500 MHz, CDCl3): δ 8.28 (s, 1H, NTs-
CH=C), 8.13 (d, J = 7.8 Hz, 1H, CHAr), 7.96 (d, J = 8.0 Hz, 1H, CHAr), 7.81 (d, J = 
8.3 Hz, 2H, CHAr tosyl), 7.37-7.30 (m, 2H, CHAr), 7.23 (d, J = 8.3 Hz, 2H, CHAr tosyl), 3.91 (s, 3H, 
CO2CH3), 2.32 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 164.1 (C=O), 145.9 (CAr), 
134.9 (CAr), 134.7 (CAr), 132.1 (NTs-CH=C), 130.2 (CHAr tosyl), 127.8 (CAr), 127.2 (CHAr tosyl), 125.4 
(CHAr), 124.5 (CHAr), 122.2 (CHAr), 113.5 (C-CO2CH3), 113.4 (CHAr), 51.7 (CO2CH3), 21.7 (CH3 tosyl) 
ppm. HRMS (ESI): calcd for C17H15NO4SNa [M + Na]+ 352.0619, found 352.0614. IR (ATR, cm-1): 
ṽ 3113 (w), 2957 (w), 1703 (s), 1541 (m), 1433 (w), 1383 (m), 256 (w), 1198 (m), 1171 (s), 1140 (s), 
1086 (s), 1057 (s), 939 (w), 768 (m), 689 (s), 658 (s). 
 
1-Tosyl-1H-indole-3-carbonitrile (307x) 
The title compond was prepared using General Procedure A to afford the title compound 
as a white solid (15.2 mg, 5% yield). Rf: 0.45 in 30:70 EtOAc:n-hexanes. 1H NMR (500 
MHz, CDCl3): δ 8.10 (s, 1H, NTs-CH=C), 8.00 (d, J = 8.4 Hz, 1H, CHAr), 7.83 (d, J = 
8.2 Hz, 2H, CHAr tosyl), 7.70 (d, J = 7.9 Hz, 1H, CHAr), 7.44 (d, J = 8.0 Hz, 1H, CHAr), 
7.38 (t, J = 7.6 Hz, 1H, CHAr), 7.30 (d, J = 8.2 Hz, 2H, CHAr tosyl), 2.38 (s, 3H, CH3 tosyl) ppm. 13C 
NMR (125 MHz, CDCl3): δ 146.5 (CAr), 134.3 (CAr), 133.8 (CAr), 133.3 (NTs-CH-C), 130.5 (CHAr 
tosyl), 128.5 (CAr), 127.4 (CHAr tosyl), 126.7 (CHAr), 124.9 (CHAr), 120.4 (CHAr), 113.9 (CHAr), 113.6 
(CH=C-CN), 93.9 (CH=C-CN), 21.8 (CH3 tosyl) ppm. NMR data match known literature values: Chem. 
Commun., 2012, 48, 3127-3129. 
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3.5.2: General procedure B - C3-Nitration of indoles 
 
 
 
Procedure adapted from: Synthesis., 1999, 7, 1117-1122. 
Preformed acetyl nitrate was generated via the drop wise addition acetic anhydride (2.0 mL) to cooled 
(0 °C) solution of 70% HNO3 (10 equiv.) followed by standing at room temperature for 5-10 minutes 
before use (beware – this solution may potentially undergo violent decomposition). To a stirred solution 
of the corresponding indole 307 (1.0 equiv.) in acetic anhydride (2.0 mL) at −70 °C (isopropanol or 
acetone slurry in dry ice) was added the preformed acetyl nitrate solution slowly drop wise. After 
complete addition of the acetyl nitrate, the reaction mixture was stirred at −70 °C until the limiting 
reagent was consumed (monitored via TLC). The reaction was treated with cold water (25 mL) to the 
cold reaction mixture and allowed to warm slowly to room temperature. The aqueous solution was then 
extracted using EtOAc (3 x 30 mL) before the volume reduced in vacuo. The crude mixture was then 
redissolved in EtOAc (30 mL) and the organic phase washed with saturated aqueous NaHCO3 (beware: 
vigorous bubbling due to CO2 gas generation) under no further gas evolution was visible. The organic 
phase was then dried over Na2SO4, filtered and solvent removed under reduced pressure. The crude was 
then purified by recrystallisation or flash column chromatography to reveal the corresponding 3-
nitroindole 308. 
 
3-Nitro-1-tosyl-1H-indole (308a) 
Recrystallisation from 1:1 EtOAc:n-hexanes or hot methanol gave the title compound 
as beige solid (1.290 g, 81% yield). 1H NMR (500 MHz, CDCl3): δ 8.56 (s, 1H, NTs-
CH=C), 8.25-8.23 (m, 1H, CHAr), 8.01-8.00 (m, 1H, CHAr), 7.88 (d, J = 8.3 Hz, 2H, 
CHAr tosyl), 7.48-7.44 (m, 2H, 2 x CHAr), 7.33 (d, J = 8.0 Hz, 2H, CHAr tosyl), 2.40 (s, 
3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 146.9 (CAr), 134.0 (CAr), 133.7 (CAr), 130.6 (CHAr 
tosyl), 130.1 (C-NO2), 128.0 NTs-CH=C), 127.8 (CHAr tosyl), 126.9 (CHAr), 126.0 (CHAr), 121.9 (CAr), 
121.3 (CHAr), 113.7 (CHAr), 21.8 (CH3 tosyl) ppm. NMR data match known literature values: 
Tetrahedron Lett., 1999, 40, 3343-3346. 
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3-Nitro-1-((4-nitrophenyl)sulfonyl)-1H-indole (308b) 
Recrystallisation from hot methanol gave the title compound as a yellow solid (65.5 
mg, 57% yield). Mp: 299-302 oC. 1H NMR (400 MHz, CDCl3): δ 8.54 (s, 1H, Ns-
CH=C), 8.38 (d, J = 9.2 Hz, 2H, CHAr nosyl), 8.28-8.25 (m, 1H, CHAr), 8.19 (d, J = 
9.1 Hz, 2H, CHAr nosyl), 8.02-8.00 (m, 1H, CHAr), 7.53-7.50 (m, 2H, CHAr) ppm. 13C 
NMR (100 MHz, CDCl3): δ 142.3 (C-NO2 nosyl), 133.8 (CH=C-NO2), 130.4 (CAr), 128.9 (CHAr 
nosyl), 127.6 (CHAr), 127.4 (CHAr), 127.3 (Ns-CH=C), 126.7 (CAr), 125.3 (CHAr nosyl), 122.1 (CAr), 
121.9 (CHAr), 113.5 (CHAr) ppm. IR (ATR, cm-1): ṽ 1914 (w), 1617 (s), 1528 (m), 1507 (w), 1448 (m), 
1395 (s), 1348 (s), 1298 (s), 1266 (s), 1219 (s), 1137 (m), 1116 (m), 1088 (m), 1046 (m), 1032 (m). 
 
3-Nitro-N-acetyl-indole (308c) 
Flash column chromatorgahy gave the title compound as a pink solid (49.6 mg, 43% 
yield). Rf: 0.36 in 25:75 EtOAc:n-hexanes Mp: 160-163 oC. 1H NMR (500 MHz, 
CDCl3): δ 8.49-8.47 (m, 1H, CHAr), 8.43 (s, 1H, NAc-CH=C), 8.28-8.26 (m, 1H, 
CHAr), 7.51-7.50 (m, 2H, 2 x overlapping CHAr), 2.76 (s, 3H, COCH3) ppm. 13C NMR 
(125 MHz, CDCl3): δ 168.6 (C=O), 134.9 (NAc-CH=C-NO2), 133.6 (CAr), 127.6 (CHAr), 126.9 (NAc-
CH=C), 126.4 (CHAr), 121.6 (CAr), 120.8 (CHAr), 116.9 (CHAr), 23.9 (COCH3) ppm. NMR data match 
known literature values: Synthesis., 1999, 1117-1122. 
 
(3-Nitro-1H-indol-1-yl)(phenyl)methanone (308d) 
Recrystallisation from hot methanol gave the title compound as a white solid (0.132 g, 
11% yield (unoptimised)). 1H NMR (500 MHz, CDCl3): δ 8.38-8.36 (m, 1H, CHAr), 
8.32-8.31 (m, 1H, CHAr), 8.28 (s, 1H, NO2C=CH-N), 7.79-7.77 (m, 2H, CHAr), 7.74-
7.71 (m, 1H, CHAr), 7.61 (t, J = 7.7 Hz, 2H, CHAr), 7.55-7.51 (m, 2H, CHAr) ppm. 13C 
NMR (125 MHz, CDCl3): δ 168.3 (C=O), 135.3 CAr), 133.7 (CHAr), 133.3 (NO2C=CH-N), 132.3 (CAr), 
129.8 (CHAr), 129.4 (CHAr), 129.2 (NO2C=CH-N), 127.3 (CHAr), 126.5 (CHAr), 121.9 (CAr), 120.9 
(CHAr), 116.5 (CHAr) ppm. NMR data match known literature values: Org. Lett., 2017, 19, 2266-2269. 
 
3-Nitro-1H-indole-1-carboxylate (308e) 
Flash column chromatography gave the title compound as a purple solid (51.6 mg, 
41% yield). Rf: 0.37 in 25:75 (EtOAc:n-hexanes). Mp: 115-118 °C. 1H NMR (500 
MHz, CDCl3): δ 8.53-8.49 (m, 1H, N-CH=C), 8.23-8.20 (m, 2H, 2 x overlapping 
CHAr), 7.47-7.44 (m, 2H, 2 x overlapping CHAr), 4.14 (s, 3H, CO2CH3) ppm. 13C 
NMR (125 MHz, CDCl3): δ 150.3 (C=O), 134.3 (CAr), 133.2 (CH=C-NO2), 127.4 (CHAr), 127.0 (N-
CH=C), 125.8 (CHAr), 121.4 (CAr), 120.8 (CHAr), 115.5 (CHAr), 55.2 (CO2CH3) ppm. HRMS (ESI): 
calcd for C10H9N2O4 [M + H]+ 221.0562, found 221.0572. IR (ATR, cm-1): ṽ 3150 (m), 1754 (s), 1587 
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(m), 1547 (m), 1497 (s), 1449 (s), 1436 (s), 1379 (s), 1338 (m), 1305 (s), 1254 (m), 1218 (s), 1149 (m), 
1081 (s), 1015 (m), 932 (m), 876 (w), 833 (m), 771 (s), 691 (m). 
 
Ethyl 3-nitro-1H-indole-1-carboxylate (308f) 
Recrystallisation from hot methanol gave the title compound as a white solid (0.170 
g, 58% yield). Mp: 122-124 °C. 1H NMR (500 MHz, CDCl3): δ 8.60 (s, 1H, N-
CH=C), 8.30-8.26 (m, 2H, 2 x overlapping CHAr), 7.51-7.47 (m, 2H, 2 x overlapping 
CHAr), 4.49 (d, J = 7.1 Hz, 2H, CO2-CH2-CH3), 1.53 (t, J = 7.1 Hz, 3H, CO2-CH2-
CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 149.8 (C=O), 134.5 (CAr), 133.2 (CH=C-NO2), 127.6 (N-
CH=C), 127.0 (CHAr), 125.8 (CHAr), 121.6 (CAr), 120.9 (CHAr), 115.6 (CHAr), 65.1 (CO2-CH2-CH3), 
14.4 (CO2-CH2-CH3) ppm. HRMS (ESI): calcd for C11H11N2O4 [M + H]+ 235.0719, found 235.0711. 
IR (ATR, cm-1): ṽ 3177, 1762, 1551, 1375, 1335, 1300, 1250, 1209. 
 
tert-Butyl 3-nitro-1H-indole-1-carboxylate (308g) 
Recrystallisation from hot methanol gave the title compound as a yellow solid (68.1 
mg, 28% yield). Mp: 135-137 °C. 1H NMR (500 MHz, CDCl3): δ 8.54 (s, 1H, NBoc-
CH=C), 8.27 (t, J = 4.6 Hz, 1H, CHAr), 8.24 (t, J = 4.6 Hz, 1H, CHAr), 7.47-7.45 (m, 
2H, CHAr), 1.71 (s, 9H, 3 x CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 148.3 (C=O), 
134.5 (CAr), 132.7 (C-NO2), 128.0 (NBoc-CH=C), 126.8 (CHAr), 125.6 (CHAr), 121.7 (CAr), 120.9 
(CHAr), 115.7 (CHAr), 86.8 (O-C-(Me)3), 28.2 (3 x CH3) ppm. HRMS (ESI): calcd for C13H14N2O4Na 
[M + Na]+ 285.0851, found 285.0859. IR (ATR, cm-1): ṽ 3174 (w), 2992 (w), 1761 (s), 1586 (w), 1553 
(m), 1500 (m), 1480 (w), 1451 (m), 1375 (m), 1333 (m), 1308 (s), 1258 (s), 1223 (s), 1151 (s), 1133 
(s), 1078 (s), 1019 (w), 848 (w), 818 (w), 756 (w), 746 (s), 694 (w). 
 
1-Methyl-3-nitro-1H-indole (308h) 
Recrystallisation from 1:1 EtOAc:n-hexanes gave the title compound as yellow solid 
(0.188 g, 28% yield). 1H NMR (500 MHz, CDCl3): δ 8.23 (d, J = 6.6 Hz, 1H, CHAr), 
8.05 (s, 1H, NMe-CH=C), 7.43-7.39 (m, 3H, 3 x overlapping CHAr), 3.88 (s, 3H, N-
CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 135.9 (CAr), 131.4 (NMe-CH=C), 128.7 
(CH=C-NO2), 124.6 (CHAr), 124.3 (CHAr), 121.0 (CAr), 120.9 (CHAr), 110.6 (CHAr), 34.1 (N-CH3) ppm. 
NMR data match known literature values: Synthesis., 1999, 1117-1122. 
 
5-Chloro-3-nitro-1-tosyl-1H-indole (308i) 
Recrystallisation from hot methanol gave the title compound as beige solid (0.135 
g, 44% yield). Mp: 198-200 °C. 1H NMR (500 MHz, CDCl3): δ 8.56 (s, 1H, NTs-
CH=C), 8.21 (s, 1H, CHAr), 7.93 (d, J = 8.9 Hz, 1H, CHAr), 7.86 (d, J = 8.3 Hz, 
2H, CHAr tosyl), 7.42 (d, J = 8.9 Hz, 1H, CHAr), 7.35 (d, J = 8.1 Hz, 2H, CHAr 
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tosyl), 2.41 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 147.2 (CAr), 133.6 (CAr), 132.44 
(C-NO2), 132.35 (CAr), 131.9 (CAr), 130.8 (CHAr tosyl), 128.9 (NTs-CH=C), 127.6 (CHAr tosyl), 127.4 
(CHAr), 122.9 (CAr), 121.0 (CHAr), 114.9 (CHAr), 21.9 (CH3 tosyl) ppm. HRMS (ESI): calcd for 
C15H12ClN2O4S [M + H]+ 351.0206, found 351.0223. IR (ATR, cm-1): ṽ 3134 (w), 1543 (w), 1507 (w), 
1435 (m), 1387 (s), 1218 (m), 1176 (s), 1094 (s), 960 (s), 843 (s), 745 (s), 669 (s). 
 
6-Chloro-3-nitro-1-tosyl-1H-indole (308j) 
Recrystallisation from hot methanol gave the title compound as a white solid 
(0.112 g, 43% yield). Mp: 189-190 °C. 1H NMR (500 MHz, CDCl3): δ 8.52 (s, 
1H. NTs-CH=C), 8.15 (d, J = 8.7 Hz, 1H, CHAr), 8.03 (s, 1H, CHAr), 7.88 (d, J = 
8.2 Hz, 2H, CHAr tosyl), 7.43 (d, J = 8.7 Hz, 1H, CHAr), 7.37 (d, J = 8.0 Hz, 2H, 
CHAr tosyl), 2.42 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 147.2 (CAr), 134.0 (CAr), 
133.8 (CAr), 133.2 (CAr), 133.1 (C-NO2), 130.8 (CHAr tosyl), 128.2 (NTs-CH=C), 127.6 (CHAr tosyl), 
126.8 (CHAr), 122.3 (CHAr), 120.4 (CAr), 114.0 (CHAr), 21.9 (CH3 tosyl) ppm. HRMS (ESI): calcd for 
C15H12ClN2O4S [M + H]+ 351.0206, found 351.0219. IR (ATR, cm-1): ṽ 3142 (w), 2351 (w), 1537 (m), 
1498 (m), 1387 (s), 1275 (s), 1188 (s), 1086 (s), 962 (s), 841 (s), 669 (s). 
 
7-Chloro-3-nitro-1-tosyl-1H-indole (308k) 
Recrystallisation from hot methanol gave the title compound as a white solid (0.187 g, 
64% yield). Mp: 212-213 °C.  1H NMR (500 MHz, CDCl3): δ 8.94 (s, 1H, NTs-
CH=C-NO2), 8.27 (dd, J = 7.0, 2.2 Hz, 1H, CHAr), 7.78 (d, J = 8.4 Hz, 2H, CHAr tosyl), 
7.38-7.34 (m, 4H, 2 x overlapping CHAr and CHAr tosyl), 2.45 (s, 3H, CH3 tosyl) ppm. 
13C NMR (125 MHz, CDCl3): δ 146.5 (CAr), 135.4 (CAr), 132.1 (NTs-CH=C), 131.7 (C-NO2), 131.2 
(CAr), 130.2 (CHAr tosyl), 129.1 (CHAr), 128.0 (CHAr tosyl), 126.8 (CHAr), 125.6 (CAr), 120.0 (CHAr), 
119.5 (CAr), 21.9 (CH3 tosyl) ppm. HRMS (ESI): calcd for C15H12ClN2O4S [M + H]+ 351.0206, found 
351.0201. IR (ATR, cm-1): ṽ 3165 (w), 1578 (m), 1499 (m), 1387 (s), 1352 (m), 1261 (m), 1192 (s), 
1176 (s), 1084 (m), 957 (s), 810 (s), 787 (s), 662 (s), 652 (s). 
 
5-Bromo-3-nitro-1-tosyl-1H-indole (308l) 
Recrystallisation from hot methanol gave the title compound as a white solid 
(0.258 g, 79% yield). 1H NMR (500 MHz, CDCl3): δ 8.54 (s, 1H, NTs-CH=C), 
8.39 (s, 1H, CHAr), 7.89-7.85 (m, 3H, CHAr & CHAr tosyl), 7.57 (d, J = 8.3 Hz, 
1H, CHAr), 7.35 (d, J = 8.0 Hz, 2H, CHAr tosyl), 2.41 (s, 3H, CH3 tosyl) ppm. 13C 
NMR (125 MHz, CDCl3): δ 147.2 (CAr), 133.7 (CAr), 132.4 (C-Br), 130.8 (CHAr tosyl), 130.1 (CHAr), 
128.7 (NTs-CH=C), 127.64 (CHAr tosyl), 127.58 (C-NO2), 124.1 (CHAr), 123.4 (CAr), 120.0 (CAr), 115.2 
(CHAr), 21.9 (CH3 tosyl) ppm. NMR data match known literature values: Org. Chem. Front., 
2016, 3, 339-343. 
N
Ts
NO2
Cl
N
TsCl
NO2
N
Ts
Br
NO2
	 185 
 
Methyl 3-nitro-1-tosyl-1H-indole-4-carboxylate (308m) 
Recrystallisation from hot methanol gave the title compound as beige solid (86.5 mg, 
33%). Mp: 133-136 °C. 1H NMR (500 MHz, CDCl3): δ 8.53 (s, 1H, NTs-CH=C), 
8.15 (d, J = 8.5 Hz, 1H, CHAr), 7.86 (d, J = 8.3 Hz, 2H, CHAr tosyl), 7.67 (d, J = 7.5 
Hz, 1H, CHAr), 7.51 (t, J = 8.0 Hz, 1H, CHAr), 7.33 (d, J = 8.2 Hz, 2H, CHAr tosyl), 
3.89 (s, 3H, CO2CH3), 2.40 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 167.7 (C=O), 
147.2 (CAr), 134.03 (C-NO2), 133.95 (CAr), 133.7 (CAr), 130.7 (CHAr tosyl), 128.6 (NTs-CH=C), 127.5 
(CHAr tosyl), 126.5 (CHAr), 126.4 (CAr), 126.1 (CHAr), 118.4 (CAr), 116.4 (CHAr), 52.5 (CO2CH3), 21.8 
(CH3 tosyl) ppm. HRMS (ESI): calcd for C17H14N2O6SNa [M + Na]+ 397.0470, found 397.0488. IR 
(ATR, cm-1): ṽ 3125 (w), 1721 (s), 1512 (m), 1358 (m), 1287 (s), 1194 (s), 1171 (s), 1091 (s), 1022 
(m), 817 (m), 754 (m), 696 (m), 664 (s). 
 
Methyl 3-nitro-1-tosyl-1H-indole-5-carboxylate (308n) 
Recrystallisation from hot methanol gave the title compound as beige solid 
(0.163 g, 62%). Mp: 187-188 °C. 1H NMR (500 MHz, CDCl3): δ 8.90 (s, 
1H, CHAr), 8.61 (s, 1H, NTs-CH=C), 8.15 (d, J = 8.8 Hz, 1H, CHAr), 8.05 (d, 
J = 8.8 Hz, 1H, CHAr), 7.89 (d, J = 7.4 Hz, 2H CHAr tosyl), 7.35 (d, J = 7.9 
Hz, 2H, CHAr tosyl), 3.96 (s, 3H, CO2CH3), 2.40 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): 
δ 166.4 (C=O), 147.3 (CAr), 135.8 (CAr), 133.6 (CAr), 133.4 (C-NO2), 130.8 (CHAr tosyl), 129.1 (NTs-
CH=C), 128.1 (CAr), 128.0 (CHAr), 127.6 (CHAr tosyl), 123.5 (CHAr), 121.7 (CAr), 113.6 (CHAr), 52.6 
(CO2CH3), 21.9 (CH3 tosyl) ppm. HRMS (ESI): calcd for C17H15N2O6S [M + H]+ 375.0651, found 
375.0634. IR (ATR, cm-1): ṽ 3144 (w), 1717 (s), 1547 (m), 1495 (s), 1431 (m), 1385 (s), 1279 (s), 1173 
(s), 1109 (s), 955 (s), 870 (m), 754 (s), 669 (s). 
 
Methyl 3-nitro-1-tosyl-1H-indole-7-carboxylate (308o) 
Recrystallisation from hot methanol gave the title compound as beige solid (41.0 mg, 
36%). Mp: 174-175 °C. 1H NMR (500 MHz, CDCl3): δ 8.50 (s, 1H, NTs-CH=C), 
8.38 (d, J = 8.0 Hz, 1H, CHAr), 7.78 (d, J = 8.3 Hz, 2H, CHAr tosyl), 7.62 (d, J = 7.4 
Hz, 1H, CHAr), 7.51 (t, J = 7.8 Hz, 1H, CHAr), 7.32 (d, J = 8.1 Hz, 2H, CHAr tosyl), 
3.96 (s, 3H, CO2CH3), 2.41 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 168.0 (C=O), 
146.7 (CAr), 134.5 (CAr), 134.0 (C-NO2), 131.1 (NTs-CH=C), 130.5 (CAr), 130.4 (CHAr tosyl), 127.57 
(CHAr), 127.53 (CHAr tosyl), 125.9 (CHAr), 123.7 (CHAr), 123.3 (CAr), 122.5 (CAr), 53.0 (CO2CH3), 21.9 
(CH3 tosyl) ppm. HRMS (ESI): calcd for C17H14N2O6SNa [M + Na]+ 397.0470, found 397.0474. IR 
(ATR, cm-1): ṽ 3144 (w), 1730 (s), 1566 (m), 1512 (m), 1402 (m), 1354 (s), 1287 (s), 1167 (s), 1090 
(m), 988 (m), 887 (m), 812 (s), 752 (m), 702 (m), 662 (s). 
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3-Nitro-1-tosyl-1H-indole-5-carbonitrile (308p) 
Recrystallisation from hot methanol gave the title compound as beige solid (0.135 
g, 59%). Mp: 221-224 °C. 1H NMR (500 MHz, CDCl3): δ 8.66 (s, 1H, NTs-
CH=C), 8.60 (s, 1H, CHAr), 8.13 (d, J = 8.7 Hz, 1H, CHAr), 7.89 (d, J = 8.3 Hz, 
2H, CHAr tosyl), 7.72 (d, J = 8.5 Hz, 1H, CHAr), 7.38 (d, J = 8.0 Hz, 2H, CHAr 
tosyl), 2.43 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 147.7 (CAr), 135.0 (CAr), 133.3 
(CAr), 132.6 (C-NO2), 131.0 (CHAr tosyl), 129.72 (CHAr), 129.68 (NTs-CH=C-NO2), 127.7 (CHAr tosyl), 
126.5 (CHAr), 122.0 (CAr), 118.4 (CAr), 114.9 (CHAr), 110.1 (CN), 22.0 (CH3 tosyl) ppm. HRMS (ESI): 
calcd for C16H12N3O4S [M + H]+ 342.0549, found 342.0549. IR (ATR, cm-1): ṽ 3148 (w), 2360 (w), 
2234 (w), 1550 (m), 1500 (m), 1457 (m), 1387 (s), 1266 (m), 1223 (m), 1172 (s), 1111 (s), 1085 (s), 
966 (s), 871 (m), 815 (s), 785 (m), 757 (m), 674 (s), 668 (s), 649 (s). 
 
3,5-Dinitro-1-tosyl-1H-indole (308q) 
Made using a slightly altered of general procedure B: Preformed acetyl nitrate 
was added at 0 oC and allowed to warm to room temperature. Recrystallisation 
from hot methanol gave the title compound as beige solid (0.193 g, 60% yield). 
Mp: 204-206 °C. 1H NMR (500 MHz, CDCl3): δ 9.13 (d, J = 1.3 Hz, 1H, CHAr), 
8.69 (s, 1H, NTs-CH=C-NO2), 8.35 (dd, J = 9.2, 1.6 Hz, 1H, CHAr), 8.15 (d, J = 9.2 Hz, 1H, CHAr), 
7.91 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.39 (d, J = 8.2 Hz, 2H, CHAr tosyl), 2.43 (s, 3H, CH3 tosyl) ppm. 
13C NMR (125 MHz, CDCl3): δ 147.8 (CAr), 146.1 (CAr), 136.1 (CAr), 133.4 (CAr), 131.0 (CHAr tosyl), 
130.4 (NTs-CH=C), 127.7 (CHAr tosyl), 127.1 (CAr), 122.0 (CHAr), 119.9 (CAr), 117.9 (CHAr), 114.5 
(CHAr), 21.9 (CH3 tosyl) ppm. HRMS (ESI): calcd for C15H12N3O6S [M + H]+ 362.0447, found 
362.0463. IR (ATR, cm-1): ṽ 3128 (w), 1526 (m), 1389 (m), 1346 (s), 1213 (m), 1177 (s), 1115 (m), 
1084 (m), 1047 (m), 965 (s), 812 (m), 743 (m), 727 (m), 667 (s). 
 
4-Methyl-3-nitro-1-tosyl-1H-indole (308r) 
Recrystallisation from hot methanol yielded the title compound as yellow solid (50.3 
mg, 16%). Mp: 167-169 °C. 1H NMR (500 MHz, CDCl3): δ 8.54 (s, 1H, NTs-CH=C), 
7.86 (m, 3H, overlapping CHAr & CHAr tosyl), 7.32-7.30 (m, 3H, overlapping CHAr & 
CHAr tosyl), 7.17 (d, J = 7.4 Hz, 1H, CHAr), 2.69 (s, 3H, Ar-CH3), 2.39 (s, 3H, CH3 
tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 146.7 (CAr), 135.4 (C-NO2), 134.3 (CAr), 133.9 (CAr), 
132.2 (CAr), 130.6 (CHAr tosyl), 128.7 (NO2-C=CH-NTs), 128.2 (CHAr), 127.6 (CHAr tosyl), 126.7 
(CHAr), 120.4 (CAr), 111.3 (CHAr), 22.3 (Ar-CH3), 21.8 (CH3 tosyl) ppm. HRMS (ESI): calcd for 
C16H13N2O4S [M − H]− 329.0596, found 329.0610. IR (ATR, cm-1): ṽ 3154 (w), 1595 (w), 1544 (m), 
1506 (m), 1375 (s), 1237 (m), 1180 (s), 1080 (s), 1047 (m), 988 (w), 883 (m), 814 (m), 749 (s), 708 (s), 
673 (s), 659 (s), 628 (s). 
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5-Methyl-3-nitro-1-tosyl-1H-indole (308s) 
Recrystallisation from hot methanol gave the title compound as beige solid (62.7 
mg, 19%). Mp: 130-132 °C. 1H NMR (400 MHz, CDCl3): δ 8.50 (s, 1H, NTs-
CH=C), 8.01 (dt, J = 1.7, 0.8 Hz, 1H, CHAr), 7.87-7.84 (m, 3H, overlapping CHAr 
& CHAr tosyl), 7.32-7.30 (m, 2H, CHAr tosyl), 7.28-7.25 (m, 1H, CHAr), 2.47 (s, 
3H, Ar-CH3), 2.38 (s, 3H, CH3 tosyl) ppm. 13C NMR (100 MHz, CDCl3): δ 146.7 (CAr), 136.2 (CAr), 
134.1 (CAr), 132.0 (C-NO2), 130.6 (CHAr tosyl), 130.3 (CAr), 128.3 (CHAr), 127.9 (NTs-CH=C), 127.5 
(CHAr tosyl), 122.1 (CAr), 121.0 (CHAr), 113.4 (CHAr), 21.8 (CH3 tosyl), 21.6 (Ar-CH3) ppm. HRMS 
(ESI): calcd for C16H14N2O4SNa [M + Na]+ 353.0572, found 353.0569. IR (ATR, cm-1): ṽ 3165 (w), 
1553 (w), 1499 (m), 1375 (s), 1225 (s), 1188 (s), 1173 (s), 1086 (s), 970 (m), 876 (s), 812 (s), 804 (s), 
677 (s), 652 (s). 
 
5-Methoxy-3-nitro-1-tosyl-1H-indole (308t) 
Purification via flash column chromatography gave the title compound as a 
yellow solid (56.3 mg, 20% yield). Rf: 0.21 in 30:70 EtOAc:n-hexanes. Mp: 
209-212 °C. 1H NMR (500 MHz, CDCl3): δ 8.49 (s, 1H, NTs-CH=C), 7.76 (d, 
J = 8.1 Hz, 2H, CHAr tosyl), 7.72 (d, J = 3.1 Hz, 1H, CHAr), 7.26 (d, J = 7.9 Hz, 
2H, CHAr tosyl), 7.12 (s, 1H, CHAr), 6.64 (d, J = 2.9 Hz, 1H, CHAr), 3.93 (s, 3H, O-CH3), 2.36 (s, 3H, 
CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 150.0 (CAr), 145.8 (CAr), 137.8 (C-NO2), 135.0 (CAr), 
134.7 (CAr), 131.4 (CHAr), 130.3 (CHAr tosyl), 127.4 (C-OMe), 127.0 (CHAr tosyl), 111.7 (NTs-CH=C), 
108.7 (CHAr), 104.7 (CHAr), 56.9 (O-CH3), 21.8 (CH3 tosyl) ppm. HRMS (ESI): calcd for C16H15N2O5S 
[M + H]+ 347.0702, found 347.0703. IR (ATR, cm-1): ṽ 2922 (w), 2851 (w), 1622 (w), 1508 (m), 1448 
(m), 1369 (s), 1339 (m), 1223 (s), 1169 (s), 1096 (w), 1011 (w), 885 (w), 844 (m), 804 (m), 669 (s). 
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3.5.3: General procedure C - Palladium(0)-catalysed [3 + 2] cycloaddition of 3-nitro-indoles with 
N-tosyl-2-vinylazirdine.  
	
 
 
In a reaction vial was loaded N-tosyl-2-vinylaziridine 300 (1.0 equiv.), the corresponding indole 308 
(1.2 equiv.), Pd2(dba)3·CHCl3 (5 mol%) and the corresponding ligand (15 mol%). A screw cap with 
septum was fitted and the vial purged with N2 flow. To this was then added the appropriate solvent 
(0.1M wrt the aziridine) and the reaction allowed to stir at room temperature. After consumption of the 
limiting reagent as indicated by TLC, the reaction mixture was then transferred to a flask using CH2Cl2 
and solvent removed under reduced pressure. The crude was then purified via flash column 
chromatography to afford the corresponding cycloadduct 313.  
 
trans-3a-Nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313a) 
Major trans isomer isolated as a white solid (29.5 mg, 81%). Mp: 139-141 °C. 
Rf: 0.30 in 30:70 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.00 
(d, J = 8.3 Hz, 2H, tosyl CHAr), 7.74 (d, J = 8.3 Hz, 1H, CHAr), 7.66 (d, J = 8.3 
Hz, 2H, tosyl CHAr), 7.46-7.42 (m, 1H, CHAr), 7.36-7.33 (m, 3H, overlapping tosyl 
CHAr & CHAr), 7.21 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.13-7.09 (m, 1H, CHAr), 7.07 
(s, 1H, NTs-CH-NTs), 5.49-5.42 (m, 1H, CH2=CH-CH), 5.28 (apparent dd, J = 31.5, 13.7 Hz, 2H, 
CH2=CH)”, 3.92 (dd J = 12.4, 6.8 Hz, 1H, CH-CH2-NTs), 3.59 (dt, J = 11.9, 7.4 Hz, 1H, CH2=CH-CH-
CH2), 2.80 (t, J = 12.2 Hz, 1H, CH-CH2-NTs), 2.45 (s, 3H, CH3 tosyl), 2.36 (s, 3H, CH3 tosyl) ppm. 
13C NMR (125 MHz, CDCl3): δ 145.3 (CAr), 144.4 (CAr), 143.6 (CAr), 136.7 (CAr), 133.2 (CAr), 132.5 
(CHAr), 130.1 (overlapping CHAr tosyl & CH2=CH), 129.9 (tosyl CHAr), 128.1 (tosyl CHAr), 128.0 
(CHAr), 127.7 (tosyl CHAr), 124.5 (CHAr), 122.3 (CH=CH2), 121.8 (CAr), 116.4 (CHAr), 101.6 (C-NO2), 
84.5 (TsN-CH-NTs), 54.0 (CH2=CH-CH-CH2), 51.8 (CH-CH2-NTs), 21.8 (2 x overlapping tosyl CH3) 
ppm. HRMS (ESI): calcd for C26H25N3O6S2Na [M + Na]+ 562.1082, found 562.1091. IR (ATR, cm-
1): ṽ 1598 (w), 1552 (m), 1464 (w), 1369 (s), 1265 (m), 1162 (s), 1091 (m), 1021 (m), 934 (m), 814 
(w), 733 (s), 703 (m), 661 (s). 
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cis-3a-Nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313a′) 
Minor cis isomer isolated as a white solid. Mp: 120-126 °C. Rf: 0.18 in 25:75 
ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.92 (d, J = 8.5 Hz, 2H, 
CHAr tosyl), 7.62 (d, J = 7.5 Hz, 1H, CHAr), 7.52-7.47 (m, 3H, CHAr tosyl & CHAr), 
7.42 (t, J = 8.0 Hz, 1H, CHAr), 7.34 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.23 (t, J = 
7.5 Hz, 1H, CHAr), 7.10 (d, J = 7.5 Hz, 2H, CHAr tosyl), 6.99 (s, 1H, N-CH-N), 
5.86 (dt, J = 16.5, 10.0 Hz, 1H, CH=CH2), 5.31 (d, J = 17.0 Hz, 1H, CH=CH2), 5.25 (d, J = 10.5 Hz, 
1H, CH=CH2), 3.93 (d, J = 11.0 Hz, 1H, CH2-NTs), 3.25 (dd, J = 10.0, 4.0 Hz, 1H, CH-CH=CH2), 3.06 
(dd, J = 10.8, 4.0 Hz, 1H, CH2-NTs), 2.44 (s, 3H, CH3 tosyl), 2.31 (s, 3H, CH3 tosyl) ppm. 13C NMR 
(125 MHz, CDCl3): δ 145.2 (CAr), 143.9 (CAr), 142.6 (CAr), 137.4 (CAr), 133.6 (CAr), 132.6 (CHAr), 
131.4 (CH=CH2), 129.8 (CHAr), 129.7 (CHAr), 127.8 (CHAr), 127.7 (CHAr), 126.7 (CAr), 126.6 (CHAr), 
126.5 (CHAr), 121.6 (CH=CH2), 118.5 (CHAr), 103.2 (C-NO2), 81.7 (N-CH-N), 53.5 (CH-CH=CH2), 
52.8 (CH2-NTs), 21.8 (CH3), 21.7 (CH3) ppm. HRMS (ESI): calcd for C26H26N3O6S2 [M + H]+ 
540.1263, found 540.1260. IR (ATR, cm-1): ṽ 1597, 1554, 1551, 1363, 1349, 1168, 1090, 1037. 
 
3a-Nitro-8-((4-nitrophenyl)sulfonyl)-1-tosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole 
(313b) 
Major trans isomer isolated beige solid (15.0 mg, 48% yield). Mp: 105-110 °C. 
Rf: 0.24 in 25:75 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.29 
(dd, J = 8.7, 1.6 Hz, 2H, CHAr), 8.03-8.02 (m, 2H, CHAr), 7.97-7.95 (m, 2H, CHAr), 
7.75 (d, J = 8.3 Hz, 1H, CHAr), 7.51-7.48 (m, 2H, CHAr), 7.38-7.34 (m, 2H, CHAr), 
7.17 (t, J = 7.6 Hz, 1H, CHAr), 7.04 (s, 1H, NNs-CH-NTs), 5.51-5.44 (m, 1H, CH-
CH-CH2), 5.34 (d, J = 10.4 Hz, 1H, CH=CH2), 5.27-5.24 (m, 1H, CH=CH2), 3.92 (dd, J = 12.5, 6.8 Hz, 
1H, CH-CH2-NTs), 3.54 (dt, J = 12.1, 7.1 Hz, 1H, CH-CH-CH2), 2.82 (t, J = 12.3 Hz, 1H, CH-CH2-
NTs), 2.46 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 151.0 (CAr), 144.8 (CAr), 142.8 
(CAr), 142.0 (CAr), 136.3 (CAr), 132.9 (CHAr), 130.0 (CHAr), 129.7 (CH-CH=CH2), 129.1 (CHAr), 128.02 
(CHAr), 127.98 (CHAr), 125.3 (CHAr), 124.7 (CHAr), 122.7 (CH=CH2), 122.1 (CAr), 116.1 (CHAr), 101.5 
(C-NO2), 84.5 (NNs-CH-NTs), 53.2 (CH-CH2-NTs), 51.9 (CH-CH2-NTs), 21.8 (CH3 tosyl) ppm. 
HRMS (ESI): calcd for C25H23N4O8S2 [M + H]+ 571.0957, found 571.0956. IR (ATR, cm-1): ṽ 3108, 
1551, 1539, 1348, 1177, 1163. 
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Methyl-3a-nitro-1-tosyl-3-vinyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate 
(313e) 
Major trans isomer isolated as a white solid (15.1 mg, 66%). Mp: 168-170 °C. 
Rf: 0.22 in 25:75 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.89-
7.87 (m, 1H, CHAr), 7.78 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.45-7.41 (m, 2H, 2 x 
overlapping CHAr), 7.35 (d, J = 8.4 Hz, 2H, CHAr tosyl), 7.11-7.07 (m, 2H, 
overlapping CHAr & N-CH-NTs), 5.61-5.54 (m, 1H, CH-CH=CH2), 5.34 (d, J = 
10.4 Hz, 1H, CH=CH2), 5.23 (d, J = 10.2, 1H, CH=CH2), 4.04-4.00 (m, 1H, CH-CH2-NTs), 3.74 (s, 
3H, CO2CH3), 3.40-3.35 (m, 1H, CH2=CH-CH-CH2), 2.97 (t, J = 12.4 Hz, 1H, CH-CH2-NTs), 2.46 (s, 
3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 152.8 (C=O), 144.5 (CAr), 143.7 (CAr), 137.0 
(CAr), 132.5 (CHAr), 130.2 (CH-CH=CH2), 130.0 (CHAr tosyl), 127.5 (CHAr), 127.3 (CHAr tosyl), 123.3 
(CHAr), 122.2 (CH=CH2), 120.3 (CAr), 115.6 (CHAr), 101.3 (C-NO2), 82.9 (N-CH-NTs), 53.4 (CO2CH3), 
53.2 (CH2=CH-CH-CH2), 52.2 (CH-CH2-NTs), 21.8 (Ar-CH3 tosyl) ppm. HRMS (ESI): calcd for 
C21H21N3O6SNa [M + Na]+ 466.1049, found 466.1062. IR (ATR, cm-1): ṽ 2956 (w), 1724 (s), 1599 
(m), 1550 (s), 1482 (s), 1441 (s), 1382 (s), 1337 (s), 1257 (m), 1158 (s), 1095 (m), 990 (m), 928 (m), 
828 (m), 799 (m), 761 (s). 
 
Ethyl-3a-nitro-1-tosyl-3-vinyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate 
(313f) 
Major trans isomer isolated as a white solid (23.0 mg, 75%). Mp: 144-147 °C. 
Rf: 0.29 in 25:75 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.87 
(d, J = 6.8 Hz, 1H, CHAr), 7.79 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.45-7.40 (m, 2H, 
2 x overlapping CHAr), 7.34 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.13 (s, 1H, N-CH-
NTs), 7.07 (m, 1H, CHAr), 5.60-5.53 (m, 1H, CH-CH=CH2), 5.32 (d, J = 10.4 Hz, 
1H, CH-CH=CH2), 5.19 (d, J = 17.2 Hz, 1H, CH-CH=CH2), 4.38-4.32 (m, 1H, CO2-CH2-CH3), 4.23-
4.16 (m, 1H, CO2-CH2-CH3), 3.93 (dd, J = 10.6, 7.1 Hz, 1H, CH-CH2-NTs), 3.33-3.28 (m, 1H, CH-
CH2-NTs), 2.96 (t, J = 12.4 Hz, 1H, CH-CH2-NTs), 2.46 (s, 3H, CH3 tosyl), 1.36 (t, J = 7.1 Hz, 3H, 
CO2-CH2-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 152.5 (C=O), 144.5 (CAr), 143.9 (CAr), 136.8 
(CAr), 132.4 (CHAr), 130.3 (CH=CH2), 130.0 (CHAr tosyl), 127.5 (CHAr), 127.4 (CHAr tosyl), 123.2 
(CHAr), 122.1 (CH=CH2), 120.4 (CAr), 115.8 (CHAr), 101.3 (C-NO2), 82.9 (N-CH-NTs), 63.0 (CO2-
CH2-CH3), 53.2 (CH-CH2-NTs), 52.1 (CH-CH2-NTs), 21.7 (CH3 tosyl), 14.5 (CO2-CH2-CH3) ppm. 
HRMS (ESI): calcd for C22H23N3O6SNa [M + Na]+ 480.1205, found 480.1222. IR (ATR, cm-1): ṽ 
2927 (w), 1718 (s), 1599 (w), 1546 (m), 1486 (m), 1412 (w), 1387 (m), 1346 (s), 1274 (w), 1246 (m), 
1165 (m), 1017 (w), 934 (m), 749 (m), 745 (m), 719 (m), 663 (s). 
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tert-Butyl 3a-nitro-1-tosyl-3-vinyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate 
(313g) 
Major trans isomer isolated as a white solid (24.0 mg, 73%). Mp: 111-113 °C. 
Rf: 0.21 in 20:80 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.82 
(d, J = 8.2 Hz, 2H, CHAr tosyl), 7.75 (dd, J = 11.0, 4.4 Hz, 1H, CHAr), 7.41 (d, J 
= 7.7 Hz, 2H, 2 x overlapping CHAr), 7.32 (d, J = 8.4 Hz, 2H, CHAr tosyl), 7.11 
(s, 1H, NBoc-CH-NTs), 7.05 (t, J = 7.6 Hz, 1H, CHAr), 5.64-5.57 (m, 1H, CH-
CH=CH2), 5.32 (d, J = 10.4 Hz, 1H, CH-CH=CH2), 5.20 (d, J = 17.2 Hz, 1H, CH-CH=CH2), 3.91 (dd, 
J = 12.3, 6.7 Hz 1H, CH-CH2-NTs), 3.43-3.38 (m, 1H, CH-CH2-NTs), 2.91 (t, J = 12.2 Hz, 1H, CH-
CH2-NTs), 2.44 (s, 3H, CH3 tosyl), 1.57 (s, 9H, 3 x CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 151.5 
(C=O), 144.3 (CAr), 144.2 (CAr), 137.1 (CAr), 132.3 (CHAr), 130.4 (CH=CH2), 129.9 (CHAr tosyl), 127.6 
(CHAr), 127.5 (CHAr tosyl), 122.9 (CHAr), 122.0 (CH=CH2), 120.6 (CAr), 116.0 (CHAr), 100.8 (C-NO2), 
83.9 (CO2-C-t-Bu), 82.7 (BocN-CH-NTs), 53.2 (CH-CH2-NTs), 52.0 (CH-CH2-NTs), 28.4 (t-Bu), 21.7 
(CH3 tosyl) ppm. HRMS (ESI): calcd for C24H27N3O6SNa [M + Na]+ 508.1518, found 508.1537. IR 
(ATR, cm-1): ṽ 2926 (w), 1716 (s), 1600 (w), 1554 (m), 1481 (m), 1371 (m), 1351 (s), 1338 (m), 1279 
(w), 1254 (s), 1158 (w), 1119 (w), 1025 (m), 764 (m), 748 (m), 662 (s). 
 
5-Chloro-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313i) 
Major trans isomer isolated as a white solid (32.0 mg, 73%). Mp: 168-170 
°C. Rf: 0.31 in 40:60 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): 
δ 7.99 (d, J = 8.3 Hz, 2H, CHAr tosyl), 7.69 (d, J = 8.9 Hz, 1H, CHAr), 7.66 
(d, J = 8.3 Hz, 2H, CHAr tosyl), 7.41 (dd, J = 8.4, 2.2 Hz, 1H, CHAr), 7.35 (d, 
J = 8.0 Hz, 2H, CHAr tosyl), 7.31 (d, J = 2.1 Hz, 1H, CHAr), 7.25 (d, J = 8.0 
Hz, 2H, CHAr tosyl), 7.07 (s, 1H, NTs-CH-NTs), 5.48-5.36 (m, 2H, overlapping olefin CH & CH2), 
5.27 (d, J = 16.5 Hz, 1H, CH=CH2), 3.95-3.91 (m, 1H, CH-CH2-NTs), 3.58 (dt, J = 21.0, 7.3 Hz, 1H, 
CH-CH2-NTs), 2.79 (t, J = 12.2 Hz, 1H, CH-CH2-NTs), 2.45 (s, 3H, CH3 tosyl), 2.38 (s, 3H, CH3 tosyl) 
ppm. 13C NMR (125 MHz, CDCl3): δ 145.7 (CAr), 144.5 (CAr), 142.2 (CAr), 136.6 (CAr), 133.0 (CAr), 
132.7 (CHAr), 130.3 (CHAr tosyl), 130.0 (CAr), 129.9 (CHAr tosyl), 129.5 (CH-CH=CH2), 128.1 (CHAr 
tosyl), 128.0 (CHAr), 127.7 (CHAr tosyl), 123.2 (CAr), 123.0 (CH-CH=CH2), 117.4 (CHAr), 101.1 (C-
NO2), 84.8 (NTs-CH-NTs), 54.1 (CH-CH2-NTs), 51.8 (CH-CH2-NTs), 21.797 (CH3 tosyl), 21.783 (CH3 
tosyl) ppm. HRMS (ESI): calcd for C26H24ClN3O6S2Na [M + Na]+ 596.0693, found 596.0693. IR 
(ATR, cm-1): ṽ 2933 (w), 1547 (m), 1470 (m), 1370 (m), 1174 (s), 1156 (s), 1089 (m), 919 (m), 831 
(m), 814 (m), 742 (s), 674 (s), 668 (s). 
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6-Chloro-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313j) 
Major trans isomer isolated as a white solid (31.6 mg, 81%). Mp: 155-157 
°C. Rf: 0.33 in 25:75 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): 
δ 7.99 (d, J = 8.3 Hz, 2H, CHAr tosyl), 7.77 (s, 1H, CHAr), 7.70 (d, J = 8.4 Hz, 
2H, CHAr tosyl), 7.36 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.27-7.26 (m, 3H, 
overlapping CHAr & CHAr tosyl), 7.09-7.07 (m, 1H, CHAr), 7.08 (s, 1H, NTs-
CH-NTs), 5.47-5.40 (m, 1H, CH-CH=CH2), 5.33 (d, J = 10.2 Hz, 1H, CH=CH2), 5.25 (d, J = 17.0 Hz, 
1H, CH=CH2), 3.93-3.89 (m, 1H, CH-CH2-NTs), 3.61-3.56 (m, 1H, CH-CH2-NTs), 2.79 (t, J = 12.2 
Hz, 1H, CH-CH2-NTs), 2.45 (s, 3H, CH3 tosyl), 2.39 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, 
CDCl3): δ 145.7 (CAr), 144.6 (CAr), 138.9 (CAr), 136.5 (CAr), 133.1 (CAr), 130.3 (CHAr tosyl), 129.9 
(CHAr tosyl), 129.75 (CH-CH=CH2), 129.71 (CAr), 128.9 (CHAr), 128.1 (CHAr tosyl), 127.7 (CHAr tosyl), 
124.8 (CHAr), 122.8 (CH=CH2), 120.0 (CAr), 116.5 (CHAr), 101.1 (C-NO2), 84.9 (NTs-CH-NTs), 54.0 
(CH-CH2-NTs), 51.7 (CH-CH2-NTs), 21.82 (CH3 tosyl), 21.79 (CH3 tosyl) ppm. HRMS (ESI): calcd 
for C26H24ClN3NaO6S2 [M + Na]+ 596.0693, found 596.0715. IR (ATR, cm-1): ṽ 2925 (s), 2854 (m), 
1558 (m), 1351 (m), 1166 (s), 1037 (m), 947 (m), 813 (m), 663 (s). 
 
7-Chloro-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313k) 
Major trans isomer isolated a white solid (27.0 mg, 70%). Mp: 182-185 °C. Rf: 
0.29 in 30:70 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.87 (d, J 
= 8.2 Hz, 2H, CHAr tosyl), 7.75 (d, J = 8.1 Hz, 2H, CHAr tosyl), 7.47-7.43 (m, 2H, 
2 x overlapping CHAr), 7.32 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.28 (d, J = 8.0 Hz, 
2H, CHAr tosyl), 7.21 (t, J = 7.7 Hz, 1H, CHAr), 7.09 (s, 1H, NTs-CH-NTs), 5.60-
5.53 (m, 1H, CH=CH2), 5.34 (d, J = 10.4 Hz, 1H, CH=CH2), 5.12 (d, J = 17.2 Hz, 
1H, CH=CH2), 3.92 (dd, J = 11.4, 7.0 Hz, 1H, CH-CH2-NTs), 3.46-3.40 (m, 1H, CH-CH2-NTs), 2.70 
(t, J = 11.6 Hz, 1H, CH-CH2-NTs), 2.44 (s, 3H, CH3 tosyl), 2.43 (s, 3H, CH3 tosyl) ppm. 13C NMR 
(125 MHz, CDCl3): δ 145.1 (CAr), 144.5 (CAr), 141.9 (CAr), 136.0 (CAr), 135.3 (CAr), 133.9 (CHAr), 
131.2 (CAr), 130.2 (CHAr tosyl), 129.6 (CHAr tosyl), 128.9 (CH-CH=CH2), 128.6 (CHAr tosyl), 127.5 
(CHAr tosyl), 127.3 (CHAr), 127.2 (CHAr), 126.9 (CAr), 122.8 (CH=CH2), 100.7 (C-NO2), 85.6 (NTs-
CH-NTs), 52.9 (CH-CH2-NTs), 51.2 (CH-CH2-NTs), 21.9 (CH3 tosyl), 21.8 (CH3 tosyl) ppm. HRMS 
(ESI): calcd for C26H24ClN3O6S2Na [M + Na]+ 596.0693, found 596.0693. IR (ATR, cm-1): ṽ 2923 
(w), 1560 (s), 1437 (w), 1345 (m), 1166 (s), 1094 (w), 1002 (w), 916 (m), 813 (m), 757 (m), 716 (s), 
672 (s), 665 (s). 
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5-Bromo-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313l) 
Major trans isomer isolated as a white solid (39.9 mg, 91%). Mp: 183-188 
°C. Rf: 0.25 in 20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.99 
(d, J = 8.2 Hz, 2H, CHAr tosyl), 7.67 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.63 (d, 
J = 8.8 Hz, 1H, CHAr), 7.55 (dd, J = 8.8, 1.6 Hz, 1H, CHAr), 7.45 (d, J = 1.5 
Hz, 1H, CHAr), 7.35 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.25 (d, J = 8.4 Hz, 2H, 
CHAr tosyl), 7.06 (s, 1H, NTs-CH-NTs), 5.48-5.41 (m, 1H, CH-CH=CH2), 5.38 (d, J = 9.7 Hz, 1H, CH-
CH=CH2), 5.27 (d, J = 16.8 Hz, 1H, CH-CH=CH2), 3.92 (dd, J = 12.5, 6.8 Hz, 1H, NTs-CH2-CH), 3.58 
(dt, J = 12.1, 7.1 Hz, 1H, CH2-CH-CH=CH2), 2.79 (t, J = 12.2 Hz, 1H, NTs-CH2-CH), 2.45 (s, 3H, CH3 
tosyl), 2.39 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 145.7 (CAr), 144.6 (CAr), 142.8 
(CAr), 136.7 (CAr), 135.5 (CHAr), 133.1 (CAr), 130.9 (CHAr), 130.3 (CHAr tosyl), 129.9 (CHAr tosyl), 
129.6 (CH-CH=CH2), 128.1 (CHAr tosyl), 127.7 (CHAr tosyl), 123.6 (CAr), 123.0 (CH-CH=CH2), 117.8 
(CHAr), 117.2 (C-Br), 101.1 (C-NO2), 84.8 (NTs-CH-NTs), 54.1 (CH2-CH-CH=CH2), 51.8 (NTs-CH2-
CH), 21.8 (CH3 tosyls) ppm. HRMS (ESI): calcd for C26H25BrN3O6S2 [M + H]+ 618.03681, found 
618.03686. IR (ATR, cm-1): ṽ 1596 (w), 1552 (m), 1468 (m), 1369 (s), 1339 (m), 1266 (w), 1164 (s), 
1090 (m), 1022 (s), 934 (m), 814 (m), 736 (s), 662 (s). 
 
Methyl 3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-5-carboxylate 
(313n) 
Major trans isomer isolated as a white solid (35.6 mg, 88%). Mp: 142-
145 °C. Rf: 0.27 in 30:70 ethyl acetate:n-hexanes. 1H NMR (500 MHz, 
CDCl3): δ 8.13 (dd, J = 8.7, 1.8 Hz, 1H, CHAr), 7.99 (d, J = 10.5 Hz, 2H, 
CHAr tosyl), 8.00 (s, 1H, CHAr), 7.80 (d, J = 8.7 Hz, 1H, CHAr), 7.71 (d, 
J = 8.0 Hz, 2H, CHAr tosyl), 7.36 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.25 
(d, J = 8.0 Hz, 2H, CHAr tosyl), 7.14 (s, 1H, NTs-CH-NTs), 5.51-5.44 (m, 1H, CH-CH=CH2), 5.37 (d, 
J = 10.3 Hz, 1H, CH-CH=CH2), 5.27 (d, J = 17.0 Hz, 1H, CH-CH=CH2), 3.94-3.90 (m, 1H, CH-CH2-
NTs), 3.89 (s, 3H, CO2CH3), 3.65-3.60 (m, 1H, CH-CH2-NTs), 2.80 (t, J = 12.4 Hz, 1H, CH-CH2-NTs), 
2.45 (s, 3H, CH3 tosyl), 2.38 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 165.7 (C=O), 
147.1 (CAr), 145.8 (CAr), 144.6 (CAr), 136.5 (CAr), 134.2 (CHAr), 133.2 (CAr), 130.3 (CHAr tosyl), 129.9 
(CHAr tosyl), 129.6 (CHAr), 129.5 (CH=CH2), 128.1 (CHAr tosyl), 127.7 (CHAr tosyl), 126.5 (CAr), 122.9 
(CH=CH2), 121.8 (CAr), 115.4 (CHAr), 101.1 (C-NO2), 85.1 (NTs-CH-NTs), 53.8 (CH-CH2-NTs), 52.5 
(CO2CH3), 51.7 (CH-CH2-NTs), 21.8 (2 x overlapping CH3 tosyls) ppm. HRMS (ESI): calcd for 
C28H28N3O8S2 [M + H]+ 598.1318, found 598.1345. IR (ATR, cm-1): ṽ 2924 (w), 1715 (m), 1551 (m), 
1374 (m), 1294 (m), 1177 (s), 1159 (m), 1090 (s), 1021 (m), 926 (m), 814 (m), 736 (m), 672 (s), 662 
(s). 
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Methyl 3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-7-carboxylate 
(313o) 
Major trans isomer isolated as a white solid (5.3 mg, 94%). Mp: 177-181 °C. Rf: 
0.30 in 40:60 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.98 (d, J 
= 8.2 Hz, 2H, CHAr tosyl), 7.95 (dd, J = 7.8, 0.7 Hz, 1H, CHAr), 7.61 (d, J = 7.8 
Hz, 1H, CHAr), 7.37-7.33 (m, 5H, 2 x overlapping CHAr tosyl and CHAr), 7.14 (d, 
J = 8.2 Hz, 2H, CHAr tosyl), 6.85 (s, 1H, NTs-CH-NTs), 5.45-5.38 (m, 1H, CH-
CH=CH2), 5.31 (d, J = 10.3 Hz, 1H, CH-CH=CH2), 5.13 (d, J = 17.0 Hz, 1H, CH-CH=CH2), 4.00 (dd, 
J = 11.5, 6.8 Hz, 1H, CH-CH2-NTs), 3.88 (s, 3H, CO2CH3), 3.56-3.50 (m, 1H, CH-CH2-NTs), 2.68 (t, 
J = 11.6 Hz, 1H, CH-CH2-NTs), 2.45 (s, 3H, CH3 tosyl), 2.38 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 
MHz, CDCl3): δ 166.9 (C=O), 145.8 (CAr), 144.0 (CAr), 142.1 (CAr), 137.3 (CAr), 133.8 (CHAr), 132.6 
(CAr), 132.3 (CHAr), 130.1 (CHAr tosyl), 129.8 (CHAr tosyl), 129.0 (CH=CH2), 128.1 (CHAr tosyl), 127.8 
(CHAr tosyl), 125.8 (CHAr), 125.7 (CAr), 125.1 (CAr), 123.0 (CH=CH2), 100.8 (C-NO2), 84.7 (NTs-CH-
NTs), 55.2 (CH-CH2-NTs), 52.5 (CO2CH3), 51.1 (CH-CH2-NTs), 21.8 (CH3 tosyl), 21.7 (CH3 tosyl) 
ppm. HRMS (ESI): calcd for C28H28N3O8S2 [M + H]+ 598.1318, found 598.1307. IR (ATR, cm-1): ṽ 
2918 (m), 2863 (w), 1722 (m), 1549 (m), 1435 (m), 1369 (s), 1361 (s), 1299 (s), 1170 (m), 1037 (m), 
939 (m), 814 (m), 781 (m), 716 (m), 660 (s). 
 
3a-Nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-5-carbonitrile (313p) 
Major trans isomer isolated as a beige solid (28.7 mg, 78%). Mp: 110-111 
°C. Rf: 0.16 in 25:75 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): 
δ 7.99 (d, J = 8.4 Hz, 2H, CHAr tosyl), 7.86 (d, J = 8.7 Hz, 1H, CHAr), 7.74-
7.71 (m, 3H, overlapping CHAr tosyl & CHAr), 7.65 (d, J = 1.6 Hz, 1H, CHAr), 
7.37 (d, J = 8.5 Hz, 2H, CHAr tosyl), 7.29 (d, J = 8.4 Hz, 2H, CHAr tosyl), 
7.16 (s, 1H, NTs-CH-NTs), 5.43-5.36 (m, 2H, overlapping CH=CH2 & CH=CH2), 5.31-527 (m, 1H, 
CH=CH2), 3.94-3.90 (m, 1H, CH-CH2-NTs), 3.61-3.56 (m, 1H, CH-CH2-NTs), 2.78 (t, J = 12.5 Hz, 
1H, CH-CH2-NTs), 2.46 (s, 3H, CH3 tosyl), 2.40 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): 
δ 146.9 (CAr), 146.2 (CAr), 144.8 (CAr), 136.4 (CHAr), 136.2 (CAr), 133.1 (CAr), 132.2 (CHAr), 130.5 
(CHAr tosyl), 130.0 (CHAr tosyl), 129.2 (CH=CH2), 128.2 (CHAr tosyl), 127.6 (CHAr tosyl), 123.6 
(CH=CH2), 122.2 (CAr), 117.9 (CAr), 116.2 (CHAr), 107.9 (C-CN), 100.7 (C-NO2), 84.8 (NTs-CH-NTs), 
54.1 (CH-CH2-NTs), 51.7 (CH-CH2-NTs), 21.83 (CH3 tosyl), 21.79 (CH3 tosyl) ppm. HRMS (ESI): 
calcd for C27H25N4O6S2 [M + H]+ 565.1216, found 565.1194. IR (ATR, cm-1): ṽ 2925 (w), 2230 (w), 
1609 (w), 1554 (m), 1479 (m), 1371 (s), 1163 (s), 1090 (m), 1021 (s), 1010 (m), 931 (m), 814 (m), 765 
(m), 729 (m), 662 (s). 
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3a,5-Dinitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313q) 
Major trans isomer isolated as a white solid (32.2 mg, 82%). Mp: 190-193 
°C. Rf: 0.20 in 20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 
8.34 (dd, J = 9.2, 1.5 Hz, 1H, CHAr), 8.22 (d, J = 1.6 Hz, 1H, CHAr), 7.99 
(d, J = 8.1 Hz, 2H, CHAr tosyl), 7.88 (d, J = 9.1 Hz, 1H, CHAr), 7.76 (d, J = 
8.1 Hz, 2H, CHAr tosyl), 7.37 (d, J = 8.1 Hz, 2H, CHAr tosyl), 7.30 (d, J = 
8.1 Hz, 2H, CHAr tosyl), 7.20 (s, 1H, NTs-CH-NTs), 5.50-5.42 (m, 2H, overlapping CH=CH2 & 
CH=CH2), 5.31-5.27 (m, 1H, CH=CH2), 3.94 (dd, J = 12.8, 6.7 Hz, 1H, NTs-CH2-CH), 3.63 (dt, J = 
12.4, 6.4 Hz, 1H, CH2-CH-CH=CH2), 2.80 (t, J = 12.5 Hz, 1H, NTs-CH2-CH), 2.46 (s, 3H, CH3 tosyl), 
2.41 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 148.4 (CAr-NO2), 146.3 (CAr), 144.9 
(CAr), 144.1 (CAr), 136.1 (CAr), 133.0 (CAr), 130.5 (CHAr tosyl), 130.0 (CHAr tosyl), 129.0 (CH-
CH=CH2), 128.4 (CHAr), 128.2 (CHAr tosyl), 127.6 (CHAr tosyl), 124.2 (CHAr), 123.7 (CH-CH=CH2), 
122.1 (CAr), 115.4 (CHAr), 100.4 (C-NO2), 85.3 (NTs-CH-NTs), 54.0 (CH2-CH-CH=CH2), 51.7 (NTs-
CH2-CH), 21.9 (CH3 tosyl), 21.8 (CH3 tosyl) ppm. HRMS (ESI): calcd for C26H25N4O8S2 [M + H]+ 
585.1114, found 585.1104. IR (ATR, cm-1): ṽ 2929 (w), 1716 (w), 1597 (w), 1554 (s), 1527 (m), 1469 
(w), 1338 (s), 1173 (m), 1159 (s), 1025 (m), 929 (m), 750 (s), 661 (s). 
 
5-Methyl-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313s) 
Major trans isomer isolated as a white solid (10.5 mg, 88%). Mp: 173-175 
°C. Rf: 0.24 in 25:75 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): 
δ 7.99 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.67 (d, J = 8.3 Hz, 2H, CHAr tosyl), 
7.63 (d, J = 9.1 Hz, 1H, CHAr), 7.55 (dd, J = 8.8, 1.8 Hz, 1H, CHAr), 7.45 (d, 
J = 1.5 Hz, 1H, CHAr), 7.35 (d, J = 8.1 Hz, 2H, CHAr tosyl), 7.25 (d, J = 8.0 
Hz, 2H, CHAr tosyl), 7.06 (s, 1H, NTs-CH-NTs), 5.48-5.23 (m, 3H, overlapping CH=CH2 & CH=CH2), 
3.92 (dd, J = 12.6, 6.8 Hz, 1H, CH-CH2-NTs), 3.61-3.55 (m, 1H, CH-CH2-NTs), 2.79 (t, J = 12.2 Hz, 
1H, CH-CH2-NTs), 2.45 (s, 6H, overlapping CH3 tosyl & Ar-CH3), 2.39 (s, 3H, CH3 tosyl) ppm. 13C 
NMR (125 MHz, CDCl3): δ 145.7 (CAr), 144.6 (CAr), 142.7 (CAr), 136.5 (CAr), 135.5 (CHAr), 132.9 
(CAr), 130.8 (CHAr), 130.3 (CHAr tosyl), 129.9 (CHAr tosyl), 129.5 (CH=CH2), 128.1 (CHAr tosyl), 127.7 
(CHAr tosyl), 123.4 (CAr), 123.1 (CH=CH2), 117.7 (CHAr), 117.3 (CAr), 101.0 (C-NO2), 84.7 (NTs-CH-
NTs), 54.1 (CH-CH2-NTs), 51.7 (CH-CH2-NTs), 21.81 (CH3 tosyl), 21.80 (CH3 tosyl), 21.78 (Ar-CH3) 
ppm. HRMS (ESI): calcd for C27H27N3O6S2Na [M + Na]+ 576.1239, found 576.1257. IR (ATR, cm-
1): ṽ 2926 (w), 1597 (w), 1545 (s), 1468 (m), 1370 (s), 1296 (m), 1175 (s), 1090 (m), 1000 (m), 918 
(m), 814 (s), 737 (s), 674 (s), 664 (s). 
 
  
N
Ts
O2N
N
Ts
O2N
H
N
Ts
O2N
N
Ts
Me
H
	 196 
trans-4-Methyl-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313r) 
Minor trans isomer isolated as a white solid (7.8 mg, 33%). Mp: 162-164 °C. Rf: 
0.24 in 20:80 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.00 (d, J 
= 8.2 Hz, 2H, CHAr tosyl), 7.71 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.66 (d, J = 8.3 
Hz, 1H, CHAr), 7.32 (d, J = 8.1 Hz, 2H, CHAr tosyl), 7.31 (t, J = 8.0 Hz, 1H, CHAr), 
7.25 (d, J = 7.1 Hz, 2H, CHAr tosyl), 6.86 (d, J = 7.6 Hz, 1H, CHAr), 6.71 (s, 1H, 
NTs-CH-NTs), 5.40 (d, J = 16.7 Hz, 1H, CH=CH2), 5.16 (d, J = 10.0 Hz, CH=CH2), 5.13-5.06 (m, 1H, 
CH=CH2), 4.28-4.22 (m, 1H, CH-CH2-NTs), 3.87 (dd, J = 12.8, 7.5 Hz, 1H, CH-CH2-NTs), 2.93 (app 
t, J = 12.3 Hz, 1H, CH-CH2-NTs), 2.45 (s, 3H, CH3 tosyl), 2.39 (s, 3H, CH3 tosyl), 1.95 (s, 3H, CH3) 
ppm. 13C NMR (125 MHz, CDCl3): δ 145.3 (CAr), 144.6 (CAr), 143.7 (CAr), 137.3 (CAr), 136.5 (CAr), 
132.9 (CAr), 131.8 (CHAr), 131.2 (CH=CH2), 130.1 (CHAr tosyl), 129.9 (CHAr tosyl), 128.3 (CHAr tosyl), 
128.0 (CHAr tosyl), 127.4 (CHAr), 122.2 (CAr), 121.9 (CH=CH2), 113.1 (CHAr), 104.0 (C-NO2), 87.7 
(NTs-CH-NTs), 52.6 (CH-CH2-NTs), 52.4 (CH-CH2-NTs), 21.8 (two overlapping CH3 tosyls), 19.5 
(CH3) ppm. HRMS (ESI): calcd for C27H27N3O6S2Na [M + Na]+ 576.1239, found 576.1238. IR (ATR, 
cm-1): ṽ 1551, 1368, 1169. 
 
cis-4-Methyl-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313r′) 
Major cis isomer isolated as a white solid (12.3 mg, 52%). Mp: 83-87 °C. Rf: 
0.13 in 20:80 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.93 (d, J 
= 8.2 Hz, 2H, CHAr tosyl), 7.45 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.37-7.34 (m, 3H, 
overlapping CHAr tosyl & CHAr), 7.29 (t, J = 7.9 Hz, 1H, CHAr), 7.10 (d, J = 8.2 
Hz, 2H, CHAr tosyl), 7.01 (d, J = 7.6 Hz, 1H, CHAr), 6.81 (s, 1H, NTs-CH-NTs), 
5.88-5.80 (m, 1H, CH=CH2), 5.26-5.22 (m, 2H, CH=CH2), 3.84 (d, J = 10.9 Hz, 1H, CH-CH2-NTs), 
3.53 (dd, J = 9.4, 4.5 Hz, 1H, CH-CH2-NTs), 3.23 (dd, J = 10.9, 4.9 Hz, 1H, CH-CH2-NTs), 2.47 (s, 
3H, CH3 tosyl), 2.45 (s, 3H, CH3 tosyl), 2.32 (s, 3H, Ar-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 
145.1 (CAr), 144.0 (CAr), 143.1 (CAr), 138.2 (CAr), 136.8 (CAr), 133.8 (CAr), 132.2 (CHAr), 132.1 
(CH=CH2), 129.8 (CHAr tosyl), 129.7 (CHAr tosyl), 129.6 (CHAr), 127.9 (CHAr tosyl), 127.8 (CHAr 
tosyl), 125.0 (CAr), 121.0 (CH=CH2), 116.4 (CHAr), 104.1 (C-NO2), 83.3 (NTs-CH-NTs), 53.5 (CH-
CH2-NTs), 49.9 (CH-CH2-NTs), 21.8 (CH3 tosyl), 21.7 (CH3), 20.0 (CH3 tosyl) ppm. HRMS (ESI): 
calcd for C27H27N3O6S2Na [M + Na]+ 576.1239, found 576.1263. IR (ATR, cm-1): ṽ: 1554, 1363, 1168. 
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cis-Methyl 3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-4-
carboxylate (313m′) 
Major cis isomer isolated as a white solid (34.2 mg, 82%). Mp: 184-186 °C. 
Rf: 0.20 in 30:70 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 
7.95 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.75 (dd, J = 14.5, 8.0 Hz, 2H, 2 x 
overlapping CHAr), 7.50 (t, J = 8.0 Hz, 1H, CHAr), 7.38-7.34 (m, 4H, 2 x 
overlapping CHAr tosyl), 7.10 (d, J = 8.3 Hz, 2H, CHAr tosyl), 6.78 (s, 1H, 
NTs-CH-NTs), 6.11-6.04 (m, 1H, CH-CH=CH2), 5.28 (d, J = 16.9 Hz, 1kH, CH-CH-CH2), 5.20 (d, J = 
10.1 Hz, 1H, CH-CH=CH2), 4.22 (dd, J = 9.5, 4.7 Hz, 1H, CH-CH=CH2), 3.91 (d, J = 11.3 Hz, 1H, 
CH-CH2-NTs), 3.85 (s, 3H, CO2CH3), 3.14 (dd, J = 11.2, 4.8 Hz, 1H, CH-CH2-NTs), 2.45 (s, 3H, CH3 
tosyl),  2.32 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 166.1 (C=O), 145.6 (CAr), 143.9 
(CAr), 137.6 (CAr), 133.38 (CAr), 133.37 (CH=CH2), 133.2 (CAr), 132.1 (CHAr), 131.0 (CAr), 130.1 (CHAr 
tosyl), 129.7 (CHAr tosyl), 128.6 (CHAr), 127.7 (CHAr tosyl), 127.6 (CHAr tosyl), 126.1 (CAr), 121.9 
(CHAr), 119.7 (CH=CH2), 104.3 (C-NO2), 84.4 (NTs-CH-NTs), 53.4 (CH-CH2-NTs), 52.92 (CH-CH2-
NTs), 52.90 (CO2CH3), 21.8 (CH3 tosyl), 21.7 (CH3 tosyl) ppm. HRMS (ESI): calcd for 
C28H27N3O8S2Na [M + Na]+ 620.1137, found 620.1141. IR (ATR, cm-1): ṽ 2958 (w), 1721 (s), 1558 
(s), 1270 (s), 1344 (s), 1281 (s), 1170 (s), 1019 (s), 934 (s), 810 (s), 663 (s). 
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3.5.4: Pyrroloindoline Manipulation 
 
Reduction of nitro to amine: (3S,3aS,8aS)-1,8-ditosyl-3-vinyl-2,3,8,8a-tetrahydropyrrolo[2,3-
b]indol-3a(1H)-amine (315) 
 
 
 
Zinc powder (92.7 mg, 1.42 mmol, 21.5 equiv) was slowly added to a solution of 313a (35.6 mg, 0.066 
mmol, 1 equiv) and trimethylsilyl chloride (0.17 mL, 1.34 mmol, 20.3 equiv) in methanol at 0°C. After 
stirring the reaction suspension at 0°C for 1 h, the suspension was filtered and washed with methanol 
(2 × 2.5 mL) then dichloromethane (2 × 2.5 mL). After the filtrate was washed with saturated sodium 
bicarbonate solution (15 mL), the organic phase was isolated while aqueous fraction was extracted with 
dichloromethane (3 × 15 mL). The combined organic fractions were dried over sodium sulphate and 
concentrated under reduced pressure. Column chromatography was performed to yield the title 
compound 315 as a white solid (24.6 mg, 0.048 mmol, 73% yield). Mp: 177-180 °C. Rf: 0.32 in 50:50 
ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.99 (d, J = 8.5 Hz, 2H, CHAr tosyl), 7.69 (d, 
J = 8.5 Hz, 2H, CHAr tosyl), 7.60 (d, J = 8.5 Hz, 1H, CHAr), 7.34-7.29 (m, 3H, overlapping CHAr tosyl 
& CHAr), 7.18 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.08 (d, J = 7.0 Hz, 1H, CHAr), 7.03 (t, J = 7.0 Hz, 1H, 
CHAr), 6.46 (s, 1H, NTs-CH-NTs), 5.43-5.36 (m, 1H, CH=CH2), 5.17 (d, J = 10.0 Hz, 1H, CH=CH2), 
5.11 (d, J = 17.0 Hz, 1H, CH=CH2), 4.47 (d, J = 22.0 Hz, 2H, NH2), 3.79 (dd, J = 11.8, 6.5 Hz, 1H, 
CH2-NTs), 3.10-3.04 (m, 1H, CH-CH=CH2), 2.77 (t, J = 12.0 Hz, 1H, CH2-NTs), 2.44 (s, 3H, CH3 
tosyl), 2.34 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 144.6 (CAr), 143.8 (CAr), 143.4 
(CAr), 137.3 (CAr), 134.5 (CAr), 132.9 (CH=CH2), 130.4 (CHAr), 129.72 (CHAr tosyl), 129.65 (CHAr 
tosyl), 128.0 (CHAr tosyl), 127.7 (CHAr tosyl), 126.81 (CHAr), 126.78 (CAr), 124.1 (CHAr), 119.8 
(CH=CH2), 116.3 (CHAr), 82.1 (TsN-CH-NTs), 80.6 (C-NH2), 50.8 (CH2-NTs), 49.3 (CH-CH=CH2), 
21.8 (CH3), 21.7 (CH3) ppm. HRMS (ESI): calcd for C26H27N3O4S2Na [M + Na]+ 532.1341 found 
523.1364. IR (ATR, cm-1): ṽ = 3510, 3504, 1363, 1340, 1172. 
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Radical denitration: (3R)-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (316) 
 
 
 
0.2 M AIBN (0.44 mL, 88 µmol, 1.2 equiv) was added to a solution of 313a (40.9 mg, 75.8 µmol, 1 
equiv) and tributyltin hydride (40 µL, 43.28 mg, 148.7 µmol, 2 equiv) in toluene (1 mL). After the 
reaction was heated at 80 °C for 48 h, the reaction was cooled to room temperature then CCl4 (150 µL) 
was added and left stirring for 40 mins. The reaction was poured into saturated potassium fluoride 
solution (15 mL) and extracted with ethyl acetate. After drying the organic fraction with sodium 
sulphate, the solution was concentrated under reduced pressure. NMR analysis indicated that no 
conversion had occurred therefore the reaction crude was resubjected to the same reaction condition for 
a longer time of 96 h. Column chromatography was performed to yield the title compound 316 as a 
white solid (23.4 mg, 62% yield). Mp: 171-175 °C. Rf: 0.23 in 30:70 ethyl acetate:n-hexanes. 1H NMR 
(500 MHz, CDCl3): δ 7.96 (d, J = 8.5 Hz, 2H, CHAr tosyl), 7.59 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.52 
(d, J = 8.0 Hz, 1H, CHAr), 7.32 (d, J = 8.0 Hz, 2H, CHAr tosyl), 7.22-7.16 (m, 3H, CHAr tosyl & CHAr), 
7.03 (d, J = 7.5 Hz, 1H, CHAr), 6.98 (d, J = 7.5 Hz, 1H, CHAr), 6.44 (d, J = 7.0 Hz, 1H, N-CH-N), 5.53-
5.46 (m, 1H, CH=CH2), 5.16-5.11 (m, 2H, CH=CH2), 3.73 (dd, J = 11.0, 6.5 Hz, 1H, CH2-NTs), 3.68 
(t, J = 7.5 Hz, 1H, CH-CH-CH=CH2), 3.07-3.00 (m, 1H, CH-CH=CH2), 2.69 (t, J = 12.0 Hz, 1H, CH2-
NTs), 2.44 (s, 3H, CH3 tosyl), 2.35 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 144.4 
(CAr), 143.7 (CAr), 142.4 (CAr), 137.6 (CAr), 134.7 (CAr), 133.8 (CH=CH2), 129.8 (CHAr), 129.7 (CHAr), 
128.7 (CHAr), 128.5 (CAr), 127.9 (CHAr), 127.5 (CHAr), 126.8 (CHAr), 124.2 (CHAr), 118.9 (CH=CH2), 
116.6 (CHAr), 81.3 (NTs-CH-NTs), 50.5 (NTs-CH2), 49.9 (CH-CH-CH=CH2), 47.7 (CH-CH=CH2), 
21.74 (CH3 tosyl), 21.70 (CH3 tosyl) ppm. HRMS (ESI): calcd for C26H26N2O4S2Na [M + Na]+ 
517.1232, found 517.1221. IR (ATR, cm-1): ṽ = 1355, 1345, 1168, 1161, 1091, 1003. 
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Heck-Coupling: (E)-3a-Nitro-3-styryl-1,8-ditosyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole 
(318) 
 
 
 
Iodobenzene 317 (0.02 mL, 0.18 mmol, 3.9 equiv.) was added to a solution of 313a (24.7 mg, 0.046 
mmol, 1.0 equiv), palladium acetate (0.5 mg, 0.0023 mmol, 5 mol%), sodium acetate (7.9 mg, 0.0963 
mmol, 2.1 equiv.) and n-tetrabutylammonium chloride (12.8 mg, 0.046 mmol, 1.0 equiv.) in DMF (2.5 
mL). After stirring reaction mixture overnight at 60 °C no reaction had occurred so further portions of 
palladium acetate (total 1.8 mg, 0.008 mmol, 17 mol%) and n-tetrabutylammonium chloride (15.2 mg, 
0.055 mmol, 1.2 equiv.) were added and the mixture warmed to 80 °C until consumption of starting 
material by TLC was observed (~ 5h). The suspension was diluted with EtOAc (20 mL) and water (20 
mL) and the aqueous layer was extracted using EtOAc (5 x 20 mL). The combined organic phases were 
concentrated under reduced pressure and purified via flash column chromatography to yield the title 
compound 318 as a white solid (25.5 mg, 0.0414 mmol, 90% yield). Mp: 106-109 °C. Rf: 0.28 in 30:70 
ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 8.02 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.77 (d, 
J = 8.3 Hz, 1H, CHAr), 7.69 (d, J = 8.2 Hz, 2H, 8.2 Hz, CHAr tosyl), 7.46 (t, J = 7.9 Hz, 1H, CHAr), 7.36 
(d, J = 8.0 Hz, 2H, CHAr tosyl), 7.33-7.28 (m, 6H, overlapping CHAr), 7.22 (d, J = 8.1 Hz, 2H, CHAr 
tosyl), 7.12-7.09 (m, 2H overlapping CHAr and NTs-CH-NTs), 6.57 (d, J = 15.9 Hz, 1H, CH=CH-Ph), 
5.67 (dd, J = 15.9, 8.8 Hz, 1H, CH-CH=CH), 3.97 (dd, J = 12.4, 6.8 Hz, 1H, NTs-CH2-CH), 3.80-3.75 
(m, 1H, CH2-CH-CH), 2.87 (t, J = 12.2 Hz, 1H, NTs-CH2-CH), 2.46 (s, 3H, CH3 tosyl), 2.37 (s, 3H, 
CH3 tosyl) ppm. 13C NMR (125 MHz, CDCl3): δ 145.4 (CAr), 144.5 (CAr), 143.6 (CAr), 136.7 (CH=CH-
Ph), 135.9 (CAr), 133.2 (CAr), 132.5 (CHAr), 130.1 (CHAr tosyl), 129.9 (CHAr tosyl), 128.9 (CHAr), 128.6 
(CHAr), 128.1 (CHAr tosyl), 127.9 (CHAr), 127.7 (CHAr tosyl), 126.6 (CHAr), 124.6 (CHAr), 121.8 (CAr), 
120.8 (CH=CH-Ph), 116.4 (CHAr), 102.1 (C-NO2), 84.4 (N-CH-N), 53.8 (CH-CH=CH2), 52.2 (CH2-
NTs), 21.81 (CH3), 21.79 (CH3) ppm ppm. HRMS (ESI): calcd for C32H29N3O6S2Na [M + Na]+ 
638.1395 found 638.1409. IR (ATR, cm-1): ṽ 1597 (w), 1550 (m), 1464 (w), 1369 (m), 1173 (s), 1091 
(m), 1021 (m), 1012 (m), 917 (w), 814 (w), 731 (s), 661 (s).  
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Boc deprotection: (3S,3aS,8aR)-3a-Nitro-1-tosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-
b]indole (319) 
 
 
 
To a solution of 313g (24.0 mg, 0.049427 mmol, 1.0 equiv.) in MeOH (1.0 mL) added 
chlorotrimethylsilane (0.3 mL, 0.2367 mmol, 5.0 equiv.). The resultant reaction solution was allowed 
to stir overnight at room temperature before the reaction was quenched by the addition of saturated 
aqueous NaHCO3 (2 mL) and extracted using CH2Cl2 (3 x 20 mL). The combined organic fractions 
were dried over sodium sulphate and concentrated under reduced pressure. Column chromatography 
(100% CH2Cl2) was performed to yield the title compound 319 as a yellow oil (18.8 mg, 0.048775 
mmol, 99% yield). Rf: 0.31 in 20:80 ethyl acetate:n-hexanes. 1H NMR (500 MHz, CDCl3): δ 7.81 (d, 
J = 8.1 Hz, 2H, CHAr tosyl), 7.38-7.34 (m, 3H, overlapping CHAr tosyl & CHAr), 7.26 (t, J = 7.7 Hz, 
1H, CHAr), 6.80 (t, J = 7.6 Hz, 1H, CHAr), 6.70 (d, J = 8.0 Hz, 1H, CHAr), 6.30 (d, J = 2.1 Hz, 1H, NH-
CH-NTs), 5.71-5.64 (m, 1H, CH=CH2), 5.29 (d, J = 10.1 Hz, 1H, CH=CH2), 5.19 (d, J = 17.2 Hz, 1H, 
CH=CH2), 4.99 (bs, 1H, NH), 3.67 (dd, J = 10.9, 7.2 Hz, 1H, NTs-CH2-CH), 3.38-3.33 (m, 1H, NTs-
CH2-CH), 3.15 (t, J = 11.0 Hz, 1H, NTs-CH2-CH), 2.46 (s, 3H, CH3 tosyl) ppm. 13C NMR (125 MHz, 
CDCl3): δ 151.0 (CAr), 144.6 (CAr), 135.5 (CAr), 132.4 (CHAr), 130.9 (CH=CH2), 130.2 (CHAr tosyl), 
128.2 (CHAr), 127.5 (CHAr tosyl), 121.5 (CH=CH2), 119.4 (CHAr), 118.2 (CAr), 110.6 (CHAr), 103.3 
(CAr), 82.1 (NH-CH-NTs), 51.4 (NTs-CH2-CH), 51.3 (NTs-CH2-CH), 21.8 (CH3 tosyl) ppm. HRMS 
(ESI): Calcd for C19H20N3O4S [M + H]+ 386.1175, found 386.1185. IR (ATR, cm-1): ṽ 3402 (w), 2923 
(w), 1607 (w), 1550 (s), 1483 (m), 1336 (s), 1163 (s), 1117 (m), 1094 (m), 930 (s), 767 (s), 663 (s). 
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Chapter 4: [3 + 3] Cycloaddition Between Aziridines and 
Cyclopropanes 
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4.0: Research Proposal 
 
As seen in the survey of the literature of the formal [3 + 3] cycloadditions there are a range of 
powerful transformations explored utilising an activated aziridine or cyclopropane as one of the 
reaction partners (Chapter 1, Section 1.3). These 3-membered ring synthons have the potential to 
provide important pharmacologically relevant saturated 6-membered scaffolds in an atom-efficient 
fashion. While the field is still in its early stages of development, it is surprising that limited progress 
has been made to date on the 1,3-dipolar cycloaddition of two different dipoles for the synthesis of 6-
membered heterocycles. Therefore, the cross-cycloaddition between two such dipoles remain a 
significant challenge and pertains to substantial synthetic difficulties including regio- and 
enantioselective control. There are currently no reports to the best of the author’s knowledge of the 
utilisation of a zwitterionic 1,3-dipole derived from the ring-opening of an aziridine or cyclopropane 
reacting directly with other aziridines or cyclopropanes in a [3 + 3] cycloaddition manner. This 
project therefore is focused on exploring this such a route through the use of palladium(0) or Lewis 
acid catalysis to generate the zwitterionic 1,3-dipole from either vinylaziridines or vinylcyclopropanes 
and pairing them with activated aryl-substituted donor-acceptor aziridines or cyclopropanes. This 
method could provide access to piperidines and piperazines scaffolds which are particularly attractive 
due to their biological activities in pharmacologically active compounds. For example, piperidine and 
piperazine scaffolds are represented in a wide range of pharmaceuticals including opioids, 
antipsychotics, selective serotonin reuptake inhibitors (SSRIs) and selective estrogen receptor 
modulators (SERMs) (Figure 4.1). 
 
 
Figure 4.1: Prevalence of piperidine and piperazines scaffolds in pharmaceuticals. 
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The proposed plan for the development of these cross-[3 + 3] cycloaddition reactions is 
summarized in Scheme 4.1. Activating vinyl-substituted aziridines or cyclopropanes 350, with a 
Pd(0)-catalyst would result in the ring-opening-formation of a reactive zwitterionic 1,3-dipole 351, 
which could then react with an aryl-substituted aziridine/cyclopropane 352. While there are examples 
of all-carbon 1,3-dipoles generated from TMM-Pd complexes pairing with aziridines,1,2,3 zwitterionic 
dipoles of type 351 derived from vinylaziridines or vinylcyclopropanes have not been reacted with 
other aziridines or cyclopropanes. The nucleophilic anion of intermediate 351 is proposed to attack 
the other 3-membered ring system in one of two pathways. It can attack at the substituted position 
(Scheme 4.1, pathway a.) or attack at the non-substituted position (Scheme 4.1 pathway b.) before 
undergoing ring-closure giving rise to two potential regioisomers, 353 or 354 respectively. In 
addition, the cycloadduct formed will contain two stereogenic centres, allowing for the creation either 
a cis or trans diastereoisomer. Furthermore, with the inclusion of stereogenic centres arises the 
potential for induction of enantioselectivity through the use of chiral starting materials or via the use 
of chiral ligands. The 6-membered cycloadducts that would be formed are particularly attractive due 
to the versatility of the pre-installed vinyl group that is amenable to further transformations. 
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Scheme 4.1: Proposed Pd(0)-catalysed ring-opening of a 3-membered rings generating a 1,3-dipole 
and potential cycloaddition pathways for the generation of 6-membered heterocycles. 
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4.1: Results and Discussion 
4.1.1: Synthesis of Starting Materials 
 
To investigate the [3 + 3] cycloaddition proposed in Scheme 4.1, the corresponding 
vinylcyclopropanes, donor-acceptor cyclopropanes, vinylaziridines, and donor-acceptor aziridine 
were accessed using known methods. The vinylcyclopropane-1,1-dicarboxylates 358/359 were 
synthesised via the base induced cyclopropanation of trans-1,4-dibromobutene 355 with the 
corresponding malonates 356/357 in high yields (Scheme 4.2, A).4 The spectroscopic data for the 
vinylcyclopropane-1,1-dicarboxylates 358 and 359 matched that reported in the literature, clearly 
showing the terminal alkene signals at δ 5.30 and 5.14 ppm, and internal alkene signals at δ 5.45–5.40 
and 5.46–5.41 ppm, respectively.4a,5 In addition, the indicative cyclopropane proton resonances were 
found at δ 2.59, 1.73, and 1.59 ppm for 358, and δ 2.57, 1.70–1.68, and 1.58–1.54 ppm for 359. The 
analogous phenylcyclopropane-1,1-diethylcarboxylate 362 was prepared from the malonate ester 357, 
which was transformed into the stable carbene precursor, phenyl iodonium ylide 360, followed by a 
rhodium-catalysed cyclopropanation with styrene 361 (Scheme 4.2, B).6 The spectroscopic data 
matched that reported in the literature as evident by the indicative cyclopropane resonances at δ 3.21 
(methine), 2.17 (methylene) and 1.70 (methylene) ppm, aromatic resonances at δ 7.27–7.25 and 7.23–
7.20 ppm, and the diethylcarboxylate signals at δ 4.30–4.18, 3,84, 1.29, and 0.86 ppm. 
 
 
Scheme 4.2: Synthesis of cyclopropane starting materials. 
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The N-tosylvinylaziridine 365 was prepared via the same method described previously in 
Chapter 3, Section 3.2.1 (Scheme 4.3, A).7 The donor-acceptor aziridine, N-tosylphenylaziridine 366, 
was synthesised via the iodine-catalysed aziridination of styrene 361 using chloramine-T trihydrate 
364 in good to high yields (Scheme 4.3, B).8 The spectroscopic data for this material matched the 
reported literature data, as evidenced by the aziridine ring signals at δ 3.77, 2.98, and 2.38 ppm, the 
indicative tosyl CH3 singlet resonance at δ 2.43 ppm, and the nine aromatic signals at δ 8.87, 7.34, 
7.29–7.26, and 7.22–7.21 ppm.9 
 
 
Scheme 4.3: Synthesis of aziridine starting materials. 
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4.1.2: [3 + 3] Cycloaddition between Vinyl-Substituted Three-Membered Rings and Aryl 
Substituted Aziridines 
 
With the required starting materials in hand, initial investigations began by using vinylcyclopropane-
1,1-dicarboxylate 359 as the precursor to deliver the zwitterionic 1,3-dipole 373 in the presence of 
Pd(0). This dipole could then subsequently react with N-tosylphenylaziridine 366 in a [3 + 3] 
cycloaddition manifold to yield two potential cycloadduct regioisomers, 374 or 375 (Scheme 4.5). 
 
 
Scheme 4.5: Proposed [3 + 3] cycloaddition between vinylcyclopropane 359 and aziridine 366 under 
Pd(0)-catalysed conditions. 
 
Pd(dba)2 was initially used as a convenient commercial source of Pd(0) and various ligands 
screened to identity conditions for the proposed reaction (Table 4.1). First, phosphorus ligands, such 
as monodentate PPh3 and bidentate BINAP, were trialed, but both saw no reaction, instead only 
returning unreacted starting materials, even at temperatures up to 80 °C (Table 4, entries 1 & 2). 
Nitrogen-containing ligands have previously been shown to be successful in promoting [3 + 2] 
cycloaddition of vinylcyclopropanes with carbonyls. 10  Therefore, bipyridine (Bipy) and 
phenanthroline (Phen) were trialed, but both gave no reaction (Table 4.1, entries 3 & 4). Next, the 
Pd(0) source was changed to, Pd2(dba)3·CHCl3.11 Interestingly, when Phen was used as the ligand 
with this Pd(0) source, no transformation was observed, but when BINAP was utilised, consumption 
of vinylcyclopropane 359 and formation of an unidentified material was observed, most likely a result 
of polymerisation (Table 4.1, entries 5 & 6). It was thought that the malonate anion of the in-situ 
generated zwitterionic 1,3-dipole intermediate 373 was not nucleophilic enough to attack the N-
tosylphenylaziridine 366, and the introduction of a Lewis acid co-catalyst to coordinate and activate 
the aziridine would provide a more electrophilic reaction partner.12 Therefore, Cu(OTf)2 was initially 
chosen as it has been previously demonstrated to be an effective activator of aziridines and a promoter 
of cycloaddition reactions, specifically in [3 + 2] cycloadditions with nitriles, carbonyl, olefins, and 
indoles.13 However, when Cu(OTf)2 was used as the co-catalyst with Pd2(dba)3·CHCl3, at room 
temperature, no reaction was observed, but, when the reaction temperature was raised to 80 °C, the 
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vinylcyclopropane 359 was consumed with the development of two new products visible on TLC 
(Table 4.1, entry 7). The two new products were isolated via flash column chromatography and found 
to correlate to the formation of γ-lactone 376 as a mixture of cis:trans diastereomers in a ratio of 
55:45 respectively, 14 and a Friedel–Crafts product 377, derived from a reaction between the solvent 
toluene and the vinylcyclopropane. When the reaction with Cu(OTf)2 was repeated in the absence of a 
Pd(0) source, it was found that heating to 80 °C favoured the formation of the linear substituted 
product 377 in 68% yield without the formation of other side-products (Table 4.1, entry 8). This 
concurrent result in the absence of a Pd(0)-catalyst supports Lewis acid activation of the 
vinylcyclopropane as responsible for the formation of the observed products. However, it should be 
noted that when the same reaction was conducted at room temperature, the return of unreacted starting 
materials was observed, indicating the requirement for elevated temperatures for electrophilic 
substitution and rearrangements of the vinylcyclopropane to occur. 
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Table 4.1: [3 + 3] Cycloaddition between vinylcyclopropane 359 and aziridine 366 under 
Pd(0)-catalysed conditions.a 
 
Entry Catalyst Ligand Conditions Notes 
1  Pd(dba)2  PPh3 RT – 80 °C, 120 h No reaction 
2 Pd(dba)2 BINAP RT – 80 °C, 120 h No reaction 
3  Pd(dba)2 Bipy RT – 80 °C, 120 h  No reaction 
4  Pd(dba)2 Phen RT – 80 °C, 120 h No reaction 
5  Pd2(dba)3·CHCl3 BINAP RT – 80 °C, 48 h Decomp. material 
6  Pd2(dba)3·CHCl3 Phen RT – 80 °C, 48 h No reaction 
7  Pd2(dba)3·CHCl3/ 
Cu(OTf)2 
Phen RT – 80 °C, 24 h 376 – 43%b 
377 – 10%  
8c Cu(OTf)2 - RT – 80 °C, 3 h 377 – 68%b (47:53) o:p 
a 1.0 equiv. of compound 359 and 1.2-2.0 equiv. of compound 366 used. b Mixture of cis:trans 
isomers. c Reaction conducted in the absence of Pd(0)-catalyst. 
 
The formation of Friedel–Crafts product 377 as a result of the reaction between 
vinylcyclopropane 359 and toluene was an unexpected outcome as there were no previous reports of a 
vinylcyclopropane undergoing substitution with toluene under Lewis acid catalysis. From analysis of 
the 1H NMR spectrum, the product 377 was isolated as an inseparable mixture of ortho:para 
substituted isomers. Distinction between the isomers was difficult due to significant peak overlap. 
However, the same compound had previously been synthesised via the palladium catalysed 1,4-
arylation of 1,3-butadienes with stabilised anions, allowing comparison of spectral data confirming 
the major isomer as the para-substituted isomer.15 In addition, the ring-opening of aryl-cyclopropanes 
with electron-rich species such as indoles, phenols, and amines under Lewis acid catalysis via a 
Friedel–Crafts type mechanism is well explored.16 Furthermore, the analogous arylaziridines are 
known to undergo C-arylation with electron-rich arenes, including toluene, under In(OTf)3 catalysed 
conditions.17 Curiously, in the present case, only reactivity of vinylcyclopropane 359 was observed, 
CO2Et
CO2Et
N
Ph
Ts
Pd(0) (2.5 mol%)
Ligand (5 mol%)
PhMe
Conditions
N
CO2Et
CO2Et
Ts
Ph
N
CO2Et
CO2Et
Ts Ph
375374
1
2
11 2
2
Cu(OTf)2 (10 mol%)
Pd(0) (2.5 mol%)
Ligand (5 mol%)
PhMe
Conditions
CO2Et
CO2Et
377
376
O
CO2Et
O
Me
359
366
or
	 213 
with all of N-tosylphenylaziridine 366 being recovered – perhaps due to preferential binding of 
Cu(OTf)2 to the diester of the cyclopropane.  
 
The Friedel–Crafts type electrophilic aromatic substitution of vinylcyclopropane 359 with 
toluene as the solvent for the formation of 377 was interesting as there was limited precedent within 
the literature. The reaction was then repeated in the non-nucleophilic solvent DCE, which resulted in 
the formation of γ-lactone 376 (43% yield), isolation of a ring-opened side product 378 which 
incorporates an ethoxy group, and the appearance of a ring-opening-elimination side product 379 as 
an inseparable mixture in trace quantity (Scheme 4.6). The product 378 was a novel compound and 
was confirmed by spectroscopic analysis. The 1H NMR spectra contained signals at δ 5.69 ppm and 
5.24–5.18 ppm with a combined integration of 3H correlating to the terminal olefin moiety. The 
ethoxy CH2 signals were found to have split into multiplets at δ 3.55–3.50 and 3.31–3.25 ppm, with 
the corresponding CH3 resonance at δ 1.15 ppm. Signals for the ester groups were found at δ 4.23–
4.15 and 1.30–1.24 ppm, respectively. The two CH resonances were found at δ 3.69 ppm as a quartet, 
and δ 3.58 ppm as a triplet. The aliphatic CH2 moiety was found at δ 2.13–2.10 ppm as a multiplet. 
Analysis of the 13C NMR spectra uncovered 13 signals, matching the predicted carbon nuclei. High-
resolution mass-spectrometric analysis detected a mass ion of 281.1370 and was assigned as [M + 
Na]+ correlating to the proposed structure of 378. 
 
 
Scheme 4.6: Cu(OTf)2 catalysed rearrangement of vinylcyclopropane 359 in the absence of an arene 
solvent. 
 
The generation of γ-lactones from vinylcyclopropanes is established within the literature and 
was first investigated by Hiyama et al. in 1981 via a bis(trimethylsilyl) sulfate Lewis acid catalysed 
process.18 Mechanistically, the Lewis acid is postulated to coordinate to the carbonyl of the ester 
moiety of 359, polarising the strained C–C bond causing it to ring-open. There is debate as to whether 
a polarisation or a formal C–C bond breaking and ring-opening of the cyclopropane occurs – it is 
likely a highly dynamic process in which reversible ring-opening occurs. The Lewis acid activated 
ring-opened cyclopropane I is proposed to undergo an intramolecular attack from the ester carbonyl 
alkyloxy forming γ-lactone 376 as a mixture of cis:trans diastereoisomers (Scheme 4.7, A). For 
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further insight into the mechanism of the γ-lactonisation of cyclopropanes under Lewis-acid catalysis 
see reference 18. The in-situ generation of ethanol can then attack and ring-open another Lewis acid 
activated vinylcyclopropane for the formation of 378 (Scheme 4.7, B). The identification of the γ-
lactone 376 was confirmed by comparison with literature values for the previously characterised 
compound.19 The 1H NMR spectrum contained signals at δ 5.97–5.84 and 5.44–5.29 ppm indicative 
of a terminal olefin. Due to the cyclic structure, diastereotopic splitting patterns were observed 
resonances at δ 2.79, 2.64, 2.47, and 2.26 ppm for the aliphatic CH2’s due to the differing chemical 
environments. Evidence for the mono pendant ethyl carboxylate was evident via resonances at δ 4.27 
and 1.32 ppm with an integration of 2H and 3H respectively. In addition, evidence for the lactone 
carbonyl and pendant ethyl carboxylate carbonyl signals were found at δ 171.6 and 167.7 ppm for the 
trans isomer, and δ 171.7 and 167.8 ppm for the cis isomer.  
 
	  
Scheme 4.7: A) Mechanism for the formation of γ-lactone 376 from vinylcyclopropane-dicarboxylate 
359. LA = Lewis acid. B) Mechanism for the formation of 378. 
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A brief investigation into the use of Sc(OTf)3 as an alternative Lewis acid in the Friedel–
Crafts reaction was then explored as it had been previously demonstrated as an effective catalyst for 
the activation of carbonyl groups.20 However, when Sc(OTf)3 was utilised in the presence of toluene, 
the formation of Friedel–Crafts product 377 was observed in a reduced yield (7%), with an increased 
preference for the formation of γ-lactone 376 in 41% yield, along with trace quantities of the alkoxy 
ring-opened product 378 as an impure mixture (Scheme 4.8, pathway a.). When the more electron-
rich anisole 380 was utilised in the presence of Sc(OTf)3, successful substitution with 
vinylcyclopropane 359 occurred, forming an inseparable mixture of linear 381a and branched 381b 
isomers in a ratio of 63:37 respectively, in 62% yield (Scheme 4.8, pathway b.). Importantly, both 
linear and branched products 381 displayed exclusive para-substitution. This result is likely due to a 
combination of increased steric bulk and the greater directing influence of the methoxy group 
favouring para-substitution. Furthermore, it is postulated that the formation of the branched isomer 
could likely be rationalised by the increased reactivity of anisole towards the activated cyclopropane 
when compared to toluene. Analysis of the 1H NMR spectrum supported the observations of linear 
and branched isomers for compound 381. The linear isomer 381a demonstrated multiplet signals at δ 
5.71–5.62 and 5.50–5.40 ppm, each with an integration of 1H, while the branched isomer 
demonstrated indicative signals consistent with the presence of a terminal olefin, with a multiplet 
signal at δ 6.05-5.85 ppm with an integration of 1H, and with a multiplet signal at δ 5.08–5.03 ppm 
with an integration of 2H. Furthermore, the olefin resonances correlated with each other in 2D 
gCOSY and gHSQC experiments. Along with the major Friedel–Crafts product, γ-lactone 376 was 
formed in 16% yield.  
 
	 216 
 
Scheme 4.8: Sc(OTf)3-promoted Friedel–Crafts substitution with toluene as reactant/solvent (a.), or 
with anisole as reactant/solvent (b.). 
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With Cu(OTf)2 identified as the superior Lewis acid for the Friedel–Crafts reaction, a brief 
substrate scope of other electron-rich arenes and heteroaromatics was investigated before returning 
attention to the [3 + 3] cycloaddition reactions (Table 4.2). It was found that benzene 382, which lacks 
a directing group, was tolerated forming a mixture of linear 383a and branched 383b substituted 
products in a ratio of 85:15 respectively, albeit in a low isolated yield of 21% (Table 4.2, entry 1). 
However, it should be noted that no side product(s) formation occurred. Gratifyingly, anisole 380 
successfully underwent substitution with vinylcyclopropane 359 forming a mixture of linear 381a and 
branched 381b isomers in a ratio of 91:9 respectively, as an inseparable mixture in 86% yield (Table 
4.2, entry 3). However, γ-lactone 376 formation was noted in 9% yield along with trace amounts of 
ethoxy ring-opened product 378. More strongly nucleophilic aromatics were next explored in the form 
of 1,2-dimethoxybenzene 384 and 1,4-dimethoxybenzene 385, however, no reaction occurred, with 
only return of unreacted starting materials observed (Table 4.2, entries 4 & 5). The highly activated 
arene, 1,3,5-trimethoxybenzene 384, saw the formation of the corresponding linear 383a and 
branched 383b isomers in a ratio of 64:36 respectively, in 64% yield, along with trace formation of γ-
lactone 376 (Table 4.2, entry 6). The outcome of the Friedel–Crafts product observed of the 1,3,5-
trimethoxybenzene 384 substrate and the null result with the 1,2-dimethoxybenzene 384 and 1,4-
dimethoxybenzene 385 substrates can be rationalised by consideration of the ortho/para directing 
influence of the methoxy groups. In the scenario of 1,2- and 1,4-dimethoxybenzene, the two methoxy 
groups direct towards different positions on the ring in a competitive manner. Conversely, the 1,3,5 
arrangement of the methoxy groups facilitate a favourable ortho directing influence that favours the 
Friedel–Crafts reaction. Next, electron-rich heteroaromatics were briefly trialled. Using DCE as 
solvent, N–methylindole 388 yielded the formation of the corresponding substituted products 389a 
and 389b in favour of the branched isomer (75:25) in 59% yield (Table 4.2, entry 7). Lastly, 
benzofuran 391 was trialed, but unfortunately saw the formation of a complex crude 1H NMR 
spectrum without the formation of the predicted product. It was also noted that when the reaction was 
conducted in 2.4 equivalents of anisole in THF in the presence of Cu(OTf)2, no reaction was 
observed, indicating the requirement for the arene to be present in large excess. 
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Table 4.2: Substrate scope for the Friedel–Crafts reaction with vinylcyclopropane 359 under 
Cu(OTf)2 catalysed conditions.a 
 
Entry Ar Product(s) Ratio 
(a:b) 
Yield 
(%) 
2  
382 
 
 
383a:383b 
85:15 21 
3b  
380  
381a:381b 
91:9 86 
4 
 
384 
No reaction - - 
5  
385 
No reaction - - 
6c  
386  
387a:387b 
64:36 64 
8d 
 
390  
391a:391b 
25:75 59 
9  
392 
No reaction - - 
a Conditions: 1.0 equiv. 359 in 0.2-0.4 M solvent/reactant. b Formed lactone 376 in 9% yield in a 
cis:trans ratio of 56:64. c Observed trace amounts of 378. d Conducted in DCE (0.2 M) with 1.5 equiv. 
of indole 390. 
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The use of 1,1-dimethylcarboxylatevinylcyclopropane 358 was then attempted as a substrate 
for the Friedel–Crafts reaction. (Scheme 4.10). Under the same conditions as the previous examples 
above, the reaction of 358 in THF at reflux saw the formation of the corresponding γ-lactone 393 in 
20% yield and methoxy ring-opened side-product 394 in 5% yield. This was a significant reduction in 
observed γ-lactone yield compared to 359 (a reduction in 20% yield). However, this low yielding 
result was likely due to volatility of starting material 358 and products formed. When toluene was 
used as the solvent/reactant, extended reaction times were required with extremely poor mass 
recovery, further reflective of the volatility of the compound 358 at elevated temperatures, without 
any formation of the corresponding substituted product. When anisole 380 was utilised, the formation 
of the corresponding Friedel–Crafts para-substituted products, 395a and 395b, were formed as an 
inseparable mixture in a ratio of 77:23 respectively, albeit in low yield (29%).  
 
 
Scheme 4.10: Cu(OTf)2 promoted Friedel–Crafts substitution using 1,1-
dimethylcarboxylatevinylcyclopropane. 
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Diethyl-2-styrylcyclopropane-1,1-dicarboxylate 396 was synthesised via the cross-metathesis 
between vinylcyclopropane 359 and styrene 361 under Grubb’s second-generation catalysed 
conditions in 70% yield (Scheme 4.11).21 Analysis of the 1H and 13C NMR spectrum matched the 
known literature values.22 With compound 396 in hand, it was then paired with anisole 380 under 
Cu(OTf)2 catalysed conditions which gratifyingly formed the Friedel–Crafts products 397a and 397b 
as an inseparable mixture in a ratio of 18:82 respectively, in 54% yield (Scheme 4.11). It was 
noteworthy that 397b was the favoured isomer, likely due to conserved alkene conjugation with the 
adjacent phenyl ring. Toluene was also used in the reaction with 396, however, the expected Friedel–
Crafts substitution product was not observed, instead yielding a complex 1H NMR spectrum of the 
crude material likely due to polymerisation. 
 
 
Scheme 4.11: Synthesis of diethyl-2-styrylcyclopropane-1,1-dicarboxylate and formation of anisole-
substituted product 397. 
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The analogous N-tosylvinylaziridine 365 was also subjected to the same conditions as above. 
Exposing N-tosylvinylaziridine 365 and anisole 380 to 10 mol% Cu(OTf)2 saw the formation of the 
electrophilic substituted products 398a and 398b in 36% yield in a ratio of 71:29 in favour of the 
linear isomer (Scheme 4.12). These results are in-line with those reported previously with indium 
triflate and N-tosylvinylaziridines.23  
 
 
Scheme 4.12: Cu(OTf)2 promoted ring-opening of vinylaziridine with anisole. 
 
At this point, while an interesting Friedel–Crafts process with vinylcyclopropanes and 
vinylaziridines had been uncovered, mixtures of linear and branched isomers were typically obtained, 
limiting the usefulness of this method. As such, attention was turned back to the proposed [3 + 3] 
cycloaddition reaction, but utilising an alternative strategy.  
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4.1.3: [3 + 3] Cycloaddition between Vinyl-Substituted Aziridines and Cyclopropanes 
 
Due to the observed preference for vinylcyclopropane substrates to undergo rearrangements and 
Friedel–Crafts substitution, rather than reacting with N-tosylphenylaziridine 366 in a formal 
cycloaddition reaction under Lewis acid catalysed conditions, it was decided to investigate cross [3 + 
3] cycloaddition reactions between vinylcyclopropane 359 and vinylaziridines 365 under Pd(0)-
catalysed conditions via the in-situ generation of the corresponding zwitterionic 1,3-dipoles 376 and 
399 respectively. It is proposed that the malonate anion of the vinylcyclopropane derived dipole 376 
will attack first as it is slightly more basic, followed by consequent ring-closure attack from the 
nitrogen anion for the generation of 400 (Scheme 4.13). Furthermore, there is also potential for homo-
coupling between the in-situ generated dipoles. 
 
 
Scheme 4.13: Proposed Pd(0)-catalysed [3 + 3] cycloaddition between ring-opened zwitterionic 1,3-
dipoles. 
 
Therefore, vinylcyclopropane 359 was paired with N-tosylvinylaziridine 365 in the presence 
of catalytic Pd2dba3·CHCl3 (2.5 mol%) at room temperature. Using PPh3 as the ligand, consumption 
of vinylaziridine 365 was observed, but with the return of unreacted vinylcyclopropane 359 (Table 
4.3, entry 1). No products could be isolated from this reaction and the aziridine consumption was 
likely due to aziridine polymerisation.24 The utilisation of the diamine ligand Phen saw no reaction 
occur, even after a further 24 hours in which the temperature was raised to 40 °C (Table 4.3, entry 2). 
Heating at temperatures greater then 40 °C was not attempted as elevating temperatures in the 
presence of Pd(0) had the potential to promote uncontrolled polymerisation of the starting materials.  
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Table 4.3: Attempted Pd(0)-catalysed [3 + 3] cycloaddition between a vinylcyclopropane and 
vinylaziridine.a 
 
Entry Ligand Yield 400 
1 PPh3 365 polymerisation 
2b Phen No reaction 
Conditions: a 1.0 equiv. 359, 1.0 equiv. 365. b After 18h temperature raised to 40 °C for 24 h 
but saw no further reaction. 
 
  
CO2Et
CO2Et N
Ts
N
CO2Et
CO2Et
Ts
Pd2dba3·CHCl3 (2.5 mol%)
Ligand (5 mol%)
PhMe, rt, 18 h359 365 400
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4.1.4: [3 + 3] Cycloaddition between Donor/Acceptor Aziridines and Cyclopropanes 
 
After the unsuccessful efforts endeavoring the combination of vinylcyclopropane 359 with 
vinylaziridine 365 under Pd(0)-catalysed conditions, an alternative approach to explore the Lewis acid 
catalysed cross-[3 + 3] cycloaddition between a donor-acceptor cyclopropane 362 with N-
tosylphenylaziridine 366 was envisaged. It was thought at this point, given the propensity of the 
vinylcyclopropanes and aziridines to be activated by Lewis acids in the Friedel–Crafts process, that 
the introduction of a Lewis acid in the presence of both substrates could potentially ring-open both 
substrates to the corresponding zwitterionic 1,3-dipoles, 401 and 402, and thereby allow consequent 
cross-[3 + 3] cycloaddition to occur for the formation of piperidine cycloadduct 403 (Scheme 4.14).  
 
 
Scheme 4.14: Proposed Lewis acid catalysed [3 + 3] cycloaddition between ring-opened zwitterionic 
1,3-dipoles and consequent [3 + 3] cycloaddition. 
 
Firstly, the pairing of aziridine 362 and cyclopropane 366 was investigated under Cu(OTf)2 
catalysed conditions in DCE at room temperature. Interestingly, full consumption of the aziridine 366 
was observed, however, cyclopropane 362 remained unreacted. Analysis of the 1H NMR spectrum of 
the crude material uncovered the appearance of weak new resonances, correlating to the formation of 
aziridine cyclodimer 404 as a mixture of cis:trans isomers in a ratio of 1:1 (Scheme 4.15). Purification 
via flash column chromatography isolated the cis-cyclodimer 404 in 10% yield. Spectroscopic 
analysis of the isolated product 404 supported the proposed structure (Figure 4.1). Analysis of the 1H 
NMR spectrum uncovered doublet of doublet signals at δ 5.87 and 4.22 ppm correlating to two 
distinct CH protons. The resonances correlating to the CH2 moieties were found to have split into 4 
distinct doublet of doublets at δ 3.81, 3.37, 3.19, and 3.03 ppm. The indicative methyl protons of the 
tosyl groups were found as two signals at δ 2.41 and 2.40 ppm, further supporting the cyclodimer 
structure. The aromatic region was found to contain an integration of 18 H, correlating to the 
predicted phenyl and tosyl aromatic protons. Inspection of the 13C NMR spectrum found 22 peaks 
correlating to the predicted carbon nuclei.  
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Scheme 4.15: Attempted Cu(OTf)2 catalysed [3 + 3] cycloaddition between donor-acceptor 
cyclopropanes and aziridine. 
 
 
Figure 4.1: 1H NMR spectrum of cis-404. 
 
Next was performed an experiment in the presence of Sc(OTf)3 at room temperature, but after 
24 h saw no change in starting materials. Therefore, the temperature of the reaction was then 
increased to 75 °C and consumption of both starting materials was observed. However, analysis of the 
1H NMR spectrum of the crude material uncovered the appearance of a complex spectrum indicative 
of polymerisation and indistinct side reactions without clean conversion towards the desired 
cycloadduct. As a control, N-tosylphenylaziridine 366 was subjected to Cu(OTf)2 conditions at room 
temperature in efforts to observe formation of the cyclodimer 404 in the absence of cyclopropane 362 
(Scheme 4.16). Indeed, the reaction progressed to completion after 48 h, however, it was noted to 
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have undergone significant polymerisation contributing to a poor mass recovery. Interestingly, in 
addition to the formation of cyclodimer 404, a new compound was isolated and was found to correlate 
to the formation trans-cyclodimer 404′ as a mixture of cis and trans isomers in a ratio of 54:46 
respectively in 18% yield. The structure of 404′ was confirmed via spectroscopic analysis (Figure 
4.2). Inspection of the 1H NMR spectrum uncovered a doublet of doublets signal at δ 4.34 ppm with a 
coupling constant of 10.7 and 4.6 Hz correlating to the CH moiety. An apparent triplet and a doublet 
of doublets resonances were found at δ 4.00 and 3.56 respectively, with a coupling constant of 10.7 
and 4.6 Hz, correlating to the CH2 group. The tosyl CH3 protons were found to correlate to a singlet at 
δ 2.44 ppm. Inspection of the 13C NMR spectrum uncovered 11 signals due to the axis of symmetry of 
the isomer, matching the predicted carbon nuclei for the proposed structure. High-resolution mass-
spectrometric analysis detected a mass ion of 569.1500 and was assigned as [M + Na]+ correlating to 
the proposed structure of 404′. This result highlighted the labile nature of the N-tosylphenylaziridine 
366 substrate under Lewis acid catalysis to undergo polymerisation and cyclodimerisation. 
 
 
Scheme 4.16: Cu(OTf)2 catalysed cyclodimerisation of aziridine 366 for the formation of piperidine 
products. 
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Figure 4.2: 1H NMR spectrum of trans-404′. 
 
The donor-acceptor cyclopropane, 362, was also subjected to a control experiment in the 
presence of Cu(OTf)2 (Scheme 4.17). Initially the reaction was conducted at room temperature, 
however no reaction was noted, therefore an increase in the reaction temperature to 75 °C was 
performed, corresponding with 100% consumption of the cyclopropane 366. After purification, ethyl 
2-oxo-5-phenyltetrahydrofuran-3-carboxylate 406 was isolated in 23% yield as an inseparable mixture 
of cis:trans isomers in ratio of 58:42 respectively, in addition to an unidentified material. 
Spectroscopic analysis of the isolated lactone 406 matched the literature values and is proposed to 
form in a similar manner as the corresponding vinylcyclopropane 359 vide-supra (Scheme 1.21).25 
This result highlighted the low reactivity of cyclopropane 362 under Lewis acid catalysed conditions 
at room temperature.  
 
 
Scheme 4.17: Cu(OTf)2 catalysed cyclodimerisation of the vinylcyclopropane 326 for the formation of 
lactone 406.  
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4.2: Conclusions 
 
In summary, efforts towards achieving cross-[3 + 3] cycloaddition between two in-situ generated 1,3-
dipoles derived from cyclopropanes and aziridines was attempted without success. The use of Pd(0)-
catalysed conditions with vinyl substituted cyclopropanes failed to observe any desired cycloaddition 
between N-tosylphenylaziridine or N-tosylvinylaziridine. However, the Lewis acid activation of 
vinylcyclopropanes instead saw isomerisation towards γ-lactones and ring-opened products. When 
electron-rich solvents were utilised, such as toluene or anisole, a competing Friedel–Crafts 
substitution product was observed. This trend was briefly explored with other electron-rich arenes and 
heterocycles for the formation of a series of allylmalonates. The utilisation of donor-acceptor 
cyclopropanes and arylaziridines under Lewis acid catalysed conditions also failed to yield the desired 
cross-[3 + 3] cycloaddition, instead, a preference towards cyclodimerisation and lactone formation 
was observed. The results uncovered as part of this investigation demonstrate the difficulties in 
promoting cross [3 + 3] cycloaddition between 3-membered ring species due to competing 
dimerisation and rearrangement reactions. However, it may be possible in future work to alter the 
nature of the electron-withdrawing groups on the activated cyclopropane and the aziridine under 
Pd(0)-catalysed conditions to encourage reactivity between the two systems. 
	
4.3: Future Directions 
	
The synthesis and use of air-stable 1,3-dipoles has recently emerged and been demonstrated to react 
as partners in [3 + 2] and [3 + 3] cycloaddition reactions. In particular, the use of air stable 
azomethine imines and azomethine ylides has been shown to pair with other in-situ generated 1,3-
dipoles in [3 + 3] cycloaddition reactions as potent entries towards the synthesis of 6-membered 
heterocycles. It is likely that further exploration of this approach is likely to be more successful than 
the generation of two transient dipoles. 
 
Guo and co-workers were the first to report the pairing between the air stable cyclic 
azomethine imine 410 with an in-situ generated azomethine ylide derived from imino ester 411 
(Scheme 4.17, A).26 Utilising a chiral Cu catalyst, they were able to achieve the formation of the 
biologically important pyrazolotriazinone-derived scaffold 412 in excellent yields and dr/ee. The 
same group then went onto explore further pairings of air stable azomethine ylides 413 as reaction 
partners with donor-acceptor cyclopropanes 414 under Lewis acid catalysed conditions forming fused 
piperidine cycloadducts 415 in excellent yields with exclusive formation of the trans diastereoisomer 
(Scheme 4.17, B).27 Furthermore, Zhang and co-workers reported the rhodium-catalysed [3 + 3] 
cycloaddition of vinylaziridines 417 with air stable azomethine imines 416 for the formation of 
	 229 
tetrahydrotriazines 418 in high yield and high dr and ee (Scheme 4.17, C).28 These above results 
demonstrate the emergence of air stable dipoles reacting with in-situ generated dipoles as a new 
method towards the formation of 6-membered heterocycles. We envisage the utilisation of these air 
stable dipoles 419 in combination with Pd-stabilised zwitterionic 1,3-dipoles from vinylaziridines 
and/or vinylcyclopropanes 420. In addition, Lewis acid derived zwitterionic 1,3-dipoles also represent 
an attractive approach, in particular, through the use of donor-acceptor aziridines 422 via C–N bond 
cleavage. The use of a donor-acceptor aziridine diesters 424 represents another unexplored route as 
these unique systems have a preference to undergo C–C bond cleavage in the presence of Lewis acids 
to potentially open access to regioisomeric cycloadducts 425.  
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Scheme 4.17: Previous efforts of [3 + 3] cycloaddition reactions of air-stable 1,3-dipoles and the 
proposed utilisation of 3-memebered rings with an air-stable azomethine ylide.  
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4.4: Experimental Section 
	
General Experimental Details: 
 
Unless stated specifically, all chemicals were purchased from commercial suppliers and used without 
purification. All reactions were conducted in oven-dried glassware under nitrogen atmosphere. The 
reaction solvents were dried by passing through a column of activated alumina and then stored over 4 
Å or 3 Å molecular sieves. The progress of reactions was tracked by TLC which was performed on 
aluminium backed silica gel sheets (Grace Davison, UV254). TLC plates were visualised under UV 
lamp at 254 nm and/ or by treatment with one of the following TLC stains: phosphomolybdic acid 
(PMA) stain; PMA (10 g), absolute EtOH (100 mL); potassium permanganate stain: KMnO4 (1.5 g), 
10% NaOH (1.25 mL), water (200 mL); vanillin stain: Vanillin (15 g), concentrated H2SO4 (2.5 mL), 
EtOH (250 mL). For NMR spectroscopy, analytes were dissolved in deuterated chloroform or stated 
otherwise. NMR spectra for each compound were collected from one of the following instruments: a 
Mercury 2000 spectrometer operating at 500 and 125 MHz for 1H and 13C NMR respectively; a 
Bruker spectrometer operating at 400, 100, and 470 MHz for 1H, 13C, and 19F NMR, respectively. 
NMR data are expressed in parts per million (ppm) and referenced to the solvent (7.26 ppm for 1H 
NMR and 77.16 ppm for 13C NMR). The following abbreviations are used to assign the multiplicity of 
the 1H NMR signal: s = singlet; bs = broad singlet; d = doublet; t = triplet; q = quartet; p = pentet; 
quin = quintet; dd = doublet of doublets; dt = doublet of triplets; m = multiplet. NMR assignments 
were made on the basis of COSY, HSQC, HMBC, and DEPT experiments. For mass spectrometry, 
analytes were dissolved in HPLC grade methanol, acetonitrile or dichloromethane. High-resolution 
mass spectra were collected from a Waters Xevo G1 QTOF mass spectrometer. Infrared spectra were 
obtained from a Shimadzu IRAffinity-1 Fourier transform infrared spectrophotometer with ATR 
attachment. Melting point measurements were performed using a Buchi M-560.  
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General Procedure A: Synthesis of Vinylcyclopropanes 
 
 
 
Method adapted from: Chem. Commun., 2009, 7116-7118. 
To a solution of trans-1,4-dibromobut-2-ene 355 (1.0 equiv.) and the corresponding malonate 
356/359 (1.0 equiv.) in anhydrous THF (0.4 M) was added Cs2CO3 (2.0 equiv.). A condenser was 
equipped under N2 flow and the reaction mixture was heated to reflux (~75-80 °C) and stirred 
overnight. The reaction was then cooled to room temperature, filtered through a short plug of silica, 
washed thorough with excess EtOAc, and solvent removed under reduced pressure. The crude product 
was then purified via flash column chromatography to yield the desired vinylcyclopropane. 
 
Dimethyl 2-vinylcyclopropane-1,1-dicarboxylate (358) 
Made using General Procedure A. Purified via flash column chromatography to 
yield the title compound as a colourless liquid (2.3330 g, 97% yield). Rf: 0.36 in 
20:80 EtOAc:n-hexanes, 1H NMR (500 MHz, CDCl3): δ 5.45-5.40 (m, 1H, CH2=CH-CH), 5.30 (dd, 
J = 16.8, 2.0 Hz, 1H, CH2=CH-CH), 5.14 (dd, J = 9.8, 2.0 Hz, 1H, CH2=CH-CH), 3.74 (s, 3H, C-
(CO2CH3)2), 2.59 (q, J = 8.3 Hz, 1H, CH-CH-CH2), 1.73 (dd, J = 7.6, 5.0 Hz, 1H, CH-CH2-C), 1.59 
(dd, J = 9.0, 5.0 Hz, 1H, CH-CH2-C) ppm. 13C NMR (125 MHz, CDCl3): δ 170.1 (C=O), 167.9 
(C=O), 133.1 (CH2=CH-CH), 118.8 (CH2=CH), 59.2 (C(CO2Me)2), 52.9 (CO2CH3), 52.7 (CO2CH3), 
31.6 (CH-CH-CH2), 20.7 (CH-CH2-C) ppm. NMR data match previously reported: Chem. Commun. 
2004, 2474-2475. 
 
Diethyl 2-vinylcyclopropane-1,1-dicarboxylate (359) 
Made using General Procedure A. Purified via flash column chromatography to 
yield the title compound as a colourless liquid (2.2603 g, 81% yield). Rf: 0.45 in 
20:80 EtOAc:n-hexanes, 1H NMR (500 MHz, CDCl3): δ 5.46-5.41 (m, 1H, CH2=CH-CH), 5.30 (d, J 
= 17.0 Hz, 1H, CH2=CH-CH), 5.14 (d, J = 10.5 Hz, 1H, CH2=CH-CH), 4.26-4.15 (m, 4H, CO2-CH2-
CH3), 2.57 (q, J = 8.0 Hz, 1H, CH2=CH-CH), 1.70-1.68 (m, 1H, CH-CH2-C), 1.58-1.54 (m, 1H, CH-
CH2-C), 1.30-1.27 (m, 6H, CO2-CH2-CH3) ppm. 13C NMR (CDCl3, 125 Hz): δ 169.5 (C=O), 167.3 
(C=O), 133.0 (CH2=CH-CH), 118.3 (CH2=CH), 61.5 (CO2CH2CH3), 61.3 (CO2CH2CH3), 35.8 
(C(CO2Et)2), 30.9 (CH-CH-CH2), 20.2 (CH-CH2-C), 14.0 (CO2CH2CH3), 13.9 (CO2CH2CH3) ppm. 
NMR data match previously reported: Chem. Commun., 2009, 7116- 7118. 
 
BrBr
RO
O
OR
O Cs2CO3
THF, reflux CO2R
CO2R
355 356, R = Me
359, R = Et
CO2Me
CO2Me
CO2Et
CO2Et
	 233 
Synthesis of diethyl 2-(phenyl-λ3-iodaneylidene)malonate (360) 
 
 
 
Method adapted from: J. Org. Chem., 2009, 74, 470. 
To a solution of diethyl malonate 357 (1.0 mL, 6.56 mmol, 1.0 equiv.) in anhydrous MeCN (0.3 M) 
was added KOH (2.0569 g, 36.7 mmol, 5.6 equiv.). The resultant solution was then cooled to 0 °C 
and stirred for 10 minutes before addition of PhI(OAc)2 (2.0889 g, 6.47 mmol, 1.0 equiv.) in one 
portion. The reaction was then kept below 0 °C and monitored via TLC. After 2 hours, the reaction 
solvent was removed under reduced pressure (beware as product decomposes above 70 oC), the beige 
precipitate was then collected via sinted glass funnel, washed with cold H2O (10 mL) and diethyl 
ether (50 mL). The resultant solid was dried in-vacuo to reveal the corresponding title compound 360 
as a beige solid (1.5281 g, 64%). 1H NMR (500 MHz, CDCl3) δ 7.75 (d, J = 7.5 Hz, 2H, CHAr), 7.52 
(t, J = 7.0 Hz, 1H, CHAr), 7.40 (t, J = 8.0 Hz, 2H, CHAr), 4.19 (q, J = 14.0, 7.0 Hz, 4H, CO2CH2CH3), 
1.27 (t, J = 7.5 Hz, 6H, CO2CH2CH3) ppm.  Note: The product partially degraded in the NMR tube. 
NMR data match that previously reported: J. Org. Chem., 2009, 74, 470. 
 
Synthesis of diethyl 2-phenylcyclopropane-1,1-dicarboxylate (362) 
 
 
 
Method adapted from: J. Org. Chem., 2009, 74, 470. 
To a solution of styrene 361 (2.0 mL, 21.1 mmol, 5.0 equiv.) in anhydrous CH2Cl2 (1.0 M) was added 
Rh2(OAc)4 (11.0 mg, 0.02 mmol, 0.005 equiv.). Next phenyliodonium ylide 360 (1.5158 g, 4.19 
mmol, 1.0 equiv.) was added and resultant green reaction solution was allowed to stir at room 
temperature overnight. The reaction mixture was then filtered through a short silica gel plug, washed 
with extra CH2Cl2 and solvent removed under reduced pressure. The crude was then purified via flash 
column chromatography (10:90 EtOAc:n-hexanes) to reveal the title compound 362 as a colourless 
liquid (0.6424 g, 58%). 1H NMR (500 MHz, CDCl3): δ  7.27-7.25 (m, 2H, CHAr), 7.23-7.20 (m, 3H, 
CHAr), 4.30-4.18 (m, 2H, CO2CH2CH3), 3.84 (q, J = 13.8, 7.3 Hz, 2H, CO2CH2CH3), 3.21 (t, J = 8.5 
Hz, 1H, Ph-CH-CH2), 2.17 (ddd, J = 7.8, 5.3, 1.7 Hz, 1H, CH-CH2-C(CO2Et)2), 1.70 (ddd, J = 9.2, 
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5.2, 1.5 Hz, 1H, CH-CH2-C(CO2Et)2), 1.29 (td, J = 7.1, 7.1, 1.5 Hz, 3H, CO2CH2CH3), 0.86 (td, J = 
7.2, 7.1, 1.5 Hz, 3H, CO2CH2CH3) ppm. 13C NMR (CDCl3, 125 Hz): δ 169.9, 166.6, 134.6, 128.5 
(x2), 128.1 (x2), 127.3, 61.7, 61.1, 37.4, 32.1, 18.7, 14.1, 13.6 ppm. NMR data match that previously 
reported: J. Org. Chem., 2009, 74, 470-473. 
 
Synthesis of 1-Tosyl-2-vinylaziridine (365) 
 
 
 
Method adapted from: Org. Biol. Chem., 2014, 12, 9113. 
To a solution of chloramine-T trihydrate 364 (2.8486 g, 10.1125 mmol, 1.0 equiv.) and PhNMe3Br3 
(0.3888 g, 1.0342 mmol, 10 mol%) in dry MeCN (40 mL, 0.25 M) was gently bubbled in 1,3-
butadiene 363 gas for 30 minutes. The reaction vessel was then sealed and allowed to stir at room 
temperature. After 5 hours, another batch of 1,3-butadiene 363 was bubbled into the reaction solution 
for 30 minutes, sealed shut and allowed to stir at room temperature overnight. The reaction solution 
was then passed through a short plug of silica gel (approx. 3 cm), washed with MeCN (100 mL) and 
solvent removed under reduced pressure. The crude was then purified via flash column 
chromatography to reveal the title compound 365 as a beige solid (0.8288 g, 37% yield). Rf: 0.29 in 
20:80 EtOAc:n-hexanes, 1H NMR (500 MHz, CDCl3): δ 7.82 (d, J = 8.2 Hz, 2H, CHAr tosyl), 7.33 
(d, J = 8.0 Hz, 2H, CHAr tosyl), 5.55-5.48 (m, 1H, CH-CH=CH2), 5.42 (d, J = 17.1, 1H, CH=CH2), 
5.23 (d, J = 10.0 Hz, 1H, CH=CH2), 3.26 (td, J = 7.2, 4.6 Hz, 1H, CH-CH=CH2), 2.77 (d, J = 7.1 Hz, 
1H, CH2-CH), 2.43 (s, 3H, CH3 tosyl), 2.21 (d, J = 4.5 Hz, 1H, CH2-CH) ppm. 13C NMR (CDCl3, 
125 MHz): δ 144.6 (CAr tosyl), 135.2 (CAr tosyl), 133.0 (CH=CH2), 129.8 (CHAr tosyl), 127.9 (CHAr 
tosyl), 120.3 (CH=CH2), 41.0 (CH-CH=CH2), 34.2 (NTs-CH2-CH), 21.7 (CH3 tosyl) ppm. NMR data 
match that previously reported: Tetrahedron Lett., 2005, 46, 2539–2542. 
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Synthesis of 2-phenyl-1-tosylaziridine (366) 
 
 
 
Method adapted from: Tetrahedron, 1998, 54, 13485. 
To a solution of chloramine-T trihydrate 364 (1.0 equiv.) and iodine (0.1 equiv.) in anhydrous MeCN 
(0.2 M) was added styrene 361 (2.0 equiv.). The resultant reaction mixture was allowed to stir at room 
temperature overnight then directly filtered through a pad a silica gel, residue washed with extra 
EtOAc and solvent removed under reduced pressure. The crude was then purified via flash column 
chromatography to yield the title compound 366 as a white solid (0.5091 g, 86% yield). Rf: 0.29 in 
20:80 EtOAc:n-hexanes, 1H NMR (500 MHz, CDCl3): δ 8.87 (d, J = 8.5 Hz, 2H, CHAr Tosyl), 7.34 (d, 
J = 8.5 Hz, 2H, CHAr Tosyl), 7.29-7.26 (m, 3H, CHAr), 7.22-7.21 (m, 2H, CHAr), 3.77 (q, J = 6.8, 4.8 
Hz, 1H, Ph-CH-CH2), 2.98 (d, J = 7.5 Hz, 1H, CH-CH2-NTs), 2.43 (s, 3H, CH3 Tosyl), 2.38 (d, J = 4.5 
Hz, 1H, CH-CH2-NTs) ppm. 13C NMR (125 MHz, CDCl3): δ 144.7, 135.1, 135.0, 129.8, 128.6, 
128.3, 128.0, 126.6, 41.1, 36.0, 21.7 ppm. NMR data match that previously reported: Chem. Commun. 
2004, 2474-2475. 
 
  
Ph
I2 (10 mol%)
MeCN, rt
overnight
N
Ts
Ph 366361 364
TsNCl Na ·3H2O
	 236 
γ-Lactones: 
 
Methyl 2-oxo-5-vinyltetrahydrofuran-3-carboxylate (393) 
Mixture of inseperable diastereoisomers (trans:cis) as a colourless oil, Rf: 0.34 
in 30:70 EtOAc:n-hexanes, 1H NMR (CDCl3, 500 MHz): δ 5.97-5.84 (m, 
1Htrans, 1Hcis, CH2=CH-CH), 5.44-5.39 (m, 1Htrans, 1Hcis, CH2=CH), 5.34-5.30 
(m, 1Htrans, 1Hcis, CH2=CH), 5.13 (q, J = 13.0, 6.5 Hz, 1Htrans, CH2=CH-CH-
O), 4.89 (dt, J = 9.4, 6.6 Hz,  1Hcis, CH2=CH-CH-O), 3.821 (s, 3Hcis, CO2CH3), 3.817 (s, 3Htrans, 
CO2CH3), 3.68-3.61 (m, 1Htrans, 1Hcis, CH2-CH-CO2Me), 2.81 (ddd, J = 13.1, 7.3, 5.9 Hz, 1Htrans, CH-
CH2-CH), 2.64 (ddd, J = 13.1, 9.1, 6.4 Hz, 1Hcis, CH-CH2-CH), 2.48 (ddd, J = 13.1, 10.9, 9.4 Hz, 
1Hcis, CH-CH2-CH), 2.25 (ddd, J = 13.1, 9.3, 6.6 Hz, 1Htrans, CH-CH2-CH) ppm. NMR data match 
known literature: Beilstein J. Org. Chem. 2011, 7, 1198–1204. 
 
Ethyl 2-oxo-5-vinyltetrahydrofuran-3-carboxylate (376) 
Mixture of inseperable diastereoisomers (trans:cis) as a yellow oil, Rf: 0.27 in 
30:70 EtOAc:n-hexanes, 1H NMR (500 MHz, CDCl3) δ 5.97-5.84 (m, 1Htrans, 
1Hcis, CH2=CH-CH), 5.42 (d, J = 17.1 Hz 1Htrans, CH2=CH), 5.40 (d, J = 17.1 
Hz 1Hcis, CH2=CH), 5.33 (d, J = 11.2 Hz, 1Htrans, CH2=CH), 5.30 (d, J = 11.7 Hz, 1Hcis, CH2=CH) 
5.12 (q, J = 6.6 Hz, 1Htrans, CH2=CH-CH-O), 4.88 (q, J = 7.3 Hz, 1Hcis, CH2=CH-CH), 4.29-4.24 (m, 
2Htrans, 2Hcis, CO2-CH2-CH3), 3.66-3.58 (m, 1Htrans, 1Hcis, CH2-CH-CO2Et), 2.79 (dt, J = 13.2, 6.6 Hz, 
1Htrans, CH-CH2-CH), 2.64 (ddd, J = 12.8, 9.1, 6.4 Hz, 1Hcis, CH-CH2-CH), 2.47 (dt, J = 12.8, 10.1 
Hz, 1Hcis, CH-CH2-CH), 2.25 (ddd, J = 13.0, 9.3, 6.5 Hz, 1Htrans, CH-CH2-CH), 1.32 (t, J = 7.2, 
3Htrans, 3Hcis, CO2-CH2-CH3) ppm. NMR data match known literature: Beilstein J. Org. Chem. 2011, 
7, 1198–1204. 
 
Ethyl 2-oxo-5-phenyltetrahydrofuran-3-carboxylate (406) 
Mixture of inseparable diastereoisomers (cis:trans) as a colourless oil, Rf: 0.16 
in 20:80 EtOAc:n-hexanes. 1H NMR (500 MHz, CDCl3) δ 7.43-7.32 (m, 5Hcis, 
5Htrans, CHAr), 5.71 (t, J = 7.2 Hz, 1Htrans, CH-CO2Et), 5.44 (dd, J = 10.2, 6.2 Hz, 
1Hcis, CH-CO2Et), 4.31 (m, 2Hcis, 2Htrans, CO2CH2CH3), 3.76 (dd, J = 11.7, 8.9 Hz, 1Hcis, Ph-CH-
CH2), 3.69 (dd, J = 9.2, 4.7 Hz, 1Htrans, Ph-CH-CH2), 3.03 (ddd, J = 12.6, 7.1, 5.0 Hz, 1Htrans, CH-
CH2-CH), 2.87 (ddd, J = 13.0, 9.0, 6.2 Hz, 1Hcis, CH-CH2-CH), 2.69 (ddd, J = 13.0, 11.6, 10.2 Hz, 
1Hcis, CH-CH2-CH), 2.43 (ddd, J = 13.2, 9.2, 7.4 Hz, 1Htrans, CH-CH2-CH), 1.35 (m, 3Hcis, 3Htrans, 
CO2CH2CH3) ppm. 13C NMR (125 MHz, CDCl3) δ 171.56 (CH-O-C=O-CHcis), 171.54 (CH-O-C=O-
CHtrans), 167.8 (CH-CO2Ettrans), 167.6 (CH-CO2Etcis), 138.8 (CAr trans), 138.2 (CAr cis), 129.1 (CHAr cis), 
129.03 (CHAr trans), 128.97 (CHAr cis), 128.83 (CHAr trans), 125.9 (CHAr cis), 125.4 (CHAr trans), 80.6 (CH2-
CH-CO2Et trans), 80.1 (CH2-CH-CO2Et cis), 62.6 (CO2CH2CH3 trans), 62.4 (CO2CH2CH3 cis), 47.9 
O
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(PhCHCH2 cis), 47.1 (PhCHCH2 trans), 35.1 (CH-CH2-CH cis), 35.0 (CH-CH2-CH trans), 14.24 
(CO2CH2CH3 trans), 14.21 (CO2CH2CH3 cis) ppm. NMR data match literature values: Org. Lett., 2013, 
15, 6054-6057. 
 
Alkoxy Ring-Opened Vinylcyclopropanes: 
 
Dimethyl 2-(2-methoxybut-3-en-1-yl)malonate (394) 
Colourless oil. Rf: 0.49 in 35:65 EtOAc:n-hexanes. 1H NMR (500 MHz, 
CDCl3): δ 5.65 (ddd, J = 17.5, 10.0, 7.4 Hz,  1H, CH2=CH-CH), 5.25-5.22 (m, 
2H, CH2=CH), 3.75 (s, 3H, CO2-CH3), 3.73 (s, 3H, CO2-CH3), 3.61-3.55 (m, 
2H, overlapping CH-CH-OMe & CH2-CH-(CO2Me)2), 3.24 (s, 3H, OCH3), 2.13 (t, J = 7.0 Hz, 2H, 
CH-CH2-CH) ppm. 13C NMR (125 MHz, CDCl3): δ 170.1 (C=O), 169.9 (C=O), 137.5 (CH2=CH), 
118.1 (CH2=CH), 80.5 (CH-CH-OMe), 56.6 (O-CH3), 52.70 (CO2-CH3), 52.68 (CO2-CH3), 48.4 
(CH2-CH-C(CO2Me)2), 34.5 (CH-CH2-CH) ppm. HRMS (ESI): calcd for C10H16O5Na [M + Na]+ 
239.0895, found 239.0900. IR (ATR, cm-1): ṽ 3341 (m), 2974 (m), 2889 (w), 1734 (m), 1437 (w), 
1272 (w), 1159 (w), 1087 (m), 1046 (s), 880 (m).  
 
Diethyl 2-(2-ethoxybut-3-en-1-yl)malonate (378) 
Colourless oil. Rf: 0.39 in 15:85 EtOAc:n-hexanes. 1H NMR (500 MHz, 
CDCl3): δ 5.69 (ddd, 1H, CH2=CH-CH), 5.24-5.18 (m, 2H, CH2=CH-CH), 
4.23-4.15 (m, 4H, CO2-CH2-CH3), 3.69 (q, J = 13.5, 7.0 Hz, 1H, CH-CH-OEt), 
3.58 (t, J = 7.3 Hz, 1H, CH2-CH-(CO2Et)2), 3.55-3.50 (m, 1H, O-CH2-CH3), 3.31-3.25 (m, 1H, O-
CH2-CH3), 2.13-2.10 (m, 2H, CH-CH2-CH), 1.30-1.24 (m, 6H, C(CO2CH2CH3)2), 1.15 (t, J = 12.5 
Hz, 3H, O-CH2-CH3) ppm. 13C NMR (125 MHz, CDCl3): δ 169.7 (C=O), 169.6 (C=O), 138.4 
(CH2=CH-CH), 117.3 (CH2=CH), 78.6 (CH-OEt), 64.2 (O-CH2-CH3), 61.5 (CO2-CH2-CH3), 48.8 
(CH2-CH-C), 34.3 (CH-CH2-CH), 15.3 (O-CH2-CH3), 14.24 (CO2-CH2-CH3), 14.21 (CO2-CH2-CH3) 
ppm. HRMS (ESI): calcd for C13H22O5Na [M + Na]+ 281.1365, found 281.1370. IR (ATR, cm-1): ṽ 
2981 (w), 1729 (m), 1265 (m), 1156 (w), 1095 (w), 735 (s), 703 (m) cm-1. 
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Thermal Rearrangement Products: 
 
Diethyl (E)-2-(but-2-en-1-ylidene)malonate (379) 
Colourless oil. Rf: 0.47 in 40:60 EtOAc:n-hexanes. 1H NMR (500 MHz, 
CDCl3): δ 7.32 (d, J = 11.5 Hz, 1H, CH-CH=C(CO2Et)2), 6.53 (t, J = 13.2 
Hz, 1H, CH=CH-CH=C(CO2Et)2), 6.33 (dq, J = 14.0, 6.8 Hz, 1H, CH3-CH=CH), 4.32 (qd, 7.2, 1.1 
Hz, 2H, CO2-CH2-CH3), 4.25 (qd, J = 7.1, 1.1 Hz, 2H, CO2-CH2-CH3) 1.91 (d, J = 6.9 Hz, 3H, CH3-
CH=CH), 1.35 (t, J = 7.0 Hz, 3H, CO2-CH2-CH3), 1.30 (t, J = 7.1 Hz, 3H, CO2-CH2-CH3) ppm. 13C 
NMR (125 MHz, CDCl3): δ 165.6 (C=O), 165.0 (C=O), 145.3 (CH3-CH=CH-CH=C), 144.4 (CH3-
CH=CH-CH=C), 127.3 (CH3-CH=CH-CH=C), 123.7 (CH=C(CO2Et)2), 61.4 (CO2-CH2-CH3), 61.3 
(CO2-CH2-CH3), 19.2 (CH3-CH=CH), 14.32 (CO2-CH2-CH3), 14.29 (CO2-CH2-CH3) ppm. NMR data 
match known literature: Org. Lett. 2007, 9, 5071-5074. 
 
Friedel–Crafts products: 
 
Diethyl (E)-2-(4-phenylbut-2-en-1-yl)malonate (383a) 
Colourless oil (14.6 mg, 21% yield) as a mixture of linear:branched 
isomers. Rf: 0.38 in 15:85 EtOAc:n-hexanes. Linear isomer: 1H NMR 
(500 MHz, CDCl3): δ 7.29-7.26 (m, 2H, CHAr), 7.19-7.16 (m, 1H, 
CHAr), 7.14 (d, J = 7.5 Hz, CHAr), 5.72-5.66 (m, 1H, Ph-CH2-CH=CH), 
5.51-5.45 (m, 1H, Ph-CH2-CH=CH-CH), 4.20-4.13 (m, 4H, CH-(CO2CH2CH3)2), 3.40 (t, J = 8.0 Hz, 
1H, CH2-CH(CO2Et)2), 3.32 (d, J = 7.0 Hz, 2H, Ph-CH2-CH=CH), 2.62 (t, J = 7.5 Hz, 2H, CH=CH-
CH2-CH), 1.24 (t, J = 7.0 Hz, 6H, CH-(CO2CH2CH3)2) ppm. 13C NMR (125 MHz, CDCl3): δ 169.1 
(C=O), 140.5 (CAr), 132.5 (Ph-CH2-CH=CH), 128.6 (CHAr), 128.5 (CHAr), 127.1 (CHAr), 126.2 
(CH=CH-CH2-CH), 61.5 (CO2CH2CH3), 52.3 (CH2-CH-(CO2Et)2), 39.1 (Ph-CH2-CH=CH), 31.9 
(CH=CH-CH2-CH), 14.2 (CO2CH2CH3) ppm. NMR data match that previously reported: J. Am. 
Chem. Soc. 2006, 128, 8150-8151. & J. Org. Chem., 2015, 80, 6529-6536. 
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Diethyl (E)-2-(4-(o-tolyl)but-2-en-1-yl)malonate & Diethyl (E)-2-(4-(p-tolyl)but-2-en-1-
yl)malonate (377) 
Orange oil (49.5 mg, 68% yield) as an inseparable mixture 
ortho:para (47:53) isomers, Rf: 0.52 in 30:70 EtOAc:n-hexanes. 
1H NMR (500 MHz, CDCl3): δ 7.11-7.07 (m, 3Hpara, 3Hortho, 
CHAr), 7.03 (d, J = 8.0 Hz, 1Hpara, 1Hortho, CHAr), 5.70-5.64 (m, 
1Hpara, 1Hortho, Ar-CH2-CH=CH), 5.49-5.43 (m, 1Hpara, Ar-CH2-
CH=CH-CH2), 5.41-5.35 (m, 1Hortho, Ar-CH2-CH=CH-CH2), 
4.20-4.12 (m, 4Hpara, 4Hortho, CH(CO2CH2CH3)2), 3.40-3.35 (m, 1Hpara, 1Hortho, CH2-CH(CO2Et)2), 
3.30-3.26 (m, 2Hpara, 2Hortho, CH-CH2-CH), 2.62-2.59 (m, 2Hpara, 2Hortho, Ar-CH2-CH), 2.31 (s, 3Hpara, 
Ph-CH3), 2.56 (s, 3Hortho, Ph-CH3), 1.25-1.21 (m, 12H, CO2-CH2-CH3) ppm. 13C NMR (125 MHz, 
CDCl3): δ 169.15 (C=O), 169.13 (C=O), 136.3 (CAr), 132.74 (Ar-CH2-CH=CHortho), 131.68 (Ar-CH2-
CH=CHpara), 130.2 (CHAr), 129.2 (CHAr), 129.1 (CHAr), 128.5 (CHAr), 126.85 (Ar-CH2-CH=CH-
CH2ortho), 126.80 (Ar-CH2-CH=CH-CH2para), 126.4 (CHAr), 126.1 (CHAr), 61.5 (CO2-CH2-CH3), 52.31 
(CH2-CH-(CO2Et)2), 52.30 (CH2-CH-(CO2Et)2), 38.6 (Ar-CH2-CHpara), 36.5 (Ar-CH2-CHortho), 31.91 
(CH-CH2-CH-(CO2Et)2), 31.89 (CH-CH2-CH-(CO2Et)2), 21.1 (Ph-CH3), 19.4 (Ph-CH3), 14.22 (CO2-
CH2-CH3), 14.20 (CO2-CH2-CH3) ppm. HRMS (ESI): calcd for C18H25O4 [M + H]+ 305.1753, found 
305.1738. IR (cm-1): ṽ 2980 (w), 1751 (m), 1730 (s), 1653 (s), 1445 (w), 1228 (m), 1149 (m), 1032 
(m), 741 (w). 
 
Diethyl-2-(4-(4-methoxyphenyl)but-2-en-1-yl)malonate (381a) 
Yellow oil (66.1 mg, 86% yield) as a mixture of linear:branched 
isomers. Rf: 0.39 in 20:80 EtOAc:n-hexanes. Linear isomer: 1H 
NMR (500 MHz, CDCl3): δ 7.05 (d, J = 8.5 Hz, 2H, CHAr), 
6.81 (d, J = 8.5 Hz, 2H, CHAr), 5.73-5.64 (m, 1H, Ar-CH2-
CH=CH), 5.48-5.41 (m, 1H, Ar-CH2-CH=CH-CH2), 4.21-4.12 (m, 4H, CH(CO2CH2CH3)2), 3.78 (s, 
3H, Ar-O-CH3), 3.39 (t, J = 7.5 Hz, 1H, CH2-CH-(CO2Et)2), 3.25 (d, J = 7.0 Hz, 2H, Ar-CH2-CH), 
2.63-2.59 (m, 2H, CH-CH2-CH), 1.25-1.21 (m, 6H, CO2-CH2-CH3) ppm. 13C NMR (125 MHz, 
CDCl3): δ 169.1 (C=O), 169.0 (C=O), 158.1 (CAr), 132.9 (Ar-CH2-CH=CH), 132.5 (CAr), 129.5 
(CHAr), 126.7 (Ar-CH2-CH=CH-CH2), 113.9 (CHAr), 61.437 (CO2-CH2-CH3), 61.389 (CO2-CH2-
CH3), 55.4 (Ar-O-CH3), 52.3 (CH2-CH-(CO2Et2)), 38.1 (Ar-CH2-CH=CH), 31.8 (CH=CH-CH2-CH), 
14.19 (CO2-CH2-CH3), 14.17 (CO2-CH2-CH3) ppm. HRMS (ESI): calcd for C18H25O5 [M + H]+ 
321.1702, found 321.1715. IR (ATR, cm-1): ṽ = 2980 (w), 1730 (s), 1512 (m), 1242 (s), 1175 (m), 
1148 (m), 1032 (m). 
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Diethyl (E)-2-(4-(2,4,6-trimethoxyphenyl)but-2-en-1-yl)malonate (387a) & diethyl 2-(2-(2,4,6-
trimethoxyphenyl)but-3-en-1-yl)malonate (387b) 
Colourless oil (95.5 mg, 64% yield) as a mixture of 
linear:branched isomers (64:36). Rf: 0.28 in 30:70 diethyl 
ether:n-hexanes. 1H NMR (500 MHz, CDCl3): Linear Isomer 
(387a) δ 6.78 (d, J = 8.5 Hz, 1H, CHAr), 6.60 (d, J = 8.5 Hz, 1H, 
CHAr), 5.70-5.64 (m, 1H, Ar-CH2-CH=CH), 5.64-5.41 (m, 1H, 
CH=CH-CH2-CH), 4.20-4.12 (m, 4H, CO2-CH2-CH3), 3.86 (s, 
3H, O-CH3), 3.84 (s, 3H, O-CH3), 3.83 (s, 3H, O-CH3), 3.38 (t, J 
= 7.5 Hz, 1H, CH2-CH-(CO2Et2)), 3.26 (d, J = 6.5 Hz, 2H, Ar-
CH2-CH=CH), 2.61 (t, J = 7.0 Hz, CH=CH-CH2-CH), 1.27-1.22 
(m, 6H, CO2-CH2-CH3) ppm. Branched Isomer (387b) δ 6.83 (d, J = 8.5 Hz, 1H, CHAr), 6.65 (d, J = 
8.5 Hz, 1H, CHAr), 5.96-5.89 (m, 1H, CH2=CH-CH), 5.05 (d, J = 13.0 Hz, 2H, CH2=CH-CH), 4.20-
4.12 (m, 4H, CO2-CH2-CH3), 3.86 (s, 3H, O-CH3), 3.84 (s, 3H, O-CH3), 3.83 (s, 3H, O-CH3), 3.68 (q, 
J = 14.5, 7.0 Hz, 1H, Ar-CH-CH2), 3.32 (t, J = 7.0 Hz, 1H, CH2-CH-(CO2Et2)), 2.35-2.30 (m, 1H, 
CH-CH2-CH), 2.26-2.20 (m, 1H, CH-CH2-CH), 1.27-1.22 (m, 6H, CO2-CH2-CH3) ppm. 13C NMR 
(125 MHz, CDCl3): Linear Isomer (387a) δ 169.0 (C=O), 152.2 (CAr), 151.7 (CAr), 142.4 (CAr), 
132.5 (Ar-CH2-CH=CH), 128.7 (CAr), 126.5 (CH=CH-CH2-CH), 123.8 (CHAr), 107.4 (CHAr), 61.4 
(CO2-CH2-CH3), 61.0 (O-CH3), 60.8 (O-CH3), 56.1 (O-CH3), 52.2 (CH2-CH-(CO2Et)2), 32.5 (Ar-
CH2-CH=CH), 31.8 (CH=CH-CH2-CH), 14.1 (CO2-CH2-CH3) ppm. Branched Isomer (387b) δ 
169.55 (C=O), 169.47 (C=O), 152.4 (CAr), 151.8 (CAr), 142.4 (CAr), 140.9 (CH2=CH-CH), 126.5 
(CAr), 122.1 (CHAr), 115.1 (CH2=CH), 107.6 (CHAr), 61.4 (CO2CH2CH3), 61.0 (O-CH3), 60.7 (O-
CH3), 56.0 (O-CH3), 50.3 (Ar-CH-CH2), 40.5 (CH2-CH-(CO2Et)2), 33.7 (CH-CH2-CH), 14.1 
(CO2CH2CH3) ppm. HRMS (ESI): calcd for C20H28O7Na [M + Na]+ 403.1733, found 403.1721. IR 
(ATR, cm-1): ṽ = 2980 (w), 1730 (s), 1512 (m), 1242 (s), 1175 (m), 1148 (m), 1032 (m). 
 
Diethyl 2-(2-(1-methyl-1H-indol-3-yl)but-3-en-1-yl)malonate  (390b) 
Colourless oil (48.2 mg, 58% yield) as a mixture of linear:branched isomers. 
Branched isomer: 1H NMR (300 MHz, CDCl3): δ 7.63 (d, J = 7.8 Hz, 1H, 
CHAr), 7.26-7.18 (m, 2H, CHAr), 7.08 (t, J = 7.8 Hz, 1H, CHAr), 6.86 (s, 1H, 
N-CH-C), 6.04-5.93 (m, 1H, CH2=CH-CH), 5.19-5.08 (m, 2H, CH2=CH), 
4.21-4.12 (m, 4H, CO2-CH2-CH3), 3.73 (s, 3H, N-CH3), 3.61 (q, J = 15.6, 7.8 Hz, 1H, CH2=CH-CH), 
3.48-3.37 (m, 1H, CH2-CH-(CO2Et)2), 2.55-2.45 (m, 1H, CH-CH2-CH), 2.38-2.28 (m, 1H, CH-CH2-
CH), 1.26-1.20 (m, 6H, CO2-CH2-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ 169.74 (C=O), 169.66 
(C=O), 140.6 (CH2=CH-CH), 137.3 (CAr), 126.1 (CAr), 125.9 (N-CH=C), 121.8 (CHAr), 119.7 (CHAr), 
118.9 (CHAr), 115.9 (CAr), 115.2 (CH2=CH), 109.4 (CHAr), 61.4 (CO2-CH2-CH3), 50.4 (CH-(CO2Et)), 
39.2 (CH2=CH-CH), 33.7 (CH-CH2-CH), 32.8 (N-CH3), 14.2 (CO2-CH2-CH3) ppm. HRMS (ESI): 
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calcd for C20H25NO4Na [M + Na]+ 366.1681, found 366.1667. IR (ATR, cm-1): ṽ = 2980 (w), 1727 
(s), 1473 (m), 1370 (m), 1261 (m), 1225 (m), 1175 (m), 1152 (m), 1028 (m), 916 (w), 860 (w), 739 
(s). 
 
Dimethyl (E)-2-(4-(4-methoxyphenyl)but-2-en-1-yl)malonate (395a) 
Pale yellow oil (31.7 mg, 29% yield) as a mixture of 
linear:branched isomers. Rf: 0.32 in 25:75 EtOAc:n-hexanes. 
Linear isomer: 1H NMR (CDCl3, 500 MHz): δ 7.09 (d, J = 
8.5 Hz, 2H, CHAr), 6.82 (d, J = 8.5 Hz, 2H, CHAr), 5.73-5.63 
(m, 1H, Ar-CH2-CH=CH), 5.47-5.40 (m, 1H, CH=CH-CH2-CH), 3.81 (s, 3H, Ar-O-CH3), 3.70 (s, 6H, 
CO2-CH3), 3.44 (t, J = 7.5 Hz, 1H, CH2-CH-(CO2Me)2), 3.25 (d, J = 7.0 Hz, 2H, Ar-CH2-CH=CH), 
2.62 (t, J = 7.0 Hz, 2H, CH-CH2-CH) ppm. 13C NMR (125 MHz, CDCl3): δ 169.5 (C=O), 158.1 
(CAr), 141.0 (CAr), 133.1 (Ar-CH2-CH=CH), 129.5 (CHAr), 126.5 (CH=CH-CH2-CH), 114.0 (CHAr), 
55.42 (CO2CH3), 55.40 (CO2CH3), 52.5 (CH2CH-(CO2Me)2), 52.0 (Ar-OCH3), 38.1 (Ar-CH2-CH), 
31.9 (CH=CH-CH2-CH) ppm. HRMS (ESI): calcd for C16H20O5Na [M + Na]+ 315.1208, found 
315.1208. IR (neat): 2953, 1751, 1734, 1511, 1436, 1242, 1197, 1176, 1151, 1032, 972, 813 cm-1. 
 
Diethyl (E)-2-(2-(4-methoxyphenyl)-4-phenylbut-3-en-1-yl)malonate (397b) 
Coloulress oil (36.7 mg, 54% yield) as a mixture of linear:branched 
isomers. Rf: 0.31 in 20:80 EtOAc:n-hexanes. Branched isomer: 1H NMR 
(500 MHz, CDCl3): δ 7.33 (d, J = 7.5 Hz, 2H, CHAr), 7.27 (t,  J = 7.5 Hz, 
2H, CHAr), 7.20-7.16 (m, 1H, CHAr), 7.17 (d, J = 8.5 Hz, 2H, CHAr),  6.86 
(d, J = 8.5 Hz, 2H, CHAr), 6.40 (d, J = 16.0 Hz, 1H, Ph-CH=CH-CH), 
6.28-6.24 (m, 1H, Ph-CH=CH), 4.18-4.10 (m, 4H, CO2-CH2-CH3), 3.78 (s, 3H, O-CH3), 3.45-3.39 
(m, 1H, Ar-CH-CH2), 3.34 (t, J = 7.5 Hz, 1H, CH2-CH-(CO2Et)2), 2.45-2.32 (m, 2H, CH-CH2-CH), 
1.29-1.19 (m, 6H, CO2-CH2-CH3) ppm. 13C NMR (75 MHz, CDCl3): δ 169.6 (C=O), 169.5 (C=O), 
158.5 (CAr), 137.2 (CAr), 134.9 (CAr), 132.7 (Ph-CH=CH-CH), 130.3 (Ph-CH=CH-CH), 128.7 (CHAr), 
128.6 (CHAr), 127.4 (CHAr), 126.3 (CHAr), 114.2 (CHAr), 61.5 (CO2CH2CH3), 55.4 (Ar-OCH3), 50.3 
(CH2-CH-(CO2Et)2), 46.2 (Ar-CH-CH2), 34.8 (CH-CH2-CH), 14.2 (CO2CH2CH3) ppm. HRMS (ESI): 
calcd for C24H28O5Na [M + Na]+ 419.1834, found 419.1834. IR (neat) 2981, 1727, 1510, 1448, 1246, 
1177, 1150, 1031, 829, 746, 694 cm-1.  
 
(E)-N-(4-(4-Methoxyphenyl)but-2-en-1-yl)-4-methylbenzenesulfonamide (398a) 
Colourless oil (37.2 mg, 36% yield) as a mixture of linear:branched 
isomers (71:29) Rf: 0.28 in 30:70 EtOAc:n-hexanes. Linear 
Isomer: 1H NMR (500 MHz, CDCl3): δ 7.73 (d, J = 8.0 Hz, 2H, 
CHAr Tosyl), 7.28 (d, J = 7.8 Hz, 2H, CHAr Tosyl), 6.99 (d, J = 8.3 Hz, 2H, CHAr), 6.80 (d, J = 8.3 Hz, 2H, 
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CHAr),  5.69 (dt, J = 14.1, 6.6 Hz, 1H, Ar-CH2-CH=CH), 5.36 (dt, J = 15.1, 6.2 Hz, 1H, CH=CH-
CH2NH), 5.15-4.97 (m, 1H, NH), 3.78 (s, 3H, Ar-OCH3), 3.54 (t, J = 6.4 Hz, 2H, CH2, CH-CH2-NH), 
3.21 (d, J = 6.8 Hz, 2H, Ar-CH2-CH), 2.42 (s, 3H, CH3 Tosyl) ppm.  13C NMR (125 MHz, CDCl3): δ 
143.5 (CAr), 134.0 (Ar-CH2-CH=CH), 133.2 (CAr), 131.7 (CAr), 129.8 (CHAr), 129.6 (CHAr), 127.3 
(CHAr), 125.7 (CH=CH-CH2-NH), 120.6 (CAr), 114.1 (CHAr), 55.4 (ArOCH3), 45.3 (CH=CH-CH2-
NH), 37.7 (Ar-CH2-CH=CH), 21.6 (CH3 Tosyl) ppm. HRMS (ESI): calcd for C18H21NO3SNa [M + 
Na]+ 354.1140, found 354.1140. IR (neat): 3300 (w), 2950 (s), 1604 (m), 1251 (s), 1041 (s) cm-1. 
 
  
	 243 
Cyclodimer: 
 
(cis)-2,5-Diphenyl-1,4-ditosylpiperazine (404) 
Colourless oil (21.2 mg, 10% yield). Rf: 0.25 in 30:70 EtOAc:n-hexanes. 1H NMR 
(500 MHz, CDCl3): δ 7.51 (d, J = 8.1 Hz, 2H, CHAr Tosyl), 7.34 (d, J = 8.0 Hz, 2H, 
CHAr Tosyl), 7.31-7.26 (m, 3H, CHAr), 7.26-7.19 (m, 7H, CHAr), 7.16 (d, J = 7.9 Hz, 
2H, CHAr Tosyl), 7.06-6.97 (m, 2H, CHAr), 5.87 (dd, J = 7.5, 3.9 Hz, 1H, Ph-CH-
CH2), 4.22 (dd, J = 9.7, 6.9 Hz, 1H, Ph-CH-CH2), 3.81 (dd, J = 12.8, 7.0 Hz, 1H, CH-CH2-NTs), 3.37 
(dd, J = 13.8, 3.9 Hz, 1H, CH-CH2-NTs), 3.19 (dd, J = 13.8, 7.4 Hz, 1H, CH-CH2-NTs), 3.03 (dd, J = 
12.8, 9.8 Hz, 1H, CH-CH2-NTs), 2.42 (s, 3H, CH3 Tosyl), 2.40 (s, 3H, CH3 Tosyl) ppm. 13C NMR (125 
MHz, CDCl3): δ 144.3 (CAr), 144.2 (CAr), 137.3 (CAr), 135.6 (CAr), 135.1 (CAr), 134.1 (CAr), 130.7 
(CHAr), 129.9 (CHAr), 129.7 (CHAr), 128.6 (CHAr), 128.5 (CHAr), 128.4 (CHAr), 128.3 (CHAr), 127.8 
(CHAr), 127.2 (CHAr), 127.1 (CHAr), 76.9 (Ph-CH-CH2), 63.6 (Ph-CH-CH2), 54.3 (CH-CH2-NTs),43.8 
(CH-CH2-NTs), 21.8 (CH3 Tosyl), 21.7 (CH3 Tosyl) ppm. LRMS found peak at 585 correlating to [M + 
K]+. IR (neat): 2973, 2884, 1344, 1161, 1050 cm-1. 
 
(trans)-2,5-Diphenyl-1,4-ditosylpiperazine (404′) 
Colourless oil. Rf: 0.44 in 30:70 EtOAc:n-hexanes. 1H NMR (500 MHz, 
CDCl3): δ 7.70 (d, J = 8.1 Hz, 4H, CHAr Tosyl), 7.31 (d, J = 8.0 Hz, 4H, CHAr 
Tosyl), 7.15-7.12 (m, 8H, CHAr), 6.92 (dd, J = 6.6, 3.0 Hz, 2H, CHAr), 4.34 (dd, J 
= 10.7, 4.6 Hz, 2H, Ph-CH-CH2), 4.00 (apparent triplet, J = 10.7 Hz, 2H, CH-
CH2-NTs), 3.56 (dd, J = 10.7, 4.6 Hz, 2H, CH-CH2-NTs), 2.44 (s, 6H, CH3 Tosyl) ppm. 13C NMR (125 
MHz, CDCl3): δ 144.2 (CAr), 142.4 (CAr), 133.1 (CAr), 130.0 (CHAr Tosyl), 128.9 (CHAr), 127.9 (CHAr 
Tosyl), 127.3 (CHAr), 125.4 (CHAr), 57.0 (CH-CH2-NTs), 49.0 (Ph-CH-CH2), 21.7 (CH3 Tosyl) ppm. 
HRMS (ESI): calcd for C30H30N2O4S2Na [M + Na]+ 569.1545, found 569.1500. IR (neat): 2973, 
2884, 1344, 1161, 1050 cm-1.  
N
N
Ts
Ts
Ph
Ph
N
N
Ts
Ts
Ph
Ph
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5.0: Supplementary Information 
 
Copies of 1H and 13C NMR spectra for new compounds. 
 
  
 247 
2-((3,5-Dinitrobenzyl)oxy)benzaldehyde (262d) 
 
  
 248 
5-Chloro-2-((3,5-dinitrobenzyl)oxy)benzaldehyde (262e) 
 
 
  
 249 
5-Bromo-2-((3,5-dinitrobenzyl)oxy)benzaldehyde (262f) 
 
  
 250 
2-((3,5-Dinitrobenzyl)oxy)-5-nitrobenzaldehyde (262g) 
 
  
 251 
2-((3,5-Dinitrobenzyl)oxy)-5-methylbenzaldehyde (262h) 
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 252 
2-((3,5-Dinitrobenzyl)oxy)-5-methoxybenzaldehyde (262i) 
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 253 
2-((3,5-Bis(trifluoromethyl)benzyl)oxy)benzaldehyde (262k) 
 
 
  
 254 
N-(4-fluoro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277b)  
 
  
 255 
N-(3-chloro-2-(hydroxymethyl)phenyl)-4-methylbenzenesulfonamide (277c) 
 
  
 256 
N-(4-fluoro-2-formylphenyl)-4-methylbenzenesulfonamide (278b) 
 
  
 257 
N-(6-chloro-2-formylphenyl)-4-methylbenzenesulfonamide (278f) 
 
  
 258 
N-(4-bromo-2-formylphenyl)-4-methylbenzenesulfonamide (278g) 
 
  
 259 
N-(3,5-Dinitrobenzyl)-N-(2-formylphenyl)-4-methylbenzenesulfonamide (280a) 
 
 
  
 260 
N-(3,5-dinitrobenzyl)-N-(4-fluoro-2-formylphenyl)-4-methylbenzenesulfonamide (280b) 
 
 
  
 261 
N-(3-chloro-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280c) 
 
  
 262 
N-(4-chloro-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280d) 
 
  
 263 
N-(5-chloro-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280e) 
 
  
 264 
N-(2-chloro-6-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280f) 
 
 
  
 265 
N-(4-bromo-2-formylphenyl)-N-(3,5-dinitrobenzyl)-4-methylbenzenesulfonamide (280g) 
 
 
  
 266 
N-(3,5-dinitrobenzyl)-N-(2-formyl-4-methylphenyl)-4-methylbenzenesulfonamide (280h) 
 
 
  
 267 
N-(3,5-dinitrobenzyl)-N-(2-formyl-4-methoxyphenyl)-4-methylbenzenesulfonamide (280i) 
 
 
 
 
 268 
10-Methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265d) 
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 270 
10-Benzyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (267d) 
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 272 
8-chloro-10-methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265e) 
  
 273 
8-bromo-10-methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265f) 
 
 
  
 274 
10-methyl-2,8-dinitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265g) 
 
 
  
 275 
8,10-dimethyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265h) 
 
 
  
 276 
8-methoxy-10-methyl-2-nitro-4,9b,10,11-tetrahydrobenzo[6,7]oxepino[5,4,3-cd]isoindole (265i) 
 
  
 277 
2-Nitro-4,9b,11,12,13,13a-hexahydrobenzo[6,7]oxepino[5,4,3-cd]pyrrolo[2,1-a]isoindole (272) 
 
 
  
 278 
10-methyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole (281) 
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 280 
10-benzyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole (282a) 
 
 
  
 281 
 
 
  
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
f2 (ppm)
-1
0
1
2
3
4
5
6
7
8
9
10
f1
 (
p
p
m
)
13dr19A_cosy
{7.43,7.82}
{7.34,7.75}
{7.80,7.41} {2.48,7.35}{7.75,7.35}
{4.43,5.56}
{3.78,5.39}
{5.54,4.41} {3.78,4.35}
{3.56,4.27}
{4.36,3.77}{5.39,3.75}
{4.28,3.55}
{7.34,2.48}
-1.0-0.50.00.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.09.510.0
f2 (ppm)
0
10
20
30
40
50
60
70
80
90
100
110
120
130
140
150
f1
 (
p
p
m
)
13dr19A_hsqc
{7.34,129.91}
{7.42,128.80}
{7.16,128.57}
{7.52,128.32}
{7.85,120.41}
{7.84,116.18}
{5.39,67.56}
{4.25,59.09} {3.56,59.02}
{3.78,57.70}{4.38,57.70}
{5.58,50.63} {4.43,50.61}
{2.48,21.61}
 282 
 
10-benzyl-8-fluoro-2-nitro-5-tosyl-5,10-dihydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole (282b′) 
 
 
  
 283 
10-benzyl-8-chloro-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282d) 
 
 
  
 284 
10-benzyl-7-chloro-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282e) 
 
 
  
 285 
10-benzyl-6-chloro-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282f) 
 
 
  
 286 
10-benzyl-8-bromo-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282g) 
 
 
  
 287 
10-benzyl-8-methyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282h) 
 
 
  
 288 
10-benzyl-8-methoxy-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (282i) 
 
 
  
 289 
10,11-dimethyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-cd]isoindole 
(284) 
 
 
  
 290 
11-benzyl-10-methyl-2-nitro-5-tosyl-5,9b,10,11-tetrahydro-4H-benzo[6,7]azepino[5,4,3-
cd]isoindole (285) 
 
 
  
 291 
3-Benzyl-1-methyl-7-nitro-1,2,3,4-tetrahydro-5H-benzo[d][1,3]diazepin-5-one (291a) 
 
 
  
 292 
3-Benzyl-1-methyl-8-nitro-1,2,3,4-tetrahydro-5H-benzo[d][1,3]diazepin-5-one (291b) 
 
  
 293 
7-Chloro-1-tosyl-1H-indole (307k) 
 
 
  
 294 
Methyl 1-tosyl-1H-indole-4-carboxylate (307m) 
 
 
  
 295 
Methyl 1-tosyl-1H-indole-5-carboxylate (307n) 
 
 
  
 296 
Methyl 1-tosyl-1H-indole-7-carboxylate (307o) 
 
 
  
 297 
Methyl 1-tosyl-1H-indole-3-carboxylate (307w) 
 
 
 
 
 298 
3-Nitro-1-((4-nitrophenyl)sulfonyl)-1H-indole (308b) 
 
 
  
 299 
3-Nitro-1H-indole-1-carboxylate (308e) 
 
 
  
 300 
Ethyl 3-nitro-1H-indole-1-carboxylate (308f) 
 
 
  
 301 
tert-Butyl 3-nitro-1H-indole-1-carboxylate (308g) 
 
 
  
 302 
5-Chloro-3-nitro-1-tosyl-1H-indole (308i) 
 
 
  
 303 
6-Chloro-3-nitro-1-tosyl-1H-indole (308j) 
 
 
  
 304 
7-Chloro-3-nitro-1-tosyl-1H-indole (308k) 
 
 
  
 305 
Methyl 3-nitro-1-tosyl-1H-indole-4-carboxylate (308m) 
 
 
  
 306 
Methyl 3-nitro-1-tosyl-1H-indole-5-carboxylate (308n) 
 
 
  
 307 
Methyl 3-nitro-1-tosyl-1H-indole-7-carboxylate (308o) 
 
 
  
 308 
3-Nitro-1-tosyl-1H-indole-5-carbonitrile (308p) 
 
 
  
 309 
3,5-Dinitro-1-tosyl-1H-indole (308q) 
 
 
  
 310 
4-Methyl-3-nitro-1-tosyl-1H-indole (308r) 
 
 
  
 311 
5-Methyl-3-nitro-1-tosyl-1H-indole (308s) 
 
 
  
 312 
5-Methoxy-3-nitro-1-tosyl-1H-indole (308t) 
 
 
  
 313 
trans-3a-Nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313a) 
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 315 
cis-3a-Nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313a′) 
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 317 
3a-Nitro-8-((4-nitrophenyl)sulfonyl)-1-tosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole 
(313b) 
 
 
  
 318 
Methyl-3a-nitro-1-tosyl-3-vinyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate 
(313e) 
 
 
  
 319 
Ethyl-3a-nitro-1-tosyl-3-vinyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate 
(313f) 
 
 
  
 320 
tert-Butyl 3a-nitro-1-tosyl-3-vinyl-2,3,3a,8a-tetrahydropyrrolo[2,3-b]indole-8(1H)-carboxylate 
(313g) 
 
 
  
 321 
5-Chloro-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313i) 
 
 
  
 322 
6-Chloro-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313j) 
 
 
  
 323 
7-Chloro-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313k) 
 
 
 
 
  
 324 
5-Bromo-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313l) 
 
 
  
 325 
Methyl 3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-5-carboxylate 
(313n) 
 
 
  
 326 
Methyl 3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-7-carboxylate 
(313o) 
 
 
  
 327 
3a-Nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-5-carbonitrile (313p) 
 
 
  
 328 
3a,5-Dinitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313q) 
 
 
 
  
 329 
5-Methyl-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313s) 
 
 
  
 330 
trans-4-Methyl-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313r) 
 
 
 
  
 331 
cis-4-Methyl-3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (313r′) 
 
 
  
 332 
cis-Methyl 3a-nitro-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-4-
carboxylate (313m′) 
 
 
  
 333 
(3S,3aS,8aS)-1,8-ditosyl-3-vinyl-2,3,8,8a-tetrahydropyrrolo[2,3-b]indol-3a(1H)-amine (315) 
 
 
  
 334 
(3R)-1,8-ditosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (316) 
 
 
  
 335 
(E)-3a-Nitro-3-styryl-1,8-ditosyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (318) 
 
 
  
 336 
(3S,3aS,8aR)-3a-Nitro-1-tosyl-3-vinyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole (319) 
 
 
 
  
 337 
Dimethyl 2-(2-methoxybut-3-en-1-yl)malonate (394) 
 
 
 
 338 
Diethyl 2-(2-ethoxybut-3-en-1-yl)malonate (378)  
 
  
 339 
Diethyl (E)-2-(4-(o-tolyl)but-2-en-1-yl)malonate & Diethyl (E)-2-(4-(p-tolyl)but-2-en-1-yl)malonate 
(377) 
 
 
 340 
 
Diethyl-2-(4-(4-methoxyphenyl)but-2-en-1-yl)malonate (381a) 
 
 
 341 
Diethyl (E)-2-(4-(2,4,6-trimethoxyphenyl)but-2-en-1-yl)malonate & diethyl 2-(2-(2,4,6-
trimethoxyphenyl)but-3-en-1-yl)malonate (387) 
 
 
 342 
Diethyl 2-(2-(1-methyl-1H-indol-3-yl)but-3-en-1-yl)malonate  (390b) 
 
 
  
 343 
Dimethyl (E)-2-(4-(4-methoxyphenyl)but-2-en-1-yl)malonate (395a) 
 
 
  
 344 
Diethyl (E)-2-(2-(4-methoxyphenyl)-4-phenylbut-3-en-1-yl)malonate (397b) 
 
 
 
 345 
(E)-N-(4-(4-Methoxyphenyl)but-2-en-1-yl)-4-methylbenzenesulfonamide (398a) 
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(cis)-2,5-Diphenyl-1,4-ditosylpiperazine (404) 
 
 
  
 347 
(trans)-2,5-Diphenyl-1,4-ditosylpiperazine (404′) 
 
 
 
 
 348 
6.0: Publications 
 
 
The Diastereoselective Synthesis of Pyrroloindolines by Pd-Catalyzed
Dearomative Cycloaddition of 1-Tosyl-2-vinylaziridine to
3‑Nitroindoles
Daniel J. Rivinoja,†,‡ Yi Sing Gee,†,‡ Michael G. Gardiner,# John H. Ryan,*,§
and Christopher J. T. Hyland*,†
†School of Chemistry, University of Wollongong, Wollongong, New South Wales 2522, Australia
#School of Physical Sciences - Chemistry, University of Tasmania, Hobart, Tasmania 7001, Australia
§CSIRO Manufacturing Flagship, Ian Wark Laboratory, Bayview Avenue, Clayton, Victoria 3168, Australia
*S Supporting Information
ABSTRACT: An efficient, diastereoselective synthesis of
densely functionalized pyrroloindolines is reported. The
reaction proceeds via cycloaddition of a vinylaziridine-derived
Pd-stabilized 1,3-dipole to electron-deficient 3-nitroindoles.
The reactions give the trans diastereoisomer with high
selectivity; however, when a 4-substituent is present on the
indole ring, a reversal of diastereoselectivity is observed.
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ABSTRACT: A trans-diastereoselective Pd-catalyzed dearomative [3 + 2] cycloaddition between vinylcyclopropane
dicarboxylates and 3-nitroindoles has been developed. The reaction provides densely functionalized cyclopenta[b]indolines
with versatile vinyl and nitro-groups. The addition of a halide additive was found to be critical for the diastereoselectivity of the
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with a 4-substituted 3-nitroindole.
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A study of the reactivity of a non-stabilised azomethine ylide, derived fromN-(methoxymethyl)-N-(trimethylsilylmethyl)
benzylamine, with nitro-substituted isatoic anhydrides was undertaken. N-Methyl-4-nitroisatoic anhydride underwent a
1,3-dipolar cycloaddition reaction exclusively at the isatoic anhydride C1-carbonyl group, followed by decarboxylative
rearrangement to yield a benzo-1,3-diazepin-5-one derivative. In contrast, N-methyl-5-nitroisatoic anhydride underwent
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